0001136261-15-000329.txt : 20151116 0001136261-15-000329.hdr.sgml : 20151116 20151116162948 ACCESSION NUMBER: 0001136261-15-000329 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151116 DATE AS OF CHANGE: 20151116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MMRGlobal, Inc. CENTRAL INDEX KEY: 0001285701 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 330892797 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-51134 FILM NUMBER: 151235505 BUSINESS ADDRESS: STREET 1: 4401 WILSHIRE BLVD. STREET 2: SUITE 200 CITY: LOS ANGELES STATE: CA ZIP: 90010 BUSINESS PHONE: 310 476 7002 MAIL ADDRESS: STREET 1: 4401 WILSHIRE BLVD. STREET 2: SUITE 200 CITY: LOS ANGELES STATE: CA ZIP: 90010 FORMER COMPANY: FORMER CONFORMED NAME: MMR Information Systems, Inc. DATE OF NAME CHANGE: 20090401 FORMER COMPANY: FORMER CONFORMED NAME: FAVRILLE INC DATE OF NAME CHANGE: 20040401 10-Q 1 form10q.htm 10-Q Q3 2015 DOC


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 10-Q

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

   

SECURITIES EXCHANGE ACT OF 1934

     
   

For the quarterly period ended September 30, 2015

     
   

OR

     

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

   

SECURITIES EXCHANGE ACT OF 1934

     
   

For the transition period from ______________ to ________________

Commission file number: 000-51134

MMRGLOBAL, INC.
(Exact name of Registrant as Specified in Its Charter)

DELAWARE

 

33-0892797

(State or Other Jurisdiction of
Incorporation or Organization)

 

(I.R.S. Employer
Identification No.)

     

4401 WILSHIRE BLVD., SUITE 200
LOS ANGELES, CA

 

90010

(Address of Principal Executive Offices)

 

(Zip Code)

(310) 476-7002
(Registrant's Telephone Number, Including Area Code)

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

                  Yes x       No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

                  Yes x       No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.    

Large accelerated filer o             Accelerated filer o    
Non-accelerated filer o (Do not check if a smaller reporting company)             Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).                   Yes o       No x

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: As of November 12, 2015, the issuer had 1,059,255,881 shares of common stock outstanding.



TABLE OF CONTENTS

                          Page
Part I.   FINANCIAL INFORMATION                     1
                           
Item 1.   Condensed Consolidated Financial Statements - Unaudited                     1
                           
    Condensed Consolidated Balance Sheets at September 30, 2015 (unaudited) and December 31, 2014 (audited)                     1
                           
    Condensed Consolidated Statements of Operations - Three and Nine Months Ended September 30, 2015 and September 30, 2014 - (unaudited)                     2
                           
    Condensed Consolidated Statements of Cash Flows - Nine Months Ended September 30, 2015 and September 30, 2014 - (unaudited)                     3
                           
    Notes to Condensed Consolidated Financial Statements - Unaudited                     4
                           
Item 2.   Management's Discussion and Analysis of Financial Condition and Results of Operations                     18
                           
Item 3.   Quantitative and Qualitative Disclosures About Market Risk                     22
                           
Item 4.   Controls and Procedures                     22
                           
Part II.   OTHER INFORMATION                     23
                           
Item 1.     Legal Proceedings                     23
                           
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds                     23
                           
Item 3.   Defaults Upon Senior Securities                     24
                           
Item 4.   Mine Safety Disclosures                     24
                           
Item 5.   Other Information                     24
                           
Item 6.   Exhibits                     25
                           
Signatures                         26

i


PART I - FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements - Unaudited

MMRGLOBAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

      September 30,     December 31,
      2015     2014
      (unaudited)     (audited)
             
ASSETS
             
Current assets:            
     Cash and cash equivalents   $   $ 309,393 
     Accounts receivable, less allowances of $173,591 in 2015 and 2014     96,829      47,718 
     Inventory     13,537      13,537 
     Prepaid expenses and other current assets     47,885      162,184 
          Total current assets     158,251      532,832 
             
Property and equipment, net      22,645      32,118 
Intangible assets, net     1,757,109      1,790,622 
          Total assets   $ 1,938,005    $ 2,355,572 
             
LIABILITIES AND STOCKHOLDERS' DEFICIT
             
Current liabilities:            
     Line of credit, related party   $ 990,723    $ 753,704 
     Related party payables     1,472,150      952,835 
     Compensation payable     594,034      491,109 
     Severance liability     620,613      620,613 
     Accounts payable and accrued expenses     4,891,497      4,668,960 
     Deferred revenue     40,262      51,312 
     Convertible notes payable     887,027      932,047 
     Notes payable, current portion     369,410      360,343 
     Notes payable, related party     253,664      253,664 
     Capital leases payable, current portion     13,221      13,221 
          Total current liabilities     10,132,601      9,097,808 
             
Commitments and contingencies (See Note 9)            
             
Stockholders' deficit:            
     Preferred stock - $0.001 par value, 5,000,000 shares authorized, 0 issued and outstanding.             
     Common stock, $0.001 par value, 1,250,000,000 shares authorized, 902,504,231 and 774,417,739 shares issued
          and outstanding as of September 30, 2015 and December 31, 2014, respectively
    902,298      774,211 
     Additional paid-in capital     56,780,651      56,437,812 
     Accumulated deficit     (65,877,545)     (63,954,259)
          Total stockholders' deficit     (8,194,596)     (6,742,236)
          Total liabilities and stockholders' deficit   $ 1,938,005    $ 2,355,572 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

1


MMRGLOBAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

      Three Months Ended   Nine Months Ended
      September 30,   September 30,
      2015     2014   2015     2014
                       
Revenues                      
Subscriber   $ 68,996    $ 50,863  $ 116,248    $ 109,581 
MMRPro     2,899      17,408    7,219      29,476 
License fees     5,769      1,828,000    15,249      2,290,538 
Other income               7,500 
     Total revenues     77,664      1,896,271    138,716      2,437,095 
Cost of revenues     45,298      88,960    179,554      230,402 
     Gross profit     32,366      1,807,311    (40,838)     2,206,693 
General and administrative expenses     383,147      1,186,972    1,331,644      3,530,193 
Sales and marketing expenses     102,504      261,553    420,199      1,087,943 
Technology development         7,254        57,890 
     (Loss) income from operations     (453,285)     351,532    (1,792,681)     (2,469,333)
Other income     8,914      1,672,820    60,750      1,672,820 
Interest and other finance charges, net     (44,629)     (104,031)   (191,355)     (362,678)
Net (loss) income   $ (489,000)   $ 1,920,321  $ (1,923,286)   $ (1,159,191)
                       
                       
Net (loss) income available to common shareholders per share:                      
Basic and diluted   $ (0.00)   $ 0.00  $ (0.00)   $ (0.00)
                       
Weighted average common shares outstanding:                      
Basic     893,373,796      754,463,150    830,417,188      731,355,958 
Diluted     893,373,796      756,876,594    830,417,188      731,355,958 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

2


MMRGLOBAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

      Nine Months Ended September 30,
      2015     2014
             
Operating activities:            
Net loss   $ (1,923,286)   $ (1,159,191)
Adjustments to reconcile net loss to net cash             
     (used in) provided by operating activities:            
          Depreciation and amortization     217,208      227,488 
          Accounts payable write-off     -       (1,672,820)
          Deferred rent     -       54,151 
          Warrants issued for services     11,170      144,232 
          Stock-based compensation     16,759      582,485 
          Common stock issued for services     38,199      293,422 
          Amortization of loan discount     55,780      176,262 
               Subtotal - Non-cash adjustments     339,116      (194,780)
Effect of changes in:            
          Accounts receivable     (49,110)     36,626 
          Inventory     -       (13,643)
          Prepaid expenses and other current assets     114,744      923 
          Accounts payable and accrued expenses     258,667      1,200,171 
          Related party payables     519,315      279,885 
          Compensation payable      102,925      77,861 
          Deferred revenue     (11,050)     (1,470)
               Subtotal - net change in operating assets & liabilities     935,491      1,580,353 
               Net cash (used in) provided by operating activities     (648,679)     226,382 
             
Investing activities:            
     Purchase of property and equpment     (1,252)     -  
     Filing of patents     -       (246,868)
     Costs of continuing MMRPro and website development         (53,627)
               Net cash used in investing activities     (1,252)     (300,495)
             
Financing activities:            
     Net proceeds from convertible notes     -       200,000 
     Proceeds from shares issued for financing activities     29,774      1,419,561 
     Book overdraft     56,163     
     Net proceeds from warrant exercises     -       42,000 
     Proceeds from note payable     30,000      88,134 
     Payments of note payable     (30,000)     (50,000)
     Proceeds on line of credit     254,601     
     Payments of line of credit     -       (140,794)
     Payments of capital lease     -       (3,637)
               Net cash provided by financing activities     340,538      1,555,264 
Net (decrease) increase in cash     (309,393)     1,481,151 
Cash, beginning of period     309,393      10,359 
Cash, end of period   $   $ 1,491,510 
             
Supplemental disclosures of cash flow information:            
     Cash paid for interest   $   $ 140,794 
     Cash paid for income taxes   $   $ 1,600 
Supplemental disclosure of non-cash investing and financing activities:            
     Conversion of convertible notes into common stock   $ 100,800    $ 190,000 
     Shares issued for reduction of payables   $ 299,420    $ 196,812 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

3


MMRGLOBAL, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
September 30, 2015

NOTE 1 - NATURE OF OPERATIONS AND BASIS OF PRESENTATION

MMRGlobal Inc. (referred to herein, unless otherwise indicated, as "MMR," the "Company," the "issuer," "we," "us," and "our") was originally incorporated as Favrille, Inc. ("Favrille") in Delaware in 2000, and since its inception and before the Merger (as defined below), operated as a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. In May 2008, Favrille's ongoing Phase 3 registration trial for the FavId vaccine failed to show a statistically significant improvement in the treatment of patients with follicular B-cell Non-Hodgkin's lymphoma. On January 27, 2009, the Company, through MyMedicalRecords, Inc. ("MMR Inc."), what is now our wholly-owned operating subsidiary, conducted a reverse merger with Favrille.

Through our wholly-owned operating subsidiary MMR Inc., the Company's primary business is to license and provide secure and easy-to-use online Personal Health Records ("PHRs") and MyEsafeDepositBox storage solutions, including a professional offering to physicians' offices and similar organizations known as MMRPro. In January 2009, as a result of the Merger, we acquired biotech assets and other intellectual property including anti-CD20 antibodies as well as data and samples from the FavId/Specifid vaccine clinical trials for the treatment of B-cell Non-Hodgkin's lymphoma.

On March 8, 2011, we formed a subsidiary, which we named MMR Life Sciences Group, Inc., exclusively to maximize the value of our biotech assets including our patents, anti-CD20 antibodies, and FavId vaccine technologies acquired by MyMedicalRecords, Inc. through the merger with Favrille. As of this date the assets have not been transferred to the subsidiary.

We (formerly Favrille) were incorporated in Delaware in 2000, MMR Inc. was incorporated in Delaware in 2005, and both are headquartered in Los Angeles, CA.

Principles of Consolidation

The consolidated financial statements include the accounts of MMRGlobal, and its wholly-owned subsidiaries MMR and MMR Life Sciences Group, Inc. All intercompany transactions and balances are eliminated upon consolidation.

Basis of Presentation

We have prepared the accompanying consolidated unaudited financial statements in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial statements and with instructions to Form 10-Q pursuant to the rules and regulations of Securities and Exchange Act of 1934, as amended, or the Exchange Act and Article 8-03 of Regulation S-X promulgated under the Exchange Act. Accordingly, these financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of our management, we have included all adjustments considered necessary (consisting of normal recurring adjustments) for a fair presentation. Operating results for the nine months ended September 30, 2015 are not indicative of the results that may be expected for the fiscal year ending December 31, 2015. You should read these unaudited condensed consolidated financial statements in conjunction with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014.

Going Concern and Management's Plan

As of September 30, 2015, our current liabilities exceeded our current assets by $9.97 million. Furthermore, during the nine months ended September 30, 2015, we incurred losses of $1,923,286, as further explained in Management's Discussion and Analysis of Financial Condition and Results of Operations appearing in Item 2 of Part I of this Quarterly Report on Form 10-Q.

4


At September 30, 2015 and December 31, 2014, we had $0 and $303,393, respectively, in cash and cash equivalents. Historically, we issued capital stock, sold convertible debt and equity securities and received funds from The RHL Group, Inc. (a significant stockholder that is wholly-owned by our Chairman and Chief Executive Officer, Robert H. Lorsch) to operate our business. Although we received additional funding from The RHL Group pursuant to the Tenth Amended and Restated Note effective May 20, 2015 (the "Line of Credit"), we will still be required to obtain additional financing in order to meet installment payment obligations and the previously existing obligations under the Line of Credit, which had a balance of $1.81 million at September 30, 2015 and a total Unpaid Balance (as defined in the Line of Credit) of $2.06 million, which includes amounts borrowed under the Line of Credit, unpaid interest fees, any amounts guaranteed by The RHL Group, and other obligations due the RHL Group pursuant to the terms of the Tenth Amended and Restated Note and the Second Amended Security Agreement dated May 20, 2015 (the "Security Agreement"). As a result of the above, we express uncertainty about our ability to continue as a going concern. The components of the RHL Group Note payable and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million related to other obligations due to The RHL Group which are included in related party payables.

Management's plan regarding our going concern is to continue utilizing the Line of Credit. According to the terms of the agreement, at September 30, 2015, there was approximately $2.37 million available under the Line of Credit at the discretion of the lender. Finally, we plan to sell additional convertible debt and equity securities, settle our existing liabilities through the issuance of equity securities, explore other debt financing arrangements, increase our existing subscriber and affiliate customer base, sell our products and services, and collect licensing fees from parties utilizing our intellectual property to obtain additional cash flow over the next twelve months. There can be no assurance that funds from these sources will be available when needed or, if available, will be on terms favorable to us or to our stockholders. If additional funds are raised by issuing equity securities, the percentage of ownership of our stockholders will be reduced, stockholders will experience additional dilution and/or such equity securities may provide for rights, preferences or privileges senior to those of the holders of our common stock. If we are unable to utilize our Line of Credit, obtain suitable alternative debt or equity financing, or increase sales of our products of increase licensing fees from the use of our intellectual property, our ability to execute our business plan and continue as a going concern may be adversely affected.

These matters raise substantial doubt about our ability to continue as a going concern. These financial statements were prepared under the assumption that we will continue as a going concern and do not include any adjustments that might result from the outcome of that uncertainty.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a) MANAGEMENT'S USE OF ESTIMATES

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, allowances for doubtful accounts, the valuation of deferred income taxes, tax contingencies, long-lived and intangible assets, valuation of derivative liabilities and stock-based compensation. These estimates are based on historical experience and on various other factors that management believes to be reasonable under the circumstances, although actual results could differ from those estimates.

(b) CASH AND CASH EQUIVALENTS

We consider cash equivalents to be only those investments that are highly liquid, readily convertible to cash and with maturities of 90 days or less at the purchase date. We maintain our cash in bank deposit accounts that, at times, may exceed federally insured limits. We have not experienced any losses in such accounts and believe that we are not exposed to any significant credit or deposit risk on our cash. We had cash and cash equivalents of $0 and $303,393 as of September 30, 2015 and December 31, 2014, respectively.

5


(c) TRADE AND OTHER RECEIVABLES

Receivables represent claims against third parties that will be settled in cash. The carrying value of receivables, net of an allowance for doubtful accounts, if any, represents their estimated net realizable value. We estimate the allowance for doubtful accounts, if any, based on historical collection trends, type of customer, the age of outstanding receivables and existing economic conditions. If events or changes in circumstances indicate that specific receivable balances may be impaired, we give further consideration to the collectability of those balances and the allowance is adjusted accordingly. We write off past due receivable balances when collection efforts have been unsuccessful in collecting the amount due.

(d) INVENTORY

Inventory is stated at the actual cost, using the first-in-first-out method. On an on-going basis, we evaluate our inventory for obsolescence. This evaluation includes analysis of sales levels, sales projections, and purchases by item. If future demand or market conditions are different than our current estimates, an inventory adjustment may be required, and would be reflected in cost of goods sold in the period the revision is made.

(e) FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC 820-10, Fair Value Measurements and Disclosures, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. ASC 820-10 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of September 30, 2015 and December 31, 2014, the carrying value of accounts receivable, deposits, related party payables, compensation payable, severance liabilities, and accounts payable and accrued expenses approximates fair value due to the short-term nature of such instruments. The carrying value of short-term debt approximates fair value as the related interest rates approximate rates currently available to us.

We utilize ASC 820-10 for valuing financial assets and liabilities measured on a recurring basis. ASC 820-10 defines fair value, establishes a framework for measuring fair value and generally accepted accounting principles, and expands disclosures about fair value measurements. This standard applies in situations where other accounting pronouncements either permit or require fair value measurements. ASC 820-10 does not require any new fair value measurements.

Accounting guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The standard describes three levels of inputs that may be used to measure fair value:

 

Level 1:

Quoted prices in active markets for identical or similar assets and liabilities.

 

Level 2:

Quoted prices for identical or similar assets and liabilities in markets that are not active or observable inputs other than quoted prices in active markets for identical or similar assets and liabilities.

 

Level 3:

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

(f) IMPAIRMENT OF LONG-LIVED ASSETS AND INTANGIBLES

We account for long-lived assets, which include property and equipment and identifiable intangible assets with finite useful lives (subject to amortization), in accordance with ASC 350-30. ASC 350-30 requires that we review long-lived assets for impairment whenever events or changes in circumstances indicate that we may not recover the carrying amount of an asset. We measure recoverability by comparing the carrying amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an impairment charge to the extent of the difference between the fair value and the asset's carrying amount. We had no impairment charges during the nine months ended September 30, 2015 and 2014.

6


(g) REVENUE RECOGNITION

We generate our revenues from services, which are comprised of providing electronic access to consumer medical records and other vital documents, and from the licensing of our intellectual property and services. We recognize revenue only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed, and we are reasonably assured of collectability of the resulting receivable.

Our subscriber revenues consist of annual and monthly recurring retail subscriptions and usage-based fees, which are primarily paid in advance by credit card, and corporate accounts that are based on either an access-fee or actual number of users, and in each case billed in advance at the beginning of each month of service. We defer the portions of annual recurring subscription fees collected in advance and recognize them on a straight line basis over the subscription period.

We license the rights to use portions of our intellectual property portfolio, which includes certain patent rights essential to the sale of certain PHR products. Licensees typically pay a license fee in one or more installments and ongoing royalties based on their sales of products incorporating or using the Company's licensed intellectual property. License fees are recognized over the estimated period of benefit to the licensee, typically five to fifteen years. The Company earns royalties on such licensed products sold by its licensees at the time that the licensees' sales occur. The Company recognizes royalty revenues based on royalties reported by licensees during the quarter and when other revenue recognition criteria are met.

We grant exclusive and non-exclusive licenses for the sale and marketing of our services in international territories in consideration of license fees and ongoing royalties. The royalty fee is usually a percentage of revenue earned by the licensee and there are usually certain minimum guarantees. We defer the recognition of license fee revenues received in advance from international licensees for the grant of the license and recognize them over the period covered by the agreement. We defer the recognition of minimum guaranteed royalty payments received in advance and recognize them over the period to which the royalty relates. We include all such revenues under "License Fees." In those cases where a license agreement contains multiple deliverables, we account for the agreement in accordance with ASC 605-25 Revenue Recognition - Multiple-Element Arrangements ..

We recognize revenue on sales of our MMRPro system in accordance with ASC 605-25, Revenue Recognition, Multiple-Element Arrangements.

Our multiple-deliverable arrangements consist solely of our MMRPro product. Significant deliverables within these arrangements include scanning equipment, various licenses to use third party software, a license to use our proprietary MMRPro application software, installation and training, dedicated telephone lines, secure online storage and warranties.

We determined all elements to be separate units of accounting as they have standalone value to the customers and/or they are sold by other vendors on a standalone basis. Delivery of the hardware and certain software elements of these arrangements occur at the inception of the agreement. We deliver installation and training at the inception of the agreement. We provide other software licenses, telephone lines and online secure storage over the three year term of the agreement. We include warranties in the arrangements, however the third party product manufacturer, and not us, is obligated to fulfill such warranties. The third-party warranty contracts are paid in advance and are not refundable.

We allocate the revenue derived from these arrangements among all the deliverables. We base such allocation on the relative selling price of each deliverable. With the exception of our proprietary MMRPro application software, we use third party evidence to set the selling prices used for this allocation. In all such cases, third parties sell the same or very similar products. For the MMRPro application software, we estimate the selling price.

We recognize the allocated revenue for each deliverable in accordance with SEC Staff Accounting Bulletin ("SAB") No. 104, Topic 13: Revenue Recognition . Under this guidance, we recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed and determinable and collectability is reasonably assured. This results in us recognizing revenue for the hardware, certain software and the warranties upon delivery to the customer, for the installation and training upon completion of these services, and ratably over the contract period for the software licenses, telephone lines and online secure storage.

7


Revenue from the licensing of our biotech assets may include non-refundable license and up-front fees, non-refundable milestone payments that are triggered upon achievement of a specific event, and future royalties or lump-sum payments on sales of related products. For agreements that provide for milestone payments, we adopted ASC 605-28-25, Revenue Recognition Milestone Method.

(h) SHARE-BASED COMPENSATION

We account for share-based compensation in accordance with ASC 718-20, Awards Classified as Equity. We apply ASC 718- 20 in accounting for stock-based awards issued to employees under the recognition of compensation expense related to the fair value of employee share-based awards, including stock options and restricted stock. Determining the fair value of options at the grant date requires judgment, including estimating the expected term that stock options will be outstanding prior to exercise, the associated volatility and the expected dividends. Judgment is required in estimating the amount of share-based awards expected to be forfeited prior to vesting. If actual forfeitures differ significantly from these estimates, share-based compensation expense could be materially impacted.

We account for options and warrants issued to non-employees in accordance with ASC 505-50, Equity-Based Payments to Non- Employees. We treat options and warrants issued to non-employees the same as those issued to employees with the exception of determination of the measurement date. The measurement date is the earlier of (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty's performance is complete. Options and warrants granted to consultants are valued at their respective measurement dates, and recognized as an expense based on the portion of the total consulting services provided during the applicable period. As further consulting services are provided in future periods, we will revalue the associated options and warrants and recognize additional expense based on their then current values.

We estimate the fair value of each stock option on the date of grant using the Black-Scholes option pricing model. We determine assumptions relative to volatility and anticipated forfeitures at the time of grant. We valued grants of stock options and warrants during the nine months ended September 30, 2015 and 2014 using the following assumptions.

  September 30, 2015   September 30, 2014
Expected life in years 2 - 5 Years   0 - 5 Years
Stock price volatility 120.51% - 122.72%   123.47% - 124.21%
Risk free interest rate 0.04% - 1.38%   0.35% - 0.46%
Expected dividends None   None
Forfeiture rate 0%   0%

We base the assumptions used in the Black-Scholes models upon the following data: (1) our use of the contractual life of the underlying non-employee warrants as the expected life; the expected life of the employee options used in this calculation is the period of time the options are expected to be outstanding and has been determined based on historical exercise experience; (2) in the absence of an extensive public market for our shares, the expected stock price volatility of the underlying shares over the expected term of the option or warrant was taken at approximately the mid-point of the range for similar companies at the various grant dates; (3) we base the risk free interest rate on published U.S. Treasury Department interest rates for the expected terms of the underlying options or warrants; (4) we base expected dividends on historical dividend data and expected future dividend activity; and (5) we base the expected forfeiture rate on historical forfeiture activity and assumptions regarding future forfeitures based on the composition of current grantees.

8


(i) NET INCOME/LOSS PER SHARE

We apply the guidance of ASC 260-10, Earnings Per Share for calculating the basic and diluted loss per share. We calculate basic loss per share by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding. We compute diluted loss per share similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. We exclude common equivalent shares from the computation of net loss per share if their effect is anti-dilutive.

We excluded all potential anti-dilutive common shares from the computation of diluted net loss per common share for the nine months ended September 30, 2015 and 2014 because they were anti-dilutive due to our net loss position.

(j) RECENT ACCOUNTING PRONOUNCEMENTS

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with no early adoption permitted. The standard permits the use of either the retrospective or cumulative effect transition method. At this time we have not selected a transition method. We are currently evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures.

In August 2014, the FABS issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern ("ASU 2014-15"). ASU 2014-15 will explicitly require management to assess an entity's ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. Earlier adoption is permitted. We are currently evaluating the impact of the adoption of ASU 2014-15. The adoption of this standard is not expected to have a material impact on the Company's consolidated financial statements.

NOTE 3 - RELATED PARTY PAYABLES, LINE OF CREDIT AND NOTE PAYABLE

On May 20, 2015, we and The RHL Group entered into a Tenth Amended and Restated Promissory Note (the "Amended Note"), effective as of May 20, 2015. The Tenth Note amends and restates that certain Ninth Amended Note entered into between the foregoing parties, effective July 10, 2014 (the " Existing Note" and together with its predecessor notes and the Amended Note, the "Credit Facility"), by: (i) extending the maturity date to April 29, 2016. In connection with the Tenth Amended Note, we issued The RHL Group warrants to purchase 1,764,642 shares of our common stock at $0.003 per share on May 20, 2015. Except as set forth above, the Amended Note does not materially alter the terms of the Existing Note.

Historically, the predecessor notes have increased over time the maximum amount of credit available under the Credit Facility from $100,000 to $1,000,000 to $3,000,000 to $4,500,000. The maximum amount of the Amended Note is $4,500,000. The Amended Note continues to bear interest at the lesser of 10% or the highest rate then permitted by law, and is secured (similar to the Existing Note) by a Security Agreement, which has been in effect since July 31, 2007, as renewed and amended to date (the "Security Agreement").

The Tenth Amended Note had a current balance of $1.81 million at September 30, 2015. The components of the Tenth Amended Note and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million for other obligations due to The RHL Group, which is included in related party payables.

Total interest expense for the three months ended September 30, 2015 and September 30, 2014 was $36,699 and $36,952, respectively. Total interest expense on the Line of Credit for the nine months ended September 30, 2015 and 2014 amounted to $102,433 and $98,985, respectively. The unpaid interest balances as of September 30, 2015 and December 31, 2014 were $36,757 and $30,160, respectively.

9


In conjunction with the Tenth Amended Note, we were required to maintain certain financial covenants, including the requirement that we have at least $200,000 of cash in our bank accounts or such other amount as necessary to maintain operations through the subsequent thirty (30) days and timely pay any obligations due respecting payroll and all associated payroll taxes on and after September 30, 2015. Since we did not meet these covenants as of September 30, 2015, we received a waiver from The RHL Group until November 30, 2015.

NOTE 4 - INCOME TAXES

Under ASC 740-270, Income Taxes - Interim Reporting, we are required to adjust our effective tax rate each quarter to be consistent with the estimated annual effective tax rate. We are also required to record the tax impact of certain discrete items, unusual or infrequently occurring, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur. In addition, we exclude jurisdictions with a projected loss for the year or a year-to-date loss where we cannot recognize a tax benefit from our estimated annual effective tax rate. The impact of such an exclusion could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings versus annual projections.

Pursuant to ASC 740, Income Taxes, we performed an analysis of previous tax filings and determined that there were no positions taken that it considered uncertain. Therefore, there were no unrecognized tax benefits As of September 30, 2015.

MMR Inc., in its capacity as the operating company taking over our income tax positions in addition to its own positions after January 27, 2009 (see Note 1), has estimated its annual effective tax rate to be zero. MMRGlobal has based this on an expectation that the combined entity will generate net operating losses in 2015, and it is not likely that those losses will be recovered using future taxable income. Therefore, no provision for income tax has been recorded as of and for the nine months ended September 30, 2015.

NOTE 5 - COMMITMENTS AND CONTINGENCIES

Leases

Effective September 1, 2013, we renewed our lease for office space in Los Angeles, California with a term through August 31, 2018. The lease currently requires a monthly payment of $8,250. Total rent expense for the nine months ended September 30, 2015 and 2014 were $86,854 and $129,276 respectively. Future minimum lease payments as of September 30, 2015, under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:

Year Ending     Operating     Capital
December 31,     Leases     Leases
             
     2015 (Remainder of)    $ 26,445    $ 13,221 
     2016      187,550      -  
     2017      206,305      -  
     2018 and there after     146,410      -  
      566,710      13,221 
     Less current portion      -       (13,221)
Total minimum lease payments    $ 566,710    $

Litigation Matters

From time to time, we are involved in various legal proceedings generally incidental to our business. While the result of any litigation contains an element of uncertainty, our management presently believes that the outcome of any known, pending or threatened legal proceeding or claim, individually or combined, will not have a material adverse effect on our financial statements.

10


On December 9, 2011, MyMedicalRecords, Inc. entered into a Non-Exclusive Settlement and Patent License Agreement with Surgery Center Management LLC ("SCM"). In consideration for the rights granted under that Agreement and in consideration of a settlement and release agreement, SCM contracted to pay MyMedicalRecords, Inc. an initial payment of $5 million payable on December 23, 2011, and additional payments of $5 million per year for five consecutive years. After unsuccessful attempts to collect the past due amount of $5 million, on January 19, 2012, MyMedicalRecords, Inc. filed a lawsuit in the Superior Court of the State of California for the County of Los Angeles for breach of contract. At this time, MMR believes that SCM owes the Company $30 million plus interest, and on August 4, 2015, the Court granted MMR leave to amend its complaint to seek damages of $30 million (plus interest) from SCM since the end of 2011. On February 13, 2014, SCM filed an answer to MMR's original complaint along with a cross-complaint alleging claims for breach of that contract, among other things. On July 10, 2014, the court granted SCM's motion for summary adjudication on the claim for breach of contract in the complaint and its counterclaim for declaratory relief. On July 30, 2014, SCM filed its second amended cross-complaint, alleging substantially the same claims against the same parties. On December 5, 2014, the Court of Appeal issued an Alternative Writ of Mandate, finding the trial court erred in granting SCM's motion for summary adjudication. Pursuant to the Court of Appeal's Alternative Writ, on January 7, 2015, the trial court vacated its order granting SCM's motion for summary adjudication. On April 24, 2015, the trial court held a new hearing on that motion, and it entered an order denying SCM's motion in its entirety. MyMedicalRecords, Inc. will continue to pursue its claim and defenses, but the Company cannot predict the chances of either a favorable or unfavorable outcome, nor does the Company have sufficient information regarding its ability to collect any judgment MyMedicalRecords, Inc. may obtain.

On April 10, 2013, MMR filed a complaint for patent infringement against Quest Diagnostics Inc. ("Quest") in the United States District Court for the Central District of California, alleging that Quest Diagnostics Inc. is infringing U.S. Patent No. 8,301,466. On October 11, 2013, MMR filed an unopposed motion to add a claim of infringement of U.S. Patent 8,498,883 to its complaint against Quest, which was granted on October 29, 2013. On December 22 and 23, 2014, the Court entered orders finding that the eight claims asserted (of the 42 total claims present) under the two asserted MMR patents were invalid. On January 9, 2015, as previously reported by the Company, the case was closed. Defendants filed a motion with the District Court to recover a portion of their fees incurred in defense of the matter, which has been denied by the Court in favor of MMR.

On February 11, 2013, MMR filed a complaint for patent infringement against WebMD Health Corp. and its wholly owned subsidiary WebMD Health Services Group, Inc. (collectively, "WebMD"), titled MyMedicalRecords, Inc. v. WebMD Health Corp et al., United States District Court, Central District of California. That complaint alleged that WebMD is infringing MMR's Personal Health Records patent U.S. Patent No. 8,301,466. On October 2, 2013, MMR filed a new complaint against WebMD in the United States District Court for the Central District of California, alleging infringement of U.S. Patent Nos. 8,301,466 and 8,498,883. On December 22 and 23, 2014, the Court entered orders finding that the eight claims asserted (of the 42 total claims present) under the two asserted MMR patents were invalid. On January 9, 2015, as previously reported by the Company, the case was closed. Defendants filed a motion with the District Court to recover a portion of their fees incurred in defense of the matter, which has been denied by the Court in favor of MMR.

On May 17, 2013, MMR filed a complaint for patent infringement against Jardogs, LLC (the "Jardogs Complaint") in the United States District Court for the Central District of California, alleging that Jardogs, LLC infringes U.S. Patent No. 8,301,466. On September 23, 2013, MMR filed a separate complaint for patent infringement against Allscripts Healthcare Solutions Inc. ("Allscripts") titled MyMedicalRecords, Inc. v. Allscripts Healthcare Solutions Inc., United States District Court, Central District of California (the "Separate Allscripts Complaint"). The Separate Allscripts Complaint alleged that Allscripts is infringing U.S. Patent Nos. 8,301,466 and 8,498,883. On October 4, 2013, MMR filed a motion to amend the Jardogs Complaint to add Allscripts as a party defendant and to allege that Allscripts is infringing U.S. Patent Nos. 8,301,466 and 8,498,883. The Court granted that motion on November 1, 2013. Thereafter, MMR dismissed the Separate Allscripts Complaint. On December 22 and 23, 2014, the Court entered orders finding that the eight claims asserted (of the 42 total claims present) under the two asserted MMR patents were invalid. On January 9, 2015, as previously reported by the Company, the case was closed. Defendants filed a motion with the District Court to recover a portion of their fees incurred in defense of the matter, which has been denied by the Court in favor of MMR.

11


Allscripts also filed a Covered Business Method ("CBM") petition on November 3, 2014, before the Patent Trial and Appeal Board ("PTAB') alleging that claims 8-12 of U.S. Patent No. 8,301,466 are invalid. MMR filed a preliminary response on February 20, 2015. On May 5th the PTAB decided to implement the CBM. On January 15, 2015, MMR filed a notice of appeal in the Federal Circuit. Subsequently, MMR filed for voluntary dismissal of the appeal which was granted on July 7, 2015. On July 30, 2015, MMR informed the PTAB of the voluntary dismissal of the appeal, and on August 26, 2015, the PTAB entered a Final Written Decision consistent with the Court's prior rulings.

On April 2, 2015, the Company and Stradling Yocca Carlson & Rauth, P.C. ("SYCR"), received a letter from an arbitrator in regards to disputes over amounts of monies due SYCR regarding prior services rendered. SYCR and the Company agreed to a mediation of the matter. As of the date hereof, the Company cannot predict the chances of either a favorable or unfavorable outcome.

On August 14, 2013, Gemini Master Fund, Ltd. purchased a convertible note from the Company. On or about February 23, 2015, Gemini filed an action against the Company for breach of contract seeking damages allegedly owed pursuant to the convertible note in the amount of $210,000 in the United States District Court for the Southern District of New York. The case has since been settled and dismissed.

NOTE 6 - STOCKHOLDERS' DEFICIT

Preferred Stock

We have 5,000,000 shares of preferred stock authorized. As of September 30, 2015, and December 31, 2014, there were no shares of preferred stock issued and outstanding.

Common Stock

As of September 30, 2015, we are authorized to issue 1,250,000,000 shares of common stock.

As of September 30, 2015, the total shares of our common stock issued and outstanding amounted to 902,504,231.

NOTE 7 - EQUITY ISSUANCES

Stock Option Activity

Our 2001 Equity Incentive Plan (the "2001 Plan") expired on June 5, 2011 and no options were issued under the 2001 Plan since that date. As of September 30, 2015, 14,184,557 shares remain issued under the 2001 Plan.

On September 1, 2011, our Board of Directors approved the adoption of a new plan to replace the 2001 Plan under the same general terms as the 2001 Plan. On June 20, 2012, our stockholders voted and approved the 2011 Equity Incentive Plan (the " 2011 Plan") at our 2012 Annual Stockholder Meeting. As of September 30, 2015, 23.36 million shares remain issued under the 2011 Plan, and 36.45 million shares of our common stock are reserved for future issuance under our 2011 Plan, which includes an automatic 5 million share annual increase pursuant to the terms of the 2011 Plan and a 20 million share increase authorized during our 2013 Annual Stockholder's Meeting.

12


A summary of option activity for the nine months ended September 30, 2015 is presented below. Options granted by MMR Inc. prior to the date of the Merger have been retroactively restated to reflect the conversion ratio of MMR Inc. to MMR shares.

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

Weighted-

 

Remaining

 

 

 

 

 

 

 

 

Average

 

Contractual

 

 

Aggregate

 

 

 

 

 

Exercise

 

Life

 

 

Intrinsic

 

 

Options

 

 

Price

 

(Years)

 

 

Value

Outstanding at December 31, 2014

 

37,541,722 

 

$

0.10 

 

4.29 

 

$

-  

Granted

 

-  

 

$

-  

 

-  

 

$

-  

Exercised

 

-  

 

$

-  

 

-  

 

$

-  

Cancelled

 

-  

 

$

-  

 

-  

 

$

-  

Outstanding at September 30, 2015 (Unaudited)

 

37,541,722 

 

$

0.10 

 

3.54 

 

$

-  

Vested and expected to vest

 

 

 

 

 

 

 

 

 

 

     at September 30, 2015 (Unaudited)

 

37,541,722 

 

$

0.10 

 

3.54 

 

$

-  

Exercisable at September 30, 2015 (Unaudited)

 

37,541,722 

 

$

0.10 

 

3.54 

 

$

The aggregate intrinsic value in the table above is before applicable income taxes and is calculated based on the difference between the exercise price of the options and the quoted price of the common stock as of the reporting date.

There were no options issued during the nine months ended September 30, 2015.

Total stock option expenses recorded during the nine months ended September 30, 2015 and 2014 were $16,759 and $151,634, respectively.

The following table summarizes information about stock options outstanding and exercisable at September 30, 2015.

 

Options Outstanding

 

Options Exercisable

           

Weighted

   

Weighted

     

Weighted

   

Weighted

 

 

 

 

 

 

Average

 

 

Average

 

 

 

Average

 

 

Average

 

Exercise

 

Number

 

 

Remaining

 

 

Exercise

 

Number

 

Remaining

 

 

Exercise

 

Price

 

of Shares

 

 

Life (Years)

 

 

Price

 

of Shares

 

Life (Years)

 

 

Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.05 - 0.09

 

12,900,000 

 

 

6.66

 

$

0.07 

 

12,900,000 

 

6.66

 

$

0.07 

$

0.10 - 0.15

 

23,011,461 

 

 

3.44

 

$

0.11 

 

23,011,461 

 

3.44

 

$

0.11 

$

> 0.15

 

1,630,261 

 

 

4.45

 

$

0.19 

 

1,630,261 

 

4.45

 

$

0.19 

 

 

 

37,541,722 

 

 

 

 

 

 

 

37,541,722 

 

       

13


Warrants

A summary of the activity of our warrants for the nine months ended September 30, 2015 is presented below:

 

 

 

 

Weighted Avg.

 

Shares

 

 

Exercise Price

Outstanding at December 31, 2014

70,028,410 

 

$

0.07 

Granted

1,764,642 

 

$

0.003 

Exercised

 

$

Cancelled

(14,650,000)

 

$

0.08 

Outstanding at September 30, 2015 (Unaudited)

57,143,052 

 

$

0.06 

 

 

 

 

 

Exercisable at September 30, 2015 (Unaudited)

55,719,441

 

$

0.06

Total warrant expenses recorded during the nine months ended September 30, 2015 and 2014 were $11,170 and $144,232, respectively.

The inputs used for the Black-Scholes option and warrant valuation model were as follows:

  September 30, 2015   September 30, 2014
Expected life in years 2 - 5 Years   0 - 5 Years
Stock price volatility 120.51% - 122.72%   123.47% - 124.21%
Risk free interest rate 0.04% - 1.38%   0.35% - 0.46%
Expected dividends None   None
Forfeiture rate 0%   0%

Shares Issued for Services or Reduction to Liabilities

During the nine months ended September 30, 2015, we issued 120,100,000 shares of common stock with a value of $413,220 to various third parties and related parties and charged the proceeds to the appropriate accounts for the following reasons:

   

Nine Months Ended September 30, 2015

Purpose

 

Shares

 

 

Value

 

 

 

 

 

 

Reduction of payables and notes 

 

112,100,000 

 

$

375,021 

Services provided 

 

8,000,000 

 

 

38,199 

Totals 

 

120,100,000 

 

$

413,220 

The 120,100,000 issued shares were not contractually restricted. However, as these shares have not been registered under the Securities Act of 1933, as amended (the "Act"), they are restricted from sale until they are registered under the Act, or qualify for resale under the rules promulgated under the Act. All such shares were calculated at the trading closing price on the date of issuance.

Stock Bonus Agreements

From time to time, we issue shares of our common stock as a bonus for services rendered. Stock bonuses may be awarded upon satisfaction of specified performance goals pursuant to the Performance Stock Bonus Agreement.

On each grant date, we valued the stock bonus based on the share price and the expenses were amortized using the straight line method. Total stock bonus expenses recorded during the nine months ended September 30, 2015 and 2014 were $0 and $ 245,375, respectively and are reflected in operating expenses in the accompanying consolidated statements of operations.

14


NOTE 8 - NOTES PAYABLE

Notes payable consisted of the following:

      September 30,     December 31,
      2015     2014
             
Promissory notes payable due to the former officers of MMRGlobal as part of severance
packages, due in full on August 31, 2009, with no stated interest
  $ 76,783    $ 76,783 
             
Promissory notes payable due to the former officers of MMRGlobal pursuant to the
Resignation and Post-Merger Employment Arrangement, due in full on August 31, 2009,
with no stated interest
    25,444      25,444 
             
Promissory notes payable due to vendors relating to settlement of certain outstanding
accounts payable, payable in 18 equal monthly installments commencing on July 27, 2009
and ending on January 27, 2011, with no stated interest
    223,116      223,116 
             
Short term loan due to a third-party with 6% interest     44,067      35,000 
             
      369,410      360,343 
Less: current portion     (369,410)     (360,343)
Notes payable, less current portion   $ -     $ -  
             
Short term loan due to a related-party, payable in full on
January 2, 2014 with 12% interest 
  $ 203,664    $ 203,664 
             
Short term loan due to a related-party, payable in full on
May 31, 2014 with 12% interest
    50,000      50,000 
             
Notes payable related party, current portion     253,664      253,664 
Less: current portion     (253,664)     (253,664)
Notes payable related party, less current portion   $ -     $ -  

NOTE 9 - CONVERTIBLE PROMISSORY NOTES

From time to time, we issue Convertible Promissory Notes. As of September 30, 2015, a total of $887,027 in convertible notes remained outstanding. As of September 30, 2015, all of these Notes have matured, however, the Company and the Holders have agreed to keep the balance as a Note Payable and the note holders have elected not to convert their note balances into shares of our common stock as of September 30, 2015.

Each Note contains the following general terms and provisions:

  • The principal amount owed under each note becomes due and payable one year or less from the investment date provided that, upon ten (10) days' prior written notice to the holder, we may, in our sole discretion, extend the maturity date for an additional six month term. The Notes can be further extended upon mutual agreement.
  • These notes bear interest at a rate of 6% per annum payable in cash or shares of common stock or a combination of cash and shares of common stock at our option.

During the third quarter of 2015, we did not enter into any Convertible Promissory Notes.

Shares issuable upon conversion for convertible notes payable was 41,679,061 as of September 30, 2015.

15


The total interest expense attributed to the Beneficial Conversion Feature of the Notes and related warrants for the nine months ended September 30, 2015 and 2014 was $55,780 and $124,120, respectively.

NOTE 10 - RESTRUCTURING ACTIVITIES

In connection with the merger with Favrille, Inc. in 2009, we signed promissory notes with certain former executives totaling $76,783.

As of September 30, 2015, the total remaining severance liabilities amounted to $620,613, which is reflected as severance liability on the accompanying consolidated balance sheets. This consists of $571,362 payable to former non-executive employees.

NOTE 11 - RELATED PARTY TRANSACTIONS

Our Chairman and Chief Executive Officer, Robert H. Lorsch, is also the Chief Executive Officer of The RHL Group, Inc. and has full voting power over all of the capital stock of The RHL Group, Inc. Mr. Lorsch directly and indirectly through The RHL Group, Inc., beneficially owns approximately 16.4% our total outstanding voting stock. The RHL Group, Inc. has loaned us money pursuant to the Tenth Amended Note and all predecessor notes. See Note 3 - Related Party Note Payable above.

The RHL Group is an investment holding company which provides consulting, operational and technical services to us, which we refer to as the RHL Services. As part of the RHL Services, The RHL Group provides us with unrestricted access to its internal business and relationship contact database of more than 10,000 persons and entities, which includes clients of The RHL Group and other individuals which may hold value to us. The RHL Group also provides infrastructure support to us, including allowing us unlimited access to its facilities, equipment, and data, information management and server systems. In addition to allowing us the use of its office support personnel, The RHL Group has also consented to allow us to utilize the full-time services of Mr. Lorsch as our President, Chairman and Chief Executive Officer, which requires substantial time and energy away from his required duties as The RHL Group's Chairman and Chief Executive Officer. In addition, The RHL Group has made its President, Kira Reed, available as our spokesperson. Ms. Reed, who is Mr. Lorsch's spouse, also manages our social networking activities.

In consideration for the above, The RHL Group, Inc. has a consulting arrangement with MMR. A copy of the consulting agreement is filed as an exhibit in our Form 8-K, as filed with the SEC on May 4, 2009 and is hereby incorporated by reference.

We incurred $12,500 during the nine months ended September 30, 2015 and 2014, toward marketing consulting services from Bernard Stolar, a director. We included $198,514 and $174,273 in related party payables as of September 30, 2015 and December 31, 2014, respectively, in connection with these services and board fees.

We contract with a significant vendor for the development and maintenance of the software applications necessary to run our MyMedicalRecords PHR, MyEsafeDepositBox and MyMedicalRecords Pro products. Our outside developer supports our software development needs through a team of software engineers, programmers, quality control personnel and testers, who work with our internal product development team on all aspects of application development, design, integration and support of our products. This vendor is also a stockholder. For the nine months ended September 30, 2015 and 2014, the total expenses relating to this stockholder amounted to $90,000 and $90,000, respectively. In addition, we capitalized $0 of software development costs for the quarter ended September 30, 2015. As of September 30, 2015 and December 31, 2014, the total amounts due to the stockholder and included in related party payables amounted to $100,000 and $10,000, respectively.

On September 15, 2009, we entered into a five year agreement with E-Mail Frequency, LLC and David Loftus, Managing Partner of E-Mail Frequency, LLC, a significant stockholder of the Company, which was amended during 2011 to increase the term for an additional five years and provide licensor a non- exclusive right to target, market and exploit the Employee Benefits market.

16


We licensed an existing 80 million person direct marketing database (the "Database") of street addresses, cellular phone numbers, e-mail addresses and other comprehensive data with E-Mail Frequency. The agreement allows us to market, through the use of the Database, our MyMedicalRecords PHR, MyEsafeDepositBox virtual vault, and MMRPro document management system to physicians and their patients. Under the terms of the Agreement, we paid $250,000 to David Loftus as a one-time consulting fee in the form of 2,777,778 shares of our common stock. We recorded the $250,000 one-time licensee fee as a prepaid consulting fee. Amortization expense for each of the quarters ended September 30, 2015 and 2014 was $0 and $37,500. Included in related party payables at September 30, 2015 and December 31, 2014 of $64,615 and $64,615, respectively, in respect to these services.

NOTE 12 - SUBSEQUENT EVENTS

We have evaluated subsequent events of our condensed consolidated financial statements.

On October 8, 2015, we received written consent from our company's board of directors to amend the Corporation's Articles of Incorporation to effect a reverse stock split, such that each five (5) shares of the issued and outstanding Common Stock of the Corporation shall be reversed split into one (1) share of Common Stock of the Corporation (the "Stock Split"). This Stock Split shall effect only issued and outstanding shares. Each record and beneficial holder who would receive a fractional share as a result of the reverse split shall receive, in lieu thereof, a whole share.

On November 4, 2015, the Corporation received the written consent of holders of more than 50% of our voting securities to effect the Stock Split.

The Stock Split will not be effective until after filing by the Corporation of its Schedule 14C Information with the Securities and Exchange Commission and amendment of the Corporation's Articles of Incorporation.

In addition, the Corporation will file a corporation action notification with FINRA to effect the Stock Split on the market, and must receive approval thereof prior to filing amended Articles of Incorporation.

The number of shares presented in this quarterly report do not reflect the reverse stock split expected to become effective in the 4th quarter of 2015.

On October 16, 2015, we granted a total of 10,000,000 shares of restricted common stock to an unrelated third party, at a price of $0.0032 per share.

On October 19, 2015, we granted a total of 7,894,000 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.

On October 19, 2015, we granted a total of 30,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.0038 in consideration of a reduction in payables.

On October 22, 2015, we granted a total of 6,842,105 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.

On October 22, 2015, The RHL Group, Inc., an entity affiliated with our Chairman & CEO Robert H. Lorsch elected to purchase 46,000,000 shares of common stock at market price in consideration for a reduction in amounts due of $174,800.00.

On October 29, 2015, we granted a total of 10,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.005 in consideration of a reduction in payables.

17


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion of our financial condition and results of operations in conjunction with our financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and the description of our business appearing in our Annual Report on Form 10-K for the year ended December 31, 2014, filed with the SEC on March 31, 2015, as amended by Form 10-K/A for the year ended December 31, 2014, as filed with the SEC on April 30, 2015 (together, the "Form 10-K"). This discussion contains forward-looking statements, which inherently involve risks and uncertainties. Please see "Cautionary Note Regarding Forward-Looking Statements" below. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks faced by us described in "Risk Factors" in Item 1A of the Form 10-K.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements. The words "anticipate," "expect," "believe," "plan," "intend," "will" and similar expressions are intended to identify such statements. Although the forward-looking statements in this Quarterly Report on Form 10-Q reflects the good faith judgment of our management, such statements are subject to various risks and uncertainties, including but not limited to the risks identified in our Form 10-K and in our press releases and other filings with the SEC.

Assumptions related to forward-looking statements involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Any of such assumptions could be inaccurate. You should not place undue reliance on these forward-looking statements, which are based on our current views and assumptions. In evaluating these statements, you should specifically consider various factors, including the foregoing risks and those outlined under "Risk Factors" in Item 1A of the Form 10-K. Our forward-looking statements represent estimates and assumptions only as of the date of this Quarterly Report on Form 10-Q. Except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q.

Overview

Background

We provide secure and easy-to-use online Personal Health Records ("PHRs") electronic safe deposit box storage solutions, and document management and imaging systems for healthcare professionals

Source of Revenues

MMR remains focused on its primary Health IT business of selling the MyMedicalRecords PHR and MMRPro document and imaging systems for healthcare professionals. We derive revenues from the provision of services, which are comprised of facilitating electronic access to consumer medical records and other vital documents through subscribers on a direct subscription basis or an "access" basis through various types of organizations including direct sales, affinity and membership groups, healthcare organizations and retailers, and in both cases, we record these revenues under "Subscriber" in our income statement. We also sell direct to consumers through paid advertising or other per enquiry marketing relationships. When sold to corporations, affinity and membership organizations, hospitals and other business to business customers, we charge a minimum monthly fee plus user fees to the organization based on the number of users who will have access to our services through such organization, whether or not such users actually activate their authorized account. During the nine months ended September 30, 2015, we received $116,248 from subscriber revenues.

In addition, MMR has numerous patents issued, pending or applied for pertaining to provisioning of online medical and Personal Health Records in 12 countries of commercial interest including the U.S., and defends its global intellectual property rights through the filing of patent infringement complaints.

18


We also generate revenues from the licensing of our Health IT and biotech assets, which may include non-refundable license and up-front fees, non-refundable milestone payments that are triggered upon achievement of a specific event and future royalties or lump-sum payments on sales of related products. We record these licensing revenues under "License Fees" in our income statement. We are sometimes paid an upfront license fee and milestone payments and we recognize those fees as revenue as payments are received. We will record those fees as revenue when payments are received. During the nine months ended September 30, 2015, we received $15,249 from license fees revenues.

We also have generated revenues from licensing the sale and marketing of our services internationally and, to a lesser extent, from ancillary fee payments including web and marketing development services, amongst others. We record these licensing revenues under "License Fees" and other ancillary revenues under "Other Revenues" in our income statement. When we enter into a licensing arrangement, we are sometimes paid an upfront license fee and typically receive ongoing royalty payments that are often based on a percentage of revenue earned by our licensee. We recognize these fees over the license period. When we receive ancillary one-time payments, we record them when services or products are delivered.

Cost of Revenue

Our cost of revenue includes the cost of manufacturing our retail product and related packaging, maintaining our voice and fax mailboxes, long-distance call transport costs, fax and voice call processing costs, credit card transaction processing costs, web hosting and management fees, website maintenance and support costs, costs associated with creating and mailing enrollment packages to our subscribers and the cost of scanners. Cost of revenue also includes customer service costs. We also charge to cost of revenue our direct selling costs, which include commissions paid to sales representatives who sell our wholesale and access based accounts.

Operating Expenses

The largest component of our operating expenses is our general and administrative expenses, which include personnel salaries and benefits, office rent and supplies, insurance costs, fees for legal and professional services, as well as our expenses for corporate telecommunications and Internet access not associated with our products. Our operating expenses also include sales and marketing expenses (which include expenses associated with attending trade shows and travel costs, as well as a portion of personnel salaries allocated to sales and marketing activities), as well as technology development expenses (which includes expenses related to research and development as well as a portion of personnel salaries allocated to development activities).

Recent Accounting Pronouncements

For a description of recent accounting pronouncements and how we apply such pronouncements to our financial statements, see the accompanying notes to our consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q.

Competition

The following competitive factors may affect our future performance.

MyMedicalRecords PHR

Although we believe that no other product in the marketplace compares to what we provide in our comprehensive PHR and other offerings, there are other PHR providers in the consumer health information management marketplace that compete for our services. These include NoMoreClipboard.com, Dossia, WebMD Health Manager, Zweena Health, MiVia, and numerous others including patient portals offered by EMR Vendors, health exchanges, and insurance companies, hospitals and HMOs for their policyholders and patients. Each of our competitors offers varying PHR products and services for online storage and access to medical records at varying price points (at the basic "free" level, with minimal recordkeeping capability that usually includes advertising).

19


MyEsafeDepositBox

Our MyEsafeDepositBox product competes with a number of online backup and electronic data storage services. The increasing use of external hard drives and flash drives to backup data also has the potential to compete with online data storage services such as our MyEsafeDepositBox product.

MMRPro

MMRPro competes with scanning services that market their services to doctors seeking to convert their historical paper records into electronic files, as well as EMR systems.

MMRPro also competes with EMR systems that offer doctors the opportunity to make their entire office paperless.

Results of Operations for the three and nine months ended September 30, 2015 as compared to the three and nine months ended September 30, 2014

Revenues

Revenues for the nine months ended September 30, 2015 and 2014 were $138,716 and $2,437,095, respectively, a decrease of $2,298,379 or 94.3%, and for the quarter ended September 30, 2015 and 2014 were $77,664 and $1,896,271, respectively, a decrease of $1,818,607 or 95.9%. The decrease for the periods were primarily due to a decrease in license fees resulting from milestone payments in the first nine months of 2014, with no similar transaction in 2015. Despite the changing environment in the US regarding patent laws the Company continues to explore opportunities to monetize its international patent portfolio globally in both health information technology and biotechnology.

Cost of revenue

Cost of revenue for the nine months ended September 30, 2015 and 2014 was $179,554 and $230,402, respectively, a decrease of $50,848 or 22.1%,. Cost of revenues for the three months ended September 30, 2015 and 2014 were $45,298 and $88,960, respectively, for an decrease of $43,662 or 49.1%.The decrease for the three and nine month period was mainly due to the decrease in phone and fax line services on the production servers.

Gross loss for the nine months ended September 30, 2015 was $(40,838) compared to a Gross profit of $2,206,693 for the nine months ended September 30, 2014, a decrease of $2,229,928 or 101.1%. Gross loss for the three months ended September 30, 2015 was $49,969 compared to a Gross Profit of $1,807,311 for a decrease of $1,757,342 or 97.2%. The decrease for the three and nine months was primarily due to the decrease in license fee revenue from the milestone payments in revenue.

Operating expenses

Total operating expenses for the nine months ended September 30, 2015 and 2014 were $1,751,613 and $4,676,026, respectively, a decrease of $2,924,413 or 62.5%. Total operating expenses for the three months ended September 30, 2015 and 2014 were $485,421 and $1,455,779, respectively for a decrease of $970,358 or 66.7%. The decrease for the quarter and nine month period was primarily due to a reduction in investor relations expenses, salaries, non-cash compensation expenses and marketing consulting fees as we work towards streamlining expenses.

General and administrative expenses for the nine months ended September 30, 2015 and 2014 were $1,331,414 and $3,530,193, respectively, a decrease of $2,247,531 or 101.9%. General and administrative expenses for the three months ended September 30, 2015 and 2014 were $383,147 and $1,186972, respectively, for a decrease of $803,825 or 67.7%. The decrease for the quarter and nine month period was primarily due to a reduction in investor relations expenses, salaries, non-cash compensation expenses, and consulting fees as we streamline operations and reduce operating costs.

Sales and marketing expenses for the nine months ended September 30, 2015 and 2014 were $420,199 and $1,087,943, respectively, a decrease of $667,744 or 61.4%. Sales and marketing expenses for the three months ended September 30, 2015 and 2014 were $102,504 and $261,553, respectively, for a decrease of $159,049 or 60.8%. The decrease for the quarter and nine month period was primarily due to lower business development fees, marketing consulting fees and stock option expense.

20


Technology development expenses for the nine months ended September 30, 2015 and 2014 were $0 and $57,890, respectively, a decrease of $57,890 or 100% and for the three month period ending September 30, 2015 and 2014 were $0 and $7,254, respectively, for a decrease of $7,254 or 100%. The decrease for the quarter and nine month period was development of our android mobile app was completed in 2014.

Interest and Other Finance Charges, Net

Interest and other finance charges for the nine months ended September 30, 2015 and 2014 were $191,355 and $362,678, respectively, a decrease of $171,323 or 47.2%. Interest and other finance charges for the three months ended September 30, 2015 and 2014 were $44,629 and $104,031, respectively, for a decrease of $59,402 or 57.1%. The decrease for the quarter and the nine month period was primarily due to decreased interest expense related to convertible notes.

Net loss

As a result of the foregoing, net loss for the nine months ended September 30, 2015 and 2014 was $1,923,286 and $1,159,191, respectively, a increase of $764,095 or 65.9%. Net loss for the third quarter ended September 30, 2015 was $489,000 and Net profit for the three months ending September 30, 2014 was $1,920,321, for a decrease of $2,409,321 or 125.5%

Going Concern

As more fully described in Note 1 to the consolidated financial statements appearing above in this Quarterly Report on Form 10-Q, our independent registered public accounting firm included an explanatory paragraph in their report on our 2014 financial statements for the year ended December 31, 2014 related to the uncertainty of our ability to continue as a going concern. As of September 30, 2015, our current liabilities of $10.13 million exceeded our current assets of $0.15 million by $9.98 million.

For a description of our management's plan regarding our ability to continue as a going concern, please see Note 1 to the financial statements included above.

Liquidity and Capital Resources

As of September 30, 2015, our current liabilities exceeded our current assets by $9.95 million. Furthermore, during the quarter ended September 30, 2015, we incurred losses of $489,000. At the current level of borrowing, we require cash of $156,000 per year to service our debt and, in order to continue operating its business, we use an average of $160,175 cash per month, or $1.9 million per year.

In addition to the above cash burn from operations, we will be required to obtain additional financing in order to meet the obligations for installment payments of $621,000 under the Creditor Plan and our obligations under the secured indebtedness to The RHL Group under the Tenth Amended Note (which had a balance of $2.06 million at September 30, 2015, amongst other debt obligations. Such obligations are currently due and payable pursuant to the terms of the notes.

To finance our activities, we have relied on the issuance of stock and debt to The RHL Group. At September 30, 2015, we had a line of credit with The RHL Group in the amount of $4.5 million. Availability under this line of credit, at the lender's discretion, was $2.44 million as of September 30, 2015.

In addition, we may offer restricted stock to accredited investors and issue limited amounts of convertible debt. During 2014, we raised $1.07 million in sales of restricted common stock to accredited investors. We expect to continue offering limited amounts of convertible debt in 2015. The Company believes it can continue to generate revenue from its biotech and health information technology assets. We also expect to continue receiving (i) royalties from license fees related to our health information technology patents and other intellectual property; and (ii) revenue from sales of PHRs, MMRPro services, and other products and services including our new mHealth applications that will help reduce annual cash burn from operations. The Company is also planning on selling data and samples from its FavId vaccine trials to pharmaceutical manufacturers, universities and others for use in helping to speed the process of clinical trials for new drugs and disease management programs.

21


Cash Flows for the nine months ended September 30, 2015 compared to nine months ended September 30, 2014

Net cash used in operating activities for the nine months ended September 30, 2015 and 2014 was $648,679 and $226,382, respectively. In 2015, we had a net loss of $1,923,286, plus non-cash adjustments (depreciation, amortization, common stock and warrants issued for services and interest, amortization of loan discount, and stock compensation expense) of $339,116, plus changes in operating assets and liabilities of $935,491. In 2014, net cash used in operating activities of $226,382 was comprised of a net loss of $1,159,191, plus similar non-cash adjustments of $194,780, plus changes in operating assets and liabilities of $1,580,353. Compared to 2014, the operating cash flow activities in 2015 were lower primarily due to a reduction in equity transactions and compensation expenses.

Net cash used in investing activities in the nine months ended September 30, 2015 and 2014 totaled $1,252 and $300,495, respectively. Compared to 2014, investing activities in 2015 were lower mainly due to a decrease product development costs.

Net cash provided by financing activities in the nine months ended September 30, 2015 and 2014 totaled $340,538 and $1,555,264, respectively. Financing activities primarily included proceeds generated from the issuance of convertible notes and common shares. Compared to 2014, financing activities in 2015 were lower primarily due to a decrease in shares issued for financing activities.

As of September 30, 2015, we had cash and cash equivalents of $0, compared to $1,491,510 as of September 30, 2014.

Description of Indebtedness

For a description of our indebtedness to The RHL Group, please See Note 3 - Related Party Note Payable, included above in this Quarterly Report on Form 10-Q.

Convertible Notes

For information relating to our Convertible Notes, please see Note 9 to our financial statements appearing elsewhere in this Quarterly Report on Form 10-Q.

Commitments and Contingencies

For information relating to our commitments and contingent liabilities, please see Note 5 to our financial statements appearing elsewhere in this Quarterly Report on Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company and therefore, we are not required to provide information required by this item of Form 10-Q.

Item 4. Controls and Procedures

Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

22


As required by Rule 13a-15(b) under the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures.

Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective and were operating at a reasonable assurance level.

Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting or in other factors identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during the quarter ended September 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

The information in response to this item is incorporated herein by reference to Note 5 - Commitments and Contingencies under the "Litigation Matters" section of the Consolidated Condensed Financial Statements of this Quarterly Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following is a summary of transactions by us since our previous disclosure Form 10-Q filed with the Securities and Exchange Commission on August 14, 2015 involving sales of our securities that were not registered under the Securities Act of 1933, as amended (the "Securities Act"). Each offer and sale was exempt from registration under either Section 4(2) of the Securities Act or Rule 506 under Regulation D of the Securities Act because (I) the securities were offered and sold only to accredited investors; (ii) there was no general solicitation or general advertising related to the offerings; (iii) each investor was given the opportunity to ask questions and receive answers concerning the terms of and conditions of the offering and to obtain additional information; (iv) the investors represented that they were acquiring the securities for their own account and for investment; and (v) the securities were issued with restrictive legends:

On October 16, 2015, we granted a total of 10,000,000 shares of restricted common stock to an unrelated third party, at a price of $0.0032 per share.

On October 19, 2015, we granted a total of 7,894,000 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.

On October 19, 2015, we granted a total of 30,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.0038 in consideration of a reduction in payables.

On October 22, 2015, we granted a total of 6,842,105 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.

On October 22, 2015, The RHL Group, Inc., an entity affiliated with our Chairman & CEO Robert H. Lorsch elected to purchase 46,000,000 shares of common stock at market price in consideration for a reduction in amounts due of $174,800.00.

On October 29, 2015, we granted a total of 10,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.005 in consideration of a reduction in payables.

23


All securities granted or sold under these agreements are unregistered and may only be resold or transferred if they later become registered or fall under an exemption to the Securities Act or applicable state laws.  Our typical investor or grantee generally relies upon Rule 144 of the Securities Act, which, in addition to requiring several other conditions before resale may occur, requires that the securities issued be held for a minimum of six months.  We generally used the proceeds of the foregoing sales of securities for repayment of indebtedness, working capital and other general corporate purposes.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

On October 8, 2015, we received written consent from our company's board of directors to amend the Corporation's Articles of Incorporation to effect a reverse stock split, such that each five (5) shares of the issued and outstanding Common Stock of the Corporation shall be reversed split into one (1) share of Common Stock of the Corporation (the "Stock Split"). This Stock Split shall effect only issued and outstanding shares. Each record and beneficial holder who would receive a fractional share as a result of the reverse split shall receive, in lieu thereof, a whole share.

On November 4, 2015, the Corporation received the written consent of holders of more than 50% of our voting securities to effect the Stock Split.

The Stock Split will not be effective until after filing by the Corporation of its Schedule 14C Information with the Securities and Exchange Commission and amendment of the Corporation's Articles of Incorporation.

In addition, the Corporation will file a corporation action notification with FINRA to effect the Stock Split on the market, and must receive approval thereof prior to filing amended Articles of Incorporation.

We will announce the effectiveness of the amendment on the market by filing a Current Report on Form 8-K.

 

 

 

24


Item 6. Exhibits

Exhibit
Number
  Exhibit Description
     
31.1   Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.
     
31.2   Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.
     
32.1   Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350.
     
32.2   Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350.
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

 

25


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 16, 2015

MMRGlobal, Inc.

By: /s/ Robert H. Lorsch                                  
Robert H. Lorsch
Chairman, Chief Executive Officer and
President

By: /s/ Bernard Stolar                                    
Bernard Stolar
Chief Financial Officer

 

 

26


EXHIBIT INDEX

Exhibit
Number
  Exhibit Description
     
31.1   Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.
     
31.2   Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.
     
32.1   Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350.
     
32.2   Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350.
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

27


EX-31.1 2 exh31-1.htm CEO 302 CERTIFICATE Q3 2015 Exhibit 31.1

Exhibit 31.1

Certification

I, Robert H. Lorsch, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MMRGlobal, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 16, 2015

 

/s/ Robert H. Lorsch


Name: Robert H. Lorsch
Title: Chief Executive Officer








EX-31.2 3 exh31-2.htm CFO 302 CERTIFICATE Q3 2015 Exhibit 31.2

Exhibit 31.2

Certification

I, Bernard Stolar, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MMRGlobal, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 16, 2015

 

/s/ Bernard Stolar


Name: Bernard Stolar
Title: Chief Financial Officer








EX-32.1 4 exh32-1.htm CEO 906 CERTIFICATE Q3 2015 Exhibit 32.1

Exhibit 32.1

Certification

I, Robert H. Lorsch, certify, pursuant to Rule 13(a)-14(b) or Rule 15(d)-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that (i) the Quarterly Report on Form 10-Q of MMRGlobal, Inc. for the quarterly period ended September 30, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of1934, and (ii) the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of MMRGlobal, Inc.

/s/ Robert H. Lorsch


Name:

 

Robert H. Lorsch

Title:

 

Chief Executive Officer

Date:

 

November 16, 2015

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and is not being "filed" as part of the Form 10-Q or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liability under that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.1 is expressly and specifically incorporated by reference in any such filing.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.








EX-32.2 5 exh32-2.htm CFO 906 CERTIFICATE Q3 2015 Exhibit 32.2

Exhibit 32.2

Certification

I, Bernard Stolar, certify, pursuant to Rule 13(a)-14(b) or Rule 15(d)-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that (i) the Quarterly Report on Form 10-Q of MMRGlobal, Inc. for the quarterly period ended September 30, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of MMRGlobal, Inc.

/s/ Bernard Stolar


Name:

 

Bernard Stolar

Title:

 

Chief Financial Officer

Date:

 

November 16, 2015

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and is not being "filed" as part of the Form 10-Q or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liability under that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.2 is expressly and specifically incorporated by reference in any such filing.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.








GRAPHIC 6 image2678.jpg LOGO begin 644 image2678.jpg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end EX-101.INS 7 mmrf-20150930.xml XBRL INSTANCE DOCUMENT 0001285701 2014-12-31 0001285701 2015-09-30 0001285701 2015-01-01 2015-09-30 0001285701 2014-01-01 2014-09-30 0001285701 2015-11-12 0001285701 MMRF:ZeroPointZeroFiveToZeroPointZeroNineMember 2015-01-01 2015-09-30 0001285701 MMRF:ZeroPointZeroFiveToZeroPointZeroNineMember 2015-09-30 0001285701 MMRF:ZeroPointOneZeroToZeroPointOneFiveMember 2015-01-01 2015-09-30 0001285701 MMRF:ZeroPointOneZeroToZeroPointOneFiveMember 2015-09-30 0001285701 MMRF:GreaterThanZeroPointOneFiveMember 2015-01-01 2015-09-30 0001285701 MMRF:GreaterThanZeroPointOneFiveMember 2015-09-30 0001285701 MMRF:FormerOfficersOfMMRGlobalSeverancePackageNotesMember 2015-01-01 2015-09-30 0001285701 MMRF:FormerOfficersOfMMRGlobalSeverancePackageNotesMember 2015-09-30 0001285701 MMRF:FormerOfficersOfMMRGlobalSeverancePackageNotesMember 2014-12-31 0001285701 MMRF:ResignationAndPostMergerEmploymentArrangementNotesMember 2015-01-01 2015-09-30 0001285701 MMRF:ResignationAndPostMergerEmploymentArrangementNotesMember 2015-09-30 0001285701 MMRF:ResignationAndPostMergerEmploymentArrangementNotesMember 2014-12-31 0001285701 MMRF:VendorsNotesPayableMember 2015-01-01 2015-09-30 0001285701 MMRF:VendorsNotesPayableMember 2015-09-30 0001285701 MMRF:VendorsNotesPayableMember 2014-12-31 0001285701 MMRF:TenthAmendedAndRestatedSecuredPromissoryNoteMember 2015-09-30 0001285701 MMRF:TenthAmendedAndRestatedSecuredPromissoryNoteMember 2014-12-31 0001285701 MMRF:TenthAmendedAndRestatedSecuredPromissoryNoteMember 2015-01-01 2015-09-30 0001285701 MMRF:TenthAmendedAndRestatedSecuredPromissoryNoteMember 2014-01-01 2014-09-30 0001285701 MMRF:September2013LeaseMember 2015-01-01 2015-09-30 0001285701 MMRF:RHLGroupMember 2015-01-01 2015-09-30 0001285701 MMRF:BernardStolarMember 2015-01-01 2015-09-30 0001285701 MMRF:BernardStolarMember 2014-01-01 2014-09-30 0001285701 MMRF:BernardStolarMember 2015-09-30 0001285701 MMRF:BernardStolarMember 2014-12-31 0001285701 MMRF:SignificantVendorMember 2015-01-01 2015-09-30 0001285701 MMRF:SignificantVendorMember 2014-01-01 2014-09-30 0001285701 MMRF:SignificantVendorMember 2015-09-30 0001285701 MMRF:SignificantVendorMember 2014-12-31 0001285701 MMRF:EMailFrequencyLLCMember 2015-01-01 2015-09-30 0001285701 MMRF:EMailFrequencyLLCMember 2014-01-01 2014-09-30 0001285701 MMRF:DavidLoftusMember 2015-01-01 2015-09-30 0001285701 MMRF:DavidLoftusMember 2014-01-01 2014-09-30 0001285701 MMRF:DavidLoftusMember 2015-09-30 0001285701 MMRF:DavidLoftusMember 2014-12-31 0001285701 MMRF:DavidLoftusMember 2009-01-01 2009-12-31 0001285701 us-gaap:FacilityClosingMember 2015-01-01 2015-09-30 0001285701 us-gaap:FacilityClosingMember 2015-09-30 0001285701 MMRF:ShortTermLoanTwoDueToThirdPartyMember 2015-01-01 2015-09-30 0001285701 MMRF:ShortTermLoanTwoDueToThirdPartyMember 2014-12-31 0001285701 MMRF:ShortTermLoanTwoDueToThirdPartyMember 2015-09-30 0001285701 MMRF:ShortTermLoanOneDueToRelatedPartyMember 2015-01-01 2015-09-30 0001285701 MMRF:ShortTermLoanOneDueToRelatedPartyMember 2014-12-31 0001285701 MMRF:ShortTermLoanOneDueToRelatedPartyMember 2015-09-30 0001285701 MMRF:ShortTermLoanTwoDueToRelatedPartyMember 2015-01-01 2015-09-30 0001285701 MMRF:ShortTermLoanTwoDueToRelatedPartyMember 2014-12-31 0001285701 MMRF:ShortTermLoanTwoDueToRelatedPartyMember 2015-09-30 0001285701 2013-12-31 0001285701 2015-07-01 2015-09-30 0001285701 2014-07-01 2014-09-30 0001285701 2014-09-30 0001285701 MMRF:TenthAmendedAndRestatedSecuredPromissoryNoteMember 2015-07-01 2015-09-30 0001285701 MMRF:TenthAmendedAndRestatedSecuredPromissoryNoteMember 2014-07-01 2014-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:USD MMRF:Unit MMRGlobal, Inc. 0001285701 10-Q 2015-09-30 false --12-31 No No Yes Smaller Reporting Company Q3 2015 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 1 - NATURE OF OPERATIONS AND BASIS OF PRESENTATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">MMRGlobal Inc. (referred to herein, unless otherwise indicated, as &#34;MMR,&#34; the &#34;Company,&#34; the &#34;issuer,&#34; &#34;we,&#34; &#34;us,&#34; and &#34;our&#34;) was originally incorporated as Favrille, Inc. (&#34;Favrille&#34;) in Delaware in 2000, and since its inception and before the Merger (as defined below), operated as a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. In May 2008, Favrille's ongoing Phase 3 registration trial for the FavId vaccine failed to show a statistically significant improvement in the treatment of patients with follicular B-cell Non-Hodgkin's lymphoma. On January 27, 2009, the Company, through MyMedicalRecords, Inc. (&#34;MMR Inc.&#34;), what is now our wholly-owned operating subsidiary, conducted a reverse merger with Favrille.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Through our wholly-owned operating subsidiary MMR Inc., the Company's primary business is to license and provide secure and easy-to-use online Personal Health Records (&#34;PHRs&#34;) and MyEsafeDepositBox storage solutions, including a professional offering to physicians' offices and similar organizations known as MMRPro. In January 2009, as a result of the Merger, we acquired biotech assets and other intellectual property including anti-CD20 antibodies as well as data and samples from the FavId/Specifid vaccine clinical trials for the treatment of B-cell Non-Hodgkin's lymphoma.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On March 8, 2011, we formed a subsidiary, which we named MMR Life Sciences Group, Inc., exclusively to maximize the value of our biotech assets including our patents, anti-CD20 antibodies, and FavId vaccine technologies acquired by MyMedicalRecords, Inc. through the merger with Favrille. As of this date the assets have not been transferred to the subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We (formerly Favrille) were incorporated in Delaware in 2000, MMR Inc. was incorporated in Delaware in 2005, and both are headquartered in Los Angeles, CA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>Principles of Consolidation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The consolidated financial statements include the accounts of MMRGlobal, and its wholly-owned subsidiaries MMR and MMR Life Sciences Group, Inc. All intercompany transactions and balances are eliminated upon consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>Basis of Presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have prepared the accompanying consolidated unaudited financial statements in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial statements and with instructions to Form 10-Q pursuant to the rules and regulations of Securities and Exchange Act of 1934, as amended, or the Exchange Act and Article 8-03 of Regulation S-X promulgated under the Exchange Act. Accordingly, these financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of our management, we have included all adjustments considered necessary (consisting of normal recurring adjustments) for a fair presentation. Operating results for the nine months ended September 30, 2015 are not indicative of the results that may be expected for the fiscal year ending December 31, 2015. You should read these unaudited condensed consolidated financial statements in conjunction with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>Going Concern and Management's Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of September 30, 2015, our current liabilities exceeded our current assets by $9.97 million. Furthermore, during the nine months ended September 30, 2015, we incurred losses of $1,923,286, as further explained in Management's Discussion and Analysis of Financial Condition and Results of Operations appearing in Item 2 of Part I of this Quarterly Report on Form 10-Q.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0">At September 30, 2015 and December 31, 2014, we had $0 and $303,393, respectively, in cash and cash equivalents. Historically, we issued capital stock, sold convertible debt and equity securities and received funds from The RHL Group, Inc. (a significant stockholder that is wholly-owned by our Chairman and Chief Executive Officer, Robert H. Lorsch) to operate our business. Although we received additional funding from The RHL Group pursuant to the Tenth Amended and Restated Note effective May 20, 2015 (the &#34;Line of Credit&#34;), we will still be required to obtain additional financing in order to meet installment payment obligations and the previously existing obligations under the Line of Credit, which had a balance of $1.81 million at September 30, 2015 and a total Unpaid Balance (as defined in the Line of Credit) of $2.06 million, which includes amounts borrowed under the Line of Credit, unpaid interest fees, any amounts guaranteed by The RHL Group, and other obligations due the RHL Group pursuant to the terms of the Tenth Amended and Restated Note and the Second Amended Security Agreement dated May 20, 2015 (the &#34;Security Agreement&#34;). As a result of the above, we express uncertainty about our ability to continue as a going concern. The components of the RHL Group Note payable and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million related to other obligations due to The RHL Group which are included in related party payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Management's plan regarding our going concern is to continue utilizing the Line of Credit. According to the terms of the agreement, at September 30, 2015, there was approximately $2.37 million available under the Line of Credit at the discretion of the lender. Finally, we plan to sell additional convertible debt and equity securities, settle our existing liabilities through the issuance of equity securities, explore other debt financing arrangements, increase our existing subscriber and affiliate customer base, sell our products and services, and collect licensing fees from parties utilizing our intellectual property to obtain additional cash flow over the next twelve months. There can be no assurance that funds from these sources will be available when needed or, if available, will be on terms favorable to us or to our stockholders. If additional funds are raised by issuing equity securities, the percentage of ownership of our stockholders will be reduced, stockholders will experience additional dilution and/or such equity securities may provide for rights, preferences or privileges senior to those of the holders of our common stock. If we are unable to utilize our Line of Credit, obtain suitable alternative debt or equity financing, or increase sales of our products of increase licensing fees from the use of our intellectual property, our ability to execute our business plan and continue as a going concern may be adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">These matters raise substantial doubt about our ability to continue as a going concern. These financial statements were prepared under the assumption that we will continue as a going concern and do not include any adjustments that might result from the outcome of that uncertainty.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>(a) MANAGEMENT'S USE OF ESTIMATES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, allowances for doubtful accounts, the valuation of deferred income taxes, tax contingencies, long-lived and intangible assets, valuation of derivative liabilities and stock-based compensation. These estimates are based on historical experience and on various other factors that management believes to be reasonable under the circumstances, although actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>(b) CASH AND CASH EQUIVALENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We consider cash equivalents to be only those investments that are highly liquid, readily convertible to cash and with maturities of 90 days or less at the purchase date. We maintain our cash in bank deposit accounts that, at times, may exceed federally insured limits. We have not experienced any losses in such accounts and believe that we are not exposed to any significant credit or deposit risk on our cash. We had cash and cash equivalents of $0 and $303,393 as of September 30, 2015 and December 31, 2014, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0"><b>(c) TRADE AND OTHER RECEIVABLES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">Receivables represent claims against third parties that will be settled in cash. The carrying value of receivables, net of an allowance for doubtful accounts, if any, represents their estimated net realizable value. We estimate the allowance for doubtful accounts, if any, based on historical collection trends, type of customer, the age of outstanding receivables and existing economic conditions. If events or changes in circumstances indicate that specific receivable balances may be impaired, we give further consideration to the collectability of those balances and the allowance is adjusted accordingly. We write off past due receivable balances when collection efforts have been unsuccessful in collecting the amount due.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0"><b>(d) INVENTORY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">Inventory is stated at the actual cost, using the first-in-first-out method. On an on-going basis, we evaluate our inventory for obsolescence. This evaluation includes analysis of sales levels, sales projections, and purchases by item. If future demand or market conditions are different than our current estimates, an inventory adjustment may be required, and would be reflected in cost of goods sold in the period the revision is made.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0"><b>(e) FAIR VALUE OF FINANCIAL INSTRUMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">ASC 820-10,<i> Fair Value Measurements and Disclosures,</i> requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. ASC 820-10 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of September 30, 2015 and December 31, 2014, the carrying value of accounts receivable, deposits, related party payables, compensation payable, severance liabilities, and accounts payable and accrued expenses approximates fair value due to the short-term nature of such instruments. The carrying value of short-term debt approximates fair value as the related interest rates approximate rates currently available to us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">We utilize ASC 820-10 for valuing financial assets and liabilities measured on a recurring basis. ASC 820-10 defines fair value, establishes a framework for measuring fair value and generally accepted accounting principles, and expands disclosures about fair value measurements. This standard applies in situations where other accounting pronouncements either permit or require fair value measurements. ASC 820-10 does not require any new fair value measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">Accounting guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">The standard describes three levels of inputs that may be used to measure fair value:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="width: 28%; padding: 0.75pt 0.75pt 6pt">&#160;</td> <td style="vertical-align: top; width: 32%; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Level 1:</font></td> <td style="vertical-align: top; width: 40%; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Quoted prices in active markets for identical or similar assets and liabilities.</font></td></tr> <tr> <td style="padding: 0.75pt 0.75pt 6pt">&#160;</td> <td style="vertical-align: top; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Level 2:</font></td> <td style="vertical-align: top; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Quoted prices for identical or similar assets and liabilities in markets that are not active or observable inputs other than quoted prices in active markets for identical or similar assets and liabilities.</font></td></tr> <tr> <td style="padding: 0.75pt 0.75pt 6pt">&#160;</td> <td style="vertical-align: top; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Level 3:</font></td> <td style="vertical-align: top; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0"><b>(f) IMPAIRMENT OF LONG-LIVED ASSETS AND INTANGIBLES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">We account for long-lived assets, which include property and equipment and identifiable intangible assets with finite useful lives (subject to amortization), in accordance with ASC 350-30. ASC 350-30 requires that we review long-lived assets for impairment whenever events or changes in circumstances indicate that we may not recover the carrying amount of an asset. We measure recoverability by comparing the carrying amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an impairment charge to the extent of the difference between the fair value and the asset's carrying amount. We had no impairment charges during the nine months ended September 30, 2015 and 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-bottom: 6pt; margin-left: 0"><b>(g) REVENUE RECOGNITION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We generate our revenues from services, which are comprised of providing electronic access to consumer medical records and other vital documents, and from the licensing of our intellectual property and services. We recognize revenue only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed, and we are reasonably assured of collectability of the resulting receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our subscriber revenues consist of annual and monthly recurring retail subscriptions and usage-based fees, which are primarily paid in advance by credit card, and corporate accounts that are based on either an access-fee or actual number of users, and in each case billed in advance at the beginning of each month of service. We defer the portions of annual recurring subscription fees collected in advance and recognize them on a straight line basis over the subscription period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We license the rights to use portions of our intellectual property portfolio, which includes certain patent rights essential to the sale of certain PHR products. Licensees typically pay a license fee in one or more installments and ongoing royalties based on their sales of products incorporating or using the Company's licensed intellectual property. License fees are recognized over the estimated period of benefit to the licensee, typically five to fifteen years. The Company earns royalties on such licensed products sold by its licensees at the time that the licensees' sales occur. The Company recognizes royalty revenues based on royalties reported by licensees during the quarter and when other revenue recognition criteria are met.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We grant exclusive and non-exclusive licenses for the sale and marketing of our services in international territories in consideration of license fees and ongoing royalties. The royalty fee is usually a percentage of revenue earned by the licensee and there are usually certain minimum guarantees. We defer the recognition of license fee revenues received in advance from international licensees for the grant of the license and recognize them over the period covered by the agreement. We defer the recognition of minimum guaranteed royalty payments received in advance and recognize them over the period to which the royalty relates. We include all such revenues under &#34;License Fees.&#34; In those cases where a license agreement contains multiple deliverables, we account for the agreement in accordance with ASC 605-25<i> Revenue Recognition - Multiple-Element Arrangements</i> .</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We recognize revenue on sales of our MMRPro system in accordance with ASC 605-25,<i> Revenue Recognition, Multiple-Element Arrangements</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our multiple-deliverable arrangements consist solely of our MMRPro product. Significant deliverables within these arrangements include scanning equipment, various licenses to use third party software, a license to use our proprietary MMRPro application software, installation and training, dedicated telephone lines, secure online storage and warranties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We determined all elements to be separate units of accounting as they have standalone value to the customers and/or they are sold by other vendors on a standalone basis. Delivery of the hardware and certain software elements of these arrangements occur at the inception of the agreement. We deliver installation and training at the inception of the agreement. We provide other software licenses, telephone lines and online secure storage over the three year term of the agreement. We include warranties in the arrangements, however the third party product manufacturer, and not us, is obligated to fulfill such warranties. The third-party warranty contracts are paid in advance and are not refundable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We allocate the revenue derived from these arrangements among all the deliverables. We base such allocation on the relative selling price of each deliverable. With the exception of our proprietary MMRPro application software, we use third party evidence to set the selling prices used for this allocation. In all such cases, third parties sell the same or very similar products. For the MMRPro application software, we estimate the selling price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We recognize the allocated revenue for each deliverable in accordance with SEC Staff Accounting Bulletin (&#34;SAB&#34;) No. 104,<i> Topic 13: Revenue Recognition</i> . Under this guidance, we recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed and determinable and collectability is reasonably assured. This results in us recognizing revenue for the hardware, certain software and the warranties upon delivery to the customer, for the installation and training upon completion of these services, and ratably over the contract period for the software licenses, telephone lines and online secure storage.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0">Revenue from the licensing of our biotech assets may include non-refundable license and up-front fees, non-refundable milestone payments that are triggered upon achievement of a specific event, and future royalties or lump-sum payments on sales of related products. For agreements that provide for milestone payments, we adopted ASC 605-28-25,<i> Revenue Recognition Milestone Method.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>(h) SHARE-BASED COMPENSATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We account for share-based compensation in accordance with ASC 718-20,<i> Awards Classified as Equity</i>. We apply ASC 718- 20 in accounting for stock-based awards issued to employees under the recognition of compensation expense related to the fair value of employee share-based awards, including stock options and restricted stock. Determining the fair value of options at the grant date requires judgment, including estimating the expected term that stock options will be outstanding prior to exercise, the associated volatility and the expected dividends. Judgment is required in estimating the amount of share-based awards expected to be forfeited prior to vesting. If actual forfeitures differ significantly from these estimates, share-based compensation expense could be materially impacted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We account for options and warrants issued to non-employees in accordance with ASC 505-50,<i> Equity-Based Payments to Non- Employees</i>. We treat options and warrants issued to non-employees the same as those issued to employees with the exception of determination of the measurement date. The measurement date is the earlier of (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty's performance is complete. Options and warrants granted to consultants are valued at their respective measurement dates, and recognized as an expense based on the portion of the total consulting services provided during the applicable period. As further consulting services are provided in future periods, we will revalue the associated options and warrants and recognize additional expense based on their then current values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We estimate the fair value of each stock option on the date of grant using the Black-Scholes option pricing model. We determine assumptions relative to volatility and anticipated forfeitures at the time of grant. We valued grants of stock options and warrants during the nine months ended September 30, 2015 and 2014 using the following assumptions.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2015</b></font></td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2014</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Expected life in years</font></td> <td style="text-align: center"><font style="font-size: 10pt">2 - 5 Years</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0 - 5 Years</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Stock price volatility</font></td> <td style="text-align: center"><font style="font-size: 10pt">120.51% - 122.72%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">123.47% - 124.21%</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Risk free interest rate</font></td> <td style="text-align: center"><font style="font-size: 10pt">0.04% - 1.38%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0.35% - 0.46%</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Expected dividends</font></td> <td style="text-align: center"><font style="font-size: 10pt">None</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">None</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Forfeiture rate</font></td> <td style="text-align: center"><font style="font-size: 10pt">0%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We base the assumptions used in the Black-Scholes models upon the following data: (1) our use of the contractual life of the underlying non-employee warrants as the expected life; the expected life of the employee options used in this calculation is the period of time the options are expected to be outstanding and has been determined based on historical exercise experience; (2) in the absence of an extensive public market for our shares, the expected stock price volatility of the underlying shares over the expected term of the option or warrant was taken at approximately the mid-point of the range for similar companies at the various grant dates; (3) we base the risk free interest rate on published U.S. Treasury Department interest rates for the expected terms of the underlying options or warrants; (4) we base expected dividends on historical dividend data and expected future dividend activity; and (5) we base the expected forfeiture rate on historical forfeiture activity and assumptions regarding future forfeitures based on the composition of current grantees.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0"><b>(i) NET INCOME/LOSS PER SHARE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We apply the guidance of ASC 260-10,<i> Earnings Per Share</i> for calculating the basic and diluted loss per share. We calculate basic loss per share by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding. We compute diluted loss per share similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. We exclude common equivalent shares from the computation of net loss per share if their effect is anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We excluded all potential anti-dilutive common shares from the computation of diluted net loss per common share for the nine months ended September 30, 2015 and 2014 because they were anti-dilutive due to our net loss position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>(j) RECENT ACCOUNTING PRONOUNCEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with no early adoption permitted. The standard permits the use of either the retrospective or cumulative effect transition method. At this time we have not selected a transition method. We are currently evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In August 2014, the FABS issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (&#34;ASU 2014-15&#34;). ASU 2014-15 will explicitly require management to assess an entity's ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. Earlier adoption is permitted. We are currently evaluating the impact of the adoption of ASU 2014-15. The adoption of this standard is not expected to have a material impact on the Company's consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 3 - RELATED PARTY PAYABLES, LINE OF CREDIT AND NOTE PAYABLE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On May 20, 2015, we and The RHL Group entered into a Tenth Amended and Restated Promissory Note (the &#34;<u>Amended Note</u>&#34;), effective as of May 20, 2015. The Tenth Note amends and restates that certain Ninth Amended Note entered into between the foregoing parties, effective July 10, 2014 (the &#34;<u> Existing Note</u>&#34; and together with its predecessor notes and the Amended Note, the &#34;<u>Credit Facility</u>&#34;), by: (i) extending the maturity date to April 29, 2016. In connection with the Tenth Amended Note, we issued The RHL Group warrants to purchase 1,764,642 shares of our common stock at $0.003 per share on May 20, 2015. Except as set forth above, the Amended Note does not materially alter the terms of the Existing Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Historically, the predecessor notes have increased over time the maximum amount of credit available under the Credit Facility from $100,000 to $1,000,000 to $3,000,000 to $4,500,000. The maximum amount of the Amended Note is $4,500,000. The Amended Note continues to bear interest at the lesser of 10% or the highest rate then permitted by law, and is secured (similar to the Existing Note) by a Security Agreement, which has been in effect since July 31, 2007, as renewed and amended to date (the &#34;Security Agreement&#34;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Tenth Amended Note had a current balance of $1.81 million at September 30, 2015. The components of the Tenth Amended Note and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million for other obligations due to The RHL Group, which is included in related party payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Total interest expense for the three months ended September 30, 2015 and September 30, 2014 was $36,699 and $36,952, respectively. Total interest expense on the Line of Credit for the nine months ended September 30, 2015 and 2014 amounted to $102,433 and $98,985, respectively. The unpaid interest balances as of September 30, 2015 and December 31, 2014 were $36,757 and $30,160, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0">In conjunction with the Tenth Amended Note, we were required to maintain certain financial covenants, including the requirement that we have at least $200,000 of cash in our bank accounts or such other amount as necessary to maintain operations through the subsequent thirty (30) days and timely pay any obligations due respecting payroll and all associated payroll taxes on and after September 30, 2015. Since we did not meet these covenants as of September 30, 2015, we received a waiver from The RHL Group until November 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 4 - INCOME TAXES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Under ASC 740-270,<i> Income Taxes - Interim Reporting</i>, we are required to adjust our effective tax rate each quarter to be consistent with the estimated annual effective tax rate. We are also required to record the tax impact of certain discrete items, unusual or infrequently occurring, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur. In addition, we exclude jurisdictions with a projected loss for the year or a year-to-date loss where we cannot recognize a tax benefit from our estimated annual effective tax rate. The impact of such an exclusion could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings versus annual projections.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Pursuant to ASC 740,<i> Income</i> Taxes, we performed an analysis of previous tax filings and determined that there were no positions taken that it considered uncertain. Therefore, there were no unrecognized tax benefits As of September 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">MMR Inc., in its capacity as the operating company taking over our income tax positions in addition to its own positions after January 27, 2009 (see Note 1), has estimated its annual effective tax rate to be zero. MMRGlobal has based this on an expectation that the combined entity will generate net operating losses in 2015, and it is not likely that those losses will be recovered using future taxable income. Therefore, no provision for income tax has been recorded as of and for the nine months ended September 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 5 - COMMITMENTS AND CONTINGENCIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Leases</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Effective September 1, 2013, we renewed our lease for office space in Los Angeles, California with a term through August 31, 2018. The lease currently requires a monthly payment of $8,250. Total rent expense for the nine months ended September 30, 2015 and 2014 were $86,854 and $129,276 respectively. Future minimum lease payments as of September 30, 2015, under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt"><b>Year Ending </b></font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Operating</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Capital</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt"><font style="font-size: 10pt"><b>December 31, </b></font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Leases</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Leases</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; 2015 (Remainder of)&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">26,445&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">13,221&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; 2016&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">187,550&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; 2017&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">206,305&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; 2018 and there after</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">146,410&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">566,710&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">13,221&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; Less current portion&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">(13,221)</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Total minimum lease payments&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">566,710&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 6 - STOCKHOLDERS' DEFICIT</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Preferred Stock</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have 5,000,000 shares of preferred stock authorized. As of September 30, 2015, and December 31, 2014, there were no shares of preferred stock issued and outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Common Stock</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of September 30, 2015, we are authorized to issue 1,250,000,000 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of September 30, 2015, the total shares of our common stock issued and outstanding amounted to 902,504,231.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 7 - EQUITY ISSUANCES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><i>Stock Option Activity</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our 2001 Equity Incentive Plan (the &#34;2001 Plan&#34;) expired on June 5, 2011 and no options were issued under the 2001 Plan since that date. As of September 30, 2015, 14,184,557 shares remain issued under the 2001 Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On September 1, 2011, our Board of Directors approved the adoption of a new plan to replace the 2001 Plan under the same general terms as the 2001 Plan. On June 20, 2012, our stockholders voted and approved the 2011 Equity Incentive Plan (the &#34; 2011 Plan&#34;) at our 2012 Annual Stockholder Meeting. As of September 30, 2015, 23.36 million shares remain issued under the 2011 Plan, and 36.45 million shares of our common stock are reserved for future issuance under our 2011 Plan, which includes an automatic 5 million share annual increase pursuant to the terms of the 2011 Plan and a 20 million share increase authorized during our 2013 Annual Stockholder's Meeting.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0">A summary of option activity for the nine months ended September 30, 2015 is presented below. Options granted by MMR Inc. prior to the date of the Merger have been retroactively restated to reflect the conversion ratio of MMR Inc. to MMR shares.</p> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 49%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 10%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 9%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 17%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted-Average</b></font></td> <td style="width: 1%; padding: 0.75pt; text-align: center">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 9%; padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted-</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Life</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Options</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>(Years)</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Outstanding at December 31, 2014</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.10&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">4.29&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Granted</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Exercised</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Cancelled</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Outstanding at September 30, 2015 (Unaudited)</font></td> <td style="padding: 0.75pt">&#160;</td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.10&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">3.54&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Vested and expected to vest</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; at September 30, 2015 (Unaudited)</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.10&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">3.54&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Exercisable at September 30, 2015 (Unaudited)</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.10&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">3.54&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The aggregate intrinsic value in the table above is before applicable income taxes and is calculated based on the difference between the exercise price of the options and the quoted price of the common stock as of the reporting date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">There were no options issued during the nine months ended September 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Total stock option expenses recorded during the nine months ended September 30, 2015 and 2014 were $16,759 and $151,634, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The following table summarizes information about stock options outstanding and exercisable at September 30, 2015.</p> <table cellspacing="1" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td colspan="9" style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding</b></font></td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Options Exercisable</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 12%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 13%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 14%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 12%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 13%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 14%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 12%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>of Shares</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Life (Years)</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>of Shares</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Life (Years)</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">0.05 - 0.09</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">12,900,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">6.66</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.07&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">12,900,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">6.66</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.07&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">0.10 - 0.15</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">23,011,461&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">3.44</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.11&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">23,011,461&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">3.44</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.11&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">&#62; 0.15</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">1,630,261&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">4.45</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.19&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">1,630,261&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">4.45</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.19&#160;</font></td></tr> <tr> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Warrants</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">A summary of the activity of our warrants for the nine months ended September 30, 2015 is presented below:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 53%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 18%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 3%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 5%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 21%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted Avg.</b></font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Outstanding at December 31, 2014</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">70,028,410&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.07&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Granted</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">1,764,642&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.003&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Exercised</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Cancelled</font></td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">(14,650,000)</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.08&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Outstanding at September 30, 2015 (Unaudited)</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">57,143,052&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.06&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Exercisable at September 30, 2015 (Unaudited)</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">55,719,441</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.06</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Total warrant expenses recorded during the nine months ended September 30, 2015 and 2014 were $11,170 and $144,232, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The inputs used for the Black-Scholes option and warrant valuation model were as follows:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2015</b></font></td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2014</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Expected life in years</font></td> <td style="text-align: center"><font style="font-size: 10pt">2 - 5 Years</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0 - 5 Years</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Stock price volatility</font></td> <td style="text-align: center"><font style="font-size: 10pt">120.51% - 122.72%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">123.47% - 124.21%</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Risk free interest rate</font></td> <td style="text-align: center"><font style="font-size: 10pt">0.04% - 1.38%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0.35% - 0.46%</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Expected dividends</font></td> <td style="text-align: center"><font style="font-size: 10pt">None</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">None</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Forfeiture rate</font></td> <td style="text-align: center"><font style="font-size: 10pt">0%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><i>Shares Issued for Services or Reduction to Liabilities</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">During the nine months ended September 30, 2015, we issued 120,100,000 shares of common stock with a value of $413,220 to various third parties and related parties and charged the proceeds to the appropriate accounts for the following reasons:</p> <table cellspacing="1" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Nine Months Ended September 30, 2015</b></font></td></tr> <tr style="vertical-align: top"> <td style="width: 42%; border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Purpose</b></font></td> <td style="width: 4%; padding: 0.75pt; text-align: center">&#160;</td> <td style="width: 23%; border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="width: 4%; padding: 0.75pt; text-align: center">&#160;</td> <td style="width: 5%; padding: 0.75pt; text-align: center">&#160;</td> <td style="width: 22%; border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Reduction of payables and notes&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">112,100,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">375,021&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Services provided&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">8,000,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">38,199&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Totals&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">120,100,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">413,220&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The 120,100,000 issued shares were not contractually restricted. However, as these shares have not been registered under the Securities Act of 1933, as amended (the &#34;Act&#34;), they are restricted from sale until they are registered under the Act, or qualify for resale under the rules promulgated under the Act. All such shares were calculated at the trading closing price on the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><i>Stock Bonus Agreements</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">From time to time, we issue shares of our common stock as a bonus for services rendered. Stock bonuses may be awarded upon satisfaction of specified performance goals pursuant to the Performance Stock Bonus Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On each grant date, we valued the stock bonus based on the share price and the expenses were amortized using the straight line method. Total stock bonus expenses recorded during the nine months ended September 30, 2015 and 2014 were $0 and $ 245,375, respectively and are reflected in operating expenses in the accompanying consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 8 - NOTES PAYABLE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Notes payable consisted of the following:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2015</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2014</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Promissory notes payable due to the former officers of MMRGlobal as part of severance packages, due in full on August 31, 2009, with no stated interest</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">76,783&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">76,783&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Promissory notes payable due to the former officers of MMRGlobal pursuant to the </font><br /> <font style="font-size: 10pt">Resignation and Post-Merger Employment Arrangement, due in full on August 31, 2009, with no stated interest</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">25,444&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">25,444&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Promissory notes payable due to vendors relating to settlement of certain outstanding accounts payable, payable in 18 equal monthly installments commencing on July 27, 2009 and ending on January 27, 2011, with no stated interest</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">223,116&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">223,116&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td><font style="font-size: 10pt">Short term loan due to a third-party with 6% interest</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">44,067&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">35,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">369,410&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">360,343&#160;</font></td></tr> <tr style="vertical-align: top"> <td><font style="font-size: 10pt">Less: current portion</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(369,410)</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(360,343)</font></td></tr> <tr style="vertical-align: top"> <td><font style="font-size: 10pt">Notes payable, less current portion</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Short term loan due to a related-party, payable in full on </font><br /> <font style="font-size: 10pt">January 2, 2014 with 12% interest&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">203,664&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">203,664&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Short term loan due to a related-party, payable in full on </font><br /> <font style="font-size: 10pt">May 31, 2014 with 12% interest </font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">50,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">50,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Notes payable related party, current portion</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">253,664&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">253,664&#160;</font></td></tr> <tr> <td style="vertical-align: top"><font style="font-size: 10pt">Less: current portion</font></td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(253,664)</font></td> <td style="text-align: right">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(253,664)</font></td></tr> <tr> <td style="vertical-align: top"><font style="font-size: 10pt">Notes payable related party, less current portion</font></td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 9 - CONVERTIBLE PROMISSORY NOTES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">From time to time, we issue Convertible Promissory Notes. As of September 30, 2015, a total of $887,027 in convertible notes remained outstanding. As of September 30, 2015, all of these Notes have matured, however, the Company and the Holders have agreed to keep the balance as a Note Payable and the note holders have elected not to convert their note balances into shares of our common stock as of September 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0">Each Note contains the following general terms and provisions:</p> <ul style="margin-top: 0in"> <li style="margin: 4pt 0; font-size: 10pt">The principal amount owed under each note becomes due and payable one year or less from the investment date provided that, upon ten (10) days' prior written notice to the holder, we may, in our sole discretion, extend the maturity date for an additional six month term. The Notes can be further extended upon mutual agreement.</li> <li style="margin: 4pt 0; font-size: 10pt">These notes bear interest at a rate of 6% per annum payable in cash or shares of common stock or a combination of cash and shares of common stock at our option.</li> </ul> <p style="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0">During the third quarter of 2015, we did not enter into any Convertible Promissory Notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0">Shares issuable upon conversion for convertible notes payable was 41,679,061 as of September 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The total interest expense attributed to the Beneficial Conversion Feature of the Notes and related warrants for the nine months ended September 30, 2015 and 2014 was $55,780 and $124,120, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 10 - RESTRUCTURING ACTIVITIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In connection with the merger with Favrille, Inc. in 2009, we signed promissory notes with certain former executives totaling $76,783.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of September 30, 2015, the total remaining severance liabilities amounted to $620,613, which is reflected as severance liability on the accompanying consolidated balance sheets. This consists of $571,362 payable to former non-executive employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 11 - RELATED PARTY TRANSACTIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our Chairman and Chief Executive Officer, Robert H. Lorsch, is also the Chief Executive Officer of The RHL Group, Inc. and has full voting power over all of the capital stock of The RHL Group, Inc. Mr. Lorsch directly and indirectly through The RHL Group, Inc., beneficially owns approximately 16.4% our total outstanding voting stock. The RHL Group, Inc. has loaned us money pursuant to the Tenth Amended Note and all predecessor notes. See Note 3 - Related Party Note Payable above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The RHL Group is an investment holding company which provides consulting, operational and technical services to us, which we refer to as the RHL Services. As part of the RHL Services, The RHL Group provides us with unrestricted access to its internal business and relationship contact database of more than 10,000 persons and entities, which includes clients of The RHL Group and other individuals which may hold value to us. The RHL Group also provides infrastructure support to us, including allowing us unlimited access to its facilities, equipment, and data, information management and server systems. In addition to allowing us the use of its office support personnel, The RHL Group has also consented to allow us to utilize the full-time services of Mr. Lorsch as our President, Chairman and Chief Executive Officer, which requires substantial time and energy away from his required duties as The RHL Group's Chairman and Chief Executive Officer. In addition, The RHL Group has made its President, Kira Reed, available as our spokesperson. Ms. Reed, who is Mr. Lorsch's spouse, also manages our social networking activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In consideration for the above, The RHL Group, Inc. has a consulting arrangement with MMR. A copy of the consulting agreement is filed as an exhibit in our Form 8-K, as filed with the SEC on May 4, 2009 and is hereby incorporated by reference.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We incurred $12,500 during the nine months ended September 30, 2015 and 2014, toward marketing consulting services from Bernard Stolar, a director. We included $198,514 and $174,273 in related party payables as of September 30, 2015 and December 31, 2014, respectively, in connection with these services and board fees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">We contract with a significant vendor for the development and maintenance of the software applications necessary to run our MyMedicalRecords PHR, MyEsafeDepositBox and MyMedicalRecords Pro products. Our outside developer supports our software development needs through a team of software engineers, programmers, quality control personnel and testers, who work with our internal product development team on all aspects of application development, design, integration and support of our products. This vendor is also a stockholder. For the nine months ended September 30, 2015 and 2014, the total expenses relating to this stockholder amounted to $90,000 and $90,000, respectively. In addition, we capitalized $0 of software development costs for the quarter ended September 30, 2015. As of September 30, 2015 and December 31, 2014, the total amounts due to the stockholder and included in related party payables amounted to $100,000 and $10,000, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">On September 15, 2009, we entered into a five year agreement with E-Mail Frequency, LLC and David Loftus, Managing Partner of E-Mail Frequency, LLC, a significant stockholder of the Company, which was amended during 2011 to increase the term for an additional five years and provide licensor a non- exclusive right to target, market and exploit the Employee Benefits market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">We licensed an existing 80 million person direct marketing database (the &#34;Database&#34;) of street addresses, cellular phone numbers, e-mail addresses and other comprehensive data with E-Mail Frequency. The agreement allows us to market, through the use of the Database, our MyMedicalRecords PHR, MyEsafeDepositBox virtual vault, and MMRPro document management system to physicians and their patients. Under the terms of the Agreement, we paid $250,000 to David Loftus as a one-time consulting fee in the form of 2,777,778 shares of our common stock. We recorded the $250,000 one-time licensee fee as a prepaid consulting fee. Amortization expense for each of the quarters ended September 30, 2015 and 2014 was $0 and $37,500. Included in related party payables at September 30, 2015 and December 31, 2014 of $64,615 and $64,615, respectively, in respect to these services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 12 - SUBSEQUENT EVENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have evaluated subsequent events of our condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 8, 2015, we received written consent from our company's board of directors to amend the Corporation's Articles of Incorporation to effect a reverse stock split, such that each five (5) shares of the issued and outstanding Common Stock of the Corporation shall be reversed split into one (1) share of Common Stock of the Corporation (the &#34;Stock Split&#34;). This Stock Split shall effect only issued and outstanding shares. Each record and beneficial holder who would receive a fractional share as a result of the reverse split shall receive, in lieu thereof, a whole share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On November 4, 2015, the Corporation received the written consent of holders of more than 50% of our voting securities to effect the Stock Split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Stock Split will not be effective until after filing by the Corporation of its Schedule 14C Information with the Securities and Exchange Commission and amendment of the Corporation's Articles of Incorporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In addition, the Corporation will file a corporation action notification with FINRA to effect the Stock Split on the market, and must receive approval thereof prior to filing amended Articles of Incorporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The number of shares presented in this quarterly report do not reflect the reverse stock split expected to become effective in the 4<sup>th</sup> quarter of 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 16, 2015, we granted a total of 10,000,000 shares of restricted common stock to an unrelated third party, at a price of $0.0032 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 19, 2015, we granted a total of 7,894,000 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 19, 2015, we granted a total of 30,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.0038 in consideration of a reduction in payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 22, 2015, we granted a total of 6,842,105 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 22, 2015, The RHL Group, Inc., an entity affiliated with our Chairman &#38; CEO Robert H. Lorsch elected to purchase 46,000,000 shares of common stock at market price in consideration for a reduction in amounts due of $174,800.00.</p> <p style="font: 10pt TimesNewRomanPSMT; margin-right: 0; margin-left: 0">On October 29, 2015, we granted a total of 10,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.005 in consideration of a reduction in payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 309393 0 10359 1491510 47718 96829 13537 13537 162184 47885 532832 158251 32118 22645 1790622 1757109 2355572 1938005 952835 1472150 198514 174273 100000 10000 64615 64615 620613 620613 620613 774211 902298 0.001 0.001 5000000 5000000 0 0 0 0 0.001 0.001 1250000000 1250000000 253664 253664 50000 50000 203664 203664 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Principles of Consolidation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The consolidated financial statements include the accounts of MMRGlobal, and its wholly-owned subsidiaries MMR and MMR Life Sciences Group, Inc. All intercompany transactions and balances are eliminated upon consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>(a) MANAGEMENT'S USE OF ESTIMATES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, allowances for doubtful accounts, the valuation of deferred income taxes, tax contingencies, long-lived and intangible assets, valuation of derivative liabilities and stock-based compensation. These estimates are based on historical experience and on various other factors that management believes to be reasonable under the circumstances, although actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>(g) REVENUE RECOGNITION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We generate our revenues from services, which are comprised of providing electronic access to consumer medical records and other vital documents, and from the licensing of our intellectual property and services. We recognize revenue only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed, and we are reasonably assured of collectability of the resulting receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our subscriber revenues consist of annual and monthly recurring retail subscriptions and usage-based fees, which are primarily paid in advance by credit card, and corporate accounts that are based on either an access-fee or actual number of users, and in each case billed in advance at the beginning of each month of service. We defer the portions of annual recurring subscription fees collected in advance and recognize them on a straight line basis over the subscription period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We license the rights to use portions of our intellectual property portfolio, which includes certain patent rights essential to the sale of certain PHR products. Licensees typically pay a license fee in one or more installments and ongoing royalties based on their sales of products incorporating or using the Company's licensed intellectual property. License fees are recognized over the estimated period of benefit to the licensee, typically five to fifteen years. The Company earns royalties on such licensed products sold by its licensees at the time that the licensees' sales occur. The Company recognizes royalty revenues based on royalties reported by licensees during the quarter and when other revenue recognition criteria are met.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We grant exclusive and non-exclusive licenses for the sale and marketing of our services in international territories in consideration of license fees and ongoing royalties. The royalty fee is usually a percentage of revenue earned by the licensee and there are usually certain minimum guarantees. We defer the recognition of license fee revenues received in advance from international licensees for the grant of the license and recognize them over the period covered by the agreement. We defer the recognition of minimum guaranteed royalty payments received in advance and recognize them over the period to which the royalty relates. We include all such revenues under &#34;License Fees.&#34; In those cases where a license agreement contains multiple deliverables, we account for the agreement in accordance with ASC 605-25<i> Revenue Recognition - Multiple-Element Arrangements</i> .</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We recognize revenue on sales of our MMRPro system in accordance with ASC 605-25,<i> Revenue Recognition, Multiple-Element Arrangements</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our multiple-deliverable arrangements consist solely of our MMRPro product. Significant deliverables within these arrangements include scanning equipment, various licenses to use third party software, a license to use our proprietary MMRPro application software, installation and training, dedicated telephone lines, secure online storage and warranties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We determined all elements to be separate units of accounting as they have standalone value to the customers and/or they are sold by other vendors on a standalone basis. Delivery of the hardware and certain software elements of these arrangements occur at the inception of the agreement. We deliver installation and training at the inception of the agreement. We provide other software licenses, telephone lines and online secure storage over the three year term of the agreement. We include warranties in the arrangements, however the third party product manufacturer, and not us, is obligated to fulfill such warranties. The third-party warranty contracts are paid in advance and are not refundable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We allocate the revenue derived from these arrangements among all the deliverables. We base such allocation on the relative selling price of each deliverable. With the exception of our proprietary MMRPro application software, we use third party evidence to set the selling prices used for this allocation. In all such cases, third parties sell the same or very similar products. For the MMRPro application software, we estimate the selling price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We recognize the allocated revenue for each deliverable in accordance with SEC Staff Accounting Bulletin (&#34;SAB&#34;) No. 104,<i> Topic 13: Revenue Recognition</i> . Under this guidance, we recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed and determinable and collectability is reasonably assured. This results in us recognizing revenue for the hardware, certain software and the warranties upon delivery to the customer, for the installation and training upon completion of these services, and ratably over the contract period for the software licenses, telephone lines and online secure storage.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0">Revenue from the licensing of our biotech assets may include non-refundable license and up-front fees, non-refundable milestone payments that are triggered upon achievement of a specific event, and future royalties or lump-sum payments on sales of related products. For agreements that provide for milestone payments, we adopted ASC 605-28-25,<i> Revenue Recognition Milestone Method.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Going Concern and Management's Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of September 30, 2015, our current liabilities exceeded our current assets by $9.97 million. Furthermore, during the nine months ended September 30, 2015, we incurred losses of $1,923,286, as further explained in Management's Discussion and Analysis of Financial Condition and Results of Operations appearing in Item 2 of Part I of this Quarterly Report on Form 10-Q.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0">At September 30, 2015 and December 31, 2014, we had $0 and $303,393, respectively, in cash and cash equivalents. Historically, we issued capital stock, sold convertible debt and equity securities and received funds from The RHL Group, Inc. (a significant stockholder that is wholly-owned by our Chairman and Chief Executive Officer, Robert H. Lorsch) to operate our business. Although we received additional funding from The RHL Group pursuant to the Tenth Amended and Restated Note effective May 20, 2015 (the &#34;Line of Credit&#34;), we will still be required to obtain additional financing in order to meet installment payment obligations and the previously existing obligations under the Line of Credit, which had a balance of $1.81 million at September 30, 2015 and a total Unpaid Balance (as defined in the Line of Credit) of $2.06 million, which includes amounts borrowed under the Line of Credit, unpaid interest fees, any amounts guaranteed by The RHL Group, and other obligations due the RHL Group pursuant to the terms of the Tenth Amended and Restated Note and the Second Amended Security Agreement dated May 20, 2015 (the &#34;Security Agreement&#34;). As a result of the above, we express uncertainty about our ability to continue as a going concern. The components of the RHL Group Note payable and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million related to other obligations due to The RHL Group which are included in related party payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Management's plan regarding our going concern is to continue utilizing the Line of Credit. According to the terms of the agreement, at September 30, 2015, there was approximately $2.37 million available under the Line of Credit at the discretion of the lender. Finally, we plan to sell additional convertible debt and equity securities, settle our existing liabilities through the issuance of equity securities, explore other debt financing arrangements, increase our existing subscriber and affiliate customer base, sell our products and services, and collect licensing fees from parties utilizing our intellectual property to obtain additional cash flow over the next twelve months. There can be no assurance that funds from these sources will be available when needed or, if available, will be on terms favorable to us or to our stockholders. If additional funds are raised by issuing equity securities, the percentage of ownership of our stockholders will be reduced, stockholders will experience additional dilution and/or such equity securities may provide for rights, preferences or privileges senior to those of the holders of our common stock. If we are unable to utilize our Line of Credit, obtain suitable alternative debt or equity financing, or increase sales of our products of increase licensing fees from the use of our intellectual property, our ability to execute our business plan and continue as a going concern may be adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">These matters raise substantial doubt about our ability to continue as a going concern. These financial statements were prepared under the assumption that we will continue as a going concern and do not include any adjustments that might result from the outcome of that uncertainty.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>(e) FAIR VALUE OF FINANCIAL INSTRUMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">ASC 820-10,<i> Fair Value Measurements and Disclosures,</i> requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. ASC 820-10 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of September 30, 2015 and December 31, 2014, the carrying value of accounts receivable, deposits, related party payables, compensation payable, severance liabilities, and accounts payable and accrued expenses approximates fair value due to the short-term nature of such instruments. The carrying value of short-term debt approximates fair value as the related interest rates approximate rates currently available to us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">We utilize ASC 820-10 for valuing financial assets and liabilities measured on a recurring basis. ASC 820-10 defines fair value, establishes a framework for measuring fair value and generally accepted accounting principles, and expands disclosures about fair value measurements. This standard applies in situations where other accounting pronouncements either permit or require fair value measurements. ASC 820-10 does not require any new fair value measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">Accounting guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 6pt; margin-left: 0">The standard describes three levels of inputs that may be used to measure fair value:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="width: 28%; padding: 0.75pt 0.75pt 6pt">&#160;</td> <td style="vertical-align: top; width: 32%; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Level 1:</font></td> <td style="vertical-align: top; width: 40%; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Quoted prices in active markets for identical or similar assets and liabilities.</font></td></tr> <tr> <td style="padding: 0.75pt 0.75pt 6pt">&#160;</td> <td style="vertical-align: top; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Level 2:</font></td> <td style="vertical-align: top; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Quoted prices for identical or similar assets and liabilities in markets that are not active or observable inputs other than quoted prices in active markets for identical or similar assets and liabilities.</font></td></tr> <tr> <td style="padding: 0.75pt 0.75pt 6pt">&#160;</td> <td style="vertical-align: top; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Level 3:</font></td> <td style="vertical-align: top; padding: 0.75pt 0.75pt 6pt"><font style="font-size: 10pt">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"><b>(h) SHARE-BASED COMPENSATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We account for share-based compensation in accordance with ASC 718-20,<i> Awards Classified as Equity</i>. We apply ASC 718- 20 in accounting for stock-based awards issued to employees under the recognition of compensation expense related to the fair value of employee share-based awards, including stock options and restricted stock. Determining the fair value of options at the grant date requires judgment, including estimating the expected term that stock options will be outstanding prior to exercise, the associated volatility and the expected dividends. Judgment is required in estimating the amount of share-based awards expected to be forfeited prior to vesting. If actual forfeitures differ significantly from these estimates, share-based compensation expense could be materially impacted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We account for options and warrants issued to non-employees in accordance with ASC 505-50,<i> Equity-Based Payments to Non- Employees</i>. We treat options and warrants issued to non-employees the same as those issued to employees with the exception of determination of the measurement date. The measurement date is the earlier of (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty's performance is complete. Options and warrants granted to consultants are valued at their respective measurement dates, and recognized as an expense based on the portion of the total consulting services provided during the applicable period. As further consulting services are provided in future periods, we will revalue the associated options and warrants and recognize additional expense based on their then current values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We estimate the fair value of each stock option on the date of grant using the Black-Scholes option pricing model. We determine assumptions relative to volatility and anticipated forfeitures at the time of grant. We valued grants of stock options and warrants during the nine months ended September 30, 2015 and 2014 using the following assumptions.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2015</b></font></td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2014</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Expected life in years</font></td> <td style="text-align: center"><font style="font-size: 10pt">2 - 5 Years</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0 - 5 Years</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Stock price volatility</font></td> <td style="text-align: center"><font style="font-size: 10pt">120.51% - 122.72%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">123.47% - 124.21%</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Risk free interest rate</font></td> <td style="text-align: center"><font style="font-size: 10pt">0.04% - 1.38%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0.35% - 0.46%</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Expected dividends</font></td> <td style="text-align: center"><font style="font-size: 10pt">None</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">None</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Forfeiture rate</font></td> <td style="text-align: center"><font style="font-size: 10pt">0%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We base the assumptions used in the Black-Scholes models upon the following data: (1) our use of the contractual life of the underlying non-employee warrants as the expected life; the expected life of the employee options used in this calculation is the period of time the options are expected to be outstanding and has been determined based on historical exercise experience; (2) in the absence of an extensive public market for our shares, the expected stock price volatility of the underlying shares over the expected term of the option or warrant was taken at approximately the mid-point of the range for similar companies at the various grant dates; (3) we base the risk free interest rate on published U.S. Treasury Department interest rates for the expected terms of the underlying options or warrants; (4) we base expected dividends on historical dividend data and expected future dividend activity; and (5) we base the expected forfeiture rate on historical forfeiture activity and assumptions regarding future forfeitures based on the composition of current grantees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>(i) NET INCOME/LOSS PER SHARE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We apply the guidance of ASC 260-10,<i> Earnings Per Share</i> for calculating the basic and diluted loss per share. We calculate basic loss per share by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding. We compute diluted loss per share similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. We exclude common equivalent shares from the computation of net loss per share if their effect is anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We excluded all potential anti-dilutive common shares from the computation of diluted net loss per common share for the nine months ended September 30, 2015 and 2014 because they were anti-dilutive due to our net loss position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>(j) RECENT ACCOUNTING PRONOUNCEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with no early adoption permitted. The standard permits the use of either the retrospective or cumulative effect transition method. At this time we have not selected a transition method. We are currently evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In August 2014, the FABS issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (&#34;ASU 2014-15&#34;). ASU 2014-15 will explicitly require management to assess an entity's ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. Earlier adoption is permitted. We are currently evaluating the impact of the adoption of ASU 2014-15. The adoption of this standard is not expected to have a material impact on the Company's consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The inputs used for the Black-Scholes option and warrant valuation model were as follows:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2015</b></font></td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2014</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Expected life in years</font></td> <td style="text-align: center"><font style="font-size: 10pt">2 - 5 Years</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0 - 5 Years</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Stock price volatility</font></td> <td style="text-align: center"><font style="font-size: 10pt">120.51% - 122.72%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">123.47% - 124.21%</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Risk free interest rate</font></td> <td style="text-align: center"><font style="font-size: 10pt">0.04% - 1.38%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0.35% - 0.46%</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Expected dividends</font></td> <td style="text-align: center"><font style="font-size: 10pt">None</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">None</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Forfeiture rate</font></td> <td style="text-align: center"><font style="font-size: 10pt">0%</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">0%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Future minimum lease payments as of September 30, 2015, under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt"><b>Year Ending </b></font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Operating</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Capital</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt"><font style="font-size: 10pt"><b>December 31, </b></font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Leases</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Leases</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; 2015 (Remainder of)&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">26,445&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">13,221&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; 2016&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">187,550&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; 2017&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">206,305&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; 2018 and there after</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">146,410&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">566,710&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">13,221&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; Less current portion&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">(13,221)</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Total minimum lease payments&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">566,710&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Notes payable consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2015</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2014</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Promissory notes payable due to the former officers of MMRGlobal as part of severance packages, due in full on August 31, 2009, with no stated interest</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">76,783&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">76,783&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Promissory notes payable due to the former officers of MMRGlobal pursuant to the </font><br /> <font style="font-size: 10pt">Resignation and Post-Merger Employment Arrangement, due in full on August 31, 2009, with no stated interest</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">25,444&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">25,444&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Promissory notes payable due to vendors relating to settlement of certain outstanding accounts payable, payable in 18 equal monthly installments commencing on July 27, 2009 and ending on January 27, 2011, with no stated interest</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">223,116&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">223,116&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td><font style="font-size: 10pt">Short term loan due to a third-party with 6% interest</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">44,067&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">35,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">369,410&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">360,343&#160;</font></td></tr> <tr style="vertical-align: top"> <td><font style="font-size: 10pt">Less: current portion</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(369,410)</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(360,343)</font></td></tr> <tr style="vertical-align: top"> <td><font style="font-size: 10pt">Notes payable, less current portion</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Short term loan due to a related-party, payable in full on </font><br /> <font style="font-size: 10pt">January 2, 2014 with 12% interest&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">203,664&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">203,664&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Short term loan due to a related-party, payable in full on </font><br /> <font style="font-size: 10pt">May 31, 2014 with 12% interest </font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">50,000&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">50,000&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">Notes payable related party, current portion</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">253,664&#160;</font></td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">253,664&#160;</font></td></tr> <tr> <td style="vertical-align: top"><font style="font-size: 10pt">Less: current portion</font></td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(253,664)</font></td> <td style="text-align: right">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(253,664)</font></td></tr> <tr> <td style="vertical-align: top"><font style="font-size: 10pt">Notes payable related party, less current portion</font></td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> 0 0.0 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">A summary of option activity for the nine months ended September 30, 2015 is presented below. Options granted by MMR Inc. prior to the date of the Merger have been retroactively restated to reflect the conversion ratio of MMR Inc. to MMR shares.</p> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 49%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 10%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 9%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 17%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted-Average</b></font></td> <td style="width: 1%; padding: 0.75pt; text-align: center">&#160;</td> <td style="width: 1%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 9%; padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted-</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Life</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Options</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>(Years)</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Outstanding at December 31, 2014</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.10&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">4.29&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Granted</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Exercised</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Cancelled</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Outstanding at September 30, 2015 (Unaudited)</font></td> <td style="padding: 0.75pt">&#160;</td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.10&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">3.54&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Vested and expected to vest</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; at September 30, 2015 (Unaudited)</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.10&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">3.54&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">- &#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Exercisable at September 30, 2015 (Unaudited)</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.10&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">3.54&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The following table summarizes information about stock options outstanding and exercisable at September 30, 2015.</p> <table cellspacing="1" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td colspan="9" style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding</b></font></td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Options Exercisable</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 12%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 13%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 14%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 12%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 13%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 14%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 1%; padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="width: 12%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>of Shares</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Life (Years)</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>of Shares</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Life (Years)</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">0.05 - 0.09</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">12,900,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">6.66</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.07&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">12,900,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">6.66</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.07&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">0.10 - 0.15</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">23,011,461&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">3.44</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.11&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">23,011,461&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">3.44</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.11&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">&#62; 0.15</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">1,630,261&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">4.45</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.19&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">1,630,261&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: center"><font style="font-size: 10pt">4.45</font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.19&#160;</font></td></tr> <tr> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">37,541,722&#160;</font></td> <td style="vertical-align: top; padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">A summary of the activity of our warrants for the nine months ended September 30, 2015 is presented below:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 53%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 18%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 3%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 5%; padding: 0.75pt; text-align: right">&#160;</td> <td style="width: 21%; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Weighted Avg.</b></font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="padding: 0.75pt; text-align: center">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Outstanding at December 31, 2014</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">70,028,410&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.07&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Granted</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">1,764,642&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.003&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Exercised</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">-&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Cancelled</font></td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">(14,650,000)</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.08&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Outstanding at September 30, 2015 (Unaudited)</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">57,143,052&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.06&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Exercisable at September 30, 2015 (Unaudited)</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">55,719,441</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">0.06</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">During the nine months ended September 30, 2015, we issued 120,100,000 shares of common stock with a value of $413,220 to various third parties and related parties and charged the proceeds to the appropriate accounts for the following reasons:</p> <table cellspacing="1" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td style="padding: 0.75pt; font-size: 12pt">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Nine Months Ended September 30, 2015</b></font></td></tr> <tr style="vertical-align: top"> <td style="width: 42%; border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Purpose</b></font></td> <td style="width: 4%; padding: 0.75pt; text-align: center">&#160;</td> <td style="width: 23%; border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="width: 4%; padding: 0.75pt; text-align: center">&#160;</td> <td style="width: 5%; padding: 0.75pt; text-align: center">&#160;</td> <td style="width: 22%; border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Reduction of payables and notes&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">112,100,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">375,021&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Services provided&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">8,000,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">38,199&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding: 0.75pt"><font style="font-size: 10pt">Totals&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">120,100,000&#160;</font></td> <td style="padding: 0.75pt; text-align: right">&#160;</td> <td style="padding: 0.75pt; text-align: right"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding: 0.75pt; text-align: right"><font style="font-size: 10pt">413,220&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 0.0 0.0 1.2051 1.2347 1.2272 1.2471 0.0040 0.0035 0.0138 0.0046 26445 187550 566710 13221 13221 37541722 37541722 12900000 23011461 1630261 0 0 0 37541722 12900000 23011461 1630261 0 0 0.10 0.10 0.10 0.07 0.11 0.19 0 0 0.05 0.10 0.15 0.09 0.15 0.07 .11 0.19 70028410 1764642 0 14650000 0.07 0.08 0.003 0 0 0 8000000 38199 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Effective September 1, 2013, we renewed our lease for office space in Los Angeles, California with a term through August 31, 2018. The lease currently requires a monthly payment of $8,250.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 86854 129276 1764642 0.003 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our Chairman and Chief Executive Officer, Robert H. Lorsch, is also the Chief Executive Officer of The RHL Group, Inc. and has full voting power over all of the capital stock of The RHL Group, Inc. Mr. Lorsch directly and indirectly through The RHL Group, Inc., beneficially owns approximately 16.4% our total outstanding voting stock. The RHL Group, Inc. has loaned us money pursuant to the Tenth Amended Note and all predecessor notes. See Note 3 - Related Party Note Payable above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The RHL Group is an investment holding company which provides consulting, operational and technical services to us, which we refer to as the RHL Services. As part of the RHL Services, The RHL Group provides us with unrestricted access to its internal business and relationship contact database of more than 10,000 persons and entities, which includes clients of The RHL Group and other individuals which may hold value to us. The RHL Group also provides infrastructure support to us, including allowing us unlimited access to its facilities, equipment, and data, information management and server systems. In addition to allowing us the use of its office support personnel, The RHL Group has also consented to allow us to utilize the full-time services of Mr. Lorsch as our President, Chairman and Chief Executive Officer, which requires substantial time and energy away from his required duties as The RHL Group's Chairman and Chief Executive Officer. In addition, The RHL Group has made its President, Kira Reed, available as our spokesperson. Ms. Reed, who is Mr. Lorsch's spouse, also manages our social networking activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In consideration for the above, The RHL Group, Inc. has a consulting arrangement with MMR. A copy of the consulting agreement is filed as an exhibit in our Form 8-K, as filed with the SEC on May 4, 2009 and is hereby incorporated by reference.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We incurred $12,500 during the nine months ended September 30, 2015 and 2014, toward marketing consulting services from Bernard Stolar, a director. We included $198,514 and $174,273 in related party payables as of September 30, 2015 and December 31, 2014, respectively, in connection with these services and board fees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We contract with a significant vendor for the development and maintenance of the software applications necessary to run our MyMedicalRecords PHR, MyEsafeDepositBox and MyMedicalRecords Pro products. Our outside developer supports our software development needs through a team of software engineers, programmers, quality control personnel and testers, who work with our internal product development team on all aspects of application development, design, integration and support of our products. This vendor is also a stockholder. For the nine months ended September 30, 2015 and 2014, the total expenses relating to this stockholder amounted to $90,000 and $90,000, respectively. In addition, we capitalized $0 of software development costs for the quarter ended September 30, 2015. As of September 30, 2015 and December 31, 2014, the total amounts due to the stockholder and included in related party payables amounted to $100,000 and $10,000, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On September 15, 2009, we entered into a five year agreement with E-Mail Frequency, LLC and David Loftus, Managing Partner of E-Mail Frequency, LLC, a significant stockholder of the Company, which was amended during 2011 to increase the term for an additional five years and provide licensor a non- exclusive right to target, market and exploit the Employee Benefits market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We licensed an existing 80 million person direct marketing database (the &#34;Database&#34;) of street addresses, cellular phone numbers, e-mail addresses and other comprehensive data with E-Mail Frequency. The agreement allows us to market, through the use of the Database, our MyMedicalRecords PHR, MyEsafeDepositBox virtual vault, and MMRPro document management system to physicians and their patients. Under the terms of the Agreement, we paid $250,000 to David Loftus as a one-time consulting fee in the form of 2,777,778 shares of our common stock. We recorded the $250,000 one-time licensee fee as a prepaid consulting fee. Amortization expense for each of the quarters ended September 30, 2015 and 2014 was $0 and $37,500. Included in related party payables at September 30, 2015 and December 31, 2014 of $64,615 and $64,615, respectively, in respect to these services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> 12500 12500 90000 90000 0 0 2777778 250000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In connection with the merger with Favrille, Inc. in 2009, we signed promissory notes with certain former executives totaling $76,783.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of June 30, 2015, the total remaining severance liabilities amounted to $620,613, which is reflected as severance liability on the accompanying consolidated balance sheets. This consists of $571,362 payable to former non-executive employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> 571362 76783 11111 327920 0 37500 774417739 902504231 774417739 902504231 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>(b) CASH AND CASH EQUIVALENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We consider cash equivalents to be only those investments that are highly liquid, readily convertible to cash and with maturities of 90 days or less at the purchase date. We maintain our cash in bank deposit accounts that, at times, may exceed federally insured limits. We have not experienced any losses in such accounts and believe that we are not exposed to any significant credit or deposit risk on our cash. We had cash and cash equivalents of $0 and $303,393 as of September 30, 2015 and December 31, 2014, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>(c) TRADE AND OTHER RECEIVABLES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Receivables represent claims against third parties that will be settled in cash. The carrying value of receivables, net of an allowance for doubtful accounts, if any, represents their estimated net realizable value. We estimate the allowance for doubtful accounts, if any, based on historical collection trends, type of customer, the age of outstanding receivables and existing economic conditions. If events or changes in circumstances indicate that specific receivable balances may be impaired, we give further consideration to the collectability of those balances and the allowance is adjusted accordingly. We write off past due receivable balances when collection efforts have been unsuccessful in collecting the amount due.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>(d) INVENTORY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Inventory is stated at the actual cost, using the first-in-first-out method. On an on-going basis, we evaluate our inventory for obsolescence. This evaluation includes analysis of sales levels, sales projections, and purchases by item. If future demand or market conditions are different than our current estimates, an inventory adjustment may be required, and would be reflected in cost of goods sold in the period the revision is made.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 0 0 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Under ASC 740-270,<i> Income Taxes - Interim Reporting</i>, we are required to adjust our effective tax rate each quarter to be consistent with the estimated annual effective tax rate. We are also required to record the tax impact of certain discrete items, unusual or infrequently occurring, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur. In addition, we exclude jurisdictions with a projected loss for the year or a year-to-date loss where we cannot recognize a tax benefit from our estimated annual effective tax rate. The impact of such an exclusion could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings versus annual projections.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Pursuant to ASC 740,<i> Income</i> Taxes, we performed an analysis of previous tax filings and determined that there were no positions taken that it considered uncertain. Therefore, there were no unrecognized tax benefits As of September 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">MMR Inc., in its capacity as the operating company taking over our income tax positions in addition to its own positions after January 27, 2009 (see Note 1), has estimated its annual effective tax rate to be zero. MMRGlobal has based this on an expectation that the combined entity will generate net operating losses in 2015, and it is not likely that those losses will be recovered using future taxable income. Therefore, no provision for income tax has been recorded as of and for the nine months ended September 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="margin: 0"><font style="font-size: 10pt"></font></p> <p style="margin: 0"><font style="font-size: 10pt">Promissory notes payable due to the former officers of MMRGlobal as part of severance packages, due in full on August 31, 2009 with no stated interest</font></p> <p style="margin: 0">&#160;</p> <p style="margin: 0">&#160;</p> <p style="margin: 0">&#160;</p> <p style="margin: 0"></p> <p style="margin: 0"><font style="font-size: 10pt">Promissory notes payable due to the former officers of<br /> MMRGlobal pursuant to the Resignation and Post-Merger Employment<br /> Arrangement, due in full on August 31, 2009 with no stated interest</font></p> <p style="margin: 0"><font style="font-size: 10pt">Promissory notes payable due to vendors relating to settlement of certain<br /> outstanding accounts payable, payable in 18 equal monthly installments commencing<br /> on July 27, 2009 and ending on January 27, 2011, with no stated interest</font></p> <p style="margin: 0"><font style="font-size: 10pt">Short term loan due to a third-party with no stated interest</font></p> <p style="margin: 0"></p> <p style="margin: 0">&#160;</p> <p style="margin: 0">&#160;</p> <p style="margin: 0"></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Short term loan due to a related-party, payable in full on<br /> May 31, 2014 with 12% interest&#160;</font></p> <p style="margin: 0"></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0">&#160;</p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Short term loan due to a related-party, payable in full on<br /> January 2, 2014 with 12% interest&#160;</font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0">&#160;</p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> 360343 369410 76783 76783 25444 25444 223116 223116 35000 44067 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">From time to time, we issue Convertible Promissory Notes. As of September 30, 2015, a total of $887,027 in convertible notes remained outstanding. As of September 30, 2015, all of these Notes have matured, however, the Company and the Holders have agreed to keep the balance as a Note Payable and the note holders have elected not to convert their note balances into shares of our common stock as of September 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0">Each Note contains the following general terms and provisions:</p> <ul style="margin-top: 0in"> <li style="margin: 4pt 0; font-size: 10pt">The principal amount owed under each note becomes due and payable one year or less from the investment date provided that, upon ten (10) days' prior written notice to the holder, we may, in our sole discretion, extend the maturity date for an additional six month term. The Notes can be further extended upon mutual agreement.</li> <li style="margin: 4pt 0; font-size: 10pt">These notes bear interest at a rate of 6% per annum payable in cash or shares of common stock or a combination of cash and shares of common stock at our option.</li> </ul> <p style="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 55780 124120 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On May 20, 2015, we and The RHL Group entered into a Tenth Amended and Restated Promissory Note (the &#34;<u>Amended Note</u>&#34;), effective as of May 20, 2015. The Tenth Note amends and restates that certain Ninth Amended Note entered into between the foregoing parties, effective July 10, 2014 (the &#34;<u> Existing Note</u>&#34; and together with its predecessor notes and the Amended Note, the &#34;<u>Credit Facility</u>&#34;), by: (i) extending the maturity date to April 29, 2016. In connection with the Tenth Amended Note, we issued The RHL Group warrants to purchase 1,764,642 shares of our common stock at $0.003 per share on May 20, 2015. Except as set forth above, the Amended Note does not materially alter the terms of the Existing Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Historically, the predecessor notes have increased over time the maximum amount of credit available under the Credit Facility from $100,000 to $1,000,000 to $3,000,000 to $4,500,000. The maximum amount of the Amended Note is $4,500,000. The Amended Note continues to bear interest at the lesser of 10% or the highest rate then permitted by law, and is secured (similar to the Existing Note) by a Security Agreement, which has been in effect since July 31, 2007, as renewed and amended to date (the &#34;Security Agreement&#34;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Tenth Amended Note had a current balance of $1.81 million at September 30, 2015. The components of the Tenth Amended Note and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million for other obligations due to The RHL Group, which is included in related party payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Total interest expense for the three months ended September 30, 2015 and September 30, 2014 was $36,699 and $36,952, respectively. Total interest expense on the Line of Credit for the nine months ended September 30, 2015 and 2014 amounted to $102,433 and $98,985, respectively. The unpaid interest balances as of September 30, 2015 and December 31, 2014 were $36,757 and $30,160, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In conjunction with the Tenth Amended Note, we were required to maintain certain financial covenants, including the requirement that we have at least $200,000 of cash in our bank accounts or such other amount as necessary to maintain operations through the subsequent thirty (30) days and timely pay any obligations due respecting payroll and all associated payroll taxes on and after September 30, 2015. Since we did not meet these covenants as of September 30, 2015, we received a waiver from The RHL Group until November 30, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> 2016-04-29 850000 690000 1540000 P5Y0M0D P5Y0M0D 0.08 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>(f) IMPAIRMENT OF LONG-LIVED ASSETS AND INTANGIBLES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We account for long-lived assets, which include property and equipment and identifiable intangible assets with finite useful lives (subject to amortization), in accordance with ASC 350-30. ASC 350-30 requires that we review long-lived assets for impairment whenever events or changes in circumstances indicate that we may not recover the carrying amount of an asset. We measure recoverability by comparing the carrying amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an impairment charge to the extent of the difference between the fair value and the asset's carrying amount. We had no impairment charges during the nine months ended September 30, 2015 and 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> P6Y238D P3Y158D P4Y162D P6Y238D P3Y158D P4Y162D <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Basis of Presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have prepared the accompanying consolidated unaudited financial statements in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial statements and with instructions to Form 10-Q pursuant to the rules and regulations of Securities and Exchange Act of 1934, as amended, or the Exchange Act and Article 8-03 of Regulation S-X promulgated under the Exchange Act. Accordingly, these financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of our management, we have included all adjustments considered necessary (consisting of normal recurring adjustments) for a fair presentation. Operating results for the nine months ended September 30, 2015 are not indicative of the results that may be expected for the fiscal year ending December 31, 2015. You should read these unaudited condensed consolidated financial statements in conjunction with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Litigation Matters</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">From time to time, we are involved in various legal proceedings generally incidental to our business. While the result of any litigation contains an element of uncertainty, our management presently believes that the outcome of any known, pending or threatened legal proceeding or claim, individually or combined, will not have a material adverse effect on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0">On December 9, 2011, MyMedicalRecords, Inc. entered into a Non-Exclusive Settlement and Patent License Agreement with Surgery Center Management LLC (&#34;SCM&#34;). In consideration for the rights granted under that Agreement and in consideration of a settlement and release agreement, SCM contracted to pay MyMedicalRecords, Inc. an initial payment of $5 million payable on December 23, 2011, and additional payments of $5 million per year for five consecutive years. After unsuccessful attempts to collect the past due amount of $5 million, on January 19, 2012, MyMedicalRecords, Inc. filed a lawsuit in the Superior Court of the State of California for the County of Los Angeles for breach of contract. At this time, MMR believes that SCM owes the Company $30 million plus interest, and on August 4, 2015, the Court granted MMR leave to amend its complaint to seek damages of $30 million (plus interest) from SCM since the end of 2011. On February 13, 2014, SCM filed an answer to MMR's original complaint along with a cross-complaint alleging claims for breach of that contract, among other things. On July 10, 2014, the court granted SCM's motion for summary adjudication on the claim for breach of contract in the complaint and its counterclaim for declaratory relief. On July 30, 2014, SCM filed its second amended cross-complaint, alleging substantially the same claims against the same parties. On December 5, 2014, the Court of Appeal issued an Alternative Writ of Mandate, finding the trial court erred in granting SCM's motion for summary adjudication. Pursuant to the Court of Appeal's Alternative Writ, on January 7, 2015, the trial court vacated its order granting SCM's motion for summary adjudication. On April 24, 2015, the trial court held a new hearing on that motion, and it entered an order denying SCM's motion in its entirety. MyMedicalRecords, Inc. will continue to pursue its claim and defenses, but the Company cannot predict the chances of either a favorable or unfavorable outcome, nor does the Company have sufficient information regarding its ability to collect any judgment MyMedicalRecords, Inc. may obtain.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On April 10, 2013, MMR filed a complaint for patent infringement against Quest Diagnostics Inc. (&#34;Quest&#34;) in the United States District Court for the Central District of California, alleging that Quest Diagnostics Inc. is infringing U.S. Patent No. 8,301,466. On October 11, 2013, MMR filed an unopposed motion to add a claim of infringement of U.S. Patent 8,498,883 to its complaint against Quest, which was granted on October 29, 2013. On December 22 and 23, 2014, the Court entered orders finding that the eight claims asserted (of the 42 total claims present) under the two asserted MMR patents were invalid. On January 9, 2015, as previously reported by the Company, the case was closed. Defendants filed a motion with the District Court to recover a portion of their fees incurred in defense of the matter, which has been denied by the Court in favor of MMR.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On February 11, 2013, MMR filed a complaint for patent infringement against WebMD Health Corp. and its wholly owned subsidiary WebMD Health Services Group, Inc. (collectively, &#34;WebMD&#34;), titled MyMedicalRecords, Inc. v. WebMD Health Corp et al., United States District Court, Central District of California. That complaint alleged that WebMD is infringing MMR's Personal Health Records patent U.S. Patent No. 8,301,466. On October 2, 2013, MMR filed a new complaint against WebMD in the United States District Court for the Central District of California, alleging infringement of U.S. Patent Nos. 8,301,466 and 8,498,883. On December 22 and 23, 2014, the Court entered orders finding that the eight claims asserted (of the 42 total claims present) under the two asserted MMR patents were invalid. On January 9, 2015, as previously reported by the Company, the case was closed. Defendants filed a motion with the District Court to recover a portion of their fees incurred in defense of the matter, which has been denied by the Court in favor of MMR.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On May 17, 2013, MMR filed a complaint for patent infringement against Jardogs, LLC (the &#34;Jardogs Complaint&#34;) in the United States District Court for the Central District of California, alleging that Jardogs, LLC infringes U.S. Patent No. 8,301,466. On September 23, 2013, MMR filed a separate complaint for patent infringement against Allscripts Healthcare Solutions Inc. (&#34;Allscripts&#34;) titled MyMedicalRecords, Inc. v. Allscripts Healthcare Solutions Inc., United States District Court, Central District of California (the &#34;Separate Allscripts Complaint&#34;). The Separate Allscripts Complaint alleged that Allscripts is infringing U.S. Patent Nos. 8,301,466 and 8,498,883. On October 4, 2013, MMR filed a motion to amend the Jardogs Complaint to add Allscripts as a party defendant and to allege that Allscripts is infringing U.S. Patent Nos. 8,301,466 and 8,498,883. The Court granted that motion on November 1, 2013. Thereafter, MMR dismissed the Separate Allscripts Complaint. On December 22 and 23, 2014, the Court entered orders finding that the eight claims asserted (of the 42 total claims present) under the two asserted MMR patents were invalid. On January 9, 2015, as previously reported by the Company, the case was closed. Defendants filed a motion with the District Court to recover a portion of their fees incurred in defense of the matter, which has been denied by the Court in favor of MMR.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-left: 0">Allscripts also filed a Covered Business Method (&#34;CBM&#34;) petition on November 3, 2014, before the Patent Trial and Appeal Board (&#34;PTAB') alleging that claims 8-12 of U.S. Patent No. 8,301,466 are invalid. MMR filed a preliminary response on February 20, 2015. On May 5th the PTAB decided to implement the CBM. On January 15, 2015, MMR filed a notice of appeal in the Federal Circuit. Subsequently, MMR filed for voluntary dismissal of the appeal which was granted on July 7, 2015. On July 30, 2015, MMR informed the PTAB of the voluntary dismissal of the appeal, and on August 26, 2015, the PTAB entered a Final Written Decision consistent with the Court's prior rulings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On April 2, 2015, the Company and Stradling Yocca Carlson &#38; Rauth, P.C. (&#34;SYCR&#34;), received a letter from an arbitrator in regards to disputes over amounts of monies due SYCR regarding prior services rendered. SYCR and the Company agreed to a mediation of the matter. As of the date hereof, the Company cannot predict the chances of either a favorable or unfavorable outcome.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On August 14, 2013, Gemini Master Fund, Ltd. purchased a convertible note from the Company. On or about February 23, 2015, Gemini filed an action against the Company for breach of contract seeking damages allegedly owed pursuant to the convertible note in the amount of $210,000 in the United States District Court for the Southern District of New York. The case has since been settled and dismissed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 0.06 0 245375 8818 63035 102433 98985 0 0 36699 36952 36757 30160 206305 120100000 413220 112100000 375021 0 55719441 P3Y194D P4Y106D 41679061 2014-04-29 299420 196812 100800 190000 0 0 9097808 10132601 13221 13221 360343 369410 932047 887027 51312 40262 4668960 4891497 491109 594034 753704 990723 2355572 1938005 -6742236 -8194596 -63954259 -65877545 56437812 56780651 173591 173591 146410 37541722 0 140794 0 1600 P3Y194D P3Y194D 49251 -1923286 -1159191 -489000 1920321 191355 362678 44629 104031 60750 1672820 8914 1672820 -1792681 -2469333 -453285 351532 0 57890 0 7254 420199 1087943 102504 261553 1331644 3530193 383147 1186972 -40838 2206693 32366 1807311 179554 230402 45298 88960 138716 2437095 77664 1896271 0 7500 0 0 15249 2290538 5769 1828000 7219 29476 2899 17408 116248 109581 68996 50863 -0 -0 -0 0 830417188 731355958 893373796 754463150 830417188 731355958 893373796 756876594 339116 -194780 55780 176262 38199 293422 16759 582485 11170 144232 0 -54151 0 1672820 217208 227488 -648679 226382 -935491 -1580353 -11050 -1470 102925 77861 519315 279885 258667 1200171 -114744 -923 0 13643 49110 -36626 -1252 -300495 0 53627 0 246868 1252 0 0 3637 -254601 140794 30000 50000 30000 88134 0 42000 56163 0 29774 1419561 0 200000 -309393 1481151 340538 1555264 <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt">On October 8, 2015, we received written consent from our company's board of directors to amend the Corporation's Articles of Incorporation to effect a reverse stock split, such that each five (5) shares of the issued and outstanding Common Stock of the Corporation shall be reversed split into one (1) share of Common Stock of the Corporation (the &#34;Stock Split&#34;). This Stock Split shall effect only issued and outstanding shares. Each record and beneficial holder who would receive a fractional share as a result of the reverse split shall receive, in lieu thereof, a whole share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On November 4, 2015, the Corporation received the written consent of holders of more than 50% of our voting securities to effect the Stock Split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Stock Split will not be effective until after filing by the Corporation of its Schedule 14C Information with the Securities and Exchange Commission and amendment of the Corporation's Articles of Incorporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In addition, the Corporation will file a corporation action notification with FINRA to effect the Stock Split on the market, and must receive approval thereof prior to filing amended Articles of Incorporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The number of shares presented in this quarterly report do not reflect the reverse stock split expected to become effective in the 4<sup>th</sup> quarter of 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 16, 2015, we granted a total of 10,000,000 shares of restricted common stock to an unrelated third party, at a price of $0.0032 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 19, 2015, we granted a total of 7,894,000 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 19, 2015, we granted a total of 30,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.0038 in consideration of a reduction in payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 22, 2015, we granted a total of 6,842,105 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On October 22, 2015, The RHL Group, Inc., an entity affiliated with our Chairman &#38; CEO Robert H. Lorsch elected to purchase 46,000,000 shares of common stock at market price in consideration for a reduction in amounts due of $174,800.00.</p> <p style="font: 10pt TimesNewRomanPSMT; margin-right: 0; margin-left: 0">On October 29, 2015, we granted a total of 10,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.005 in consideration of a reduction in payables.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> 1059255881 EX-101.SCH 8 mmrf-20150930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - NATURE OF OPERATIONS AND BASIS OF PRESENTATION - Note 1 link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Note 2 link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - RELATED PARTY PAYABLES, LINE OF CREDIT AND NOTE PAYABLE - Note 3 link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - INCOME TAXES - Note 4 link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - COMMITMENTS AND CONTINGENCIES - Note 5 link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - STOCKHOLDERS' DEFICIT - Note 6 link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - EQUITY ISSUANCES - Note 7 link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - NOTES PAYABLE - Note 8 link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - CONVERTIBLE PROMISSORY NOTES - Note 9 link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - RESTRUCTURING ACTIVITIES - Note 10 link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - RELATED PARTY TRANSACTIONS - Note 11 link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUBSEQUENT EVENTS - Note 12 link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - EQUITY ISSUANCES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Accounting Policies (Cash and Cash Equivalents) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Accounting Policies (Intangible Assets and Impairments) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Accounting Policies (Share-Based Compensation Schedule Of Assumptions Used In Black-Scholes Model) (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Related Party Note Payable (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Commitments and Contingencies (Operating Leases) (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Commitments and Contingencies (Capital Leases) (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Commitments and Contingencies (Leases Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Equity Issuances (Stock Option Activity Summary Of Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Equity Issuances (Stock Option Activity Summary Of Stock Options Outstanding and Exercisable) (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Equity Issuances (Stock Option and Warrant Expense Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Equity Issuances (Summary Of Warrant Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Equity Issuances (Summary Of Warrants Outstanding and Exercisable) (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Equity Issuances (Inputs Used In Black-Scholesl) (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Equity Issuances (Shares Issued for Services or Reduction to Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Equity Issuances (Warrants) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Equity Issuances (Stock Bonus Agreements) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Convertible Promissory Notes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Restructuring Activities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Related Party Transactions (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Subsequent Events (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 mmrf-20150930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 mmrf-20150930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 mmrf-20150930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Furniture and Fixtures Property, Plant and Equipment by Type [Axis] Computer Equipment Website and Software Development Costs Indefinite-lived Intangible Assets by Major Class [Axis] Domain Names Patents $0.05 - $0.09 Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Axis] $0.10 - $0.15 > $0.15 $0.02 - $0.25 Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Award Type and Plan Name [Axis] $0.06 - $0.10 > $0.10 Severance Package Notes Debt Instrument [Axis] Resignation and Post-Merger Employment Arrangement Notes Notes Payable - Vendors Short-term Loan Due To Third-Party Tenth Amended and Restated Secured Promissory Note Related Party Transactions, by Related Party [Axis] Ninth Amended and Restated Secured Promissory Note September 2013 Lease Operating Lease [Axis] The RHL Group, Inc. Bernard Stolar The Rebensdorf Group, Inc. George Rebensdorf Jack Zwissig Significant Vendor E-Mail Frequency, LLC David Loftus Favrille Restructuring Cost and Reserve [Axis] Creditor Plan April 15, 2011 July 19, 2011 13 Surgery Centers Major Customers [Axis] Chartis Ambulatory Surgery Center Short Term Loan Two Related Party One Related Party Two Related Party Three UST Global Whole Foods January 10 2013 Class of Warrant or Right [Axis] January 21 2013 First January 21 2013 Second January 21 2013 Third February 20 2013 March 13 2013 Sales Concentration Risk Benchmark [Axis] Group A Concentration Risk Type [Axis] Group B Group C Group D VisiInc. XN Financial UST Global E-Mail Frequency Celgene May 10 2013 Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] May 28 2013 March 18 2013 A March 18 2013 B April 1 2013 A April 1 2013 B May 13 2013 A May 13 2013 B May 13 2013 C May 13 2013 D May 20 2013 June 12 2013 A March 4 2014 Eighth Amended and Restated Secured Promissory Note Olympia March 4 2014 B March 4 2014 C March 27 2014 Ninth Amended and Restated Secured Promissory Note April 8 2014 April 30 2014 May 29 2014 A May 29 2014 B July 10 2014 Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Accounts receivable, less allowances of $173,591 in 2015 and 2014 Inventory Prepaid expenses and other current assets Total current assets Property and equipment, net Intangible assets, net Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Line of credit, related party Related party payables Compensation payable Severance liability Accounts payable and accrued expenses Deferred revenue Convertible notes payable Notes payable, current portion Notes payable, related party Capital leases payable, current portion Total current liabilities Commitments and contingencies (See Note 9) Stockholders' deficit: Preferred stock - $0.001 per value, 5,000,000 shares authorized, 0 issued and outstanding. Common stock, $0.001 par value, 1,250,000,000 shares authorized, 902,504,231 and 774,417,739 shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively Additional paid-in capital Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Allowances Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Subscriber MMR Pro License fees Other income Total revenues Cost of revenues Gross profit General and administrative expenses Sales and marketing expenses Technology development (Loss) income from operations Other income Interest and other finance charges, net Net (loss) income Net (loss) income per share: Basic and diluted Weighted average common shares outstanding: Basic Diluted Statement of Cash Flows [Abstract] Operating activities: Net loss Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Depreciation and amortization Accounts payable write-off Deferred rent Warrants issued for services Stock-based compensation Common stock issued for services Amortization of loan discount Subtotal - non-cash adjustments Effect of changes in: Accounts receivable Inventory Prepaid expenses and other current assets Accounts payable and accrued expenses Related party payables Compensation payable Deferred revenue Subtotal - net change in operating assets and liabilities Net cash (used in) provided by operating activities Investing activities: Purchase of property and equipment Filing of patents Cost of continuing MMRPro and website development Net cash used in investing activities Financing activities: Net proceeds from convertible notes Proceeds from shares issued for financing activities Book overdraft Net proceeds from warrant exercises Proceeds from note payable Payments of note payable Proceeds (payments) of line of credit Payments of capital lease Net cash provided by financing activities Net (decrease) increase in cash Cash, beginning of period Cash, end of period Supplemental disclosures of cash flow information: Cash paid for interest Cash paid for income taxes Supplemental disclosure of non-cash investing and financing activities: Conversion of convertible notes into common stock Shares issued for reduction of payables Notes to Financial Statements NATURE OF OPERATIONS AND BASIS OF PRESENTATION - Note 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Note 2 RELATED PARTY PAYABLES, LINE OF CREDIT AND NOTE PAYABLE - Note 3 INCOME TAXES - Note 4 COMMITMENTS AND CONTINGENCIES - Note 5 Legal Matters and Contingencies - Note 5 STOCKHOLDERS' DEFICIT - Note 6 EQUITY ISSUANCES - Note 7 NOTES PAYABLE - Note 8 CONVERTIBLE PROMISSORY NOTES - Note 9 RESTRUCTURING ACTIVITIES - Note 10 RELATED PARTY TRANSACTIONS - Note 11 SUBSEQUENT EVENTS - Note 12 Principles of Consolidation Basis of Presentation Going Concern and Management's Plan Management's Use of Estimates Cash and Cash Equivalents Trade and Other Receivables Inventory Fair Value of Financial Instruments Impairment of Long-Lived Assets and Intangibles Revenue Recognition Shared-Based Compensation Net Income/Loss Per Share Recent Accounting Pronouncements Income Taxes Share-based Compensation Tables Schedule of Valuation Assumptions to Determine the Fair Value of Stock Options Commitments And Contingencies Tables Schedule of Future Minimum Rental Payments for Operating and Capital Leases Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Summary of Outstanding Option Awards Summary of Stock Options Outstanding and Exercisable Summary of Outstanding Warrant Awards Black-Scholes option and valuation model assumptions Shares Issued for Services or Reduction to Liabilities Notes Payable Tables Notes Payable Accounting Policies Cash And Cash Equivalents Narrative Details Accounting Policies Intangible Assets And Impairments Narrative Details Impairment charges Accounting Policies Share-based Compensation Schedule Of Assumptions Used In Black-scholes Model Details Expected life, in years, maximum Stock price volatility, minimum Stock price volatility, maximum Risk-free interest rate, mimimum Risk-free interest rate, maximum Expected dividends Forfeiture rate Statement [Table] Statement [Line Items] Related Party [Axis] Date of note Maximum line of credit under note Interest rate Maturity date Warrants granted for shares Warrant price per share Expiration date of warrants Debt component classification: Line of credit, related party Related party payables Total note payable balance Interest expense on line of credit Related party accrued interest Income Taxes Narrative Details Unrecognized tax benefits Income tax rate Commitments And Contingencies Operating Leases Details Year ending December 31: 2015 (Remainder of) 2016 2017 2018 and there after Total minimum lease payments Commitments And Contingencies Capital Leases Details Year ending December31: 2015 (Remainder of) Total minimum lease payments OperatingLeaseAxis [Axis] Operating lease description Rent expense Equity Issuances Stock Option Activity Summary Of Option Activity Details Outstanding at December 31, 2014 Granted Exercised Cancelled Outstanding at September 30, 2015 (Unaudited) Vested and expected to vest at September 30, 2015 (Unaudited) Exercisable at June 30, 2015 (Unaudited) Weighted-Average Exercise Prices, Outstanding at December 31, 2014 Weighted-Average Exercise Prices, Granted Weighted-Average Exercise Prices, Exercised Weighted-Average Exercise Prices, Forfeited, cancelled or expired Weighted-Average Exercise Prices, Outstanding at September 30, 2015 Weighted-Average Exercise Prices, Vested and expected to vest Weighted-Average Exercise Prices, Exercisable Weighted-Average Remaining Contractual Life (in years), Outstanding at December 31, 2014 Weighted-Average Remaining Contractual Life (in years), Outstanding at September 30, 2015 Weighted-Average Remaining Contractual Life (in years), Vested and expected to vest Weighted-Average Remaining Contractual Life (in years), Exercisable Aggregate Intrinsic Value, Outstanding at December 31, 2014 Aggregate Intrinsic Value, Outstanding at September 30, 2015 Aggregate Intrinsic Value, Vested and expected to vest Aggregate Intrinsic Value, Exercisable Exercise Price Range [Axis] Range of Exercise Price, Minimum Range of Exercise Price, Maximum Options Outstanding, Number of Shares Options Outstanding, Weighted-Average Remaining Life (in years) Options Outstanding, Weighted-Average Exercise Price Per Share Options Exercisable, Number of Shares Options Exercisable, Weighted-Average Remaining Life (in years) Options Exercisable, Weighted-Average Exercise Price Per Share Equity Issuances Stock Option And Warrant Expense Narrative Details Stock option expense Warrant expense Equity Issuances Summary Of Warrant Activity Details Warrants outstanding at December 31, 2014 Granted Exercised Cancelled Warrants outstanding at September 30, 2015 Warrants exercisable at September 30, 2015 Weighted-average exercise price, beginning balance Weighted-average exercise price, granted Weighted-average exercise price, exercised during period Weighted-average exercise price, cancelled during period Weighted-average exercise price, ending balance Warrants exercisable, weighted average exercise price Award Type [Axis] Range of Exercise Price, Minimum Range of Exercise Price, Maximum Warrants outstanding, Weighted-average remaining life, in years Warrants outstanding, Weighted-average exercise price Warrants exercisable Warrants exercisable, Weighted-average remaining life, in years Warrants exercisable, Weighted-average exercise price Equity Issuances Inputs Used In Black-scholesl Details Risk-free interest rate, minimum Equity Issuances Shares Issued For Services Or Reduction To Liabilities Details Common stock issued Reduction of payables, shares Reduction of payables, amount Services provided, shares Services provided, amount Total payment of services provided through issuance of common stock, shares Total payment of accounts payable through issuance of common stock, amount Number of warrants granted Exercise price, per share Title of Warrants Outstanding Shares issued for services under Stock Bonus Agreement, shares Shares issued for services, price per share Stock Bonus Agreement expense Unrecognized compensation cost Notes payable consisted of the following: Short-term Debt, Terms Short-term debt Related party short-term debt Convertible Promissory Notes Narrative Details Debt instrument, description Debt Instrument, Convertible, Number of Equity Instruments Creation of note discount Note discount Amortization of loan discount Convertible notes converted Converted notes, shares issued Interest expense Restructuring Type [Axis] Restructuring and Related Activities, Description Number of employees terminated Severance liability relating to former Favrille employees at merger date Warrants issued as settlement of severance liability Promissory notes with certain former executives Severance liabilty payable to former non-executive employees in 18 monthly installments starting on July 27, 2009 Estimated payroll tax on severance liabilty Total remaining severance liability Amount settled under creditor plan Accounts payable settled Promissory notes settled Nature of Common Ownership or Management Control Relationships Related Party Transaction, Amounts of Transaction Related Party Transaction, Expenses from Transactions with Related Party Related Party Transaction, Revenues from Transactions with Related Party Shares issued for services, related party, shares Shares issued for services, related party, amount Amortization of licensee fee Interest expense with related party Software development costs Subsequent Events Narrative Details Subsequent Event, Description Common Stock Issued Abstract Services paid to third party vendors by the issuance of common stock Highest exercise price range of stock options Line of credit borrowing due to related party. Related party accrued interest The number of shares into which warrants exercisable as of the balance sheet date can be currently converted in the customized range of exercise prices. The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on warrants currently exercisable in the customized range of exercise prices. The weighted average remaining life of the exercisable warrants as of the balance sheet date for all in the customized range of exercise prices. The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock warrants awards other required information pertaining to awards in the customized range. The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock warrants awards other required information pertaining to awards in the customized range. The future forfeture rate assumption based on the composition of current grantees that is used in valuing an option on its own shares. Tabular disclosure of common stock shares issued in payment of services or as a reduction in accounts payable or accrued liabilities. Short-term loan member Total payment of accounts payable and services provided through issuance of common stock, shares Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. Warrant issued for a specific purpose during a specific period of time. USTGlobalMember NinthAmendedAndRestatedSecuredPromissoryNoteMember Assets, Current Assets Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Revenue, Net Gross Profit Operating Income (Loss) Other Income Interest and Debt Expense AccountsPayableWriteoff Increase (Decrease) in Deferred Charges Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Accounts Payable, Related Parties Increase (Decrease) in Accrued Salaries Increase (Decrease) in Deferred Revenue SubtotalNetChangeInOperatingAssetsAndLibilities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Payments to Acquire Machinery and Equipment Payments to Acquire Intangible Assets Payments to Develop Software Net Cash Provided by (Used in) Investing Activities, Continuing Operations Repayments of Notes Payable Repayments of Lines of Credit Repayments of Debt and Capital Lease Obligations Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) Inventory, Policy [Policy Text Block] Line of Credit, Current Accounts Payable, Related Parties, Current Operating Leases, Future Minimum Payments Due Capital Leases, Future Minimum Payments Due, Next Twelve Months Capital Leases, Future Minimum Payments Due Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceRangeLowerRangeLimit SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceRangeUpperRangeLimit Amortization of Financing Costs and Discounts EX-101.PRE 12 mmrf-20150930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 13 R39.htm IDEA: XBRL DOCUMENT v3.3.0.814
Convertible Promissory Notes (Narrative) (Details)
9 Months Ended
Sep. 30, 2015
USD ($)
Sep. 30, 2014
USD ($)
Convertible Promissory Notes Narrative Details    
Debt instrument, description

From time to time, we issue Convertible Promissory Notes. As of September 30, 2015, a total of $887,027 in convertible notes remained outstanding. As of September 30, 2015, all of these Notes have matured, however, the Company and the Holders have agreed to keep the balance as a Note Payable and the note holders have elected not to convert their note balances into shares of our common stock as of September 30, 2015.

Each Note contains the following general terms and provisions:

  • The principal amount owed under each note becomes due and payable one year or less from the investment date provided that, upon ten (10) days' prior written notice to the holder, we may, in our sole discretion, extend the maturity date for an additional six month term. The Notes can be further extended upon mutual agreement.
  • These notes bear interest at a rate of 6% per annum payable in cash or shares of common stock or a combination of cash and shares of common stock at our option.

 
Debt Instrument, Convertible, Number of Equity Instruments 41,679,061  
Interest expense $ 55,780 $ 124,120

EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`$2%<$>9D_GWS`$``-,:```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V9RT[#,!!%?Z7*%C6N[?(494/9`A+\@$FFC=4XMFRWE+_'3@%!51"O M2G>31^]X[DW&.9N>WS\Y"H.U:;LP*9H8W1ECH6K(J%!:1UU29M8;%=.MGS.G MJH6:$Q.CT1&K;!>IB\.8>Q07YS;"/7X4C?)4WT6?YKO[VWA? ML+\<>:[]]6=#[\7`^M,>(?&C'`(DAP3),0;)<0B2XP@DQS%(CA.0'*<@.?@( M)0@*43D*4CD*4SD*5#D*53D*5CD*5SD*6#D*604*604*604*604*604*604* M604*604*604*604*624*624*624*624*624*624*624*624*624*624*6<[%````*P(```L```!? M.0Q(OW[ MCMB`PD.MQ-*O>X^NO`ZIK`XTHO8<4M?'5$Q^#*G*_=ITJK$"2+8CCVG!D4*> M-BP>-9?20D0[8$NP+,L5R*V.V:SGVL7.U49V[M,41Y26M#;3"&>6X9MY6&3I M//B)]!=C;IK>TI;MR5/0!_ZS#0//>997'L=V+YRO+0O]C^AY%.!)T:'B1?4C M9@,2[2F]@OIZ`(4QOCLEFI2"(S>C@KN_V/P"4$L#!!0````(`$2%<$=YY7JT ML0$``!L:```:````>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/%V<`94`*S=LU1MH8*`$^I/.&/7NK2P,_LP7%R3?IDT[R9EWT3QI MVD4;R_EC.%7IT+6Q/O1Q\M:0D(:PY6@O@6CA>"P!; M.&(+(%LX9@M`6SAJ"V!;.&X+@%LX<@N@6SAV"\!;.'HKT%LY>BO06TGOVNAE MFZ.W`KV5H[<"O96CMP*]E:.W`KV5H[<"O96CMP*]E:.W`KV5H[X[>'NCM.7K["[UC70UA^Y2&0[N/UZ[Y-AP67>`=T_LI7#_E/!4V M7&B=QIV".Q^O_M2^2#M-T`,``*T+ M```0````9&]C4')O<',O87!P+GAM;+U677/B-A3]*QI>RLXT:T(RVS;#,F., M=J-9L%U;L,VC8HN@B2VQELR$_OI>V4!@(RCI0_-`9/DSI:\9/HC0"2\7:BJ9`8>JR=/+18BXV.5U267 MQNOW>I\\_F*XS'E^M=H?VAD.K!5_M2I$QHQ0#+R?`0T# M3DYY5E?";(:]%G.XU6#2C!4\`%O#!2LT;U&OFPTF4.6*R8W7/DV$?-:S%55C M9O@AZ_A%>_J253P'HT>G[S<;S/T&=!:6&RR9?.+Y(?;MRUTLYKS25NEU_V,/ M_O8AV.VW9W.6"_D4,U'IX6!M[M8\,ZK:IFEM_FN6WR M3V7`;MB/==H<*4W`=+6)6F?\I%(VF72!NMY%HA>Z.0$SF"$L#Y8B( M;$U!\@Y#LE\%2FI5B!R**T$E>-2-V;]S4@/_K)<:J06*H!#? MRPF87CHYH4]G"4;1%Q3%./$IB<(4^>$8C?R4I,C)26?3J9\\6%)*OH;D"PG\ MD"(_"*)92(F3D^")3_$8Q7Y"'^#WP1]-'HUJT\FDX)G>*0MLX'$?@1?L5A0"S5K8)&P;?[:#+&2?H+&F-00>C.S";Y2"<(@MPO,FPELIUWTW MOBY+5FULU:7B20IH5!@-R,\R5[[^<$$"ST);=08F'8JA!3/[!>[:IFOF2G`YAT@#7Q=Q2K23TWS& MKD9,GT@Z+YJ)8`?NIDU=S#96#.J&S#U*B,Q4R1%E+]8`H"H8AVO^`77'W#!Q M8OR4I3#MR&E4J\91+JV7_1.%?Y;SQ_LY-SUWXG_4S637NK;3UP;-J.P99JF= M\NX&.\NY<1?_><[-I9QM"T4+]-W]>7C+(7)50T!F&C+M'L$..[9P=+/#\W?I M&2E9:^2[VP8J3+^66%,PQ8F^@=RM[=W2(N'C70JM5=46J:V[$_4,OW5FX.X( M;>!G4)BBN?*V=7I!#]"*2TD#PB%3>E#'D\PX(XZ.MY@L$&D^)EFF M]-\;0FE%O'#SUNWN^^R[V:04C@GKX=E;!QX5A)N]KDU@PLVS#:)CA`2Q`KS; M^3K!I"!0@P:#@=`1)5GU:K;&-J8D@[XJH^.:!UQ8J58*Y%T[E%VF8F<$K\-1 M#K)OG_[^Z2%E2-95[H/JJYJF&3635!<'IN1]\?22SB97)B`W`J(J*(:M@WEV MZOPVN7]8/F;5N*#3G-*621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:( ME/)X8-DOV]:[MR_>X%#BV MR]*+41B1% MG\@MNN01.+5)#3(3/PB=AIAJ4!P"I`DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMO MFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7` M\:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y`\FIS_I M,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z>`HWEL:\4*Z">P'_T=HWPJOX M@L`Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU M)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^`VVZG=PZ.)Z8 MD;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8 MS\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+:`'@Z]1`O)256`Q6\8# M*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]5 M6_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V M^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41`71%`B.5'`86%S+D M4.Z2D`83``>LX=SFWJXPD6L_UC6'ODRWSEPVSK> M`U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X`Q\U*M:I60K M$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F`6/,,H68XWX=%FAHSU8NL.8T* M;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0` M```(`$2%<$>XJHG"6P(``%(+```-````>&POBPESO%$(RI/12EEY= M28SRVC@QZLU\/_08(APF$6_8G*D:9*+A*H:?>@@X_SN1XQ@^7KS_W0AU^PZX MNRFT2%X$.29]`!250_@16BVCXPYIF@0@*E;U%'L0A'##N+.T1) M*HD!"\0(73MX9@![\9T=(UQ(&]M%V(TS]8=(LDQCZ'>_YX=+!W8[F.,12K>/ MIX$DJI!26/*Y7H!NOEA7^G!<<.Q$6KL#UJ5$ZV!V-7*P@XZ;"IECV4<.X`9* M(HH+I1TD*9=F5*(RTH52@NE)3E`I.**&J*KK^2DG)&79B'307W>H0 M?;"'/HG0AA4LA21/VMX40J8!+"%88:E(-D;^2%0M<*NZ"O;:8I_"8X_\FII. MG[5!C2[!MT[/T<$M=-^P%,NY_>M[N:2/UX>OS'Z=<$?FVU;-$1).D!S3%<]6 M6GB^TEZGIDY1[3?GJLR\1?Y/FM?UK%%CW&J+/0K2AE!%^$8#,@^9>Z.;;G6L MH25JSKP=NJ'=52C5#]RM*)HLQP5JJ/I)5D+9S1@.\^]&?A#V5HN>(H;#_`?. M2<-NK(+A%9W\!5!+`P04````"`!$A7!'0>T#*ML$``![#@``#P```'AL+W=O M;(/1AW3TZ4CGJSI_$O+A3H@'\ER5M3J7$V>C]?9\ M,%#%AE54_2&VK(;_UD)65,.EO!^(]9H7;":*IF*U'KC#X?%`LI)J+FJUX5OE MO-+4_Z&IK61TI3:,Z:KL8!7EM?/MJSI?\Y+=,*D`3.AV&].*39SGTB$E53I< M<&DNCH9'SL#`=D-=2%*(%>M@^8:K[Z]_.&3%UK0I M=0Z=W;UWXHSL>=PSSV`UG3PH#S0U""\T?64[O)L[0(;31XH*7FLD9U>Q2 MBF;+ZWM@.63-I=*9&6[[9,5K7O&?IM]PI3;BZ4I(_E/4FI99(459MJW,'VTC M>(-ZNP-]U+SH/:CI76IF8N(<#P'XR!6_XR77+Q.G_5TR,Y+!+T-IP__^B]1M M<'933&B](F&M@4*BNIL\"(WI`SP<1`IT@T,D^*`VO_3R>M/K\/L=W(=Q::? M"'2*0*?[H"@.DGE(C9;=`[_6D80E2C+ MEGXO8T,H[#*(XO+?7/RU(\SPS-&&QA& M89E'5ING&<0:)I^$-ZT"KV$RP7W'8)5'%I>SIJJH?#'+,N/W-8?=BT)2\XM" M-/6H%W(L\\ABC[.+U78M:EM1V89*=CBEJH?":KLVM=I`BW:TK#9#=;'>+M;;M>C],>H,H[#>KDWOCU#>$._66&_/IO>/ICUY*-68 M/=],GQ;%`VS6YA2"\YR')?=LF?LCE(>SBH=M]RRV?XSR,*IW'K'8;D&]IJQD M3;[W3C;8=L]B^SXJJK<-S,%2@;CX`.!AVSV+[99>F56CVCMLA5'8=L]B^[_% M:BKJ1A$?H[#MGL5VL^K4^[)K5TO9RU,>MMRS6EX_FH.S`2RDJ+A20G;KV:Q% MC,*6>Q;+4R@[9%/H1IK\XIL:@&O^MJ3Q41);/K98WD\NN:2U,C4%'#%_32YC M;/G88GG6W"GVHS$G]_"Q78&]#(-1V/*Q^UH:O%<#4!#QFJU,K:3:UT"Q49@" M"KZZ4\[XR.QTYGH.1=7$,94/%#E-609P+ZFO!6WK@XZ\*YF^_0-02P,$%``` M``@`1(5P1Y/078UJ`@``P@@``!@```!X;"]W;W)KW:($U`!,]L)W;^?+X0:UVIX M";;Y+C[FG!P7(Z%OK,:8>^]=V[.=7W,^;(.`537N$'LB`^[%FS.A'>)B2B\! M&RA&)T7JV@"&81ITJ.G]LE!K+[0LR)6W38]?J,>N78?HOSUNR;CS@7]?>&TN M-9<+05D$,^_4=+AG#>D]BL\[_QEL#R"5$(7XW>"1&6-/;OY(R)N<_#SM_%#N M`;>XXE("B<<-'W#;2B7A_'<2_?"41'-\5_^NPA7;/R*&#Z3]TYQX+78;^MX) MG]&UY:]D_(&G&!(I6)&6J5^ONC).NCO%]SKTKI]-KYZC?A.#B>8FP(D`9P), MOR1$$R&:"2!6D>J=J;B^(8[*@I+18P.27QML!9Q*$:'LB6"8FJKCTJNW,BR" MFY19(/8:`14"S(A`:#L-X-)@#PTZ=!D<3$3TV""R(H@4/5+T^#$]MNBQHL>* MGC@/P$2DCPT2RR`QZ-G2H-<&&I'H$X9YDH4KSCFU;%+#)G?&82(VCPTRRR`S MZ,"=*@O(BAARRR(W^+B8'A"A>[AD%D*@"WRP(#5[C8I0[,2H:1 MJQ8/$V8JQC#9P"3)\Q6Y#.RZ!V;A0W>J39A48];DFEWVP*QJF#K_7R9,,GV? M3SD=&"VCP_2B6BGS*G+MN>X-\^K\H'!```-Q(``!@```!X;"]W;W)KFN3PD2?U\#$56?RXOX=S^;_MK7:KLI7YO\=`Y?JU7]6A19]>\N MY.7U<0WKVX5OIY=CTUU(MIOD'K<_%>%@\A#P\-UT767MX"VG(\ZZG=N0?8Z?_C]D%TO-;[[_W MTVWM/V5U2,O\G].^.;9NQ7JU#X?L-6^^E=<_PC@'W77X7.9U_[MZ?JV;LKB% MK%=%]G,XGL[]\3K\X\08Q@?@&(#W`%#O!L@Q0$8!R>"LG]>7K,FVFZJ\KNI+ MUMUM>&CE5==)V_.JG4S=-_OE&JZ^;=%NDK>NGXED-TAPD'"*=*)P=TG2CL^: MP,@$]O%RB/PBI2JI#"2R\_-J(B(XH:`=;( M(-&]Q!M'IDO-4)6R%A8LJHZ\:.H%62^:C`)22\MZF5?->C&1%T.]2-:+FC9AS* M2R<$OT`3(4JMM5WBZ1=B`J&57+#*$.,.D,Z*7;_=J!DYX85%-FW2BI4`QJ;T2?#JG$YWR M0#?MO*,8J$")JGBB`H6E06%@YK:]HYMW%&,5*%<5SU68@-5Y4)['_%1HC/-& M+/`4TQ4H7A6/5Z#@5`(-NYCI1*9!PI)TC?D*%+`\.G=`V>F<%7$E=#-$=5ZB M4`N>A1!3%BAF%8]9H/R4QBN8R;6IKDV`!?L(8\PBQ:SB,8L3>FII#)]K[^GF M'<601:".'.\()H4)(O^0?D7"I4B6_'('C5#!0FB')]JEDP]!C$J\KS3"U(08W`B!:>6O$_-^Z2O&7.:>2V73G36JK;D6N`HQB527&H>3SCAH&EWBYDI2".EDM8M@2;& MT$0*3P1BC$RDZ]0RH*!(_.?!*>W8&Z51I MVEN(I.J=?_N,\2DI/C4/JU%C/ZQ2)T*^2DW(*_XE>PE_9=7+Z5ROGLJF*8O^ M0\&A+)O0=B<^MSES#-G^WLC#H>E.;7M>#=\UAD937FZ?:>[?BK;_`5!+`P04 M````"`!$A7!'%FI4+T@"``!M"```&````'AL+W=O$[PWII9&"(!%U.*F"ZO2[+WRJF0G29N.O/)`G-H6\[]K0MFP"F%X MV7AKCK74&U%51E??OFE))QK6!9P<5N$7N-Q`I"5&\:LA@W#F@8;?,O:N%S_V MJQ!H!D+)3NH06`UGLB&4ZD@J\Y\QZ/^-\2C(9X8(DMFZOJ*):Y*SH9`]%C_VG"IY%P'49$#58PP2W-<=O=AF*I]Z1>=4L"P33.P2X-`LOS:BQ!4,TO@#^LWFDG2?[=+M! MERSSDT$G6P%4N@3%_L.ZD699DL`LBY^XK^#TPH/(Y8]G)@3!(5$+RHJZ-6O?^ZH.0@]313&PO=V]R:W-H965T M&ULC9A+;^,V$,>_BN![5YRA^#(<`RM917LHL-A#]ZS$2FRL M9+F2$F^_?:E'')(=Q[K8%OV;QY_/$3>7IOW9'HJ1L9D7!?'TVJ[&=N^M=M-\]I7 MQU/YK8VZU[HNVG_3LFHN#RM8O3=\/[X<^J$AWF[BJ]W^6)>G[MBQO'3.[VA(_K%I?@X/?^X?5FS(H:S*IWYP4=BOMS(KJVKP9"/_ M,SO]B#D8NK_?O?\^RK7I/Q9=F375C^.^/]ALV2K:E\_%:]5_;RY_E+,&,3A\ M:JIN_(R>7KN^J=]-5E%=_)J^CZ?Q^S+]D^C9C#;`V0"O!M)W5TB=PDEG(ZY*44'4K0K19%2M!M$24G.T$Q[PV0DAAO-+,KCN%9` M]E_N8IAP99?6?7$F$&=<<>1J2(T3)Q%H2"IS*6W%T>-EO/5GA"![*GC_T,-!,<:"'S@-_L_L+I_=$CT-D4AJ^0.+_ M#E=P)&JRR].9F25J#@DYAS./`]#2**0U>B#G(!-Z%/W(@C-8)!)#D>B*)/L] MG9DY)X:"T4O0XU""$/31YG$)VLSIO3*(JY5)ED@,#W[@KD2RV].9^6R_]!"% M].+:W7>4>XA0VBS8-B&L1L`M1S1=CLS,^WH1'#5Y#F8>R`58DA;G.;1;#$IZ MRN0^B8E=@7S)V(6E"7BU"7W4@5LL:`,W)J=7G4B%&NE=U`,EL\<:K?`S?[<% MAE4*N&6*IHLOD-XX)A+I2L7GP.[L_,9&ZH,&N"`G1NZ#7*)4"\H5".L5<`L6 M>@ZF,Z-FD795T'56YH%@D'&\H=+S:$D[_^G#/B!!&-LG"W2&Q0QHYQU#+ZA9 M(:P8P"T9-%T/S8SZ;*^ZB^SN(_D-Y/:+85@D('/[8\',P?`,1N\,ILL,!&_] M6JF5%(8^MGROGZO%!6ICYQZC+MN7\0:IBYZ:UU,_38AKZ_66ZNMX216T MI[#.@&C?P3J?[J`^W&\WY^*E_*MH7XZG+GIL^KZIQXN7YZ;I2YL[^V([_E`6 M^^M#53[WPT\UC,AT$S4]],WY_6+M>KNW_0]02P,$%`````@`1(5P1VFH8:=! M!0``LQH``!@```!X;"]W;W)KU%@L1?MM1(KB;&VE4K*9OOVU<%Q.,P8XDUL*?^0_Y#T MQQ&U?JN;'^US576+7\?#J;U;/G?=R^UJU3X\5\>R_5*_5*?^/X]UKC M>\AR<2Q_39_[T_CY-OW'9^

,QT7-T$C?\J)/IATOQ^&:[O[_1S:$9+M),%1\J%8]8VK M/:#L88M!.&H=%*'")?1`40XTQM.4`\['0(Z&W MFK"00C`YY`D9F)!CZ1"4(#$&FIKX] MBZ:NR(-NO!`RS(DQ98@P=H3"$>B.,$S>.*_/F9"!LVA3',74`Q*.4'=$X1A1 M#J!C2^AZP''H_;JGF*3``;@@HX0F8O2!$6FQGI8)[7*?UI61#G5D^Y%.0&V7J;4*=B#%<,X7IE M3]GB?*TJ)#>&+*;,5,Q6],+-%6[XM)D2,LHRSE-(%K,5\W#]0<(2IAB&E(FL M]"V#LMDQ%I)^L\BRA`5(,0E)%)J@HY!D!>FWL^A<\HEE(0R% M,N^!$IZR*68I"9:"SE(RT4_OFB.A,XD+.B8J":*"3E023_6&K?X\4Y`L63ES M*8<1%&.5!%91QRK-8U5(;LA2`E4IIBH)JJ).50IQ29P9TD]'A`Z,,6A3!BC& M*N7"D_Z(0;E<1SGI9U4%R3,!#TDG%!R#F@6H\$8QVAE(P8WH9KC&(4L4(@Z"MF*A9GY*W26NCR-SAR3 MD`4)22?A6>3.Y4;..C$+H8/<^D_UV"IX%W"LFJ?Q'4F[>*A?3]UTX'ZY>WD/ M\Q6'=PG1_2W<%M/;E(]F-NN7\JGZJVR>]J=V<5]W77T<7U(\UG57]0:S+_T< M/E?E[G)QJ!Z[X:OKOS?3.Y7IHJM?WE\17=Y3;?X'4$L#!!0````(`$2%<$?P MEAJ1GP$``+$#```8````>&PO=V]R:W-H965T&ULC5/+;MLP M$/P5@A\0ZF&GA2$+B%,4[:%`D$-[IJ651(3DJB1EI7]?/F3%-H*T%W%W-3,[ MRT#<^..,=L,H+B]PQ&T_].A4=SYU/3,C@9X&TE*LB++ M[IGB0M.ZBK4G4UYO1<>!;]X$*!U15;>:U0H*U` M30QT>_J0[PZ;@(B`GP)F>Q&3X/V(^!*2[^V>9L$"2&A<4.!^.<$C2!F$?./? MB^9;RT"\C,_J7^.TWOV16WA$^4NT;O!F,TI:Z/@DW3/.WV`981L$&Y0V?DDS M68?J3*%$\=>T"AW7.?W9WB^T]PG%0BA6PN[,QC=.GZJG.R[QBIR!TA3DD3)$P*X)Y]7=;%-I8TN"D7=J\M;K>SHV.]LX-6\9LW8/B]@8' MT/Y/BT9QYU/3,3L8X$TD*:5F6L/9NJQ-%)H>'9$#LJQ#XBO(7EL M=C0+%D!"[8("]\L1[D'*(.0;O\V:GRT#\3P^J3_$:;W[`[=PC_*W:%SOS6:4 M--#R4;H7G'["/,(F"-8H;?R2>K0.U8E"B>+O:14ZKE/ZL\EGVM>$?";D"^$V MB\93HVCS!W>\*@U.Q`X\G-UJZ^$FB'AEXKW9F,;I4_58K=9%R8Y!Z`*S3Y@\ M818$\^I?ML@O6^SS,WK^;_KZRN$ZTM>SP_\0**X$BBA0_'7$2\SFJ@D[VU,% MIHM7QY(:1^W2YBW5Y7;>Q4-DG_"J''@'3]QT0EMR0.=/-AYJB^C`F\AN-I3T M_OTLB836A?"[CTVZ4BEQ.)P>R/)*JP]02P,$%`````@`1(5P1P$@?@*?`0`` ML0,``!@```!X;"]W;W)KQ-W5S.PL'\6(YLUV M`(Z\*ZGMEG;.]1O&;-6!XO8&>]#^3X-&<>=3TS+;&^!U)"G)\BQ;,\6%IF41 M:R^F+'!P4FAX,<0.2G'S;P<2QRU=T*GP*MK.A0(K"S;S:J%`6X&:&&BV]&&Q MV:T"(@)^"QCM24R"]SWB6TB>ZRW-@@604+F@P/UR@$>0,@CYQG^/FI\M`_$T MGM1_QFF]^SVW\(CRCZA=Y\UFE-30\$&Z5QR?X#C";1"L4-KX)=5@':J)0HGB M[VD5.JYC^K.>:-<)^9&0SX3[+!I/C:+-']SQLC`X$MOS<':+C8>;(.*5B?=F M8QJG3]5#N5BN"W8(0F>87<+D"3,CF%>_VB(_;['+3^CY]_3EA<-EI"^/#O]# M8'4AL(H"JR]'/,?<731A)WNJP+3QZEA2X:!=VKRY.M_.ASR>R2>\+'K>PB]N M6J$MV:/S)QL/M4%TX$UD-[>4=/[]S(F$QH7PSL&PO=V]R:W-H965T&ULC5/+;MLP$/P5@A\0RI+3IH8L($X1M(<`00[IF996$A&2JY"4E?Q] M^)`5VPC:7L3=UA<*K"K9PFN$`FT%:F*@W=+;U6:W#H@(>!8PV9.8!.][Q)>0_&ZV-`L60$+M M@@+WRP'N0,H@Y!N_SIJ?+0/Q-#ZJW\=IO?L]MW"'\H]H7._-9I0TT/)1NB>< M?L$\PG40K%':^"7U:!VJ(X42Q=_2*G1EP8G8@8>S6VT\W`01KTR\-QO3.'VJ'JI5<5.R0Q`ZP^P2)D^8!<&\^IN.F$MF2/SI]L/-06T8$WD5U=4]+[][,D$EH7 MPN\^-NE*I<3A<'P@RRNM/@!02P,$%`````@`1(5P1P80<6"K`0``%@0``!D` M``!X;"]W;W)K&ULC53);MLP$/T50A\0:G-;&+*` M.$70'@H$.;1G6AI)1$B.0E)6^O?E8BN68:2YF)S1VP8D7VI&#:P-)"EHGJ9?J&1<)745>D^ZKG"R M@BMXTL1,4C+]=P\"YUV2)>?&,^\'ZQNTKNC":[D$93@JHJ';)??9=K_QB`#X MS6$V%WOBLQ\07WSQL]TEJ8\``AKK%9A;CO``0G@A9_QZTGRW],3+_5G],4SK MTA^8@0<4?WAK!Q*RF5"&Z6/W M6&=E6M&C%UIA]A&31\R"H$[]ID6^MMCG%_3\__3B*F$1Z$5T+SXA4%X)E$&@ M_'#$->830VZN3#8K@?RFR1I37)G0BX.3H/MP/PUI<%(VGM#279[`?1X._AU> M5R/KX1?3/5>&'-"ZZQ-N3H=HP85([UR*P3W2I1#06;_]ZO8ZWMM86!S/KW#Y M*ZC_`5!+`P04````"`!$A7!'IC2*.Y^:@=G)`.\B24E69-DGIKC0M*EC[>Q3"Z4&!-S59>)Q1H*U`3`_V.WN?;?140$?!3P&(O8A*\'Q!?0O*] MV]$L6``)K0L*W"]'>``I@Y!O_'K2?&\9B)?Q6?TQ3NO='[B%!Y2_1.=&;S:C MI(.>S](]X_(-3B-L@F"+TL8O:6?K4)TIE"C^EE:AX[JD/V5^HGU,*$Z$8B5\ MR:+QU"C:_,H=;VJ#"[$3#V>7;SWF[RJ:G8,0E>8?<(4 M";,BF%?_L$5QW6)?7-"+?]/+&X=EI)>I>_D?`M6-0!4%JK^.>(W9W#1A%WNJ MP`SQZEC2XJQ=VKRUNM[.^R*>R3N\J2<^P`]N!J$M.:#S)QL/M4=TX$UD=QM* M1O]^UD1"[T+XV<&PO=V]R:W-H965TFJVGU8J>I#^^S``%9M#[5-Z/Y]?4EH$E6[^X)GAG/.G/&EFM&\ MV0'`D0\EM=W0P;EQS9AM!E#<7N$(VO_IT"CN?&IZ9D<#O(TD)5F>93=,<:%I M7<7:DZDKG)P4&IX,L9-2W/S9@L1Y0U?T6'@6_>!"@=456WBM4*"M0$T,=!MZ MOUIORX"(@!_XQ8>4+Z*U@W>;$9)"QV?I'O&^2<<1K@.@@U*&[^DF:Q#=:10 MHOA'6H6.ZYS^%-F!]CTA/Q#RA7`7"2PUBC9_<,?KRN!,[,C#V:W6'FZ"B%;VH@D[V5,%IH]7QY(&)^W2YBW5Y7;>Y_%,ON!U-?(> M?G/3"VW)#IT_V7BH':(#;R*[NJ9D\.]G221T+H2W/C;I2J7$X7A\(,LKK3\! M4$L#!!0````(`$2%<$=D=T-%H`$``+$#```9````>&PO=V]R:W-H965TV&#LZ-:\9L,X#B]@I'T/Y/ MAT9QYU/3,SL:X&TD*:UE6L/9JZPLE)H>'1$#LIQ)+2'ZW&YH% M"R"A<4&!^V4/=R!E$/*-7P^:GRT#\30^JM_':;W[';=PA_*/:-W@S6:4M-#Q M2;HGG'_!883K(-B@M/%+FLDZ5$<*)8J_I57HN,[I3Y$=:%\3\@,A7P@WD\K@S.Q(X\G-UJ[>$FB'AEXKW9F,;I4W5?K\J;BNV#T!EFFS!YPBP( MYM6_;)&?M]CF)_3\W_3BPF$1Z47J7OR'0'DA4$:!\J\CGF-^7#1A)WNJP/3Q MZEC2X*1=VKRENMS.VSR>R2>\KD;>PP,WO="6[-#YDXV'VB$Z\":RJVM*!O]^ MED1"YT+XW<&PO=V]R:W-H965TV&]LX-:\9LW8/B]@8'T/Y/BT9QYU/3,3L8X$TD*:5F6L MO9JJQ-%)H>'5$#LJQ``I@Y!O_''0_&H9B*?Q M4?TI3NO=[[B%!Y2_1>-Z;S:CI(&6C]*]X?0,AQ%60;!&:>.7U*-UJ(X42A3_ M3*O0<9W2G^+N0+M.R`^$?";<9=%X:A1M/G+'J]+@1.S`P]DMUAYN@HA7)MZ; MC6FI>_$? M`LL+@6446'X[XCGFOCB4UCMJES9NK\^V\S^.9?,&K`1[IDGP$``+$#```9````>&PO=V]R:W-H965TV.]LX-6\9LW8/B]@8'T/Y/BT9Q MYU/3,3L8X$TD*:5F6L/9NJQ-%)H>'9$#LJQ#XBO(7EL=C0+%D!" M[8("]\L1[D'*(.0;OYTT/UL&XGD\JS_$:;W[`[=PC_*W:%SOS6:4--#R4;H7 MG'[":81-$*Q1VO@E]6@=JIE"B>+O:14ZKE/Z4\RTKPGYB9`OA-LL&D^-HLT? MW/&J-#@1._!P=JNMAYL@XI6)]V9C&J=/U6.UVN0E.P:A"\P^8?*$61#,JW_9 M(K]LL<_/Z/F_Z<65PR+2B]2]^`^!]97`.@JL_SKB)::X:L+.]E2!Z>+5L:3& M4;NT>4MUN9UW>3R33WA5#KR#)VXZH2TYH/,G&P^U173@360W&TIZ_WZ61$+K M0OC=QR9=J90X'.8'LKS2Z@-02P,$%`````@`1(5P1^P(JZF@`0``L0,``!D` M``!X;"]W;W)K&ULC5/+;MLP$/P5@A\0RI*<%(8L M($Y1-(<"00[MF996$A&2JY*4E?Y]^;`5VPB27,3=U3%WA MY*30\&2(G93BYM\.),Y;NJ*GPK/H!Q<*K*[8PFN%`FT%:F*@V]+[U697!D0$ M_!8PV[.8!.][Q)>0/+9;F@4+(*%Q08'[Y0`/(&40\HW_'C7?6@;B>7Q2_Q&G M]>[WW,(#RC^B=8,WFU'20LY^0'PGY0OB61>.I4;3YG3M>5P9G8D<>SFZU\7`31+PR\=YL3./T MJ7JH5^NR8H<@=('9)4R>,`N">?5W6^27+7;Y&3W_G%Y<.2PBO4C=BR\(E%<" M910H/QSQ$K.^:L+.]E2!Z>/5L:3!2;NT>4MUN9WW>3R3-WA=C;R'7]ST0ENR M1^=/-AYJA^C`F\ANUI0,_OTLB83.A?#.QR9=J90X'$\/9'FE]7]02P,$%``` M``@`1(5P1^G'KP^@`0``L0,``!D```!X;"]W;W)K&ULC5/+;MLP$/P5@A\0RI*=!(8L($Y1)(<"00[MF996$A&2JY*4E?Y]^+`5 MVS"27L3=U3%7BZ*30\&*('97BYM\6)$X;NJ#'PJOH>A<* MK"K9S&N$`FT%:F*@W="'Q7J[#(@(^"U@LB6XV-`L60$+M@@+W MRQX>01P%*C:/,'=[PJ M#4[$#CR&7BO=F8QNE3=5\M5KA,\PV8?*$F1',JU]MD9^W MV.8G]/Q[>G'AL(CT(G4O_D-@>2&PC`+++T<\Q]Q=-&$G>ZK`=/'J6%+CJ%W: MO+DZW\Z'/)[))[PJ!][!+VXZH2W9H?,G&P^U173@360W*TIZ_W[F1$+K0GCG M8Y.N5$H<#L<',K_2Z@-02P,$%`````@`1(5P1_0)ZRQ6`@``Z@@``!D```!X M;"]W;W)K&ULC9;=CILP$(5?!?$`B\U_(H*TV:IJ M+RJM]J*]=A(GH#68VD[8OGUMD[",ERC)M_I4*3,1E$4PQAWJAK:RYJTGZ''C/^/U M%F=&8A6_:]K+R;UGDM]Q_FX&/P\;'YD<**-[92R(OESH"V7,.&GRWZOI)],$ M3N]O[M_M\ZD_?7V9ZEX MZM==^>)+$U[#Y@/`:$(X!.;*)#R";YC>B2%D(WGNR(^;EX;66 M"V.BG3V=F[1#N_IA]E+B)"^"BS$"FNV@"0?-J`BT^RPBA(AM.`D/'X='3H:1 M#8\&>K3`('8,8FL07Y>XFETBT*3H,21Q(`DPP+,0J%FPDM2!I,`@FH5`3?P8 MDCF0#!@DLQ"H21]#<@>2`X-L%@(U^6/(RH&L@,'\BP>:;,&+Q\BM(#2QF.Q/ M4$$(8!84$?Y2J!A8W.%`4;2`$[J<$%C$\QPH2A9PW++&$;!(YSE0E"W@N-6/ M06EG=TXX*%HMX+@'``;5G:-Y#A0MV0?N&8!!@>=W]@$4+=D'[C&`08WG=_8! M%+G[()CTHH:*DVVYTMOS%ATYT5]$G.I6>CNN=$>T MS?#(N:(Z"_2D_]5*?WB,`T:/RMQF^EX,K7@8*-[=OBS&SYOR/U!+`P04```` M"`!$A7!'G5Z$C*,!``"Q`P``&0```'AL+W=O#+MS\VX/$<4<7]%1X%VWG0H&5 M!9MYM5"@K4!-##0[^K38[E0,@CYQG\GS:^6@7@>G]1?XK3>_8%;>$;Y1]2N\V8S2FIH^"#=.XZO,(UP M'P0KE#9^2358A^I$H43QS[0*'=;$SC]*EZ+!>;AX(=@]`%9I\P><+,".;5;[;(+UOL M\S-Z_CU]>>5P&>G+R>'Z>X'5E<`J"JPF@*C!MO#J65#AH MES9OKLZW\RF/9_(%+XN>M_"+FU9H2P[H_,G&0VT0'7@3V=T])9U_/W,BH7$A M7/O8I"N5$H?]Z8',K[3\#U!+`P04````"`!$A7!'?5B>)Z(!``"Q`P``&0`` M`'AL+W=OQ-W5S.PL'^6$]LWU`)Z\:V7< MCO;>#UO&7-V#%NX.!S#A3XM6"Q]2VS$W6!!-(FG%>%$\,"VDH569:B^V*G'T M2AIXL<2-6@O[9P\*IQU=T5/A57:]CP56E6SA-5*#<1(-L=#NZ--JN]]$1`+\ ME#"YLYA$[P?$MYA\;W:TB!9`0>VC@@C+$9Y!J2@4&O^>-3]:1N)Y?%+_FJ8- M[@_"P3.J7[+Q?3!;4-)`*T;E7W'Z!O,(]U&P1N72E]2C\ZA/%$JT>,^K-&F= M\I_'AYEVF\!G`E\(GXID/#=*-K\(+ZK2XD3<(.+9K;8!;J-(4";!FTMIFCY7 MC]7J\*@?1P0]A.VD< M.:`/)YL.M47T$$P4=_>4].']+(F"UL?P,<0V7ZF<>!Q.#V1YI=5?4$L#!!0` M```(`$2%<$?0?84!V@$``$4%```9````>&PO=V]R:W-H965TL&?\_R`]5`VCTR5FC3EZM=7O$6.4U<*(>1`N-.2F%Y$2;4%98 MM1)(X4B4W`\)Q;A`+\I]&JV1[;VBQ`?-OA9G#S?E@`,5-F[MAY,X&FG;A'`DA!,A\5WA@Y$K\P?1 M)$NEZ)%JB;V[X&C@THH8961J4RYTW0_9:Q8\1BF^6J$%YCQ@P@$S(;!1W[0( MEQ;G<$8/[]-WJPIWCKX;*]S?%XA6`I$3B$:!PV:+2TQ\WV2_,MDO!))-DR7F M\;[)865RF`F8X=HT66*^<5WQRB1>"(2;)G-,D'RCDV1EDBQ,=ILF2TRT,L&S M_YR#K-PX*Y2+KM'##SUEIQ?C*71S\@7/TI94\(O(BC8*780VT^8&K11"@RG" M?S"75ILW;0H8E-IN8[.7PY@/@1;M[=&:7L[L/U!+`P04````"`!$A7!'OB5: M1Z(!``"Q`P``&0```'AL+W=O':326)A>[*VT[!_O[:3AK:JQ$L\,SGGS!E? M\@'MEVL!//G6RK@M;;WO-HRYL@4MW`UV8,*?&JT6/J2V8:ZS(*I$THKQ++ME M6DA#BSS5WFR18^^5-/!FB>NU%O;?#A0.6[J@Q\*[;%H?"ZS(V\2OF+Q46YI%"Z"@]%%!A.4`CZ!4%`J-_TZ: M/RTC\30^JC^E:8/[O7#PB.I35KX-9C-**JA%K_P[#L\PC;".@B4JE[ZD[)U' M?:10HL7WN$J3UF'\PY<3[3J!3P0^$^ZS9'QLE&S^$5X4N<6!N$[$LUML`MQ& MD:!,@C>7TC3]6#T4/%OG[!"%SC"[$<,39C$C6%"_VH*?M]CQ$SK_G;Z\<+A, M].7D\/9W@=6%P"H)K":!NZLCGF/N+YJPDSW58)MT=1PIL3=^W+RY.M_.!Y[. MY`=>Y)UHX%781AI']NC#R:9#K1$]!!/9S9J2-KR?.5%0^QC>A=B.5VI,/';' M!S*_TN(_4$L#!!0````(`$2%<$>M'\W.QP$``*8$```9````>&PO=V]R:W-H M965T9'@*,'X$0G6M'%9^+$751;R8GC3PHN*]$4( MIGX_`Y?])B;Q;>"U.=?&#:"R0*/NU`AH=2/;2$&UB;^0]9XZP@,_&^CUI!^Y MW`]2OKG@^VD38Y<"<#@:Y\!L8) M#[)E03((DE%`TG\*Z""@GQ6D@R#]K"`;!-F=`(7:_<[MF&%EH60?Z8ZYZT36 M%E?.Q#I'=KNT#_V!A-%KF>"\0%=G-&.>`Y,$9HG8SHBG)60W159D"=G/7`@> M&63K6"PFN2LF\09T,"#_-Z!W!M0;I-Z`XGF2;=B,@*P\LDALIP3%.'7]M*BD-6"_\8,NN[:,Q M!APJX[HKMQ_A/PJ!D=WM51B?IO(/4$L#!!0````(`$2%<$?YOH_AP0$``#T$ M```9````>&PO=V]R:W-H965T:=<;Y\!E@1=>0SD(3:5`"MI#])+L MJ]PA/.`7A4FO]LCE?I+RPQFOS2&*70K`H#9.@=CE#!4PYH1LX#^SYC6D(Z[W M%_7OOEJ;_8EHJ"3[31O3VV3C"#70DI&9=SG]@+F$1R=82Z;]%]6C-I)?*!'B MY#.L5/AU"B?/\4S;)J0S(5T(2YQM0C83LBO!7QT.F?FZOA%#RD+)">F!N,=. M]A:NG(A51K88[4U_7<%[+M,D+?#9"=U@C@&3>DRR(+!5WPR1WH8XIBOZ9H!J MC=C]1X3LKHC,\[.YB.S?`OF=0.X%\ED@OTU2A#("9NK1K4CO+B\&@-6Z[LWL5VCL81@Z785W^&.474$L#!!0````(`$2%<$>8 M*UB%-`(``'@'```9````>&PO=V]R:W-H965TV$Z=_7#T(P[4ES/C%$FUY'4H>H[1R9`H M"6,(UR%%;1<4N=E[XT7.+I*T'7[C0%PH1?Q?B0D;]D$4W#;>V[J1>B,L\G#B MG5J*.]&R#G!\W@>OT:Z*H(88Q.\6#V(V!]K\@;$/O?AYV@=0>\`$'Z660&JX MX@H3HI54Y+^CZ#VF)L[G-_7O)EUE_X`$KACYTYYDH]S"`)SP&5V(?&?##SSF ML-*"1T:$^07'BY",WB@!H.C3CFUGQL%^V<"1YB?$(R&>"%,3/C>2+8QD MCH#_@;J8M=>(B\F>&]DLC&P<`>_]ER[&>WV5@TG@IIIN;<-@:[D*R_];FIV1;_`5!+`P04````"`!$A7!'CD#,FK("```["@`` M&0```'AL+W=OPO#<\%KO]D(U1%49C;Q-W=*.UZP+>KJ= MAX]PMH*Q@FC$[YJ>^*0G(D[+9_65[JZ,_T8X7;+F3[T1>YD6A,&&;LFQ$:_L](,.?4B4X)HU7/\' MZR,7K#U3PJ`EG^99=_IY,F]R,-#\!#00T$@8??R$>"#$7P1\E8`'`KXW4C(0 MDGL=TH&0.H3(#)8>ZB%,A.L4`3.O(9+*>(#'HSW!1YOBVRLD3R MVSV)G?&,-1\/XYEX@]J8]+8)=DRP)9!Y36S,'3U)')/$$BB\)A8&@]LFJ6.2 M6@+.E'3&Q&`2L[:R%*<8W3;*'*/,,D)>(X/)-08\`!#?MLD=FUQ+Q(/-'0*% M(U!,RH[](OZL[ M'KPQ(8]G?3)O&1-4Y@8/&ULA53;;ILP&'X5BP>HP9!EBPA2TZK:+B95O=BN'?@!JSY0VX3N M[>=#H"&*E!OL_^<[&=N4D]+OI@>PZ%-P:?9);^VPP]C4/0AJ'M0`TKUIE1;4 MNE)WV`P::!-(@F.2IM^PH$PF51EZK[HJU6@YD_"JD1F%H/K?`;B:]DF6S(TW MUO76-W!5XH77,`'2,"61AG:?/&:[P\8C`N`/@\E_FGV2^@C` MH;9>@;KA!$_`N1=RQA]GS2]+3[R%+\+VML[\*F"6J@I2.W M;VKZ">6[G(%'DG8^"]X50ZT@]]4=TP: M=%36'9]P.>O4/FBT[G=AJ$X-<*H>1`^=>5,+R:DV MH3R'JI=`*Y?$69A$$0DY;;N@+-S:BRP+<=&L[>!%(G7AG,J_!V!BV`=Q<%MX M;<^-M@MA68137M5RZ%0K.B2AW@=/\>Z06X43_&IA4+,YLK4?A7BSP8]J'T2V M!&!PTI9`S7"%9V#,@HSQGY'YW](FSN[]Z+1.<%.'5@A::@]!Z0K0.H`V0C(EE5VODJOR;V&9!F^;Y,%"\13YA#8 M(Z*8;/K,1?%CCG%TWPBOC/#2*-\T6HI(&GVB([+:.++8.+SI0^8-922+/]%0 MOO+)%S[;&Y?//A`F)/_@$\Y^W9Z>X2>5Y[93Z"BT.07N`-1":#"PZ,'L3F/N MFBE@4&L[S$D4J;LQYQQ_?QA3CVC?7`_@ MR8=6QFUH[_VP9LSM>]#"/>``)KSIT&KA0VL/S`T61)M(6C%>%(],"VEH4Z?9 MBVUJ/'HE#;Q8XHY:"_MG"PK'#2WI>?`J#[V/`];4;.:U4H-Q$@VQT&WHUW*] MK2(B`7Y)&-U%36+V'>);;'ZT&UK$"*!@[Z."",L)GD"I*!2,WR?-?Y:1>%F? MU;^EW8;T.^'@"=5OV?H^A"TH::$31^5?N8WRQ7$^T^@4\$/A-X#IZ-4LQGX4536QR)&T0\NW(=X#:*!&42LKG4 MIMWGZ:GARU7-3E'H"K/-&)XQU9<9PX+^71-^8\*3P&(R^0^!Q8W`(@E4DT!U MG=+DE!FS2IARP7GYN4UU8U-=V3S>M:D^L6$7WW\0!_@I[$$:1W;HPU&F4^P0 M/02MXF%)21\NS-PHZ'PL5Z&V^1_*CX9PS M9QR/TY&+-]D"*/3.:"_/7JO4B]+;>Y%9"F_*MKU\"*0O#)&Q)\<*!_/7N@]$J]=TRJ3\+/4GWA5 MQZ"7'>^1@/KL/8>G(C8("_C9P2AG>V2\7SA_,\'WZNP%Q@)0*)51('JY00&4 M&B%=^/==\Z.D(<[W#_6OMEOM_D(D%)S^ZBK5:K.!ARJHR96J5SY^@WL+UF') MJ;2_J+Q*Q=F#XB%&WMW:]78=W9?D>*=M$_"=@"?"(?@G87B2)8*/B(Y$/-GAR<-%T9$*R/=C+2A/2Z7O64X/J;^S0@M,+G#8(L))X2O MU3=+X&6)',_H>*M`,4?L/U%AMVIB9_F1JY`$RQJ]<^$P>XLY)(<*M+G@2;MK]&PO=V]R:W-H965TVTW1O/]L0&GN>$GH3L/G.^1UB^^-4)RY>Y9XQ M%;UW;2^7\5ZIPWV2R/6>=53>\0/K]9,M%QU5>BAVB3P(1C/8E('KN.BC\KUO+3,D;Q>>*YV>V5F4CJ*IGB-DW'>MGP M/A)LNXP?T/T*7_T(E>^3MKV:C]KK:-(XV;$N/K7KFIV]L?(?" M)%SS5MK?:'V4BG?GD#CJZ/MP;7I[/0U/2#J&A0-@#(`I(,.V\`%DR_Q"%:TK MP4^1/%"S>.A>RX5)HC-'NC9IA_;MA]FW&LJ\2MY,(D>S&C1@-6A2)#I[$`$N M8@47X5`6UQ-D7HV939"-"!#X''$X1YL"\ M[8#\,XXRAU*&*=E,BF\$R'$"''8"E,^D^":`'!?`81<8178/W;HTOA4@QPMP MV`M&T9PMX/L!<@R!I.&OA"NZA>.;`G)<@4"8XXJR&SB^)2#'$\A_OGJ+N1SP M_0` MF&D$X!L!.$9`PB=G%(7_L>2BS^J8V-EV4D9K?NS5T%!-LU/+^@"V3_N0U]6! M[M@/*G9-+Z,7KG2W9QN]+>>*Z1K2.VT3>]U43X.6;96YQ?I>#&WF,%#\<.Z: MI]:]_@M02P,$%`````@`1(5P1\S6.J8G`P``0`\``!D```!X;"]W;W)K&ULI5?;B=WIM`^=R>2A?2:V M;#,!Y"(Y3O^^0LC$4HF]3GDP")_=L[OH+.ST*-H7N>-2^Y<7:&-55!(2D45V433B?FGN/[7PJ#JHJ M&_[8!O)0UT7[9\$K<9R%-#S=>"JW.]7=B.;3:+!;ES5O9"F:H.6;6?A`[Y?, M0`SB9\F/\NPZZ()_%N*E6WQ?ST+2Q<`KOE*=BT*?7OF25U7G23/_MD[?.3O# M\^N3]Z\F71W^3,*B+M_Y<-N9\[/^9$&LV;@#6``8#FETT8-:`O1O$)M,^,I/7ET(5\VDK MCH'<%]W3IO<:WG9.M.=`)R/-TI2KO_LZAYQ,H]?.D8-9]!@P&#H@(NU]E`)< MB@6P M"T*(C/[3*BAB3UO04+J,.`=B`U/P>0&QA2WHYF+ZK82ZO20?+R:[N9A^?Z#G M#8(1,IY4_-_%]-L!31Q>C`M?YS1%Z-2"S&9%=B[J]P.:(:1*W8Y`$1V!^BV! M3A!JM:!^AX$N'8U33%9^9Z`Y1JZY\Y@0W1C\M@`$(5<+&JJ'>;W[?0$H0I\6 M=&OUP&\&``A].B!<]?P^`.R2/D\\+H@A>/P^`&X?0+PUP9-'9P%+S=FL&.1FLQ*%1_60RW!V&Q0

:-#,+XP$``-($```9````>&PO M=V]R:W-H965T3):Y3J MCQC+H@%&Y!/OH=-/*BX843H4-9:]`%):$J,X]/T]9J3MO"RUN5>1I7Q0M.W@ M52`Y,$;$OS-0/IZ\P+LEWMJZ42:!LQ3/O+)ET,F6=TA`=?)>@F,>&X0%_&YA ME(L],MXOG+^;X&=Y\GQC`2@4RB@0O5PA!TJ-D"[\=]*\ES3$Y?ZF_MUVJ]U? MB(2VZ?@NK(3H MMU'$CQ5I,5_1GG3RR9FR%@LY99>(]XS@DPYJFP@!D$4MKKNP+/3:$RL+>A5- MW9$G%O!KVV+V>T\:.NQ"&-X7GNM+)=1"5!;1%'>J6]+QFG8!(^==^`"W>Y@H MB5;\J,G`9^-`)7^@]$5-OIUV(5`YD(8.6"MO>0 M,&CQJ[G7G;X/YDF:CV'^`#0&H"D@!CIQ`])I?L8"EP6C0\![K/X\N)5RIDRD MQM_)64.J34(B5>4CHCP3Q+LF3! MEC('E%F@U`O*9J`%>\D=1&XA,B\BGR$^P21+@;P^1JT=U-I"Y5[4>H9*TQQN MDF3!6=HXI(U%6GM)1K,Q[VT%`<``!D```!X;"]W;W)K&UL MC57;CILP$/T5BP]8C"$AB0C20E6U#Y56^]`^.\0):#&FMA.V?U]?",'(4?8E MMH=SSIS!9"8;&/\0-2$2?-*V$_N@EK+?A:&H:D*Q>&$]Z=23$^,42W7DYU#T MG."C(=$V1!"N0XJ;+L@S$WOC><8NLFTZ\L:!N%"*^;^"M&S8!U%P"[PWYUKJ M0)AGX<0[-I1THF$=X.2T#UZC71E!#3&(WPT9Q&P/M/D#8Q_Z\/.X#Z#V0%I2 M22V!U7(E)6E;K:0R_QU%[SDU<;Z_J7\WY2K[!RQ(R=H_S5'6RBT,P)&<\*65 M[VSX0<8:5EJP8JTPOZ"Z",GHC1(`BC_MVG1F'>R3]7:D^0EH)*"),.7Q$^*1 M$-\)B:G4.C-U?<,2YQEG`Q`]UK<=[12<:Q&E#%0QPAS-Z[+1:QZC)`NO6LC! M%!:##"::$*%2]Z9`;HH"S>C(EZ"<(](O9(@71<2&'X]%K)X+)`N!Q`@DUF*4 M>M^"B]EX"WF$>6ADM3"R<@2V7B,.!D&O$1?SA5>Z7AA9.P+>:RM<3.PUXF*2 MYT;2A9%T)A"CM==(ZB3Q8DH7DSXWLED8V3@"WOLO7(SW^DH'$\/G1K8+(UM' M('*3=-:(Q:0&`WV(TH]X:"*"R\8!'1O^+V0!\G\B#T'63#AK:)3PLVGT`E3L MTDG;-*;H-$Q>D6Z(BWBAAXQIE'>9/.OQF?S"_-QT`AR85.W6=-H38Y(H=_!% M_95J-0:G0TM.4F]3M>=V,-B#9/UMSDW#-O\/4$L#!!0````(`$2%<$?$6W=W M!`(``,0%```9````>&PO=V]R:W-H965TQ/<]"U218'Z`!'>F;Z0_1O<"TAL8:5 M8,K]HNJLM."WD`!Q^N7'IG5C[]]D^!JV'$"N`60((*E+W(-)!D5HW!<19(K8D5%X M3++[!O$LQ]@9Q%>#_+[!:F:P<@8K;Q#C:9&MS])K$E]D1")LG_NH9(9*)JAH M$>4UJ=>D"28/?-3UC+.><,@B9STJ*<,/%I3.0.D$%"^"TG%!690_<$39#)-- M,*M%3#8^(H(?/:)\ALHGJ&01E8\J6D4Q(7-..+IF'.3)=1.%*G%NM;]/P^[0 ML)Z)NZ;?\K+HZ`E^47EJ6H7V0IO+[N[Y40@-)@_\9/XKM6FIPX+!4=MI:N;2 M=QF_T**[]A/W32,6)L:%JL>X5D-J3.,-)'#]B3JB(BMSG/E21R\$P*N!# M(3UP3M2_(S`Y'J)-=$E\TK8S+H&+',^\FG(0FDJ!%#2'Z&FS+U.'\(`_%$:] MV"/G_23EEPO>ZD,4.PO`H#).@=CE#"4PYH1LX>])\UK2$9?[B_J+[]:Z/Q$- MI61_:6TZ:S:.4`T-&9CYE.,K3"WLG&`EF?9?5`W:2'ZA1(B3G[!2X=-9%Z M_G9J(KNM(8*+@,D\)EY#E$M$LMVEV>[."5X<+0?5^I'3J)*#,,'^G)VG^BEQ M5W.7/]II#\-YE2GRGK3P3E1+A48G:>S%^SMOI#1@_<4/NPAU]CW.`8/&N&UF M]RJ,:`B,["\/;G[UQ7]02P,$%`````@`1(5P1\)Q6',$`P``L@T``!D```!X M;"]W;W)K&ULE5?;)Y[KW5ZHB:@LHM%N4[>TXS7K@IYN ME^$#OE]!KB`:\;NF)SYY#Q3Y%\9>U>#G9ADBQ8$V="V4BTH^WNB*-HWR)"/_ M'9Q^Q%2&T_>S]^\Z74G_I>)TQ9H_]4;L)5L4!ANZK8Z->&:G'W3(@2B':]9P M_1NLCURP]FP2!FWU;IYUIY\G\P_)!K-Y`Q@,8#18H"\-XL$@'@UPHC,US'1> MWRI1E47/3@$_5&JU\;V$]\J)]!S(9+@>ZG*9V;CXINHVZ2`8C5YC( MHD,\7'S2-KZU[AA<%^!1>0>4>L1Q%8QCC^(/H/.>3Y+Y+3_`R`SL,B'WBX#M M3T+FX<)5,28WE]]5'DY]RF^#/+Z?V!4HSGS*GTW+#S'&Z7S]LVG];=QE2J[D ML:UGG^JY@L;YK0L`K@H!>2R`#2+((XXK5<`>"S"`S`(D"4JSV?H/,'*F@WP( MN<('2]/$I^V[FH:;VS*X*H3$I_P6B'CT)W"E"CX=%Z8M5Y5U_@``TY9KPRX3 M

\%=/'$\Q7.4(HF1^26 M]CM]=>#!FAT[8<["X^QX/7D`?<3^@)?%H=K17U6_JSL>O#`A#^KZC+YE3%!) M!-W)C;"7%ZAQT-"M4*^9?._-E<(,!#N<;TCC-:W\#U!+`P04````"`!$A7!' MI@HK5O`!```8!0``&0```'AL+W=OK52W]WU9U,"(?.(=M'JEXH(1I4-Q\64G@)26Q*B/ M@R#U&6E:+\]L[E7D&;\JVK3P*I"\,D;$GR-0WA^\T+LGWII+K4S"SS-_Y)4- M@U8VO$4"JH/W'.Y/J4%8P*\&>CF9(U/[F?-W$_PH#UY@2@`*A3(*1`\W.`&E M1D@;?PR:7Y:&.)W?U;_9;G7U9R+AQ.GOIE2U+C;P4`D5N5+UQOOO,+20&,&" M4VF_J+A*Q=F=XB%&/MW8M';LW4JR&VCK!#P0\$C8!O\D1`,A&@G8=>HJLWV] M$$7R3/`>R8Z8GQWN-5P8$:V,=#/2AG:[7/:61TF<^3-XNV9QFF*B)'EL$BWZB*Q`-`BDCP7BA4!L!>)!8+.Z$7/,]K%) MLC!)9@*[N4GK3!PFL9@X3#>[(/V/34\73NG4*0U6G1QF8S%)LMFNHDY35(CC M$`>+:OS)B6,@+O8F2E3P:ZO@ZPN>](;5^ID:`PJ5,M.-G@MW'=_A\;',/\+4$L# M!!0````(`$2%<$>W4]X]"0(``#(&```9````>&PO=V]R:W-H965TTX:QO2_??K M(X0D2@LOV.-\QXR/(>\8_Q`5@$2?E#1BXU12MFO7%64%%(LGUD*COAP9IUBJ MD)]_?5NI1$&\+N&3HSF2.>^9^Q#!S\/&\?3 M*0"!4FH%K(8+[(`0+:2,__::-TM-',^OZB^F6I7]'@O8,?*G/LA*)>LYZ`!' M?";RG76OT)<0:\&2$6%^47D6DM$KQ4$4?]JQ;LS8V2^9U].6"4%/"!XEA#TA M'`A^9"JUF9FZ?F")BYRS#HD6Z\/VUPK.M8A21JH884*S77;U4H2)G[L7+33! M;"TF,)@;PE7JBQ;!U&(;C.C!DL%N@LCN.X2S(D+#C_HB9AZ-S<)B4H-)`B_Q MPR78[AO8E^E$LW2B23H/",0S@7@B$"T>RA03WS=)9B;)1"!9W+1DM!MIDF8/ MU)+.;-*)3;IH8S&QP<2I/S["+WVRF4\V\OB;*/X#4$L#!!0````(`$2% M<$?GT?&.#@,``/P,```9````>&PO=V]R:W-H965TI]MDU'5OZ9TLLR",C^C-J*/.$+ZM@O1]RW%67+_A20 M2X^J@S!JFP"&81JT5=WY92'V7OJRP%?:U!UZZ3UR;=NJ_[M&#;ZM?.#?-U[K MTYGRC:`L@M'N4+>H(S7NO!X=5_XS6.X@Y!"!^%6C&U'N/4[^#>-WOOAQ6/DA MYX`:M*?<1<4N'VB#FH9[8I'_#$X?,;FA>G_W_DVDR^B_501MS?QO;;ZE->Z$]>;_"6+!C.[`1P, MX&B0AU\:1(-!-!J`^$N#>#"('P;IEP;)8)`8$0*9NZCRT0/D\T)?-T8H-.K-"),CCO(#$<))J#R-I_'1//!TF-(*GFP"'-S'"0.;#4 M,>E\D-P(DFL.,FMO<[6W,`FMG=U,HR;)+`PRB_ESME"C+/($Q-9C)F&)A&4Q M5,HWR0:$IDR$6G$<'ASPG](`AR8:H(5#'&C&@0Y]'$##PQ>&$XT<8(D%-DW( ME`S@H!E`$XUPBM!NP"4/G`,A4S2`IAJYBPM3-H"+;NB@'#C$,94#I"[-3)7B M330R5>KFDK"I0$"3EQS:B636*!H1%<*TT*F!IE(!3:IREP?:U!?@(#!`E8XT M3D%B/Y.J$.FPZ?]_4V"@)C"Y5B_B2&;>+M\;6C!_EG,\\;^ M&BPW\.4#:1B%CUB3!'C%CZQW,_L561<-.A(^6W& MBR*'<[F@^')_UQA?>,I_4$L#!!0````(`$2%<$>X(.3-I`$``+$#```9```` M>&PO=V]R:W-H965TZAM0O?OUS:$)E&DON"9X9PS9WS)!S0?M@5PY$M);;>T M=:[;,&;+%A2W=]B!]G]J-(H[GYJ&VR>% MAC=#;*\4-_]V(''8T@4]%=Y%T[I08$7.9EXE%&@K4!,#]98^+3:[+"`BX(^` MP9[%)'@_('Z$Y%>UI4FP`!)*%Q2X7XZP!RF#D&_\.6E^MPS$\_BD_A*G]>X/ MW,(>Y5]1N=:;32BIH.:]=.\XO,(TPBH(EBAM_)*RMP[5B4*)XE_C*G1;H*(5R;>FXUIG'ZL'HOE M^B%GQR!T@=F-F#1B%C.">?6;+=++%KOTC)[^3%]>.5Q&^G)RN/Y9(+L2R*)` M-@D\WASQ`O.87#5A9WNJP#3QZEA28J_=N'ES=;Z=3VD\DV]XD7>\@=_<-$); M:HWHP)M([E:4M/[]S(F$VH7PP<=FO%)CXK`[/9#YE1;_`5!+`P04 M````"`!$A7!'^5OH>4MS``!#A0$`%````'AL+W-H87)E9%-T&UL M[+UI<]M(EBCZ>?)7(!RNL10!LKAIJYZI%[0L5ZG;6DJ4JZ;BQ?L`D:"$-@FP M`5*R.NZ/OV?-3&P49??<>"_F1727*1+(Y>3)LR__413K8),F_]C$I]DF7?_G MF^%)_TWP=;E(B_]\\[!>KW[Z\<=B^A`OHZ*;K>(4?IEG^3):PY_Y_8_%*H^C M6?$0Q^OEXL=!KW?XXS)*TC<__T>1_/P?ZY\_9-/-,D[7093.@K-TG:R?@_.4 M1TBR-.@$Q4.4Q\5__+C^^3]^Q'?XO9/@(DO7#P6\,XMGU5\G\:H;#'MA,.CU M#ZH_7F:/W:`_:/[1KF?KBXN:71787+4(8 M:]IM&>04ILVC!3PRB[\&?XN?6]=V^[RJS='O=7YK?>$ZSI,,]S,+/D3KVKL* M+O-O_]8$DS&,,:-Q/BZB^^JO\VA1U$8\W>0YO9`44]C2GW&4M\[>Z?0'G6&_ M^O5YH?"/@C_BQ:+S)TF`21T66QK/@O"@V^K..GC(A31*NOQRRD(%GR$KVL+ M_FWXTMMTAHWOGF9ID2V2&6QS%KR/%E$ZC6%Y<.4+N+^?)Q^"O;?[M>'C*>!< MGV[AJ`U]HJ*`07ZJ_1P5#T0PIO@A_L8P6\'QM9>/I%(E6$>3Q-(:'[A9Q M&"SBH@@`\MD3+K0(LGGPMG\T#`].^D&2$E6@P9L6=IX^PCP-9WF=QZLHF07Q M5Z"!!8R*(V3K!SC>:6DSU1=OLS4`=_LSUSE0UAP1&`;%[:[P8,(@C=?U!0(R MW">P41FK\2F>M'DRA?TBB>Z21;).XOH!?$K2&.$VS>-9`@O)XP4=_BJ"558? MOO%_A/\^XS$T(-$2(<=47QZJTZG'."?LTL75)K,G+D,0R*+I--_$[G#JN#B/ M8=,SV`<<[Z9.S3(X=KBA.%Z:K>.B;8&7_H^A/56ZWG7F47EZ*Q!/HU6"9[8` M\O>**?$NF,7S9)JL:W@%MTA.HL#G@7J\[75[ MO7X`Z!_`'=_`C@_"7J^'_Q?)((@VZX]07C0&X6#89\F.SH:A:/^47@T/-''FY<"UPZO#O#< M=;R\@WVIG$(/`EF4;X4T(EX4JWBZ3A[C11W=9W#_X-SAD)'\=(!^31E3&B[& M9KEA#!/P-R-+T712S8]Z^$2+W^G5;=QB[SI"1'V(UPFPG/UV[C&VY/L%%`K= MH;[X9.V4=WV##WK7I[-VCEW&RM:5EQ][<=F-CS>ON?'1K0OV#A/%I)A)""#X M%=Q9HN9;A(#ASE)\C1/?,*FNG?]DQM/'])LD=T_PQ4%HI*1-%%]:N\3+'!?]A[, M\VP99/9$&Z2.&#!E[4D]\R2EFST%'+J/F\60RW@=["V\>5Y\@!@!H66-=[R/ MBF1*"Y@EB\VZCDY_Q,G]`^)IA%+$/2Q-D+V&Y3:()]`FM\L?R%<$"QU=O#W32%I15[`;_$S"/"=S`X.Y93WG[`C[$P.NG"4MKA*=+%$#^V:@DUV2RISQ9QYUL/M\BB-4Q M\H\H1PW;\E50R@,4-Y(&+D#B1NK`99*?EF, MW>##0/Z!^M.X3_%=`1BXC?S9O%FZ1&R=-\Q;(V%9]B7(8)Y9'LT;MUM>U!/?-N`B<3Y-&MA(>5&X[C:M MZ#IZMB1PZW,ZXMY*WMBG.U92-K<-/O65I-83]7%X%\@1$YK%,#V,2HR(/@4D M:Q-6X(CY:H7'>58'--8&XODRZ`H50 MU=J%P(5GEE\CL:ZMJW8I`%LV4Z73;5:'R_'MYYNSX.IC<'5]=C.^/;^ZG`3C MRP_!^_'D?(+?7]^<3J*K&F9+,O!GM4Y8#$@AL5)&@:;%$U>AN2RIX0P=P;ZU1K56%!&W\`8 MX9L`?@W>B`%2_R1PYO#7FZ<8_[LIX+]PJ.9-MLG?[`.1`%3,$T#U:+%X)L3) M5UE.H@_\]#%ZS),%FBEX<6_TBS=XC4#7741`9F*VNH&JS4ID@F)C@GP>/JSP M!`U^?Q?#J<:TKHL81,H\V(,I4,E$:_`=$/*G_5"8$D\?!7=)M@+$6`*P-Z12 MDC``&P0,F1)E!_3`$3U.(.:/Y1+I7K009F\`B=8HR>+8R7*Y20F<0'#@X!'= M<)0U$`;B[7P_8?FY)Q'#;6'C#0X%3],H<5`\%X`H70!1I_![3'7Q"*'@-?WH@_@VG/$-9T?WCJ?@.]D3 M8H`31PI0`9-9`K.&2$J0#"!"D"Z6`PR7C#ZT%P5T-[B5E>PTL-%EE;;S#C6Z M9(G;O=L`'J.A.2&ZL!`E$[%!^`_(F%.DG"3H1,5S9YUU-B@$I<3PKF&I9-?Y M-8X6L%"!"T#D^M>;XLT^W8F+Y[,BFL<@C6<@T+S/OB)Q)-T&5)`-J6HA7J/% MABU/I'#"JMAB!`(XG@&%2>)TN(=?H^RK]S&98('G>7W42IWH0C( M%6/@BK%01K&)*78 M2_+C9`7JRSQQMV4*4"<*05>JY4XWH;LIH?M%!+)L<$PVBS[M%7DSH9^'EH#) M"3P&OZ81_HC8]"F9Q\%D"O<,8?\+(.,J%!2+O\*V"S(`XEDMHZ]P*O]D6D@& M(EP;XFT%G`Y<^*.(RF$C[)CVE@G(6@T%!%M[9,]MEU7O,BZK^8Z-A?@E=$"Q MP2=EK0^@E2.S!TH>(UT#3'2<#)]SX.L&?\3!'L$U!XCH\,".8F(F'A-*4E/G M,GIWB7U5'J\RI0,&S!U@98#?/L31[!^`YRA'T?.?LB(8@X*U0!B>CKO!-5RI M:4(XARJ_M08@N;Y]0*N#9Q^86WFA<)8"/C:!CNI[,);G1L8U(8LL$2H+(3PO MW"21B&VH%8P!FTDH5+Y(@(](;BJ8[;*%MJ#=QPM`O)16OEG!?J;^[KH!FDEH MI=#L%N#0N_F,K$N$7P(C'&GE M@'_/5C1`$/@=C>TS96V?T\3:9FBY8T`D0&>0'G+SRWA\'3IA.5DV+X/42)P\ M28$9LZ#)$B"@98#.^&"UR8L-=WA#?O+'S!)/.?R$976X6]WQ\ M,%)]%$`(@BV`<@%4"GY&PVC3_F<9759!572G6K'&B]X@^3_+UBS$Y[$C(0AF M@C*BP0*DJL9INN:&86PB[@MSAQ M&@,F%\BE]NA;UE)(=X$EHS47767$7]P`^P;7&:$\E0V#0W6W#"4DE$UF+93)E"\?//3W3%J1VP@3`:H;(CIH;$6IJ?8A/!D,`P'QX=$!.8\!6+# M(B+5)TG+._T`:+$A&8^)`HAZST*7G7H*<&+/(3US(^A6=MM$JQ5`''4/F.(< MEAL,B+@#]PO.+2/_C;GAXKGA['X#@K)NV*MI<77279X%;WNTJK?#WC`8Z?4CB M.1!F6`$1A2L2R$%TOLD`7NO@URZ('7DQ?=A'WB(J+PN`HG8@9U\_D#3V%+NU M1\Y=C-O`HZUOI,:X;M$E&XR9^RB^K(E*D#DD)L,U+I056*%N>V1"T%"14[+> M@18'"P(UNV# MJ`G%V2L2L"7^)?E M>?94XNC536QX=C7^D:@_%]'K-]@ME3`Z;5GWVS3RJ'IXBR3'V7/<9$ M&H"(YJBD;Y!I(.*AX^$NVZSI,DF(44"F1_(CQ*S7DD$&OT-6TQ6I?@D"L1JB MRX"Y]&S>1C>JT3Z*510B6Q(OM@2*Y+00M,-D3\5/&+YR<0GQQ;F-@E M4IJWL)$83`N!B<%2X"J`=++.0.4*T#\;\E[)0)%G:*L3PY-X8$.QQY(Q2.QH MQ+=B->H@4N'>'#[@8,T&I$8.XSPIZ!]C@2W^"L?V%"\>56ZC:P[@`*X./,ND M&4J!&XY&),;NR04L8A>P#%2HA3F(+E2F#KR=S]&-KGT;Q+.#N/ M'K.<7H3E;]#B;G`?L$D_X*H;G,^K#)ZU]CQ*"J;L>.04&E(_;N*3,2P8J,\] M&Y1`/LF+AV2E6I<_FWFRS!O.#)52_U?>`RHL.1D=_'51=(8(GC^BJWTS?6B0 MN5#I44LIN7,P>`/6N2(/!UDR3(8XDSPFBQB]Y4`XDRSGZYX55I72)0!**Z9FB_@B%)6W>B*P`)D+_:RD+YNKT@1B66H MA/'PMWW"XGC@+Q9ALD3\A$S2N9:)NM@ MP.6*_2!X`Y]BQCN=QS3LC.*#*K8+%(3\P!D<:XGHIG*#/0+8%+E&";6BM2\W M=.LAKY\O+L8W?Z(K;W+^R^7YQ_/3\>5M,#X]O?I\>7M^^4MP??7I_/3\;*)^ MQ<'NKL(!O//B!,9.L!?M!Q?CR_$O9Q=GE[?O)L'G"?D8SR:WYQ?C6WCB]D%A M;(-;6NQOIFI_(UN."/&%9YMA6_47$+.`(2S)V$:,P!Z;P)J12Z0B5"'CF95, M81G-P2I&^2JI/G,QB&PQ/S0-C?$Q$J'''%6C]T5WCR.@3;E-SV`G/=KY08Q3 MQQQRL00(D[?O&(WRM%^TT=K=^ZX8)E&>?*7+P)@M4!_7),EY60I(`^ENS3<+ MHU;AT+H`[*'-U`'L>_%#_*<37\D? M3Q_.?OM\_OOX$]RI"=JYU=18,TO(^K(4/3@XK.$@"8_BD'`;Z\ M_P0$]\8&\*%E7!0_,UU$"8A\T7V$Q@VTL.4S*^$R3$3P8E%_IM8P44-!,">7 MBG4+NCA!CL$EBIHZRM)&6%`F10>]71J9;I/94$\*D4#,I"D)TOH(<^G& MF8+Z3$073)DNB-S/H0Z@+R$E>UYQ.)AH$:$H="(D_1>8)GE[B'1?MFGHKC`^+/]H/SR]^! M)EZ!<&(SYG"=8O$!&LX^0"+`TZQ`(U6A8\V3O%AWDK3#']`:LXP!"L1X`V*\ MG1+G14..<%R1CG5*Q+CLKL@`!:9(?O"2P#)BR]B,LZ=Y9G*6T1<8$X0Z-?T% M4O;?&3JBDBI))3]`PB$\(#-MUAC4,8N7Q,=RB") M"U'J[<6)J(I::C?E]3P1_Z*OYPMV%-$Y<2#L?9:!-DA&;S$&L3!C6#1Z3,A? MD"#:SO`,X_W@X_C\)@#F]IDDQ8_GE^/+T_/Q)W-^.;F]^7Q!/&\\.0V.![U. MOXVXXPHNL-*P%B!7OO)+D++8]WBZ1XP','7A\MXZ`Y5DHQ0__:#-MFRZ`V[],#$J&F(>D5`\Z/5:I$P"0*.MA&;VQ/9(%@F M*LT.%`V5$89XG-`#<,)+YHN"*>US>^WW#K4@HEY)NMH(:F".3/7) M3>J>-?(LT;FF$V;N:8$/!($L5P5C*R(/JR*\B M2[!2*!Z^+(_I9P7BC'Y$N/[QW[.MX4_!Y[0^L5UAL5F),G>'TC+;/'-8N)); M"35^%G:IKWE"H_!;#RG5-,PK0P':6UBP-P>N=G$--!$I'U+$3U>7OW0^G?]^ M]L&,)Y.S6P[3/;^\'5_^9]CK>I_=]52A M'!D&4`1?@^1UT'F3Q$,KQ_N&098KI>3(>FUBYKY5L1.$28 MQGNF0-_K4->QS'U<10S7+@%LW3TEW*>CXB^UFRLL4:"CQ:) MU+PXB]&.2Q%U#Z*/\4RP0\,A;V[!:`%&(,Y?VJ^H8&4;0_-JW4I#<0>CB>&? M2-J-=UJNJ"[=JF!P2=V<1M(# M7QLL80LTP,6\WP>]"L1-D%-`O[KZY?*<(N-A.CT6DJ\T$U.2:*Q[@:Z@0?*` M*)*3J9P3D1X3TB-BE*:`P6)V(8G`8LLL-NC#6'(D)`$5XW.=M_21P@UF4D9# MY`)K2G167K;IFF:'A>\*(1"ZPU.+$1D5B+.QKSMAG6">?"7W@D4_QBT8MMA$ M!263HG%='$"`"9Y/AW4E,2_)]#@FO,SAK")RLGINK2[/[!-A`)8UF7)@4UD] M`[D>O0O.762/2H*T>($8'T3N4\(-F,R)?7F\CI*%#K%RWO]-`8JA6*;([>TY M*#E4&^TKXAY'>S?10B07;%,`))ZI!TJB1$W)+E*V:(G@%:6"*1V8$X]`-)UT M0TB,P@D`53`"YB4SXQ3-,W<8R%I:BQ`,FT^$*B$]3U`@;87/A["#K'^,!UP0 MHG"P\^#E`XJ]#'):E;DY[D7P#49=!IB,$6#Z`=G'*5+]CJ,^E427QE:+Z1^Q M#8$G+"!G#KNSRDMMOPGXU#Q;)%DM%$)L\!+@K(,#^&-V26@`<;1@PX$\?OWK MC77`=`-)`T>1[WDE*1*K"&L&+5R".(6@I'2D&./E!Z#(S1>;<)X]1PL2L"QN ML/7$NG^LZ\<%(!,QR(W3A%U:@:QAUNS6M*OGLXQRCTS,W,DX)L''@LNX`Q(Y M3RS3DWGBT(/"'&D%_#Y/YFND^QB&Q^Y072`@9`['YS:=B67/+MONEC104ICM MIF)KI43[HN61QO[\3J$V!?PM3VRWJ;,_.^)A(>_697T`)#;J[![OD=!N"E`A MDLJDO,$X#Q0BP?C@B,"]%/GC7G(F)5Z?<`+SXMPW,FUAHQH)+8-T^'K.3 M<12`ROES<:3*('K-2#?;+%V,$?$QXRB5#]3RVMU9V@@VCSH1*RW#Q9VI0II4-G*VFM[G5D0:TJKW8IY@=!6%@07D,G> MVCLW]A^Q8."'8M/EL\!C5\@;I1$?\0C><&0UFA:G9,1BRX*C=G;'Y#9":W2P M1,Z]HE!)%/IS,2H_E;6<$KB:PO51L3CL'70&!T:*>%!RDX*Q$US(/)TSSC0- MQEZT29L,5':L@0LSEK`$$(YBJI.G:?-HCIHR@7%O"_]SP?XH&*04\S"+)<<4B-4B7CT` MVS0H+E"0$B6^2:*;9JR10,E)YXF@M%6<.*@_7L2VM`4Y0,A9'9M-FHBGV!FB M(G)7/+,/BNTZ"^3PXS@:9\.[ MM2M5#`K=$9+$IRR%CX\.T^@I6K+%AC,*V<=#;)Y8\=B=NUJGRP%F#]E3[`9V M>"QW"'WO&W01PTKRT##370,ZA\C5)&:1C73SS6*>*(7TT>U6A^[PT/(;.5\! MG!26ADI#156@@`:QF>4QQERQ1O,'>VBFZ@530D5>]'CFQ8F58NE06<9C@Q62 MUNV1`QKSCD*(R&G*H].9IBZB%$4,#*@3F[1$]Z&^X(T%0VGF!AH15IK@_*J[ M_\265O\XK$))$8QKT1Z]Q11L+&4VD13>)BC3Q[(N8DEAQ?M)<8(L,2U)!*<[ MIP9%)\E_%";TTNI+7DI9IJ%E5A1M=;3L%%/-YG/? M3OY^`T(\?`KVWDS&[]_L!Y=9-^CW1F%PFX'<'?2'/S6Q)?M=W8R@YU=)`44C MFMXR%$0=CI9RDC>K#@R92FQX]4F`,``+K[^58JSNNP9UZQY%)4,9@0`0=-]K MPFSD?*1D`A0C"-NH/'TA#Q:;Y:I3;)9N"I^GVP#BTBE;8B*!(7Z\8'W-+*G, M,G+=6/Y_W"8"!!=VA`MQ/^X][`>37\*XTW#?+Z+IE\YD^I#108O1`.X@/K#,X&J5!8%2\)@E>+#,QPP_ M+]3DCU1]FJPHH11`-8^3-;O@/$53ET,ST!9F_`7[@+U=5$#\2ENE45NE[^.F MT'TIQ:0;ZIH&0V?MJY$Y4\OT`O-Z$]'(*23P@,KT%D'/?394"TN8@0>F_J#7 M/>C_``_V!X/NT>`'^'?8'1WQ-Z/NH/^#N<$XFGE.A@])'B%[:J_;&]%SW>'Q M#_#7\`#_ZG5'AS^XU`S)=XB?`_YJ,]"QGH!_R?,K9R4&=A:R_5,,40 M:A2)&FY<'+#R\0WIB7/[/6E'"[)4^S?&'3>+DLX?@"__ MQ=2^TO'L`%EM%PE:Q1=3S)7E1)Y$0,A?A0HCU`,NC"`U/ M6&Z.L.,Z3EXPUE^"O<&^%;CN"F<+9N,_V2M6&Q"?INI7([*S$>I6A&4H%,V( M5H>S5MRSABF[14]2%&(`$VHI*DS&6$=?8LJX*F=EX`O+!&2W+''J/HE53(Q% M2."<\\01`E66F"XAE2H`*D,L)>!0,F^Y!4BJ-NS?GIG/W0D(D3GYGYZ##ZB; MK$4#]MYQAHG2GHL&("D..`#@TD9N:7'MHE6"I_1[5PRCZM.R3ZB_E).`]@[* M`/`SCTO7MSR?^]64_*]EFJWY/;($GSK[ME+.J"JL:47#8^ZM$6DO`;'I[#8X MOP0^?/;CIZO)Q%R?W3"')EX)DA^;;VQ8`B;[`]<;''+(REF4HYI4F&O`1"HA M10SNJY=)OLK68D:FLAF2$)-LV/1%\7I$8L#>>?-ZG<3M8*:8DTIY: M98LDE%-5T,.M@2)65#=>+)IGM[2VLV0MN*PV!!ICX>74:^$1,=$OR1W(P5-> M64CR`.K:T%7^6??#>3%YO`)VA>=9K%W<89,5V6(FD&$B(11,3Z;G!!W#&,-= MN`Q;"6##[M2JK@5RH.X726>LV[`V6>QPRD-,,#;MH]IUEUFNS3-:: M[N'"8OC[PH^R$8\7ZY_K/-,(6(JBY(+3Y&J4$'^$+F]<0_K&:V:,Q/N>O*#A M(A:'5-3TVA]L;!:J@(F]$M/'`I;1"5%-\8Z'HV=I#@T/?K$<"QMGI7*V"^>B MHD?CS3V@@7])QN\G]A+`O*C7T=S]@]!\*-7+^VR31Q(;'`9H?:;])\8N<^:T ME#E3KG2P]\;NKW]`&:_N3]JNP4P^K,1-+E..Z2HG::"N6'AWZEVQ8]H.JW/K MS%J0%$Y:],,#&-J[U1A6BOQ@)$.4MHBF,M^`)?Q-AZ*M+-V:?Q+2BLU^.;VS_A MOW]2"'H8?#J_I.#.TYNS#^>W%+]$V47RA.8E57N#;,E+&L([VV8S6V:[2DMI MW:RO`WXA)%V&<4SR%+I/$'.W%2>X)OI=8/`L;8/3Q.VS]-V9$F?Z2U)V/T93 MQOYR+0D.KXAG5$2&PLU0H-/B,Y2\-S,LU*H@3R&,FZ7'DR2PH"EQN#H[<<2W M?>E!`+M]V[<="?"O8>FO47C`?[%KKSXS3E':.^"@]Q:!N?2[7GQAEI&K'ZKB M,Z:8,#_I@QHGK`>36.`9DXN-P.,GY'>-GB3PH1#C,0B<*J"+8;YT*OOX5M10 M"L"59Q`5*$F5T5`12?/7#=Q>SL_H'5'U%+C1\9/@B913PCE9+B'T:*XB@+`I M8QI!B`M#J&@JX?1FMP(1;74#&J9Y5#P]N6:`22![%8LH&76O+%? M#("+2FE8%)1YD<.!)6BS58*NFU1(M7P[/`P/`2:<`W08GAP,JCD]+4O( MFFIXF&^3[/F^,EK"W1^$H^&0EW1R')X<']261%ICN<"'YG68UV4PL2*!6S\Z M.-)4J+!_V*O.>=YT64%^J_Q0R"$5R^"0A/=(M%SGBVDUP.5KBPRK*M/ M^,\_409GH'7V2:AIHB83(GD8;IJP^XM*Y+"'T4*U-:1-^Y8KX8KQ->BNCV`A9+0HQ`(EU=V,K8X8?2'3 M#(*&,XTTQ]9JUVQIEW('."WYII]2[P$^PVIA7&""VF2IOQ\24[,!6R8A/82$ M7"<3X[3,9$F7_6>,E5A=06ABBV11(=&3$$@$SL@ES8O1XHX,AZ)2D_AM@V?3 M>&U<#5S.W0RD49I6HE1Y=I%\H2*E/#)&E\CSKER$1M:P,5RL0+`5\9\A0*76 MQIS*J*6B713*7#R@6\[/T;?L+"$+YNQ5AI4Z\@+>79S?2I(39OM>D9'D[-+/ MUZ]V2MR"S0?PSO8Q/W%QZ#-[O&Z93)^'IEL9U6")CJL<(%C9BD\M-.!G.%%PV^-K;@%XLXQMLM2_LAI;!7V M_#HNR)SH^#`\/A@Q)^H/3L+!T6&9$YF/C#X:=\6KMA[$=F+'0C=7K`>RR9*X MA^1\%GM2X3,A^Q_E42TEL(*>,&R[1;'S*P6&HP\VY:B'_:K$9;0))K[N"D=* M8S=3XL:""_R/X1I7-S3WC,3M_>!M,#@,1Z,#^`"(,1CT\:G#H']\%!X<]((. M_GD$FST,A[T#_O/8#]0C$M0?P1A]?/K@$)@^?)*Q/N%F*JWE`('W^.=]P^?< M`O6W@8[V%MZIM5N*[^'5"ZD?0M7N2JWF7G6U/L'),&.U(WXD2RSI7QG]&VJ8 M>I(^9@N)(12[/]R@>XZCQ50*M`1[:7Z8T(=9-QQ!7*ZN]\<#=M59VX!V)CJ4 MBZ0+LF%S2'47UB/NE0P)3;F6J4KRBV>OKH'2:*_T"$Y$%;@QFI_QB2X95JJ. MD8Q7=T5Y-YA8'E*6S6,RHQ!-P^57B?1+V2&DX54[A%2!4=5*[&;-AH>KU(F5 M)U($V[24BQ9%/A!%'AW-9S9,=D+9[3;]Z9I#NS6$T56#XQ"+#1:;Y@ZZ,+&K M*A9\^G1J]MY,3B]0B3NO1LHJ;9*(<78MN`HS:#JT$TFH?BW4-I)$?/L0J"]$ M&[P28S"_=3^R!(R280M8*.F7*8Y/80^L-JE=E#(/UH.A5APG(=%66S(KKSV* M/P:\0[%9W#[FD4M7:+U)B?`>$Y$H97[C)5NNUI("PS6YR"RBV>7.W.!F"]$O MI>).G]$"5*N6_<^I:T&$=@(LLZ1ZZ&1#UKTW+LQ@^P]U'DV*. MZ#%W:QWVZK"$04S!%2W5VE2!5>B`Y571$K>.!JR(&J3CR\58&4GT5:IA:$!\HQ+8%)=$W4M/(84W=:R&"I MDAFQ#(0B-\9AA*129O%<0G3O-NL2:<+(\(Q$"AB`4[@GWM:R?8Q; MY&)[WBD).1@R?59&X>XMK,%($A@L",]*V++\+_1P.IL"R<1B3H?<^KLG[*W'L(,>F#HMU"'N',9J56 M12=*"Z+"+QWM)X]Y=T%X$ZI``!.#WD[T(F(K2R"H.)$BJIR+K9I?02P)9'BD M>ZE*%^\SR3F5RY:'3U*]^BH)<45&[2SC186EB;]DG`@-KGC/B>I?W%1$@B;L M!Y5F)<_E5R8:8E$JJJ[EAJ@`O'E# M;V`M<8G>:"$BC]WZ<@*L#K'HAELO>5B[W2A&NMN--A(28DH23RRE)GC.\M5F M0:JMJ9,`=.O]-WK_!TT'A/RI?F-E)=]!U;2J.N,<`*FTDSBB)VV70;R!WODJMKG'9L#>C=WYL.-:'@J:'RG32 M>V*;'.33$E.G)4H61TUGY(E"I%GC/FJHIY*2MQX*=6(']$SO*Z4-XZ.TAV_> M0I4[2PI,-`EUA8*6T[@_R>__Q\BOSY" M+HI,%VQ.Q87V7HMZWX_;M]4R:FG+-B=407D6?5H*&LD8+;3I"U!8X.20*7@)2<=6M;M^CY#K4K-,#F MFX6UTHGUI&S=9!,!1=H`4YE17N6?V70:`4O)`8_3X-^CY>HOP4VT63^$P77W M%)G>Y,_3&Q3IO2"$18QWARV::);,[Y(U6=\X3.B>HLHQ?"LI5INU9I2X^MYF MF5&R!QJF<7C/-,%;L?'<.?7B0/I`SVG`E=T+VO*Y]C`5?(H\&B`WW#6WE&PW MI-'9G%-DFHTRP;<:91CT?,9]R_=^B=$A!P);@4#[")06Y)WUK&NT4BD+;>76 MVBYS0=9(8V.P+<4CNQLYU#.6:9RQF(.`?/ND;M?96XUO;T5K-J=JL4%;A`)2 M#>-9K8]0;1<#8,^1_YLE2!-68*

,(#:EWDN08WZ,\N_:#7E(B:2 MS:9T(MQ:=IFL;\IW&XK_WUZ=_NW7JT\?SFXF[X(/9Q_/3\]OU;EYN'O3R>?QY:D+&CG:_?"/X)W: M,`RW*XXK'VN>%18D&?1Z?4T5!J$?3\$S<]N5=DS\A)Q3Q+W(<`KMD3GQ>@I>Q%0R MJFO:L7TP[`YM'[F702]3\_4?'G9'!]5W&VZ+X9ICA+PL($E@EVTRQ5/(5G2* M:D^[%*][AGZ$:5"95L/?;)N<"ILPI3Q*.P>#'_ZNC&:'5^.]GQ[MFUK6;91;BCW_^$.ZP3 M&S`2%K?.LTCLIG@^:]=N9&Z=]\Q@2?JCN`;1/Z2I-SF!Y>B[Y@_2^^)99XPE M+^YC]T5PH\%11GZSV7P(Q?']/4I?Z]B<:28RM:4^AT=`<$BF1K=\30G$>Y2\ MOB\%Q:]\"KQN"%T>'H4'HWYX!!KMVZ#7[?>"47=P@A%(YAB_=@WE M;T\I%FQ1^;8R=\,![GW6;KK[#0L9=@]&--#O<:$$P<_[P3X@YKL&EMUP`:KO M&(ASEO2@,*:`CT8*/(AT)9VOL(DBHJZHDU)FQ05Q2MRR9'IHWGL\*V?YMM25 MM=GJMH8-!^3::@PD5OO5IUV:O\?#(TL07!,?9E.W)2%&!Q9R6"GP8%Z,'N5X M.+]DA&LE9$-3>53SK<&0?0S+E^R$_D$_/!S66H[@\;E*"'1.0J2H0J+GI#4L MWI>+7)3$'$+2%]"J:^^L?T?T.P\K+94(VC]8JM'RKZ,;EUQ&U=*;X.5?S+7B MR(1Y&-$>I3$O_VCPIF`@)?YS$@"[/Q'I\[![>$CWJ'?4\K616X;OPK&")H4R MS.BP#_=N-.([V&_Y&M[]]_OU7_A-//->.(`G1EV*_(1O3YJ_-=XE]S[^H34M M2LR+I"45)(6Y:\F![^5D/[FC'S^"F"(0MB?&T'V1O!\!5`?'%*PJ0%6J#AL[ M'(6'(R9FO=ZP2ML]JKX'(N@A:P[[_/CQ*ZG[P5'8'\%)'U/1@"^Q[U;F::_,8KQ". MUQZ,RK%('0(OXOE_:#D;P?%S9B8(3NO4SI`X804KA"7P_D]>*X8/.Y<5,JY? M/,\!FP_[6]5A#=6SI9K>CBB8FW)'M0I*N=Z:G_?N?\\$;/VNHG76]R#&Q1N+)$:,%(I@=)$A3M%:T^ M?2#&"I*W0`,/@(#TC3T(25A'3XS:$8;'8?_DA&/;BQ)(WP8*++PK_B\"?X&Y MB!,NNI'#K!'1T,"$UI9?N9)A*!HE5O/C=VW=`Q'<[]$(6^YW.7'=4<=LKNJ? M#(JKT:N3C7WA.-.R.+`X6NNEI%M#6I7$:& M"[=$4Y*R6>=E@*IMV[(:)MO<&R2>>47*RF7>M?*&+^LRP/[EHJ[PJV`P.@CQ MYI88EBVY6>ISY7)W[&J25+J,2?:>U*UPM1.\&A^DPFNJ9]V6A]:X2;4JPO'N MAKQC?**HW`()%"$B[.4+6NA#,V/U;[[!5MUI.64,B_AH(1DQ,%CV^C8X M`K7E>&@_?/]*J^Z!FQC;^KC:M]=9L>Z()83K%E;+-X?!Z[9C['8&!R"ZC>2? M%[>B98.Y3B%WHO>213+7BJ"D>0G;-#)::(>%!_O'6.H9WKE2$&EYK";R*$!8\FAB/^^D/?O`1>]`;AH>'(_?I>R9$'[=+ MPZ_-QCJ+_%,&0KE<0EB#QN"`ERG_ML%:?MYWG[9/LPWR#42[MER&TRP*GG3707F#>[U1DF'B/*=CT^`FGR M2/+!2LY)M:S'%:?7EH$7"V[SB<+@I2LI0WU],3'O047&JG<=__Y5?`V$6_:ZD0DF\(T-=RH#H"KMH\^,-HX2V41KG^$VY1XEW(`VL;AU+N7KM; MH#4#%XLP@2ACR\Q0HF191Z@X8-*92P,'Q>&6E`_JN8C<2US!3U9Z)4F)URHU MU&;2H\JESTEY>GVE>IE]47%,E7Z?^# MT&$5GE%G"@_>N1ZS/*8*J,L-F>*]&NRWA'6,N+4*/Y$4>9PC*5]15Y24"S0K M^:(R&UKLV-,YC1@6P8RU8*UYP M^B?GDZ;/IOFJ!W+519LDA8+J,*VRU'>%S"D[MGJ[9?,&XWI&_?#PZ`086W\+ MGM]:7W.M;$RT!JWL;L-N`#KW]]2-A[)J3]U*/L9$"E0VY(/VM7-;JO8;D^VC MPKQ%R]2Q&HH&HQ"UW(JAJ%Y5#!O!GMY^OL'RD>/3V_/?SV^]\@C]WNXTG>RC MK0-RYFX:E^O-@$I"4A[]_3%ZS+%YEL3%4GT*$N6X[2.Y"2KB&KUG2]"PS!E_ ME238@D\-D>\MBZZ[1138$@'&R=%^P\U2?9]#`/(A%7;00DA.J<&PD]H(SZK1 MM6LU6H6*BD-)6UE5,"0-^*@?#@\']B)C6P3>/; MU]6E._S^*PZ_7ZL:5QH2@QM.'[!EH#AT3Q^2>(Y&9%GI%6L*H;G!4.!U\&LW M^`22]_2!&D!0["0QS^;7$"AX3;W"5)*)S>6524A[S+A>3X:9L1QGMK#A=U,I MXB!DKWFXBUQ7!00+0Q9$E\7(6OE32W(TO!Y*JZXIIX=F3^@'\VL@!_W#[N@' M*BD@DHJG5,CJ)3*F:76X491:R0*`M"-^KJE:+:7)J$RNJXMG4B&P6LZ&:@(* MJ;HF_:`LB*`GL;(H.K;4Y\3(11G7">TESTE8,R,X-Q8,G28O0:W8#R&E"L5^ M_=:-+2I+557FG/`L@1ZXD(EMNSAVRK'\:`V)867==D$;H2^;U+.^N?Z1R;K0 MWE4+6U?"$74400D@?J(VD*8`H%BE7U!L0/! M#D03SHX??'K`\#\/9+!`>!9.#K/2BDPP0`;)2(A*XS4V=F>S"CDX$RGV3&[U#$-YU#]N&1E?6J^H^[EF@V\X!KPWQ]2.ZXS@6N_"-@ M='#<^1N9]>DY8^4=;"4CQH*19]:!`3&:X8Y*UFB;4@H9(K(6I]+1QF8I@("' M93];&EEL+YXH,:`9&KZ]EH7>3BV"$ZJ]1Q*74Y#J(D*_AS"_+/<[0.&:3H[# M@_[(L`1Z-`H'1\/V?S3/CVN:@*(6"`19KED4BF61BIW='%N9O(F4OG\@G M6$$LHI1RU]8,\YYB*M4.L]WGT9+KMI/K:/UL"'C9PM%38J(F04>.&=KL_4JY0MS@=@`)87AA#D^UP/E$.AZ;4Y' MC9^L:$JNG;=8&],TGN\T*SS]497L]HBG-E5H2]`X[]IH>H9G[R]MER3BEZK! M5LND>F#I-X*E'$=\$#KML%*&:JX%D!S%9@)\UKG`'M,?OSA&DD7&(E@7&0)>VZU/938 M+ZCM&#[H]WV>,:^3NL['/;\4%:8$,5?P.(J*O(9]VA_DSS?[1';6.58WA(D(>+S@,_/*P7M7@N4$,498`MMBN@+5R=[;-+OO2#I?V"VM+A\*TD6*![VD=OMB,#@%F6];B^ M=,=6]QW9Y\*CHR/X__$6"[%MM9?/Q(FM4]M9;"-HFH,S<_.8EEF>'Z@2>[$C M/P+3-NK3[0IQV]$R!D2311(,H\,RZ><[$*?&.+#FFLMHD,$`-GE`/E?D%4-S MT1=",PNG2#0D'WU^/SG[[3/V=SG[G)O=Q4TEBM:V+MF5(N!1LDL8(=YH1HA)F44[\/M4^ MZUF*-:<`4Z;27O#<]6!G_5!J'4;4LP6+'[)EIP#Q`FX)!K-P)C3A%=%5[)GD MT)S<",T)1*7T)TOGW>PPB);*I:EG/"OS)R1MV-N,9J**0R^,)IG[]/,$Q^$\ M?9`QO.]D3EO@$?W*S8O7-`#RWO"U94G9&:Z%@[%`MUG,]`B1M^8<'*.)5WR9 M705-#M06@'L+DQ%(;%\D\09E*$JNQ$+5&)[(PQ$2V7SG2LD]!Q+;@!M_J*`5 MKD)]86)J"X6+@:*R?0AGFU@T_W1*6"N,X$X/=$M#0_G["LFF5(^QA(MX"K\TLW0 M4`0,,-WQ@E2$S.HR:8NHN9*^;+\W$AB%SK&Y"NELNC^_O!FW`U%-WLII<>E+ MC->PB$795=$B$+1P"3("2Y&9S)8=X3FQS$#B!5]D%\NL[?N$=U!0'RD.LTQ; M_]ITF@:246GB1^D1[O2%;8[@OZ4Z7X<>'=0\(.>&-OVF%$C/V%ARJY%+C(R1 MS+&\MKTA^_IL%L5;"J,>D,?/W2N[JI/MJSH*CT]&[8MZ<36-BSEN*;V:VR#0 MQ-9%+5ZUW.$+0+3KG0"3^?),,C\7L((+6A;\4=B>(\9Y&5FV%D7;KLPW[6HP MV+ZKP_!XA.&O!__O.`2WW";'AG&]W"S\9LX.8(V07#3@].PJJ'IY;,0"ETFD M9/=@=/A"AC!NDFD*=WVN;X]4J/+^?.T5(8.&JN,>PJ>\X^UH%[B[:_Y/H]U! M;9]FVS'69$N7-S+QE%>OX=]UAMW&L'RZ?MJO#G+-D1M"BD^M=`BS[R2@;GE? MNNJ\U-1-3`PV0E0J1K@X0RWKJ67K.I6R=;A!3(P4W8QSAB93:JQ:+EZ'X<]D MS+)=)+"='7/#@G0+&TY#AC0NC;+6H(VIO[OZ>;R/BH16?NVU`=H)B(UO6OF> M5*Q<=+)6;[/9:&Y+&YAK7:PL_J>7/OBGNZ)*QM;W?Z_Q6\W5R5#L[Y.ZE8Z_8O'SARECA MRH7DC_R0_%#;8I4>I%H[+(T$QYW>$-^\L?,$D\Y_U0/J:Z-TZ=91/1/4$5DK M;-R_2"G:"-[S7/LN-.Z:P8W[//\04!QJ2LD!,5AP9]T\#;F"UI2GF:3"'LH5 M[D/;M<>:^,B"._O[AMV\A:5,&']F;>%[$K]`T:MS+$F[I%`+]&>0@.<&V#=, MM:DQN=\:J^LU76"5X[7Q,I+<@6[2*=TFG-N7+U]2F*=AZ8_VPP((E:C8O6J,' M'JFDQG.C'2K=)!?I;S9A4#<:-U@]ZF2LW-.2B*K%&BR<"01R)Z*VPSA;PGC( MGB!!K5[0CL'V'O&,8CK=`UB\#``&U^/M2??D2`V:W>`C!]\MJ7W-*YO%0XWE`M/!L-P<'S(CD$;WT=EW?A@2CO%7J,;I^N-0>E^%GKO&OD"G,0G MCL_<"!K#(U>N[Q65EJ)T#ICB'`V-5/8+K=O!.=\`&/8W58P:<.(WJJ[?D-C5 MXBMXXL9ZF@8R[`W#XD5:(%L3BIW;G2986R4#45=SEVL0QY6_R[X+PEDJ/"OEU='XCDX`+P7"=93R(RSW?^8V?>]EA+VH,+-XKK>W/C%Y M.MX.,$NXVJ?15DP1=>0NRW,O^KEI$]4F@>C61MWKV0YR#W>8FJL3SZ^@M7.; MU-HZ;D6;DJ>AAD.FC$-Z5!/NF:`/UGMR!LSV&C"MN7_GN&1H-%ZLQQ.Q:O0- M^:UYI/P97J;=.B&W=?-T@*$-:OBP;G2GCIYMGM;OZ.A)]=AV[.AI'\"+V8P! ME<:>,K?4V6GVEABG8I;X%A5ID]`;D1'KT5/ MX^VUMAJ'(S8NQYW3P-*DEQ<8+@>+@/G9! ME^9%A7F:)W?BVG>F"I!.UAD&';-[E/;JQV#8,#X.LR0V+PTDV"%(?"O6."/- M4'?XH$$D],Z&`TF`2?)5KG,8DB'F&+W'+9Q18(N_PK$]Q8M'E=NT<`RG69B4 M2MAN.$:;&+LG%XB7#I8QC5T#1(44V,._;M4*9L_;B)3\8Y%B7#TBNHP(%\DE,L MJFAS_FS&M76$,T-EMU0`C7Y%12@GLXB_KEG"Y:GQ7'_4GJQUF0N5*8U3H.1S MZM052JU!LK5@%[-5GCPF6$028^936QTK`&7*]?0%!L.^[US3,/.J'AGQ2:2/I?L$%R$ MFP)@1&ZP1^"UXJ.G/+FAKMB6F-MG/KPSZ>M:[*32[D7[P<7XU!R_38 M`5L@%#F7G:W#[0KPJHZ,K_KZM')#SV2]U1C1-'0:K\G5EDI>GXVF$XT[9A>U MEOVB[G%<3SQ*398R0MRA#33T]ZUQ#06W:=+=E]M1(V'QI")=!CK$[U-QBU*4 M$)MUJ748W@AJH2?69HX$=#5T,&Y!"ZCZ%=1"ZG0[]9MDA@%V7^LL6)NC@#FX M>/<)1U$CQ,/JP$`@F3Z5CB$53T.'JT6@^`HP="[1HG3^>>QJMSU8_;I$X+G\ MM-:38:$!*V)0+`;=*`=I[:]GN'TQUX2I2%%3K,6]1++"0H"JLU)44`UO4S*8 M<2TYO:>9O_B&!K]J.Z`/9\YVL-N=O-L/3L>37[F/+W[`.JV_CS]IC(R:,6NF M"6G63$$6M$CCDEST3@&@'X#R++"?*+PY"\D6F,#?OJD"::EN@NZR9(TFS%E. M>I2;:M-;Y85('1T[;XC8.5V9$<<7`1R1G(N^2;NTPG"@ MHFUW+K0=HY:)'M"4='+Z"'/^76=JHEK:40KK<&&1'Z2SSRO:F&HFH2B)(G"Y M*"AOY\)Z1-E!LT6V3*9DID^DF`Q(EQH7EP?LO6';O$_;C'@5!-VE=-#4F\IY M"44N2Y:K**$*`>AC1MJN5N&R%]N64:<-VSS2N=!('=;:)!Q8,?"=1").S5)7 M$YT$!DXA8.:N]VO36DG)<;!&*R$E&A!%H%)7?G]9D[B'1:.7U/X9(L!NMV.V M'YQ?8K`B%H0X3Q'TF/-+8?5^O2GA(1CY'G+5(\."2%ZL.TG:X0]H!M+21R0[ M`!YU2L+#DPN&%+%8Z%],.0N'(N]BQYN]TL=LGT?##"L'"XS.1V4^ MDO):?V<0BBZL=)P<$'`42T(TJ;H\BY?$BG.-V';X2&14JZZN.;C-\VH83^*1 M!$S>BY.-%?_48,OKX5B_NTI9)@0NHMI]EH$:2M9VL4*Q/*8!4]Q[`K:/V6)U MBOD1G7F_*^%Q_HMS@P_0/VO!$C MXA,955A<+,T.Y!2U*X:X],<`S%DRDQ<,;)_;.P=J8OP2R@Y8%;[]9;>0 M>Q#"N(S*HLA,!<[N_8<$0`G7\CFH9&6Z""=2J[Z"9"1YH:K.WR&&2ED-*L5) M48Y)6GMRD[IGC3Q+1+;IA)EU6^`#H2%3'#)\7F[N^27!%Y.23[84,$DT&J,CSH=88]IC#\V=UV55B0KP&!J6V(T<I35;$YM=9C'9NM+3:'G/TN]WAG;=@ MK/."0)R_M$Y13\O6G.;5NI5JY@D:<_X9DQSD3HO+W[K]KUT`?5LU^PK+M5M[ M5U27;M73-*O/67QS,>ANK7Z+6*QNG,5J-P'J?A]431"N07H"E?/JE\MS+-&" MJ];3)6E2+&)BMW9>'+K)U"R$DN_((T$!^VCB)PT*94=@^Z#ZN&(0E.:%KJ(E M9\])YHF?R_=(41V:'2?2BK78.F.ZI"8U^X5\CY--3&,<4!,?V6V(WW)(0<)J MTCSY2EXV;7$P.P2;G3N+2RQLHIX)Y7SAZ5Q-CQ`C&\BS1"+33IA-$\7F-&I0SA6C(` M205=64R)%%W@^8$!4MB&8/$<2!0"NA6(I"+58;,-W(69.OJDBH$IF9[*)DAM MEY8*IG0P/1!C__A4738'D/I<,"*1&KK4V>LN68B90]-03S@`HB%@YT'+Q]0[,R1TZK,S>%%@F\P*B:XFZA2A?>. M@W:5TI?&5A.W2[IE+""?&7L-RTMMOPGXU#Q;)%F]CHS4RY(VMS(XIM9*T1%) MZ<8:T9FK<'K]ZXV77?]),CI!$'U><9`6AD9@RS]9N*238KX;:B\9A1)XI4[9 MTLQZ>)X]1PL2^_RBQT!RK9?->MA<@0PB!KEQU8Y/;1ZAS5ANA(U=/9]EE'MD M8N9.QO$:T71A&9PE9X4TS6L-/2A0+B%E+LW7R#XH75N;Q'+X.'P#Q^V&Y39W]VQ,-"WJW+[\OJ M9O?B(;7*`&K21%*9E#=X4X!")!C>'1&XER+&W$O+!$U71YS@"F;ZC4SKNE@0 M6A)9LWGFZM;6PA_8%2L5?RZYJN$SS)[EHE?4,F`6)71HPLLNE:M4F!%J8_KX MAM7NBL-=MX_'[$0EFP,M`D0N_FH91*\9:8R;I0OE(CYF'*7R@5I>NSM+&RCH M42=BI66XN#-5Z/*!:&"+#(VG6Z5K>DGD:DREGZV*A:X^98G*5M9>V^O,@EC" M`-U6S`N$MK(@N(!,]M;>N;'#K_#+UE#T.ET^"SSV7;U1&O$1C^`-!\:CM75* M)CNV=SAJYVH+V&*H2^3<*XI(1=TA%SO[4UE9*H&K*=L"]9/#WD%G<&`:9+Z@ M$US(/)TS*4OM%"';9W^E;7:_21-Q[3OS M&!?->V:C/EN;%LBY;=4X4M+$JU)HR,]:6T\HFQ))7JJFDPG4&XQMH.8#'YJ5 M<4$SFG$9)90;A0RZJD2ZBVS>=+3$Y)0A8B=+VS&RB0[1Q*;U&'8<1\.9>+=V MI8I!H3M"DOB4I?#QT6$:/45+MMB<1QD75/NE<6+%8W?N:HLOQ_%)O6D9V.&Q MUF%:1ND&??JPDCPTS'377-ZOT-!0-AW.-XMYHA321[=;'5KKQ?-OS[;$%LM5 M556!(E#$DI?'&-K&<?[+2:JF-0"16%/<0S+QRO%+*(.C>7(F3EW2,'-"85 M7&2_-(].9YJZP%T4,3!NT>M6(OJ"-Q8,I8DW:(M8:<;EJ^[^$]M__>.P"B5W M%1#MT5M,J9T3U;#237#-/CT88DEA4&[^0^&8+#$M202G.Z=F3B?):Q&LEU9? M2R9F>I-9P,3[Y;^`T6"%OLH[F<]]Z_WX#0CQ\PB;CX_=O M]JE-?;\W"H/;#.3NH#_\J8DMV>_J9@0]O[LDP^*B:M=#2Y7>,A1$'8[ZTE"P M675@R%1"\*M/`H0!6'C]K11C==\UJ%OW*"H92@T%@&"$A%IK(^0LE]'BZC=,NG7+D>NQ0GIL?EEE?,TLJV((7;37\'*8D4I=M"23VR3XIJX$8%'KTJRHNSBN>VO M5E9;=3DT@S1`NF<@HHVFU-6R!.)79N,96PG*[=MU*/`VU/V?VNM.V60Y$E=8 MCX@7)4PQA!J%=%$HP1,KL/U$Y8V0MGI%U+QV:@PX^9YTK069S_T;XXY;JCG' M/M3_8FI?Z7AV@*RV"Z^%+4";)^K#8@C$W5=TAD9Z.]&L(R%(IF1*O# M6:M56#.7W:(G=VKC==M&E#)HUM&7F-+DRJDT^,(R`4DP2YSQ@(0T)L8BS,Q"Z_>D4*5ME:3-S(H3J

UC(N5%1$& MF[6+P,;'Q26*0:]474FS4&B^;^O=<1=/(Z!2W.N1._F55B?I>7CQW=1R-@UM M'>)I7"GF4@K!V>TX_KY/X:B7M\'X]/3J\^4M=O.XOKFZA,^G9QQA=9Y*\J86 MAW5!7=[L$XE<*"W)\*=6NR0AZE0M M$N'6>!VKFQ@O'M$SU%ICH:WSI483&F/AU8"@RB]S]DIQ.Q(47"@VSF\ZB2Y/ M71N&&'S6_7"^51ZO@*,BDA1K%WO:9#:WZ`Z<@J@CJ$=""GQ@I6>G,<^Q:RH$H@W;N66;=5$LLNC>K1"?Q]Z5Z_.+B M8X5[G6<:58V^_^EFN1$A4NO&(71YXQJQ.5XS[R;V_.0%HA=:,BIJ>NT/MJX+ MX<*$<0G9%.>[+50'O,@['HZ@ICDTY/S%0D1LC6:%RXNJHQI[TI?0NR3C]Q-[ M"6!>5&1I[OY!Z`4C(N@^VZ2DQ,;H`5J?$5IC=3^7D75:RL@J5]#8>V/WUS^@ M3&KW)VW78(8H".QK\A%S:%TYC0B5X\*[4^^*'=/!6']=V^X2%DY:I,8#&$4. MB_6O%#$CI?T`I2VB:9R[JUA`)6/0Z"G=,\J(+1Y=$?:D=@L7:]38?\,EI?N' MV-@L7R3HU5)\9U>^HOP+J$51'U,K!]E!B%]9R$M%8O>CD;+ALL.DL-D6*G]R M@SC,$4$_VL+.DU:70%YT[Z%];>X1PXZ[]`7$,&4),,4(I!*Y1]C:W!%U!6"Y%@. MVM:,*\L>6?'VFH:0X?LI]1Y@)"@WTP0RL%=HZYO^?DABOO4&FX3N/"&4PS^< MEJ0RYAO_C'.XV*[E*2D*),9/=60XWF>*.XOD2TQ"$XV,KBMYWJ7\JMN.=6,1"F$K8IQ#@$J^])Q* MX:29:^%GN&:7!;K5A6PMZ$BB*6:ODHP:[$9M5I^]6S+UUHK333SSCV]G"FZ; M4G1^MN588;6_V\#^L9\HF0&=<,%M<5`.9V M_<-+"B0M7`1&5T/B?ZH5H]ZP].+B_%9R`3##[XJ$V+/+4^Q&UX8X5%Y7$OG& MF%GHYVSN@#T?^09=B%_[!F,"%LZBAZ?L2IAQZB(7,_J$&>.[H8[,H;[S!>6: M6RMP)<_-N$(8[-9&*\L4V2I7,/!H":T@V),B>PGI212A+]WP9";6F#$*ZRL% M]Z$=7?IP[E<+FAC$'A!8B-VZCQCF][#<#0Z M@`_]83@8]/&IPZ!_?!0>'`"VXI]'L-G#<-@[X#^/_6`+HO3]T2$U+NZ8@\/# M\`@^R5B?FMKA=H(]_GG?<-/T%JB_#72TIN:YF%AZ^V=P/IE\'H/ZU(Y^9?FO M1+FT^]II1H&&/H6SZ/5_C^\*TH[^GRTE/Z^\+#BF6&+UW@GYQD'AAA+9Q9H; M=J#R%A])IK+%F>]BP)>N4E!;;O7NV0H&KB*T;]$FOQ6WD'3I:*1G1-IK/M?R M1*0'4F*3$8ND=N>D0"`:RCH&DB060JHR"<)0GH+),C6[YFFCK'I';?>8LQC\JX.'US@/8 MT#X\&`\"[7A?0#VCN";7._D5`R.VS"B@7Z/.?G0-X!19_5B;;YK8-D-AY%\QT!;Z^/ZC+UT=2*JRFY7 ML#/3=[9R*CPBUXDB\KQ"GH:UO;(;)*M,'[\$@*YI6KE^YZW>XG/0_L'B=\N_ M#L,O.6S7WHS@Y5_,M?K>I:CC/R<@>X0G4CCZL'MX2"?> M.VKYV@@^X+N`-(-AV.OWP]%A'S!D-&)LZ;=\#>_^^_WZ+_QF/SP$R`_@B5&7 MN!1\>]+\K?'0T?NX(]G^0V3!;Z7;:TZ=9:(M?G"U01MKP]/`H[(_@Z`]DNL-7DAWLR=P_`:FE+^_7JS\W.6'Q>E\#NP_W=]>OUW:\%D7]ML1 MB5L]XA#B'2I'M?C&-O\[SJ_ACB"@HG+&D$@+Y*T"^0&%!IN-8(OZ6H+,>1D@ MM5[B1B]XHV=M?N7K38Y%+)0F,<=VH$;SL&TFQ`%6\*G?'UB0O(6;?P!8WK>= M:%V;^F-;^'YX'/9/3ECZ+$H@?1LHL&J^F"LL*70]_A.+2;0*F]R$7%OX-NLV MI6=V:SSD]UC7B$[.<"E!NZJH^B2`I7_24Z^K';]U9*_WG'2^YJZO>;D&/&HC MVOC7]>*&17_!1J.AP6&P=3CVA\ZLN9;)$'67$P.XR)!6A7T;<$=Q^^'[5UHM MNWE##0]=D.(U2/X=$78Y)*0:9QL&K]N.L=L9'`")&LD_+VY%XSO]IH=<<43C MF-2.6Q)9Y.9IVHW*4(PYV^(,;930*>X='P?"` M&D$,#T^(90T/>^%P-"2=\J>:4KDGC^WC)WIPWY2N33/G'2J:Y,.TJU M1L,:-`8'O$SYMPW6\O.^^[1]FFV0KQ':QI89K66I8`V7*&6A8@J?/U`2'GS; M"3Y//@1[;^OF@!A448'><)>Y:<9QP]2!G3B0:7?:BDL3+R6/VZS6UV^I:9KZ M+./R+"^O_KR6:+O3_MB*4H]'=`VZKN8E._!G?/(\K9AI+U`^^^;MMQJK=UM$ MX2^B#3XE"UXKJ ME$WA]5%[]4VH(?&:&!JYN%0&;+O+6^K&4ZUN',V)##1D.TT3RQT*%K7;L4J.<=JUZZ-URR@7J6EFN,_.-,*#_I)ZTA^C*7M1RHT.6(&)9]0Y)$\#%@73O,`6`4U35>OJ[!168_LO4R]FJWS@7\/27R/LH(I_<4)D?6:< MHK3WI/#?(C"7?M?H`8FXB7)WC\0CBBR9@U+ZV,*1MX'5%=&$F$LLM!>40MFJ MT9.X0PM)N9D%>QJ(*`)VZ53V\:VHH4Z]ZQT@[LTDU6B5`O.$#(FC(F(?46L/ MD!WB)\$3;?8,*4A^')P:!:;+)E"5E3@XG7F>MLS&&E]_H@'`V'O*23X_#D M^*"V)(J.+7>?<%4'7U5:DSW6N/6C@R.MT1GV#VO]WL];>A_543J517]3A/J=>$0X, M*)):&W5ES\4<-4F]?@Q'5(OAV'-A"!QJL&6/?S8W>JN=8T.P0L,CM5B$9G1H MCC!XY2;+826OW&+##E^83F(W7F<*N.'"283/#=@EI`--'[R-ZC-7Y=`5*8VX M:L@G_/G,ANFY@<6L(B2)!39TA/%@)%^0F38@#0+)_*<,+1/W,55Q.(U`E<[R M-(G4B8'V,:/TNV1Y[1\S!^6A7=RH"U:W9D_;_0JDN^-P<-"KU?V2;,1S:?J" M5@S/28U-)=FOI[[#JWGUIU?>ZK?!CT(4FTEC;4&O74\;07C)25AK0,A4O*Y& MBWNP7C]>_(0O3+S=Q5=]>4N\P^L'JS@;_[H!DK_+>]6`E8K_%?#W10_L_PK< MP;]^>/76?M\HSK/[?>.(G03KL$VM-OPVC7C6RB[OP M8Y0XFD)-@OLOHT9UGI$$C_9[AR2<_C>MHP[7ZD1#7.]@+BO&,FG@PUO?@-/W#FRJRS+M-^VAJ%" M#7BRH4L[O?0"16A-K?RY(;+KY26\E<`I_/>D)J-1$F\VKRPAU`CGW9]O-H;O MMG]WARKWICKN$_Q>$QFWCMXF+$R]8LDVOT$%;?F[8 MMJ,8-NKNE6+TZ^7G]CG;]FXM&=G+'*%Y%4Y@:UFE)XHU/^'"[MJ>L*M\,7*U M?0B]79'<+EM98<6$QA9^;3.EO#C"?;,:\>)[L860E"CA;,-7C^,DU.\;1[3Z M-C`TG`7JPA*[V3SHR_?EG'.:&OWDN[G(:V,V#BE>[U:']Q9_;R/C:KCYWQ13 M^4K=>E>*4%K+1W\M5_Y:;DMK:85-4Y!BJ"&:;3>OY2VV;=?W6HEH?''XAC>: MAV8KF6&+C-Z\Y?I.'P2UFK.T4&_#?'&WJAV>:>GAF:ZAB'6JOC0QMAM2W;7<[,G5`ZZ/HT-=. MMG-0:>-YTR$'GS`Z\?8IV^FP=P_XW.E(_*B:JW2W6)3O"*S5&$)_=98CN"A=ML^A^I3`^%P&3TKTL]")I7P8&?W6#< MZIV$LR?*3];WXZ.P-SB2>N%V.,9=3HHECX&5M[<.C!=>Z]=>NH@>ZO>)O$XJ MMH:EVBP:D?&K=+YF3S02=[*C?(GC%?VND1I4?Z,4T:4CX*K-@S^,%D]!'R[7 M\,`MXL,)QQRY!H`4`^42.*K-MUN]O5A(8_K@HGRH*'8YY4):ETE2,:[6EAR+Y*LTK4#HL`>)48=;U]M>D3PF0@47O=R0A=$K''Q+ M6,>(6PNPBJ26V!S#VE=4RC_EJJ)*<2C*P3K&G:!C)#LQQ^`D*EIA2V79SJPM M:3\P+T*'=?6:AXNHP+E'!;SK[-NS5)9J[2!8L@(S**DIVTT<-V M\8CE19-**,V2 M90;Z6Q<4&LJ`IIHBE#+"WC:UA0X%[UU)*+:"GNXBVGR"B! M+'FQF.*MVP!H_)9PI:BEPT$O/"3_K89WN;:54=%T!!I!A<(\$5@I5.2*Y91" MWK3QH4B[W%7XX*@?#@\'3@_(=./JH9-C45QK5%<;%#5'VXMK(7A!2LVA5Q1]37WKC^H)2@5R""B>TVF);XL11B0;ET]`:,J'I(5TKL+5QR+G#K9@B\I;@0>V4W7 MP)8(IP^8M1"Q%'_ZD,1D.)=3NV*1.S0WV1VRYE^[(-_FQ?2!JK1C&TL6%II? MP[4W;#30JJ4D1SYF'!X&/#7G0DH8':8E6Z5*AY#YYN$NI`O#-BG+CA,M"S4,.L&64/KH+GN,*XNB8TM]R0.E M!B9"1(\,DS(11;B0%W?_"EV,8,1A?%BT/*7"GW[-P8TMA$A1+=1V)=,26KB0 MB>V--G:JJOQH\U##RKKM@C9"K#8IQ9?AM+O"/@76^+#9>8,][[>+OLMI-TGD?*EFV/3X6WBR"-5*S=8!.9 M1;),ZO"9<]P][<;K0H(M=A`>H5\%PJ_"%TEC.XP\I"XM7%_0+V[F3^]58.1F M'QS*)"MGX*;QHG+2!B\,[1U1+U9>2P/3J)GMCTQR/-"0#JE@%@?1&N)(`FH& M<'6O`5NHKV>X(\6KU/+$0-AU),W)<#I&"A!>@-@\19+#\$`B@,3_SC8L,13E M#;XK=EH!=U<0T%9O`\((>UP38+VM_2W)(R`)9+FT>1<"@6*5?<%P7`0[$$TX M.W[PZ2%#JN!`!@N$9^'D0D/GP!@@@V04O)S&:^P)S2FU*A)JN+37U\HV%T)2 M5-F$"'ETW!Z9\=N(\$V_N+@!4@&/K&SE"/]QU[<(&R@N6/2BRG8/R5VR5C7H M(V!T<-SY&V5'T'/&RJ#8[T$214=>2B\,B)&2=\]>PS=.[2"RQKW8JVS[/9*> M?(;.Q$54C:]L9L/<505#\F;!V_X`$U5:2LQO#_>7"I\9EN3P6I-YP+)WA+"U MO%0T/3##S'*_TPNNZ>0X/.B/J`C9@_'+,?2C&CJJ> M4,3&+AZ'N:-*OO-&Z;95Q`O5DRL`*$E_-%/IU9K8ZW5]8@OCKL>KI>O/-XSU%\\7W.ST1GJ= M7O]Z$\*W9T4TCS_$5(/R??:5:'_]6=?RJN"&GRCZ8`E5620R`B;G2AUD8?XF M4BZ#(1(8QJA&5.+==5=*[P'#L8`R=@.YSZ,E5U/&7/Q$N_ED"\E<<*(WW.)G_X+!"&O0^=P9OY6.N M!X_`B8H?RZ&JD!RQA,@6&M?N9J*N=IZRKGK!,PPDV M]+DAV<7R&\QF$>&;8N'?]DI'Y@-TBM7@+*77\LWME37;+)0EZF`<=7"[YOT4 MOFN@M%V2^5]*KZKF'7E@Z3>"I:9[=BZP<>W'G/)BID"Q/GTZW4W=2OW8[X/0 M632&\I&A1Z%N4;1;\TRM,VUL1'8\M!NX M=IR&6L/2<6-._3JT3>PYHF^1)9RAJ1UJ@*MQRH8\Z#>RG;%<("F7QSV;M\BD MQ3#[\UBG50\X9?*#_/EFGQO$Y)AX!)O#N!H4IC%F8D.=K:CQ&O<.1B&[LT30 MVR<]W8`:6,ES"VO\8DN.WP-2S"/24Y6 MW,<(A`=.9)7V7-H?V]<-I&TCEME^>"Y0FQ;%B:WY*Z!27/;YL\T"+O6]\'-= M_W=S5[/;-@R#[WH*'XJ=C&W-G,3%@`%#T4,N*[`\0=`D:##7'N*E1??T$S^2 MHN2_I#L,.[0HDMJB*(GB_\>0;>YJ-@]%O_'VYAB#9S#K_9%Z(W"_&C-$#_E\ MN5SZGW(B>A"PPX[L?-]E.K0+HP3D5!H#!/AE0S%B.KZ7;T_4L>/W)LX!"\AC M.ET1D]-UDLXJ-D5"49\VJF!>72#F!G.:ALLAR:M(#YFT,1N:?<+`GJLL6MU^:!7+=K`<&,.![_1-&OY`A) MMW=6QH%/PO8#I!)N";E"!"V[J0DSP.^+!P&)6QF2-CL0I*Q]`R"*8RLWO#=( M*ZK)1D$K<.-PF'"9$%:-G6W$U7BI(60C7YVX4=?J2^Q01B_1GN08>LNC\J5, M\IPPI3"2,Z?LZ-NDR!Y?K^D]7%U_T#13?"9CRJ2;FASBP\1K&UB$,UE6L1T4 MG)<2_Q-]^%1M=0D],_='MG+(5?.*BM4+:(HRHQ2P*,,GW1W5:>"@T.BR\N@R]N3OT66&:KLY4; M%QS8W1A`-'8Q8_FZC#F-AO,4:4X@&U#CZ[C6>']`I$C@HV/"Q8,5FN%<%[=^ MYYJ/S!P)1AJG\#\\(AL=M8MMJ[8#3H:FE/CGW(4')-71>V1BBN3:@$,E?.YX M[1$MUCI@B;>MOGW_.LY$#5:I>@%SE+*%PL8B/_GSILID6UB#9.&E*(IN8D:T M3G6(I\I!MH:>"ILF%V;UZA@0WBLA"N!:*>D#(J,#GH:B75M]T14*_SN+Q.#U M(I*#6I=M>1E.[(2TIV3DC4[BS"0(:WBK^;Z(P%=S#GX'S-F_M\X5;R#WTQDF!GK7_I+Y\0I#IWD1 M+/O4VB$+8T\[+NK(':R6L5FYOYK5;#8]JT5>%M1><_Y_+(*1.Q3Y<@90%?BW M-3=*\%*_VSS]_)S=WMUGW3!@2.$AO?]T]-+.'[]B,;"RW=P+EBF,W=N?'NS& M='ZQ\8^^,\LB+S\2?](93V^[S,ZN^]?;;MZ;IYM:1E/>/K3MKR]_`%!+`0(4 M`Q0````(`$2%<$>9D_GWS`$``-,:```3``````````````"``0````!;0V]N M=&5N=%]4>7!E&UL4$L!`A0#%`````@`1(5P1TAU!>[%````*P(```L` M`````````````(`!_0$``%]R96QS+RYR96QS4$L!`A0#%`````@`1(5P1WGE M>K2Q`0``&QH``!H``````````````(`!ZP(``'AL+U]R96QS+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+`0(4`Q0````(`$2%<$>XJHG"6P(``%(+ M```-``````````````"``8`0``!X;"]S='EL97,N>&UL4$L!`A0#%`````@` M1(5P1T'M`RK;!```>PX```\``````````````(`!!A,``'AL+W=O3T%V-:@(``,((```8``````````````"` M`0X8``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`1(5P1Q9J5"](`@``;0@``!@````````` M`````(`!ZQX``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0# M%`````@`1(5P1_"6&I&?`0``L0,``!@``````````````(`!B2L``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`1(5P1]9I7"B@ M`0``L0,``!@``````````````(`!"#$``'AL+W=O&UL4$L!`A0#%`````@`1(5P M1Z7-%A6?`0``L0,``!D``````````````(`!P#0``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`1(5P1S7,LN"@`0``L0,` M`!D``````````````(`!1#H``'AL+W=OZ9)\!``"Q`P``&0``````````````@`$;/``` M>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`1(5P1^G'KP^@`0``L0,``!D````````````` M`(`!R#\``'AL+W=O&PO=V]R:W-H965T M=7H2,HP$``+$#```9```` M``````````"``2Q$``!X;"]W;W)K&UL4$L!`A0# M%`````@`1(5P1WU8GB>B`0``L0,``!D``````````````(`!!D8``'AL+W=O M&PO=V]R:W-H965T^)5I'H@$``+$#```9``````````````"``?!) M``!X;"]W;W)K&UL4$L!`A0#%`````@`1(5P1ZT? MS<['`0``I@0``!D``````````````(`!R4L``'AL+W=O&PO=V]R:W-H965T8*UB%-`(``'@'```9``````````````"``;]/``!X;"]W;W)K&UL4$L!`A0#%`````@`1(5P1XY`S)JR`@``.PH``!D` M`````````````(`!*E(``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`1(5P1ZQ]]164`0``H@,``!D``````````````(`! M"%D``'AL+W=O&PO=V]R:W-H965T)<``!X;"]W;W)K&UL4$L!`A0#%``` M``@`1(5P1\S6.J8G`P``0`\``!D``````````````(`!TE\``'AL+W=O&PO=V]R:W-H965TOJ5UI6`(``-T'```9``````````````"``4IE``!X M;"]W;W)K&UL4$L!`A0#%`````@`1(5P1^DX`S`<``!D``````````````(`!V6<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`1(5P1\)Q6',$`P``L@T``!D````` M`````````(`!&PO=V]R M:W-H965TW4]X]"0(``#(& M```9``````````````"``=1S``!X;"]W;W)K&UL M4$L!`A0#%`````@`1(5P1^?1\8X.`P``_`P``!D``````````````(`!%'8` M`'AL+W=O0``>&PO=V]R:W-H965T v3.3.0.814
Equity Issuances (Stock Option and Warrant Expense Narrative) (Details) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Equity Issuances Stock Option And Warrant Expense Narrative Details    
Stock option expense $ 11,111 $ 327,920
Warrant expense $ 8,818 $ 63,035

XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 17 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Accounting Policies (Share-Based Compensation Schedule Of Assumptions Used In Black-Scholes Model) (Details) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Accounting Policies Share-based Compensation Schedule Of Assumptions Used In Black-scholes Model Details    
Expected life, in years, maximum 5 years 5 years
Stock price volatility, minimum 120.51% 123.47%
Stock price volatility, maximum 122.72% 124.71%
Risk-free interest rate, mimimum 0.40% 0.35%
Risk-free interest rate, maximum 1.38% 0.46%
Expected dividends $ 0 $ 0
Forfeiture rate 0.00% 0.00%
XML 18 R42.htm IDEA: XBRL DOCUMENT v3.3.0.814
Subsequent Events (Narrative) (Details)
9 Months Ended
Sep. 30, 2015
Subsequent Events Narrative Details  
Subsequent Event, Description

On October 8, 2015, we received written consent from our company's board of directors to amend the Corporation's Articles of Incorporation to effect a reverse stock split, such that each five (5) shares of the issued and outstanding Common Stock of the Corporation shall be reversed split into one (1) share of Common Stock of the Corporation (the "Stock Split"). This Stock Split shall effect only issued and outstanding shares. Each record and beneficial holder who would receive a fractional share as a result of the reverse split shall receive, in lieu thereof, a whole share.

On November 4, 2015, the Corporation received the written consent of holders of more than 50% of our voting securities to effect the Stock Split.

The Stock Split will not be effective until after filing by the Corporation of its Schedule 14C Information with the Securities and Exchange Commission and amendment of the Corporation's Articles of Incorporation.

In addition, the Corporation will file a corporation action notification with FINRA to effect the Stock Split on the market, and must receive approval thereof prior to filing amended Articles of Incorporation.

The number of shares presented in this quarterly report do not reflect the reverse stock split expected to become effective in the 4th quarter of 2015.

On October 16, 2015, we granted a total of 10,000,000 shares of restricted common stock to an unrelated third party, at a price of $0.0032 per share.

On October 19, 2015, we granted a total of 7,894,000 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.

On October 19, 2015, we granted a total of 30,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.0038 in consideration of a reduction in payables.

On October 22, 2015, we granted a total of 6,842,105 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.

On October 22, 2015, The RHL Group, Inc., an entity affiliated with our Chairman & CEO Robert H. Lorsch elected to purchase 46,000,000 shares of common stock at market price in consideration for a reduction in amounts due of $174,800.00.

On October 29, 2015, we granted a total of 10,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.005 in consideration of a reduction in payables.

 

 

 

 

XML 19 R37.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Issuances (Stock Bonus Agreements) (Narrative) (Details) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Stock Bonus Agreement expense $ 0 $ 245,375
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814
INCOME TAXES - Note 4
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
INCOME TAXES - Note 4

NOTE 4 - INCOME TAXES

Under ASC 740-270, Income Taxes - Interim Reporting, we are required to adjust our effective tax rate each quarter to be consistent with the estimated annual effective tax rate. We are also required to record the tax impact of certain discrete items, unusual or infrequently occurring, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur. In addition, we exclude jurisdictions with a projected loss for the year or a year-to-date loss where we cannot recognize a tax benefit from our estimated annual effective tax rate. The impact of such an exclusion could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings versus annual projections.

Pursuant to ASC 740, Income Taxes, we performed an analysis of previous tax filings and determined that there were no positions taken that it considered uncertain. Therefore, there were no unrecognized tax benefits As of September 30, 2015.

MMR Inc., in its capacity as the operating company taking over our income tax positions in addition to its own positions after January 27, 2009 (see Note 1), has estimated its annual effective tax rate to be zero. MMRGlobal has based this on an expectation that the combined entity will generate net operating losses in 2015, and it is not likely that those losses will be recovered using future taxable income. Therefore, no provision for income tax has been recorded as of and for the nine months ended September 30, 2015.

 

 

XML 21 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies (Capital Leases) (Details)
Sep. 30, 2015
USD ($)
Year ending December31:  
2015 (Remainder of) $ 13,221
Total minimum lease payments $ 13,221
XML 22 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies (Operating Leases) (Details)
Sep. 30, 2015
USD ($)
Year ending December 31:  
2015 (Remainder of) $ 26,445
2016 187,550
2017 206,305
2018 and there after 146,410
Total minimum lease payments $ 566,710
XML 23 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies (Leases Narrative) (Details) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Rent expense $ 86,854 $ 129,276
September 2013 Lease    
Operating lease description

Effective September 1, 2013, we renewed our lease for office space in Los Angeles, California with a term through August 31, 2018. The lease currently requires a monthly payment of $8,250.

 
XML 24 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Issuances (Stock Option Activity Summary Of Option Activity) (Details)
9 Months Ended
Sep. 30, 2015
USD ($)
$ / shares
shares
Equity Issuances Stock Option Activity Summary Of Option Activity Details  
Outstanding at December 31, 2014 37,541,722
Granted 0
Exercised 0
Cancelled 0
Outstanding at September 30, 2015 (Unaudited) 37,541,722
Vested and expected to vest at September 30, 2015 (Unaudited) 37,541,722
Exercisable at June 30, 2015 (Unaudited) 37,541,722
Weighted-Average Exercise Prices, Outstanding at December 31, 2014 | $ / shares $ 0.10
Weighted-Average Exercise Prices, Granted | $ / shares 0
Weighted-Average Exercise Prices, Exercised | $ / shares 0
Weighted-Average Exercise Prices, Forfeited, cancelled or expired | $ / shares 0
Weighted-Average Exercise Prices, Outstanding at September 30, 2015 | $ / shares 0.10
Weighted-Average Exercise Prices, Vested and expected to vest | $ / shares $ 0.10
Weighted-Average Remaining Contractual Life (in years), Outstanding at December 31, 2014 4 years 106 days
Weighted-Average Remaining Contractual Life (in years), Outstanding at September 30, 2015 3 years 194 days
Weighted-Average Remaining Contractual Life (in years), Vested and expected to vest 3 years 194 days
Weighted-Average Remaining Contractual Life (in years), Exercisable 3 years 194 days
Aggregate Intrinsic Value, Outstanding at December 31, 2014 | $ $ 0
Aggregate Intrinsic Value, Outstanding at September 30, 2015 | $ 0
Aggregate Intrinsic Value, Vested and expected to vest | $ 0
Aggregate Intrinsic Value, Exercisable | $ $ 0
XML 25 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814
RELATED PARTY PAYABLES, LINE OF CREDIT AND NOTE PAYABLE - Note 3
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
RELATED PARTY PAYABLES, LINE OF CREDIT AND NOTE PAYABLE - Note 3

NOTE 3 - RELATED PARTY PAYABLES, LINE OF CREDIT AND NOTE PAYABLE

On May 20, 2015, we and The RHL Group entered into a Tenth Amended and Restated Promissory Note (the "Amended Note"), effective as of May 20, 2015. The Tenth Note amends and restates that certain Ninth Amended Note entered into between the foregoing parties, effective July 10, 2014 (the " Existing Note" and together with its predecessor notes and the Amended Note, the "Credit Facility"), by: (i) extending the maturity date to April 29, 2016. In connection with the Tenth Amended Note, we issued The RHL Group warrants to purchase 1,764,642 shares of our common stock at $0.003 per share on May 20, 2015. Except as set forth above, the Amended Note does not materially alter the terms of the Existing Note.

Historically, the predecessor notes have increased over time the maximum amount of credit available under the Credit Facility from $100,000 to $1,000,000 to $3,000,000 to $4,500,000. The maximum amount of the Amended Note is $4,500,000. The Amended Note continues to bear interest at the lesser of 10% or the highest rate then permitted by law, and is secured (similar to the Existing Note) by a Security Agreement, which has been in effect since July 31, 2007, as renewed and amended to date (the "Security Agreement").

The Tenth Amended Note had a current balance of $1.81 million at September 30, 2015. The components of the Tenth Amended Note and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million for other obligations due to The RHL Group, which is included in related party payables.

Total interest expense for the three months ended September 30, 2015 and September 30, 2014 was $36,699 and $36,952, respectively. Total interest expense on the Line of Credit for the nine months ended September 30, 2015 and 2014 amounted to $102,433 and $98,985, respectively. The unpaid interest balances as of September 30, 2015 and December 31, 2014 were $36,757 and $30,160, respectively.

In conjunction with the Tenth Amended Note, we were required to maintain certain financial covenants, including the requirement that we have at least $200,000 of cash in our bank accounts or such other amount as necessary to maintain operations through the subsequent thirty (30) days and timely pay any obligations due respecting payroll and all associated payroll taxes on and after September 30, 2015. Since we did not meet these covenants as of September 30, 2015, we received a waiver from The RHL Group until November 30, 2015.

 

 

XML 26 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Issuances (Stock Option Activity Summary Of Stock Options Outstanding and Exercisable) (Details) - $ / shares
9 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Options Outstanding, Number of Shares 37,541,722 37,541,722
Options Outstanding, Weighted-Average Exercise Price Per Share $ 0.10 $ 0.10
Options Exercisable, Number of Shares 37,541,722  
$0.05 - $0.09    
Range of Exercise Price, Minimum $ 0.05  
Range of Exercise Price, Maximum $ 0.09  
Options Outstanding, Number of Shares 12,900,000  
Options Outstanding, Weighted-Average Remaining Life (in years) 6 years 238 days  
Options Outstanding, Weighted-Average Exercise Price Per Share $ 0.07  
Options Exercisable, Number of Shares 12,900,000  
Options Exercisable, Weighted-Average Remaining Life (in years) 6 years 238 days  
Options Exercisable, Weighted-Average Exercise Price Per Share $ 0.07  
$0.10 - $0.15    
Range of Exercise Price, Minimum 0.10  
Range of Exercise Price, Maximum $ 0.15  
Options Outstanding, Number of Shares 23,011,461  
Options Outstanding, Weighted-Average Remaining Life (in years) 3 years 158 days  
Options Outstanding, Weighted-Average Exercise Price Per Share $ 0.11  
Options Exercisable, Number of Shares 23,011,461  
Options Exercisable, Weighted-Average Remaining Life (in years) 3 years 158 days  
Options Exercisable, Weighted-Average Exercise Price Per Share $ .11  
> $0.15    
Range of Exercise Price, Minimum $ 0.15  
Options Outstanding, Number of Shares 1,630,261  
Options Outstanding, Weighted-Average Remaining Life (in years) 4 years 162 days  
Options Outstanding, Weighted-Average Exercise Price Per Share $ 0.19  
Options Exercisable, Number of Shares 1,630,261  
Options Exercisable, Weighted-Average Remaining Life (in years) 4 years 162 days  
Options Exercisable, Weighted-Average Exercise Price Per Share $ 0.19  
XML 27 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restructuring Activities (Narrative) (Details) - USD ($)
9 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Total remaining severance liability $ 620,613 $ 620,613
Favrille    
Restructuring and Related Activities, Description

In connection with the merger with Favrille, Inc. in 2009, we signed promissory notes with certain former executives totaling $76,783.

As of June 30, 2015, the total remaining severance liabilities amounted to $620,613, which is reflected as severance liability on the accompanying consolidated balance sheets. This consists of $571,362 payable to former non-executive employees.

 

 

 
Promissory notes with certain former executives $ 76,783  
Severance liabilty payable to former non-executive employees in 18 monthly installments starting on July 27, 2009 571,362  
Estimated payroll tax on severance liabilty 49,251  
Total remaining severance liability $ 620,613  
XML 28 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Balance Sheets - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 0 $ 309,393
Accounts receivable, less allowances of $173,591 in 2015 and 2014 96,829 47,718
Inventory 13,537 13,537
Prepaid expenses and other current assets 47,885 162,184
Total current assets 158,251 532,832
Property and equipment, net 22,645 32,118
Intangible assets, net 1,757,109 1,790,622
Total assets 1,938,005 2,355,572
Current liabilities:    
Line of credit, related party 990,723 753,704
Related party payables 1,472,150 952,835
Compensation payable 594,034 491,109
Severance liability 620,613 620,613
Accounts payable and accrued expenses 4,891,497 4,668,960
Deferred revenue 40,262 51,312
Convertible notes payable 887,027 932,047
Notes payable, current portion 369,410 360,343
Notes payable, related party 253,664 253,664
Capital leases payable, current portion 13,221 13,221
Total current liabilities $ 10,132,601 $ 9,097,808
Commitments and contingencies (See Note 9)  
Stockholders' deficit:    
Preferred stock - $0.001 per value, 5,000,000 shares authorized, 0 issued and outstanding.
Common stock, $0.001 par value, 1,250,000,000 shares authorized, 902,504,231 and 774,417,739 shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively $ 902,298 $ 774,211
Additional paid-in capital 56,780,651 56,437,812
Accumulated deficit (65,877,545) (63,954,259)
Total stockholders' deficit (8,194,596) (6,742,236)
Total liabilities and stockholders' deficit $ 1,938,005 $ 2,355,572
XML 29 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
NATURE OF OPERATIONS AND BASIS OF PRESENTATION - Note 1
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
NATURE OF OPERATIONS AND BASIS OF PRESENTATION - Note 1

NOTE 1 - NATURE OF OPERATIONS AND BASIS OF PRESENTATION

MMRGlobal Inc. (referred to herein, unless otherwise indicated, as "MMR," the "Company," the "issuer," "we," "us," and "our") was originally incorporated as Favrille, Inc. ("Favrille") in Delaware in 2000, and since its inception and before the Merger (as defined below), operated as a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. In May 2008, Favrille's ongoing Phase 3 registration trial for the FavId vaccine failed to show a statistically significant improvement in the treatment of patients with follicular B-cell Non-Hodgkin's lymphoma. On January 27, 2009, the Company, through MyMedicalRecords, Inc. ("MMR Inc."), what is now our wholly-owned operating subsidiary, conducted a reverse merger with Favrille.

Through our wholly-owned operating subsidiary MMR Inc., the Company's primary business is to license and provide secure and easy-to-use online Personal Health Records ("PHRs") and MyEsafeDepositBox storage solutions, including a professional offering to physicians' offices and similar organizations known as MMRPro. In January 2009, as a result of the Merger, we acquired biotech assets and other intellectual property including anti-CD20 antibodies as well as data and samples from the FavId/Specifid vaccine clinical trials for the treatment of B-cell Non-Hodgkin's lymphoma.

On March 8, 2011, we formed a subsidiary, which we named MMR Life Sciences Group, Inc., exclusively to maximize the value of our biotech assets including our patents, anti-CD20 antibodies, and FavId vaccine technologies acquired by MyMedicalRecords, Inc. through the merger with Favrille. As of this date the assets have not been transferred to the subsidiary.

We (formerly Favrille) were incorporated in Delaware in 2000, MMR Inc. was incorporated in Delaware in 2005, and both are headquartered in Los Angeles, CA.

Principles of Consolidation

The consolidated financial statements include the accounts of MMRGlobal, and its wholly-owned subsidiaries MMR and MMR Life Sciences Group, Inc. All intercompany transactions and balances are eliminated upon consolidation.

Basis of Presentation

We have prepared the accompanying consolidated unaudited financial statements in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial statements and with instructions to Form 10-Q pursuant to the rules and regulations of Securities and Exchange Act of 1934, as amended, or the Exchange Act and Article 8-03 of Regulation S-X promulgated under the Exchange Act. Accordingly, these financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of our management, we have included all adjustments considered necessary (consisting of normal recurring adjustments) for a fair presentation. Operating results for the nine months ended September 30, 2015 are not indicative of the results that may be expected for the fiscal year ending December 31, 2015. You should read these unaudited condensed consolidated financial statements in conjunction with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014.

Going Concern and Management's Plan

As of September 30, 2015, our current liabilities exceeded our current assets by $9.97 million. Furthermore, during the nine months ended September 30, 2015, we incurred losses of $1,923,286, as further explained in Management's Discussion and Analysis of Financial Condition and Results of Operations appearing in Item 2 of Part I of this Quarterly Report on Form 10-Q.

At September 30, 2015 and December 31, 2014, we had $0 and $303,393, respectively, in cash and cash equivalents. Historically, we issued capital stock, sold convertible debt and equity securities and received funds from The RHL Group, Inc. (a significant stockholder that is wholly-owned by our Chairman and Chief Executive Officer, Robert H. Lorsch) to operate our business. Although we received additional funding from The RHL Group pursuant to the Tenth Amended and Restated Note effective May 20, 2015 (the "Line of Credit"), we will still be required to obtain additional financing in order to meet installment payment obligations and the previously existing obligations under the Line of Credit, which had a balance of $1.81 million at September 30, 2015 and a total Unpaid Balance (as defined in the Line of Credit) of $2.06 million, which includes amounts borrowed under the Line of Credit, unpaid interest fees, any amounts guaranteed by The RHL Group, and other obligations due the RHL Group pursuant to the terms of the Tenth Amended and Restated Note and the Second Amended Security Agreement dated May 20, 2015 (the "Security Agreement"). As a result of the above, we express uncertainty about our ability to continue as a going concern. The components of the RHL Group Note payable and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million related to other obligations due to The RHL Group which are included in related party payables.

Management's plan regarding our going concern is to continue utilizing the Line of Credit. According to the terms of the agreement, at September 30, 2015, there was approximately $2.37 million available under the Line of Credit at the discretion of the lender. Finally, we plan to sell additional convertible debt and equity securities, settle our existing liabilities through the issuance of equity securities, explore other debt financing arrangements, increase our existing subscriber and affiliate customer base, sell our products and services, and collect licensing fees from parties utilizing our intellectual property to obtain additional cash flow over the next twelve months. There can be no assurance that funds from these sources will be available when needed or, if available, will be on terms favorable to us or to our stockholders. If additional funds are raised by issuing equity securities, the percentage of ownership of our stockholders will be reduced, stockholders will experience additional dilution and/or such equity securities may provide for rights, preferences or privileges senior to those of the holders of our common stock. If we are unable to utilize our Line of Credit, obtain suitable alternative debt or equity financing, or increase sales of our products of increase licensing fees from the use of our intellectual property, our ability to execute our business plan and continue as a going concern may be adversely affected.

These matters raise substantial doubt about our ability to continue as a going concern. These financial statements were prepared under the assumption that we will continue as a going concern and do not include any adjustments that might result from the outcome of that uncertainty.

 

 

XML 30 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Issuances (Inputs Used In Black-Scholesl) (Details) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Equity Issuances Inputs Used In Black-scholesl Details    
Expected life, in years, maximum 5 years 5 years
Stock price volatility, minimum 120.51% 123.47%
Stock price volatility, maximum 122.72% 124.71%
Risk-free interest rate, minimum 0.40% 0.35%
Risk-free interest rate, maximum 1.38% 0.46%
Expected dividends $ 0 $ 0
Forfeiture rate 0.00% 0.00%
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814
NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2015
Notes Payable Tables  
Notes Payable

Notes payable consisted of the following:

 

      September 30,     December 31,
      2015     2014
             
Promissory notes payable due to the former officers of MMRGlobal as part of severance packages, due in full on August 31, 2009, with no stated interest   $ 76,783    $ 76,783 
             
Promissory notes payable due to the former officers of MMRGlobal pursuant to the
Resignation and Post-Merger Employment Arrangement, due in full on August 31, 2009, with no stated interest
    25,444      25,444 
             
Promissory notes payable due to vendors relating to settlement of certain outstanding accounts payable, payable in 18 equal monthly installments commencing on July 27, 2009 and ending on January 27, 2011, with no stated interest     223,116      223,116 
             
Short term loan due to a third-party with 6% interest     44,067      35,000 
             
      369,410      360,343 
Less: current portion     (369,410)     (360,343)
Notes payable, less current portion   $ -     $ -  
             
Short term loan due to a related-party, payable in full on
January 2, 2014 with 12% interest 
  $ 203,664    $ 203,664 
             
Short term loan due to a related-party, payable in full on
May 31, 2014 with 12% interest
    50,000      50,000 
             
Notes payable related party, current portion     253,664      253,664 
Less: current portion     (253,664)     (253,664)
Notes payable related party, less current portion   $ -     $ -  

 

 

XML 32 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Issuances (Shares Issued for Services or Reduction to Liabilities) (Details)
9 Months Ended
Sep. 30, 2015
USD ($)
shares
Equity Issuances Shares Issued For Services Or Reduction To Liabilities Details  
Reduction of payables, shares | shares 112,100,000
Reduction of payables, amount $ 375,021
Services provided, shares | shares 8,000,000
Services provided, amount $ 38,199
Total payment of services provided through issuance of common stock, shares | shares 120,100,000
Total payment of accounts payable through issuance of common stock, amount $ 413,220
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814
Accounting Policies (Intangible Assets and Impairments) (Narrative) (Details) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Accounting Policies Intangible Assets And Impairments Narrative Details    
Impairment charges $ 0 $ 0
XML 34 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 35 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Note 2
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Note 2

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a) MANAGEMENT'S USE OF ESTIMATES

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, allowances for doubtful accounts, the valuation of deferred income taxes, tax contingencies, long-lived and intangible assets, valuation of derivative liabilities and stock-based compensation. These estimates are based on historical experience and on various other factors that management believes to be reasonable under the circumstances, although actual results could differ from those estimates.

(b) CASH AND CASH EQUIVALENTS

We consider cash equivalents to be only those investments that are highly liquid, readily convertible to cash and with maturities of 90 days or less at the purchase date. We maintain our cash in bank deposit accounts that, at times, may exceed federally insured limits. We have not experienced any losses in such accounts and believe that we are not exposed to any significant credit or deposit risk on our cash. We had cash and cash equivalents of $0 and $303,393 as of September 30, 2015 and December 31, 2014, respectively.

(c) TRADE AND OTHER RECEIVABLES

Receivables represent claims against third parties that will be settled in cash. The carrying value of receivables, net of an allowance for doubtful accounts, if any, represents their estimated net realizable value. We estimate the allowance for doubtful accounts, if any, based on historical collection trends, type of customer, the age of outstanding receivables and existing economic conditions. If events or changes in circumstances indicate that specific receivable balances may be impaired, we give further consideration to the collectability of those balances and the allowance is adjusted accordingly. We write off past due receivable balances when collection efforts have been unsuccessful in collecting the amount due.

(d) INVENTORY

Inventory is stated at the actual cost, using the first-in-first-out method. On an on-going basis, we evaluate our inventory for obsolescence. This evaluation includes analysis of sales levels, sales projections, and purchases by item. If future demand or market conditions are different than our current estimates, an inventory adjustment may be required, and would be reflected in cost of goods sold in the period the revision is made.

(e) FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC 820-10, Fair Value Measurements and Disclosures, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. ASC 820-10 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of September 30, 2015 and December 31, 2014, the carrying value of accounts receivable, deposits, related party payables, compensation payable, severance liabilities, and accounts payable and accrued expenses approximates fair value due to the short-term nature of such instruments. The carrying value of short-term debt approximates fair value as the related interest rates approximate rates currently available to us.

We utilize ASC 820-10 for valuing financial assets and liabilities measured on a recurring basis. ASC 820-10 defines fair value, establishes a framework for measuring fair value and generally accepted accounting principles, and expands disclosures about fair value measurements. This standard applies in situations where other accounting pronouncements either permit or require fair value measurements. ASC 820-10 does not require any new fair value measurements.

Accounting guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The standard describes three levels of inputs that may be used to measure fair value:

  Level 1: Quoted prices in active markets for identical or similar assets and liabilities.
  Level 2: Quoted prices for identical or similar assets and liabilities in markets that are not active or observable inputs other than quoted prices in active markets for identical or similar assets and liabilities.
  Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

(f) IMPAIRMENT OF LONG-LIVED ASSETS AND INTANGIBLES

We account for long-lived assets, which include property and equipment and identifiable intangible assets with finite useful lives (subject to amortization), in accordance with ASC 350-30. ASC 350-30 requires that we review long-lived assets for impairment whenever events or changes in circumstances indicate that we may not recover the carrying amount of an asset. We measure recoverability by comparing the carrying amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an impairment charge to the extent of the difference between the fair value and the asset's carrying amount. We had no impairment charges during the nine months ended September 30, 2015 and 2014.

(g) REVENUE RECOGNITION

We generate our revenues from services, which are comprised of providing electronic access to consumer medical records and other vital documents, and from the licensing of our intellectual property and services. We recognize revenue only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed, and we are reasonably assured of collectability of the resulting receivable.

Our subscriber revenues consist of annual and monthly recurring retail subscriptions and usage-based fees, which are primarily paid in advance by credit card, and corporate accounts that are based on either an access-fee or actual number of users, and in each case billed in advance at the beginning of each month of service. We defer the portions of annual recurring subscription fees collected in advance and recognize them on a straight line basis over the subscription period.

We license the rights to use portions of our intellectual property portfolio, which includes certain patent rights essential to the sale of certain PHR products. Licensees typically pay a license fee in one or more installments and ongoing royalties based on their sales of products incorporating or using the Company's licensed intellectual property. License fees are recognized over the estimated period of benefit to the licensee, typically five to fifteen years. The Company earns royalties on such licensed products sold by its licensees at the time that the licensees' sales occur. The Company recognizes royalty revenues based on royalties reported by licensees during the quarter and when other revenue recognition criteria are met.

We grant exclusive and non-exclusive licenses for the sale and marketing of our services in international territories in consideration of license fees and ongoing royalties. The royalty fee is usually a percentage of revenue earned by the licensee and there are usually certain minimum guarantees. We defer the recognition of license fee revenues received in advance from international licensees for the grant of the license and recognize them over the period covered by the agreement. We defer the recognition of minimum guaranteed royalty payments received in advance and recognize them over the period to which the royalty relates. We include all such revenues under "License Fees." In those cases where a license agreement contains multiple deliverables, we account for the agreement in accordance with ASC 605-25 Revenue Recognition - Multiple-Element Arrangements .

We recognize revenue on sales of our MMRPro system in accordance with ASC 605-25, Revenue Recognition, Multiple-Element Arrangements.

Our multiple-deliverable arrangements consist solely of our MMRPro product. Significant deliverables within these arrangements include scanning equipment, various licenses to use third party software, a license to use our proprietary MMRPro application software, installation and training, dedicated telephone lines, secure online storage and warranties.

We determined all elements to be separate units of accounting as they have standalone value to the customers and/or they are sold by other vendors on a standalone basis. Delivery of the hardware and certain software elements of these arrangements occur at the inception of the agreement. We deliver installation and training at the inception of the agreement. We provide other software licenses, telephone lines and online secure storage over the three year term of the agreement. We include warranties in the arrangements, however the third party product manufacturer, and not us, is obligated to fulfill such warranties. The third-party warranty contracts are paid in advance and are not refundable.

We allocate the revenue derived from these arrangements among all the deliverables. We base such allocation on the relative selling price of each deliverable. With the exception of our proprietary MMRPro application software, we use third party evidence to set the selling prices used for this allocation. In all such cases, third parties sell the same or very similar products. For the MMRPro application software, we estimate the selling price.

We recognize the allocated revenue for each deliverable in accordance with SEC Staff Accounting Bulletin ("SAB") No. 104, Topic 13: Revenue Recognition . Under this guidance, we recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed and determinable and collectability is reasonably assured. This results in us recognizing revenue for the hardware, certain software and the warranties upon delivery to the customer, for the installation and training upon completion of these services, and ratably over the contract period for the software licenses, telephone lines and online secure storage.

Revenue from the licensing of our biotech assets may include non-refundable license and up-front fees, non-refundable milestone payments that are triggered upon achievement of a specific event, and future royalties or lump-sum payments on sales of related products. For agreements that provide for milestone payments, we adopted ASC 605-28-25, Revenue Recognition Milestone Method.

(h) SHARE-BASED COMPENSATION

We account for share-based compensation in accordance with ASC 718-20, Awards Classified as Equity. We apply ASC 718- 20 in accounting for stock-based awards issued to employees under the recognition of compensation expense related to the fair value of employee share-based awards, including stock options and restricted stock. Determining the fair value of options at the grant date requires judgment, including estimating the expected term that stock options will be outstanding prior to exercise, the associated volatility and the expected dividends. Judgment is required in estimating the amount of share-based awards expected to be forfeited prior to vesting. If actual forfeitures differ significantly from these estimates, share-based compensation expense could be materially impacted.

We account for options and warrants issued to non-employees in accordance with ASC 505-50, Equity-Based Payments to Non- Employees. We treat options and warrants issued to non-employees the same as those issued to employees with the exception of determination of the measurement date. The measurement date is the earlier of (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty's performance is complete. Options and warrants granted to consultants are valued at their respective measurement dates, and recognized as an expense based on the portion of the total consulting services provided during the applicable period. As further consulting services are provided in future periods, we will revalue the associated options and warrants and recognize additional expense based on their then current values.

We estimate the fair value of each stock option on the date of grant using the Black-Scholes option pricing model. We determine assumptions relative to volatility and anticipated forfeitures at the time of grant. We valued grants of stock options and warrants during the nine months ended September 30, 2015 and 2014 using the following assumptions.

  September 30, 2015   September 30, 2014
Expected life in years 2 - 5 Years   0 - 5 Years
Stock price volatility 120.51% - 122.72%   123.47% - 124.21%
Risk free interest rate 0.04% - 1.38%   0.35% - 0.46%
Expected dividends None   None
Forfeiture rate 0%   0%

We base the assumptions used in the Black-Scholes models upon the following data: (1) our use of the contractual life of the underlying non-employee warrants as the expected life; the expected life of the employee options used in this calculation is the period of time the options are expected to be outstanding and has been determined based on historical exercise experience; (2) in the absence of an extensive public market for our shares, the expected stock price volatility of the underlying shares over the expected term of the option or warrant was taken at approximately the mid-point of the range for similar companies at the various grant dates; (3) we base the risk free interest rate on published U.S. Treasury Department interest rates for the expected terms of the underlying options or warrants; (4) we base expected dividends on historical dividend data and expected future dividend activity; and (5) we base the expected forfeiture rate on historical forfeiture activity and assumptions regarding future forfeitures based on the composition of current grantees.

(i) NET INCOME/LOSS PER SHARE

We apply the guidance of ASC 260-10, Earnings Per Share for calculating the basic and diluted loss per share. We calculate basic loss per share by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding. We compute diluted loss per share similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. We exclude common equivalent shares from the computation of net loss per share if their effect is anti-dilutive.

We excluded all potential anti-dilutive common shares from the computation of diluted net loss per common share for the nine months ended September 30, 2015 and 2014 because they were anti-dilutive due to our net loss position.

(j) RECENT ACCOUNTING PRONOUNCEMENTS

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with no early adoption permitted. The standard permits the use of either the retrospective or cumulative effect transition method. At this time we have not selected a transition method. We are currently evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures.

In August 2014, the FABS issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern ("ASU 2014-15"). ASU 2014-15 will explicitly require management to assess an entity's ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. Earlier adoption is permitted. We are currently evaluating the impact of the adoption of ASU 2014-15. The adoption of this standard is not expected to have a material impact on the Company's consolidated financial statements.

 

 

XML 36 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Balance Sheets (Parenthetical) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Current assets:    
Allowances $ 173,591 $ 173,591
Stockholders' deficit:    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 1,250,000,000 1,250,000,000
Common stock, shares issued 902,504,231 774,417,739
Common stock, shares outstanding 902,504,231 774,417,739
XML 37 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
SUBSEQUENT EVENTS - Note 12
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
SUBSEQUENT EVENTS - Note 12

NOTE 12 - SUBSEQUENT EVENTS

We have evaluated subsequent events of our condensed consolidated financial statements.

On October 8, 2015, we received written consent from our company's board of directors to amend the Corporation's Articles of Incorporation to effect a reverse stock split, such that each five (5) shares of the issued and outstanding Common Stock of the Corporation shall be reversed split into one (1) share of Common Stock of the Corporation (the "Stock Split"). This Stock Split shall effect only issued and outstanding shares. Each record and beneficial holder who would receive a fractional share as a result of the reverse split shall receive, in lieu thereof, a whole share.

On November 4, 2015, the Corporation received the written consent of holders of more than 50% of our voting securities to effect the Stock Split.

The Stock Split will not be effective until after filing by the Corporation of its Schedule 14C Information with the Securities and Exchange Commission and amendment of the Corporation's Articles of Incorporation.

In addition, the Corporation will file a corporation action notification with FINRA to effect the Stock Split on the market, and must receive approval thereof prior to filing amended Articles of Incorporation.

The number of shares presented in this quarterly report do not reflect the reverse stock split expected to become effective in the 4th quarter of 2015.

On October 16, 2015, we granted a total of 10,000,000 shares of restricted common stock to an unrelated third party, at a price of $0.0032 per share.

On October 19, 2015, we granted a total of 7,894,000 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.

On October 19, 2015, we granted a total of 30,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.0038 in consideration of a reduction in payables.

On October 22, 2015, we granted a total of 6,842,105 shares of restricted stock to an unrelated third party at a price of $0.0038 in consideration of a reduction in payables.

On October 22, 2015, The RHL Group, Inc., an entity affiliated with our Chairman & CEO Robert H. Lorsch elected to purchase 46,000,000 shares of common stock at market price in consideration for a reduction in amounts due of $174,800.00.

On October 29, 2015, we granted a total of 10,000,000 shares of restricted stock to Spanky LLC owned by David Loftus, an affiliate of the Company, at a price of $0.005 in consideration of a reduction in payables.

 

 

 

 

XML 38 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2015
Nov. 12, 2015
Document And Entity Information    
Entity Registrant Name MMRGlobal, Inc.  
Entity Central Index Key 0001285701  
Document Type 10-Q  
Document Period End Date Sep. 30, 2015  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   1,059,255,881
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2015  
XML 39 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of MMRGlobal, and its wholly-owned subsidiaries MMR and MMR Life Sciences Group, Inc. All intercompany transactions and balances are eliminated upon consolidation.

 

 

 

 

 

 

 

 

 

 

 

 

Basis of Presentation

Basis of Presentation

We have prepared the accompanying consolidated unaudited financial statements in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial statements and with instructions to Form 10-Q pursuant to the rules and regulations of Securities and Exchange Act of 1934, as amended, or the Exchange Act and Article 8-03 of Regulation S-X promulgated under the Exchange Act. Accordingly, these financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of our management, we have included all adjustments considered necessary (consisting of normal recurring adjustments) for a fair presentation. Operating results for the nine months ended September 30, 2015 are not indicative of the results that may be expected for the fiscal year ending December 31, 2015. You should read these unaudited condensed consolidated financial statements in conjunction with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014.

 

 

 

 

 

Going Concern and Management's Plan

Going Concern and Management's Plan

 

As of September 30, 2015, our current liabilities exceeded our current assets by $9.97 million. Furthermore, during the nine months ended September 30, 2015, we incurred losses of $1,923,286, as further explained in Management's Discussion and Analysis of Financial Condition and Results of Operations appearing in Item 2 of Part I of this Quarterly Report on Form 10-Q.

At September 30, 2015 and December 31, 2014, we had $0 and $303,393, respectively, in cash and cash equivalents. Historically, we issued capital stock, sold convertible debt and equity securities and received funds from The RHL Group, Inc. (a significant stockholder that is wholly-owned by our Chairman and Chief Executive Officer, Robert H. Lorsch) to operate our business. Although we received additional funding from The RHL Group pursuant to the Tenth Amended and Restated Note effective May 20, 2015 (the "Line of Credit"), we will still be required to obtain additional financing in order to meet installment payment obligations and the previously existing obligations under the Line of Credit, which had a balance of $1.81 million at September 30, 2015 and a total Unpaid Balance (as defined in the Line of Credit) of $2.06 million, which includes amounts borrowed under the Line of Credit, unpaid interest fees, any amounts guaranteed by The RHL Group, and other obligations due the RHL Group pursuant to the terms of the Tenth Amended and Restated Note and the Second Amended Security Agreement dated May 20, 2015 (the "Security Agreement"). As a result of the above, we express uncertainty about our ability to continue as a going concern. The components of the RHL Group Note payable and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million related to other obligations due to The RHL Group which are included in related party payables.

Management's plan regarding our going concern is to continue utilizing the Line of Credit. According to the terms of the agreement, at September 30, 2015, there was approximately $2.37 million available under the Line of Credit at the discretion of the lender. Finally, we plan to sell additional convertible debt and equity securities, settle our existing liabilities through the issuance of equity securities, explore other debt financing arrangements, increase our existing subscriber and affiliate customer base, sell our products and services, and collect licensing fees from parties utilizing our intellectual property to obtain additional cash flow over the next twelve months. There can be no assurance that funds from these sources will be available when needed or, if available, will be on terms favorable to us or to our stockholders. If additional funds are raised by issuing equity securities, the percentage of ownership of our stockholders will be reduced, stockholders will experience additional dilution and/or such equity securities may provide for rights, preferences or privileges senior to those of the holders of our common stock. If we are unable to utilize our Line of Credit, obtain suitable alternative debt or equity financing, or increase sales of our products of increase licensing fees from the use of our intellectual property, our ability to execute our business plan and continue as a going concern may be adversely affected.

These matters raise substantial doubt about our ability to continue as a going concern. These financial statements were prepared under the assumption that we will continue as a going concern and do not include any adjustments that might result from the outcome of that uncertainty.

 

 

Management's Use of Estimates

(a) MANAGEMENT'S USE OF ESTIMATES

 

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, allowances for doubtful accounts, the valuation of deferred income taxes, tax contingencies, long-lived and intangible assets, valuation of derivative liabilities and stock-based compensation. These estimates are based on historical experience and on various other factors that management believes to be reasonable under the circumstances, although actual results could differ from those estimates.

 

 

Cash and Cash Equivalents

(b) CASH AND CASH EQUIVALENTS

We consider cash equivalents to be only those investments that are highly liquid, readily convertible to cash and with maturities of 90 days or less at the purchase date. We maintain our cash in bank deposit accounts that, at times, may exceed federally insured limits. We have not experienced any losses in such accounts and believe that we are not exposed to any significant credit or deposit risk on our cash. We had cash and cash equivalents of $0 and $303,393 as of September 30, 2015 and December 31, 2014, respectively.

 

Trade and Other Receivables

(c) TRADE AND OTHER RECEIVABLES

Receivables represent claims against third parties that will be settled in cash. The carrying value of receivables, net of an allowance for doubtful accounts, if any, represents their estimated net realizable value. We estimate the allowance for doubtful accounts, if any, based on historical collection trends, type of customer, the age of outstanding receivables and existing economic conditions. If events or changes in circumstances indicate that specific receivable balances may be impaired, we give further consideration to the collectability of those balances and the allowance is adjusted accordingly. We write off past due receivable balances when collection efforts have been unsuccessful in collecting the amount due.

 

 

Inventory

(d) INVENTORY

Inventory is stated at the actual cost, using the first-in-first-out method. On an on-going basis, we evaluate our inventory for obsolescence. This evaluation includes analysis of sales levels, sales projections, and purchases by item. If future demand or market conditions are different than our current estimates, an inventory adjustment may be required, and would be reflected in cost of goods sold in the period the revision is made.

 

Fair Value of Financial Instruments

(e) FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC 820-10, Fair Value Measurements and Disclosures, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. ASC 820-10 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of September 30, 2015 and December 31, 2014, the carrying value of accounts receivable, deposits, related party payables, compensation payable, severance liabilities, and accounts payable and accrued expenses approximates fair value due to the short-term nature of such instruments. The carrying value of short-term debt approximates fair value as the related interest rates approximate rates currently available to us.

We utilize ASC 820-10 for valuing financial assets and liabilities measured on a recurring basis. ASC 820-10 defines fair value, establishes a framework for measuring fair value and generally accepted accounting principles, and expands disclosures about fair value measurements. This standard applies in situations where other accounting pronouncements either permit or require fair value measurements. ASC 820-10 does not require any new fair value measurements.

Accounting guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The standard describes three levels of inputs that may be used to measure fair value:

  Level 1: Quoted prices in active markets for identical or similar assets and liabilities.
  Level 2: Quoted prices for identical or similar assets and liabilities in markets that are not active or observable inputs other than quoted prices in active markets for identical or similar assets and liabilities.
  Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

 

Impairment of Long-Lived Assets and Intangibles

(f) IMPAIRMENT OF LONG-LIVED ASSETS AND INTANGIBLES

We account for long-lived assets, which include property and equipment and identifiable intangible assets with finite useful lives (subject to amortization), in accordance with ASC 350-30. ASC 350-30 requires that we review long-lived assets for impairment whenever events or changes in circumstances indicate that we may not recover the carrying amount of an asset. We measure recoverability by comparing the carrying amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an impairment charge to the extent of the difference between the fair value and the asset's carrying amount. We had no impairment charges during the nine months ended September 30, 2015 and 2014.

Revenue Recognition

(g) REVENUE RECOGNITION

 

We generate our revenues from services, which are comprised of providing electronic access to consumer medical records and other vital documents, and from the licensing of our intellectual property and services. We recognize revenue only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed, and we are reasonably assured of collectability of the resulting receivable.

Our subscriber revenues consist of annual and monthly recurring retail subscriptions and usage-based fees, which are primarily paid in advance by credit card, and corporate accounts that are based on either an access-fee or actual number of users, and in each case billed in advance at the beginning of each month of service. We defer the portions of annual recurring subscription fees collected in advance and recognize them on a straight line basis over the subscription period.

We license the rights to use portions of our intellectual property portfolio, which includes certain patent rights essential to the sale of certain PHR products. Licensees typically pay a license fee in one or more installments and ongoing royalties based on their sales of products incorporating or using the Company's licensed intellectual property. License fees are recognized over the estimated period of benefit to the licensee, typically five to fifteen years. The Company earns royalties on such licensed products sold by its licensees at the time that the licensees' sales occur. The Company recognizes royalty revenues based on royalties reported by licensees during the quarter and when other revenue recognition criteria are met.

We grant exclusive and non-exclusive licenses for the sale and marketing of our services in international territories in consideration of license fees and ongoing royalties. The royalty fee is usually a percentage of revenue earned by the licensee and there are usually certain minimum guarantees. We defer the recognition of license fee revenues received in advance from international licensees for the grant of the license and recognize them over the period covered by the agreement. We defer the recognition of minimum guaranteed royalty payments received in advance and recognize them over the period to which the royalty relates. We include all such revenues under "License Fees." In those cases where a license agreement contains multiple deliverables, we account for the agreement in accordance with ASC 605-25 Revenue Recognition - Multiple-Element Arrangements .

We recognize revenue on sales of our MMRPro system in accordance with ASC 605-25, Revenue Recognition, Multiple-Element Arrangements.

Our multiple-deliverable arrangements consist solely of our MMRPro product. Significant deliverables within these arrangements include scanning equipment, various licenses to use third party software, a license to use our proprietary MMRPro application software, installation and training, dedicated telephone lines, secure online storage and warranties.

We determined all elements to be separate units of accounting as they have standalone value to the customers and/or they are sold by other vendors on a standalone basis. Delivery of the hardware and certain software elements of these arrangements occur at the inception of the agreement. We deliver installation and training at the inception of the agreement. We provide other software licenses, telephone lines and online secure storage over the three year term of the agreement. We include warranties in the arrangements, however the third party product manufacturer, and not us, is obligated to fulfill such warranties. The third-party warranty contracts are paid in advance and are not refundable.

We allocate the revenue derived from these arrangements among all the deliverables. We base such allocation on the relative selling price of each deliverable. With the exception of our proprietary MMRPro application software, we use third party evidence to set the selling prices used for this allocation. In all such cases, third parties sell the same or very similar products. For the MMRPro application software, we estimate the selling price.

We recognize the allocated revenue for each deliverable in accordance with SEC Staff Accounting Bulletin ("SAB") No. 104, Topic 13: Revenue Recognition . Under this guidance, we recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed and determinable and collectability is reasonably assured. This results in us recognizing revenue for the hardware, certain software and the warranties upon delivery to the customer, for the installation and training upon completion of these services, and ratably over the contract period for the software licenses, telephone lines and online secure storage.

Revenue from the licensing of our biotech assets may include non-refundable license and up-front fees, non-refundable milestone payments that are triggered upon achievement of a specific event, and future royalties or lump-sum payments on sales of related products. For agreements that provide for milestone payments, we adopted ASC 605-28-25, Revenue Recognition Milestone Method.

 

 

 

Shared-Based Compensation

(h) SHARE-BASED COMPENSATION

 

We account for share-based compensation in accordance with ASC 718-20, Awards Classified as Equity. We apply ASC 718- 20 in accounting for stock-based awards issued to employees under the recognition of compensation expense related to the fair value of employee share-based awards, including stock options and restricted stock. Determining the fair value of options at the grant date requires judgment, including estimating the expected term that stock options will be outstanding prior to exercise, the associated volatility and the expected dividends. Judgment is required in estimating the amount of share-based awards expected to be forfeited prior to vesting. If actual forfeitures differ significantly from these estimates, share-based compensation expense could be materially impacted.

We account for options and warrants issued to non-employees in accordance with ASC 505-50, Equity-Based Payments to Non- Employees. We treat options and warrants issued to non-employees the same as those issued to employees with the exception of determination of the measurement date. The measurement date is the earlier of (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty's performance is complete. Options and warrants granted to consultants are valued at their respective measurement dates, and recognized as an expense based on the portion of the total consulting services provided during the applicable period. As further consulting services are provided in future periods, we will revalue the associated options and warrants and recognize additional expense based on their then current values.

We estimate the fair value of each stock option on the date of grant using the Black-Scholes option pricing model. We determine assumptions relative to volatility and anticipated forfeitures at the time of grant. We valued grants of stock options and warrants during the nine months ended September 30, 2015 and 2014 using the following assumptions.

  September 30, 2015   September 30, 2014
Expected life in years 2 - 5 Years   0 - 5 Years
Stock price volatility 120.51% - 122.72%   123.47% - 124.21%
Risk free interest rate 0.04% - 1.38%   0.35% - 0.46%
Expected dividends None   None
Forfeiture rate 0%   0%

We base the assumptions used in the Black-Scholes models upon the following data: (1) our use of the contractual life of the underlying non-employee warrants as the expected life; the expected life of the employee options used in this calculation is the period of time the options are expected to be outstanding and has been determined based on historical exercise experience; (2) in the absence of an extensive public market for our shares, the expected stock price volatility of the underlying shares over the expected term of the option or warrant was taken at approximately the mid-point of the range for similar companies at the various grant dates; (3) we base the risk free interest rate on published U.S. Treasury Department interest rates for the expected terms of the underlying options or warrants; (4) we base expected dividends on historical dividend data and expected future dividend activity; and (5) we base the expected forfeiture rate on historical forfeiture activity and assumptions regarding future forfeitures based on the composition of current grantees.

 

 

Net Income/Loss Per Share

(i) NET INCOME/LOSS PER SHARE

 

We apply the guidance of ASC 260-10, Earnings Per Share for calculating the basic and diluted loss per share. We calculate basic loss per share by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding. We compute diluted loss per share similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. We exclude common equivalent shares from the computation of net loss per share if their effect is anti-dilutive.

We excluded all potential anti-dilutive common shares from the computation of diluted net loss per common share for the nine months ended September 30, 2015 and 2014 because they were anti-dilutive due to our net loss position.

 

 

 

 

Recent Accounting Pronouncements

(j) RECENT ACCOUNTING PRONOUNCEMENTS

 

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with no early adoption permitted. The standard permits the use of either the retrospective or cumulative effect transition method. At this time we have not selected a transition method. We are currently evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures.

In August 2014, the FABS issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern ("ASU 2014-15"). ASU 2014-15 will explicitly require management to assess an entity's ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. Earlier adoption is permitted. We are currently evaluating the impact of the adoption of ASU 2014-15. The adoption of this standard is not expected to have a material impact on the Company's consolidated financial statements.

 

 

 

 

 

 

 

Income Taxes

Under ASC 740-270, Income Taxes - Interim Reporting, we are required to adjust our effective tax rate each quarter to be consistent with the estimated annual effective tax rate. We are also required to record the tax impact of certain discrete items, unusual or infrequently occurring, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur. In addition, we exclude jurisdictions with a projected loss for the year or a year-to-date loss where we cannot recognize a tax benefit from our estimated annual effective tax rate. The impact of such an exclusion could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings versus annual projections.

Pursuant to ASC 740, Income Taxes, we performed an analysis of previous tax filings and determined that there were no positions taken that it considered uncertain. Therefore, there were no unrecognized tax benefits As of September 30, 2015.

MMR Inc., in its capacity as the operating company taking over our income tax positions in addition to its own positions after January 27, 2009 (see Note 1), has estimated its annual effective tax rate to be zero. MMRGlobal has based this on an expectation that the combined entity will generate net operating losses in 2015, and it is not likely that those losses will be recovered using future taxable income. Therefore, no provision for income tax has been recorded as of and for the nine months ended September 30, 2015.

 

 

 

 

XML 40 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenues        
Subscriber $ 68,996 $ 50,863 $ 116,248 $ 109,581
MMR Pro 2,899 17,408 7,219 29,476
License fees 5,769 1,828,000 15,249 2,290,538
Other income 0 0 0 7,500
Total revenues 77,664 1,896,271 138,716 2,437,095
Cost of revenues 45,298 88,960 179,554 230,402
Gross profit 32,366 1,807,311 (40,838) 2,206,693
General and administrative expenses 383,147 1,186,972 1,331,644 3,530,193
Sales and marketing expenses 102,504 261,553 420,199 1,087,943
Technology development 0 7,254 0 57,890
(Loss) income from operations (453,285) 351,532 (1,792,681) (2,469,333)
Other income 8,914 1,672,820 60,750 1,672,820
Interest and other finance charges, net (44,629) (104,031) (191,355) (362,678)
Net (loss) income $ (489,000) $ 1,920,321 $ (1,923,286) $ (1,159,191)
Net (loss) income per share:        
Basic and diluted $ (0) $ 0 $ (0) $ (0)
Weighted average common shares outstanding:        
Basic 893,373,796 754,463,150 830,417,188 731,355,958
Diluted 893,373,796 756,876,594 830,417,188 731,355,958
XML 41 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
EQUITY ISSUANCES - Note 7
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
EQUITY ISSUANCES - Note 7

NOTE 7 - EQUITY ISSUANCES

Stock Option Activity

Our 2001 Equity Incentive Plan (the "2001 Plan") expired on June 5, 2011 and no options were issued under the 2001 Plan since that date. As of September 30, 2015, 14,184,557 shares remain issued under the 2001 Plan.

On September 1, 2011, our Board of Directors approved the adoption of a new plan to replace the 2001 Plan under the same general terms as the 2001 Plan. On June 20, 2012, our stockholders voted and approved the 2011 Equity Incentive Plan (the " 2011 Plan") at our 2012 Annual Stockholder Meeting. As of September 30, 2015, 23.36 million shares remain issued under the 2011 Plan, and 36.45 million shares of our common stock are reserved for future issuance under our 2011 Plan, which includes an automatic 5 million share annual increase pursuant to the terms of the 2011 Plan and a 20 million share increase authorized during our 2013 Annual Stockholder's Meeting.

A summary of option activity for the nine months ended September 30, 2015 is presented below. Options granted by MMR Inc. prior to the date of the Merger have been retroactively restated to reflect the conversion ratio of MMR Inc. to MMR shares.

              Weighted-Average      
          Weighted-   Remaining      
          Average   Contractual     Aggregate
          Exercise   Life     Intrinsic
    Options     Price   (Years)     Value
Outstanding at December 31, 2014   37,541,722    $ 0.10    4.29    $ -  
Granted   -     $ -     -     $ -  
Exercised   -     $ -     -     $ -  
Cancelled   -     $ -     -     $ -  
Outstanding at September 30, 2015 (Unaudited)   37,541,722    $ 0.10    3.54    $ -  
Vested and expected to vest                    
     at September 30, 2015 (Unaudited)   37,541,722    $ 0.10    3.54    $ -  
Exercisable at September 30, 2015 (Unaudited)   37,541,722    $ 0.10    3.54    $

The aggregate intrinsic value in the table above is before applicable income taxes and is calculated based on the difference between the exercise price of the options and the quoted price of the common stock as of the reporting date.

There were no options issued during the nine months ended September 30, 2015.

Total stock option expenses recorded during the nine months ended September 30, 2015 and 2014 were $16,759 and $151,634, respectively.

The following table summarizes information about stock options outstanding and exercisable at September 30, 2015.

  Options Outstanding   Options Exercisable
            Weighted     Weighted       Weighted     Weighted
            Average     Average       Average     Average
  Exercise   Number     Remaining     Exercise   Number   Remaining     Exercise
  Price   of Shares     Life (Years)     Price   of Shares   Life (Years)     Price
                                 
$ 0.05 - 0.09   12,900,000      6.66   $ 0.07    12,900,000    6.66   $ 0.07 
$ 0.10 - 0.15   23,011,461      3.44   $ 0.11    23,011,461    3.44   $ 0.11 
$ > 0.15   1,630,261      4.45   $ 0.19    1,630,261    4.45   $ 0.19 
      37,541,722                37,541,722           

Warrants

A summary of the activity of our warrants for the nine months ended September 30, 2015 is presented below:

        Weighted Avg.
  Shares     Exercise Price
Outstanding at December 31, 2014 70,028,410    $ 0.07 
Granted 1,764,642    $ 0.003 
Exercised   $
Cancelled (14,650,000)   $ 0.08 
Outstanding at September 30, 2015 (Unaudited) 57,143,052    $ 0.06 
         
Exercisable at September 30, 2015 (Unaudited) 55,719,441   $ 0.06

Total warrant expenses recorded during the nine months ended September 30, 2015 and 2014 were $11,170 and $144,232, respectively.

The inputs used for the Black-Scholes option and warrant valuation model were as follows:

  September 30, 2015   September 30, 2014
Expected life in years 2 - 5 Years   0 - 5 Years
Stock price volatility 120.51% - 122.72%   123.47% - 124.21%
Risk free interest rate 0.04% - 1.38%   0.35% - 0.46%
Expected dividends None   None
Forfeiture rate 0%   0%

Shares Issued for Services or Reduction to Liabilities

During the nine months ended September 30, 2015, we issued 120,100,000 shares of common stock with a value of $413,220 to various third parties and related parties and charged the proceeds to the appropriate accounts for the following reasons:

    Nine Months Ended September 30, 2015
Purpose   Shares     Value
           
Reduction of payables and notes    112,100,000    $ 375,021 
Services provided    8,000,000      38,199 
Totals    120,100,000    $ 413,220 

The 120,100,000 issued shares were not contractually restricted. However, as these shares have not been registered under the Securities Act of 1933, as amended (the "Act"), they are restricted from sale until they are registered under the Act, or qualify for resale under the rules promulgated under the Act. All such shares were calculated at the trading closing price on the date of issuance.

Stock Bonus Agreements

From time to time, we issue shares of our common stock as a bonus for services rendered. Stock bonuses may be awarded upon satisfaction of specified performance goals pursuant to the Performance Stock Bonus Agreement.

On each grant date, we valued the stock bonus based on the share price and the expenses were amortized using the straight line method. Total stock bonus expenses recorded during the nine months ended September 30, 2015 and 2014 were $0 and $ 245,375, respectively and are reflected in operating expenses in the accompanying consolidated statements of operations.

 

 

XML 42 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814
STOCKHOLDERS' DEFICIT - Note 6
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
STOCKHOLDERS' DEFICIT - Note 6

NOTE 6 - STOCKHOLDERS' DEFICIT

Preferred Stock

We have 5,000,000 shares of preferred stock authorized. As of September 30, 2015, and December 31, 2014, there were no shares of preferred stock issued and outstanding.

Common Stock

As of September 30, 2015, we are authorized to issue 1,250,000,000 shares of common stock.

As of September 30, 2015, the total shares of our common stock issued and outstanding amounted to 902,504,231.

 

 

 

XML 43 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
Accounting Policies (Cash and Cash Equivalents) (Narrative) (Details) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Sep. 30, 2014
Dec. 31, 2013
Accounting Policies Cash And Cash Equivalents Narrative Details        
Cash and cash equivalents $ 0 $ 309,393 $ 1,491,510 $ 10,359
XML 44 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2015
Share-based Compensation Tables  
Schedule of Valuation Assumptions to Determine the Fair Value of Stock Options

The inputs used for the Black-Scholes option and warrant valuation model were as follows:

  September 30, 2015   September 30, 2014
Expected life in years 2 - 5 Years   0 - 5 Years
Stock price volatility 120.51% - 122.72%   123.47% - 124.21%
Risk free interest rate 0.04% - 1.38%   0.35% - 0.46%
Expected dividends None   None
Forfeiture rate 0%   0%

 

 

 

 

 

 

 

 

XML 45 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814
RESTRUCTURING ACTIVITIES - Note 10
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
RESTRUCTURING ACTIVITIES - Note 10

NOTE 10 - RESTRUCTURING ACTIVITIES

In connection with the merger with Favrille, Inc. in 2009, we signed promissory notes with certain former executives totaling $76,783.

As of September 30, 2015, the total remaining severance liabilities amounted to $620,613, which is reflected as severance liability on the accompanying consolidated balance sheets. This consists of $571,362 payable to former non-executive employees.

 

 

 

 

 

 

 

XML 46 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814
NOTES PAYABLE - Note 8
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
NOTES PAYABLE - Note 8

NOTE 8 - NOTES PAYABLE

Notes payable consisted of the following:

      September 30,     December 31,
      2015     2014
             
Promissory notes payable due to the former officers of MMRGlobal as part of severance packages, due in full on August 31, 2009, with no stated interest   $ 76,783    $ 76,783 
             
Promissory notes payable due to the former officers of MMRGlobal pursuant to the
Resignation and Post-Merger Employment Arrangement, due in full on August 31, 2009, with no stated interest
    25,444      25,444 
             
Promissory notes payable due to vendors relating to settlement of certain outstanding accounts payable, payable in 18 equal monthly installments commencing on July 27, 2009 and ending on January 27, 2011, with no stated interest     223,116      223,116 
             
Short term loan due to a third-party with 6% interest     44,067      35,000 
             
      369,410      360,343 
Less: current portion     (369,410)     (360,343)
Notes payable, less current portion   $ -     $ -  
             
Short term loan due to a related-party, payable in full on
January 2, 2014 with 12% interest 
  $ 203,664    $ 203,664 
             
Short term loan due to a related-party, payable in full on
May 31, 2014 with 12% interest
    50,000      50,000 
             
Notes payable related party, current portion     253,664      253,664 
Less: current portion     (253,664)     (253,664)
Notes payable related party, less current portion   $ -     $ -  

 

 

XML 47 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONVERTIBLE PROMISSORY NOTES - Note 9
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
CONVERTIBLE PROMISSORY NOTES - Note 9

NOTE 9 - CONVERTIBLE PROMISSORY NOTES

From time to time, we issue Convertible Promissory Notes. As of September 30, 2015, a total of $887,027 in convertible notes remained outstanding. As of September 30, 2015, all of these Notes have matured, however, the Company and the Holders have agreed to keep the balance as a Note Payable and the note holders have elected not to convert their note balances into shares of our common stock as of September 30, 2015.

Each Note contains the following general terms and provisions:

  • The principal amount owed under each note becomes due and payable one year or less from the investment date provided that, upon ten (10) days' prior written notice to the holder, we may, in our sole discretion, extend the maturity date for an additional six month term. The Notes can be further extended upon mutual agreement.
  • These notes bear interest at a rate of 6% per annum payable in cash or shares of common stock or a combination of cash and shares of common stock at our option.

During the third quarter of 2015, we did not enter into any Convertible Promissory Notes.

Shares issuable upon conversion for convertible notes payable was 41,679,061 as of September 30, 2015.

The total interest expense attributed to the Beneficial Conversion Feature of the Notes and related warrants for the nine months ended September 30, 2015 and 2014 was $55,780 and $124,120, respectively.

 

XML 48 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814
RELATED PARTY TRANSACTIONS - Note 11
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
RELATED PARTY TRANSACTIONS - Note 11

NOTE 11 - RELATED PARTY TRANSACTIONS

Our Chairman and Chief Executive Officer, Robert H. Lorsch, is also the Chief Executive Officer of The RHL Group, Inc. and has full voting power over all of the capital stock of The RHL Group, Inc. Mr. Lorsch directly and indirectly through The RHL Group, Inc., beneficially owns approximately 16.4% our total outstanding voting stock. The RHL Group, Inc. has loaned us money pursuant to the Tenth Amended Note and all predecessor notes. See Note 3 - Related Party Note Payable above.

The RHL Group is an investment holding company which provides consulting, operational and technical services to us, which we refer to as the RHL Services. As part of the RHL Services, The RHL Group provides us with unrestricted access to its internal business and relationship contact database of more than 10,000 persons and entities, which includes clients of The RHL Group and other individuals which may hold value to us. The RHL Group also provides infrastructure support to us, including allowing us unlimited access to its facilities, equipment, and data, information management and server systems. In addition to allowing us the use of its office support personnel, The RHL Group has also consented to allow us to utilize the full-time services of Mr. Lorsch as our President, Chairman and Chief Executive Officer, which requires substantial time and energy away from his required duties as The RHL Group's Chairman and Chief Executive Officer. In addition, The RHL Group has made its President, Kira Reed, available as our spokesperson. Ms. Reed, who is Mr. Lorsch's spouse, also manages our social networking activities.

In consideration for the above, The RHL Group, Inc. has a consulting arrangement with MMR. A copy of the consulting agreement is filed as an exhibit in our Form 8-K, as filed with the SEC on May 4, 2009 and is hereby incorporated by reference.

We incurred $12,500 during the nine months ended September 30, 2015 and 2014, toward marketing consulting services from Bernard Stolar, a director. We included $198,514 and $174,273 in related party payables as of September 30, 2015 and December 31, 2014, respectively, in connection with these services and board fees.

We contract with a significant vendor for the development and maintenance of the software applications necessary to run our MyMedicalRecords PHR, MyEsafeDepositBox and MyMedicalRecords Pro products. Our outside developer supports our software development needs through a team of software engineers, programmers, quality control personnel and testers, who work with our internal product development team on all aspects of application development, design, integration and support of our products. This vendor is also a stockholder. For the nine months ended September 30, 2015 and 2014, the total expenses relating to this stockholder amounted to $90,000 and $90,000, respectively. In addition, we capitalized $0 of software development costs for the quarter ended September 30, 2015. As of September 30, 2015 and December 31, 2014, the total amounts due to the stockholder and included in related party payables amounted to $100,000 and $10,000, respectively.

On September 15, 2009, we entered into a five year agreement with E-Mail Frequency, LLC and David Loftus, Managing Partner of E-Mail Frequency, LLC, a significant stockholder of the Company, which was amended during 2011 to increase the term for an additional five years and provide licensor a non- exclusive right to target, market and exploit the Employee Benefits market.

We licensed an existing 80 million person direct marketing database (the "Database") of street addresses, cellular phone numbers, e-mail addresses and other comprehensive data with E-Mail Frequency. The agreement allows us to market, through the use of the Database, our MyMedicalRecords PHR, MyEsafeDepositBox virtual vault, and MMRPro document management system to physicians and their patients. Under the terms of the Agreement, we paid $250,000 to David Loftus as a one-time consulting fee in the form of 2,777,778 shares of our common stock. We recorded the $250,000 one-time licensee fee as a prepaid consulting fee. Amortization expense for each of the quarters ended September 30, 2015 and 2014 was $0 and $37,500. Included in related party payables at September 30, 2015 and December 31, 2014 of $64,615 and $64,615, respectively, in respect to these services.

 

 

 

 

 

 

 

 

 

XML 49 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Issuances (Summary Of Warrant Activity) (Details)
9 Months Ended
Sep. 30, 2015
$ / shares
shares
Equity Issuances Summary Of Warrant Activity Details  
Warrants outstanding at December 31, 2014 | shares 70,028,410
Granted | shares 1,764,642
Exercised | shares 0
Cancelled | shares (14,650,000)
Warrants exercisable at September 30, 2015 | shares 55,719,441
Weighted-average exercise price, beginning balance $ 0.07
Weighted-average exercise price, granted 0.003
Weighted-average exercise price, exercised during period 0
Weighted-average exercise price, cancelled during period 0.08
Weighted-average exercise price, ending balance 0.08
Warrants exercisable, weighted average exercise price $ 0.06
XML 50 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814
EQUITY ISSUANCES (Tables)
9 Months Ended
Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Outstanding Option Awards

A summary of option activity for the nine months ended September 30, 2015 is presented below. Options granted by MMR Inc. prior to the date of the Merger have been retroactively restated to reflect the conversion ratio of MMR Inc. to MMR shares.

              Weighted-Average      
          Weighted-   Remaining      
          Average   Contractual     Aggregate
          Exercise   Life     Intrinsic
    Options     Price   (Years)     Value
Outstanding at December 31, 2014   37,541,722    $ 0.10    4.29    $ -  
Granted   -     $ -     -     $ -  
Exercised   -     $ -     -     $ -  
Cancelled   -     $ -     -     $ -  
Outstanding at September 30, 2015 (Unaudited)   37,541,722    $ 0.10    3.54    $ -  
Vested and expected to vest                    
     at September 30, 2015 (Unaudited)   37,541,722    $ 0.10    3.54    $ -  
Exercisable at September 30, 2015 (Unaudited)   37,541,722    $ 0.10    3.54    $

 

 

 

Summary of Stock Options Outstanding and Exercisable

The following table summarizes information about stock options outstanding and exercisable at September 30, 2015.

  Options Outstanding   Options Exercisable
            Weighted     Weighted       Weighted     Weighted
            Average     Average       Average     Average
  Exercise   Number     Remaining     Exercise   Number   Remaining     Exercise
  Price   of Shares     Life (Years)     Price   of Shares   Life (Years)     Price
                                 
$ 0.05 - 0.09   12,900,000      6.66   $ 0.07    12,900,000    6.66   $ 0.07 
$ 0.10 - 0.15   23,011,461      3.44   $ 0.11    23,011,461    3.44   $ 0.11 
$ > 0.15   1,630,261      4.45   $ 0.19    1,630,261    4.45   $ 0.19 
      37,541,722                37,541,722           

 

 

 

 

Summary of Outstanding Warrant Awards

A summary of the activity of our warrants for the nine months ended September 30, 2015 is presented below:

        Weighted Avg.
  Shares     Exercise Price
Outstanding at December 31, 2014 70,028,410    $ 0.07 
Granted 1,764,642    $ 0.003 
Exercised   $
Cancelled (14,650,000)   $ 0.08 
Outstanding at September 30, 2015 (Unaudited) 57,143,052    $ 0.06 
         
Exercisable at September 30, 2015 (Unaudited) 55,719,441   $ 0.06

 

 

 

 

 

 

 

Black-Scholes option and valuation model assumptions

The inputs used for the Black-Scholes option and warrant valuation model were as follows:

  September 30, 2015   September 30, 2014
Expected life in years 2 - 5 Years   0 - 5 Years
Stock price volatility 120.51% - 122.72%   123.47% - 124.21%
Risk free interest rate 0.04% - 1.38%   0.35% - 0.46%
Expected dividends None   None
Forfeiture rate 0%   0%

 

 

 

 

 

 

 

 

Shares Issued for Services or Reduction to Liabilities

During the nine months ended September 30, 2015, we issued 120,100,000 shares of common stock with a value of $413,220 to various third parties and related parties and charged the proceeds to the appropriate accounts for the following reasons:

    Nine Months Ended September 30, 2015
Purpose   Shares     Value
           
Reduction of payables and notes    112,100,000    $ 375,021 
Services provided    8,000,000      38,199 
Totals    120,100,000    $ 413,220 

 

 

 

 

XML 51 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814
Related Party Note Payable (Narrative) (Details) - Tenth Amended and Restated Secured Promissory Note - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Date of note     Apr. 29, 2014    
Maximum line of credit under note    

On May 20, 2015, we and The RHL Group entered into a Tenth Amended and Restated Promissory Note (the "Amended Note"), effective as of May 20, 2015. The Tenth Note amends and restates that certain Ninth Amended Note entered into between the foregoing parties, effective July 10, 2014 (the " Existing Note" and together with its predecessor notes and the Amended Note, the "Credit Facility"), by: (i) extending the maturity date to April 29, 2016. In connection with the Tenth Amended Note, we issued The RHL Group warrants to purchase 1,764,642 shares of our common stock at $0.003 per share on May 20, 2015. Except as set forth above, the Amended Note does not materially alter the terms of the Existing Note.

Historically, the predecessor notes have increased over time the maximum amount of credit available under the Credit Facility from $100,000 to $1,000,000 to $3,000,000 to $4,500,000. The maximum amount of the Amended Note is $4,500,000. The Amended Note continues to bear interest at the lesser of 10% or the highest rate then permitted by law, and is secured (similar to the Existing Note) by a Security Agreement, which has been in effect since July 31, 2007, as renewed and amended to date (the "Security Agreement").

The Tenth Amended Note had a current balance of $1.81 million at September 30, 2015. The components of the Tenth Amended Note and the related balance sheet presentation as of September 30, 2015 are as follows: $0.99 million, which is included in the line of credit, related party; and $0.82 million for other obligations due to The RHL Group, which is included in related party payables.

Total interest expense for the three months ended September 30, 2015 and September 30, 2014 was $36,699 and $36,952, respectively. Total interest expense on the Line of Credit for the nine months ended September 30, 2015 and 2014 amounted to $102,433 and $98,985, respectively. The unpaid interest balances as of September 30, 2015 and December 31, 2014 were $36,757 and $30,160, respectively.

In conjunction with the Tenth Amended Note, we were required to maintain certain financial covenants, including the requirement that we have at least $200,000 of cash in our bank accounts or such other amount as necessary to maintain operations through the subsequent thirty (30) days and timely pay any obligations due respecting payroll and all associated payroll taxes on and after September 30, 2015. Since we did not meet these covenants as of September 30, 2015, we received a waiver from The RHL Group until November 30, 2015.

 

 

 

 

   
Maturity date     Apr. 29, 2016    
Warrants granted for shares     1,764,642    
Warrant price per share     $ 0.003    
Debt component classification:          
Line of credit, related party $ 850,000   $ 850,000    
Related party payables 690,000   690,000    
Total note payable balance 1,540,000   1,540,000    
Interest expense on line of credit 36,699 $ 36,952 102,433 $ 98,985  
Related party accrued interest $ 36,757   $ 36,757   $ 30,160
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.3.0.814
Related Party Transactions (Narrative) (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2009
Dec. 31, 2014
Related party payables $ 1,472,150     $ 952,835
The RHL Group, Inc.        
Nature of Common Ownership or Management Control Relationships

Our Chairman and Chief Executive Officer, Robert H. Lorsch, is also the Chief Executive Officer of The RHL Group, Inc. and has full voting power over all of the capital stock of The RHL Group, Inc. Mr. Lorsch directly and indirectly through The RHL Group, Inc., beneficially owns approximately 16.4% our total outstanding voting stock. The RHL Group, Inc. has loaned us money pursuant to the Tenth Amended Note and all predecessor notes. See Note 3 - Related Party Note Payable above.

The RHL Group is an investment holding company which provides consulting, operational and technical services to us, which we refer to as the RHL Services. As part of the RHL Services, The RHL Group provides us with unrestricted access to its internal business and relationship contact database of more than 10,000 persons and entities, which includes clients of The RHL Group and other individuals which may hold value to us. The RHL Group also provides infrastructure support to us, including allowing us unlimited access to its facilities, equipment, and data, information management and server systems. In addition to allowing us the use of its office support personnel, The RHL Group has also consented to allow us to utilize the full-time services of Mr. Lorsch as our President, Chairman and Chief Executive Officer, which requires substantial time and energy away from his required duties as The RHL Group's Chairman and Chief Executive Officer. In addition, The RHL Group has made its President, Kira Reed, available as our spokesperson. Ms. Reed, who is Mr. Lorsch's spouse, also manages our social networking activities.

In consideration for the above, The RHL Group, Inc. has a consulting arrangement with MMR. A copy of the consulting agreement is filed as an exhibit in our Form 8-K, as filed with the SEC on May 4, 2009 and is hereby incorporated by reference.

 

 

 

 

 

 

     
Bernard Stolar        
Nature of Common Ownership or Management Control Relationships

We incurred $12,500 during the nine months ended September 30, 2015 and 2014, toward marketing consulting services from Bernard Stolar, a director. We included $198,514 and $174,273 in related party payables as of September 30, 2015 and December 31, 2014, respectively, in connection with these services and board fees.

 

 

 

 

 

 

 

     
Related Party Transaction, Expenses from Transactions with Related Party $ 12,500 $ 12,500    
Related party payables $ 198,514     174,273
Significant Vendor        
Nature of Common Ownership or Management Control Relationships

We contract with a significant vendor for the development and maintenance of the software applications necessary to run our MyMedicalRecords PHR, MyEsafeDepositBox and MyMedicalRecords Pro products. Our outside developer supports our software development needs through a team of software engineers, programmers, quality control personnel and testers, who work with our internal product development team on all aspects of application development, design, integration and support of our products. This vendor is also a stockholder. For the nine months ended September 30, 2015 and 2014, the total expenses relating to this stockholder amounted to $90,000 and $90,000, respectively. In addition, we capitalized $0 of software development costs for the quarter ended September 30, 2015. As of September 30, 2015 and December 31, 2014, the total amounts due to the stockholder and included in related party payables amounted to $100,000 and $10,000, respectively.

 

 

 

 

 

 

 

 

 

     
Related Party Transaction, Expenses from Transactions with Related Party $ 90,000 90,000    
Related party payables $ 100,000     10,000
E-Mail Frequency, LLC        
Nature of Common Ownership or Management Control Relationships

On September 15, 2009, we entered into a five year agreement with E-Mail Frequency, LLC and David Loftus, Managing Partner of E-Mail Frequency, LLC, a significant stockholder of the Company, which was amended during 2011 to increase the term for an additional five years and provide licensor a non- exclusive right to target, market and exploit the Employee Benefits market.

We licensed an existing 80 million person direct marketing database (the "Database") of street addresses, cellular phone numbers, e-mail addresses and other comprehensive data with E-Mail Frequency. The agreement allows us to market, through the use of the Database, our MyMedicalRecords PHR, MyEsafeDepositBox virtual vault, and MMRPro document management system to physicians and their patients. Under the terms of the Agreement, we paid $250,000 to David Loftus as a one-time consulting fee in the form of 2,777,778 shares of our common stock. We recorded the $250,000 one-time licensee fee as a prepaid consulting fee. Amortization expense for each of the quarters ended September 30, 2015 and 2014 was $0 and $37,500. Included in related party payables at September 30, 2015 and December 31, 2014 of $64,615 and $64,615, respectively, in respect to these services.

 

 

 

 

 

 

 

 

 

 

     
Related Party Transaction, Expenses from Transactions with Related Party $ 0 0    
Amortization of licensee fee 0 37,500    
David Loftus        
Related party payables 64,615     $ 64,615
Shares issued for services, related party, shares     2,777,778  
Shares issued for services, related party, amount     $ 250,000  
Interest expense with related party $ 0 $ 0    
XML 53 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Operating activities:    
Net loss $ (1,923,286) $ (1,159,191)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 217,208 227,488
Accounts payable write-off 0 (1,672,820)
Deferred rent 0 54,151
Warrants issued for services 11,170 144,232
Stock-based compensation 16,759 582,485
Common stock issued for services 38,199 293,422
Amortization of loan discount 55,780 176,262
Subtotal - non-cash adjustments 339,116 (194,780)
Effect of changes in:    
Accounts receivable (49,110) 36,626
Inventory 0 (13,643)
Prepaid expenses and other current assets 114,744 923
Accounts payable and accrued expenses 258,667 1,200,171
Related party payables 519,315 279,885
Compensation payable 102,925 77,861
Deferred revenue (11,050) (1,470)
Subtotal - net change in operating assets and liabilities 935,491 1,580,353
Net cash (used in) provided by operating activities (648,679) 226,382
Investing activities:    
Purchase of property and equipment (1,252) 0
Filing of patents 0 (246,868)
Cost of continuing MMRPro and website development 0 (53,627)
Net cash used in investing activities (1,252) (300,495)
Financing activities:    
Net proceeds from convertible notes 0 200,000
Proceeds from shares issued for financing activities 29,774 1,419,561
Book overdraft 56,163 0
Net proceeds from warrant exercises 0 42,000
Proceeds from note payable 30,000 88,134
Payments of note payable (30,000) (50,000)
Proceeds (payments) of line of credit 254,601 (140,794)
Payments of capital lease 0 (3,637)
Net cash provided by financing activities 340,538 1,555,264
Net (decrease) increase in cash (309,393) 1,481,151
Cash, beginning of period 309,393 10,359
Cash, end of period 0 1,491,510
Supplemental disclosures of cash flow information:    
Cash paid for interest 0 140,794
Cash paid for income taxes 0 1,600
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of convertible notes into common stock 100,800 190,000
Shares issued for reduction of payables $ 299,420 $ 196,812
XML 54 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814
COMMITMENTS AND CONTINGENCIES - Note 5
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
COMMITMENTS AND CONTINGENCIES - Note 5

NOTE 5 - COMMITMENTS AND CONTINGENCIES

Leases

Effective September 1, 2013, we renewed our lease for office space in Los Angeles, California with a term through August 31, 2018. The lease currently requires a monthly payment of $8,250. Total rent expense for the nine months ended September 30, 2015 and 2014 were $86,854 and $129,276 respectively. Future minimum lease payments as of September 30, 2015, under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:

Year Ending     Operating     Capital
December 31,     Leases     Leases
             
     2015 (Remainder of)    $ 26,445    $ 13,221 
     2016      187,550      -  
     2017      206,305      -  
     2018 and there after     146,410      -  
      566,710      13,221 
     Less current portion      -       (13,221)
Total minimum lease payments    $ 566,710    $

 

 

 

 

Legal Matters and Contingencies - Note 5

Litigation Matters

From time to time, we are involved in various legal proceedings generally incidental to our business. While the result of any litigation contains an element of uncertainty, our management presently believes that the outcome of any known, pending or threatened legal proceeding or claim, individually or combined, will not have a material adverse effect on our financial statements.

On December 9, 2011, MyMedicalRecords, Inc. entered into a Non-Exclusive Settlement and Patent License Agreement with Surgery Center Management LLC ("SCM"). In consideration for the rights granted under that Agreement and in consideration of a settlement and release agreement, SCM contracted to pay MyMedicalRecords, Inc. an initial payment of $5 million payable on December 23, 2011, and additional payments of $5 million per year for five consecutive years. After unsuccessful attempts to collect the past due amount of $5 million, on January 19, 2012, MyMedicalRecords, Inc. filed a lawsuit in the Superior Court of the State of California for the County of Los Angeles for breach of contract. At this time, MMR believes that SCM owes the Company $30 million plus interest, and on August 4, 2015, the Court granted MMR leave to amend its complaint to seek damages of $30 million (plus interest) from SCM since the end of 2011. On February 13, 2014, SCM filed an answer to MMR's original complaint along with a cross-complaint alleging claims for breach of that contract, among other things. On July 10, 2014, the court granted SCM's motion for summary adjudication on the claim for breach of contract in the complaint and its counterclaim for declaratory relief. On July 30, 2014, SCM filed its second amended cross-complaint, alleging substantially the same claims against the same parties. On December 5, 2014, the Court of Appeal issued an Alternative Writ of Mandate, finding the trial court erred in granting SCM's motion for summary adjudication. Pursuant to the Court of Appeal's Alternative Writ, on January 7, 2015, the trial court vacated its order granting SCM's motion for summary adjudication. On April 24, 2015, the trial court held a new hearing on that motion, and it entered an order denying SCM's motion in its entirety. MyMedicalRecords, Inc. will continue to pursue its claim and defenses, but the Company cannot predict the chances of either a favorable or unfavorable outcome, nor does the Company have sufficient information regarding its ability to collect any judgment MyMedicalRecords, Inc. may obtain.

On April 10, 2013, MMR filed a complaint for patent infringement against Quest Diagnostics Inc. ("Quest") in the United States District Court for the Central District of California, alleging that Quest Diagnostics Inc. is infringing U.S. Patent No. 8,301,466. On October 11, 2013, MMR filed an unopposed motion to add a claim of infringement of U.S. Patent 8,498,883 to its complaint against Quest, which was granted on October 29, 2013. On December 22 and 23, 2014, the Court entered orders finding that the eight claims asserted (of the 42 total claims present) under the two asserted MMR patents were invalid. On January 9, 2015, as previously reported by the Company, the case was closed. Defendants filed a motion with the District Court to recover a portion of their fees incurred in defense of the matter, which has been denied by the Court in favor of MMR.

On February 11, 2013, MMR filed a complaint for patent infringement against WebMD Health Corp. and its wholly owned subsidiary WebMD Health Services Group, Inc. (collectively, "WebMD"), titled MyMedicalRecords, Inc. v. WebMD Health Corp et al., United States District Court, Central District of California. That complaint alleged that WebMD is infringing MMR's Personal Health Records patent U.S. Patent No. 8,301,466. On October 2, 2013, MMR filed a new complaint against WebMD in the United States District Court for the Central District of California, alleging infringement of U.S. Patent Nos. 8,301,466 and 8,498,883. On December 22 and 23, 2014, the Court entered orders finding that the eight claims asserted (of the 42 total claims present) under the two asserted MMR patents were invalid. On January 9, 2015, as previously reported by the Company, the case was closed. Defendants filed a motion with the District Court to recover a portion of their fees incurred in defense of the matter, which has been denied by the Court in favor of MMR.

On May 17, 2013, MMR filed a complaint for patent infringement against Jardogs, LLC (the "Jardogs Complaint") in the United States District Court for the Central District of California, alleging that Jardogs, LLC infringes U.S. Patent No. 8,301,466. On September 23, 2013, MMR filed a separate complaint for patent infringement against Allscripts Healthcare Solutions Inc. ("Allscripts") titled MyMedicalRecords, Inc. v. Allscripts Healthcare Solutions Inc., United States District Court, Central District of California (the "Separate Allscripts Complaint"). The Separate Allscripts Complaint alleged that Allscripts is infringing U.S. Patent Nos. 8,301,466 and 8,498,883. On October 4, 2013, MMR filed a motion to amend the Jardogs Complaint to add Allscripts as a party defendant and to allege that Allscripts is infringing U.S. Patent Nos. 8,301,466 and 8,498,883. The Court granted that motion on November 1, 2013. Thereafter, MMR dismissed the Separate Allscripts Complaint. On December 22 and 23, 2014, the Court entered orders finding that the eight claims asserted (of the 42 total claims present) under the two asserted MMR patents were invalid. On January 9, 2015, as previously reported by the Company, the case was closed. Defendants filed a motion with the District Court to recover a portion of their fees incurred in defense of the matter, which has been denied by the Court in favor of MMR.

Allscripts also filed a Covered Business Method ("CBM") petition on November 3, 2014, before the Patent Trial and Appeal Board ("PTAB') alleging that claims 8-12 of U.S. Patent No. 8,301,466 are invalid. MMR filed a preliminary response on February 20, 2015. On May 5th the PTAB decided to implement the CBM. On January 15, 2015, MMR filed a notice of appeal in the Federal Circuit. Subsequently, MMR filed for voluntary dismissal of the appeal which was granted on July 7, 2015. On July 30, 2015, MMR informed the PTAB of the voluntary dismissal of the appeal, and on August 26, 2015, the PTAB entered a Final Written Decision consistent with the Court's prior rulings.

On April 2, 2015, the Company and Stradling Yocca Carlson & Rauth, P.C. ("SYCR"), received a letter from an arbitrator in regards to disputes over amounts of monies due SYCR regarding prior services rendered. SYCR and the Company agreed to a mediation of the matter. As of the date hereof, the Company cannot predict the chances of either a favorable or unfavorable outcome.

On August 14, 2013, Gemini Master Fund, Ltd. purchased a convertible note from the Company. On or about February 23, 2015, Gemini filed an action against the Company for breach of contract seeking damages allegedly owed pursuant to the convertible note in the amount of $210,000 in the United States District Court for the Southern District of New York. The case has since been settled and dismissed.

 

 

XML 55 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Narrative) (Details)
9 Months Ended
Sep. 30, 2015
USD ($)
Income Taxes Narrative Details  
Unrecognized tax benefits $ 0
Income tax rate 0.00%
XML 56 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 58 220 1 false 17 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://mmrglobal.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://mmrglobal.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://mmrglobal.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://mmrglobal.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Cash Flows Sheet http://mmrglobal.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 00000006 - Disclosure - NATURE OF OPERATIONS AND BASIS OF PRESENTATION - Note 1 Sheet http://mmrglobal.com/role/NatureOfOperationsAndBasisOfPresentation-Note1 NATURE OF OPERATIONS AND BASIS OF PRESENTATION - Note 1 Notes 6 false false R7.htm 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Note 2 Sheet http://mmrglobal.com/role/SummaryOfSignificantAccountingPolicies-Note2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Note 2 Notes 7 false false R8.htm 00000008 - Disclosure - RELATED PARTY PAYABLES, LINE OF CREDIT AND NOTE PAYABLE - Note 3 Sheet http://mmrglobal.com/role/RelatedPartyPayablesLineOfCreditAndNotePayable-Note3 RELATED PARTY PAYABLES, LINE OF CREDIT AND NOTE PAYABLE - Note 3 Notes 8 false false R9.htm 00000009 - Disclosure - INCOME TAXES - Note 4 Sheet http://mmrglobal.com/role/IncomeTaxes-Note4 INCOME TAXES - Note 4 Notes 9 false false R10.htm 00000010 - Disclosure - COMMITMENTS AND CONTINGENCIES - Note 5 Sheet http://mmrglobal.com/role/CommitmentsAndContingencies-Note5 COMMITMENTS AND CONTINGENCIES - Note 5 Notes 10 false false R11.htm 00000011 - Disclosure - STOCKHOLDERS' DEFICIT - Note 6 Sheet http://mmrglobal.com/role/StockholdersDeficit-Note6 STOCKHOLDERS' DEFICIT - Note 6 Notes 11 false false R12.htm 00000012 - Disclosure - EQUITY ISSUANCES - Note 7 Sheet http://mmrglobal.com/role/EquityIssuances-Note7 EQUITY ISSUANCES - Note 7 Notes 12 false false R13.htm 00000013 - Disclosure - NOTES PAYABLE - Note 8 Notes http://mmrglobal.com/role/NotesPayable-Note8 NOTES PAYABLE - Note 8 Notes 13 false false R14.htm 00000014 - Disclosure - CONVERTIBLE PROMISSORY NOTES - Note 9 Notes http://mmrglobal.com/role/ConvertiblePromissoryNotes-Note9 CONVERTIBLE PROMISSORY NOTES - Note 9 Notes 14 false false R15.htm 00000015 - Disclosure - RESTRUCTURING ACTIVITIES - Note 10 Sheet http://mmrglobal.com/role/RestructuringActivities-Note10 RESTRUCTURING ACTIVITIES - Note 10 Notes 15 false false R16.htm 00000016 - Disclosure - RELATED PARTY TRANSACTIONS - Note 11 Sheet http://mmrglobal.com/role/RelatedPartyTransactions-Note11 RELATED PARTY TRANSACTIONS - Note 11 Notes 16 false false R17.htm 00000017 - Disclosure - SUBSEQUENT EVENTS - Note 12 Sheet http://mmrglobal.com/role/SubsequentEvents-Note12 SUBSEQUENT EVENTS - Note 12 Notes 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://mmrglobal.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies 18 false false R19.htm 00000019 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://mmrglobal.com/role/Share-basedCompensationTables SHARE-BASED COMPENSATION (Tables) Tables 19 false false R20.htm 00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://mmrglobal.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://mmrglobal.com/role/CommitmentsAndContingencies-Note5 20 false false R21.htm 00000021 - Disclosure - EQUITY ISSUANCES (Tables) Sheet http://mmrglobal.com/role/EquityIssuancesTables EQUITY ISSUANCES (Tables) Tables http://mmrglobal.com/role/EquityIssuances-Note7 21 false false R22.htm 00000022 - Disclosure - NOTES PAYABLE (Tables) Notes http://mmrglobal.com/role/NotesPayableTables NOTES PAYABLE (Tables) Tables http://mmrglobal.com/role/NotesPayable-Note8 22 false false R23.htm 00000023 - Disclosure - Accounting Policies (Cash and Cash Equivalents) (Narrative) (Details) Sheet http://mmrglobal.com/role/AccountingPoliciesCashAndCashEquivalentsNarrativeDetails Accounting Policies (Cash and Cash Equivalents) (Narrative) (Details) Details 23 false false R24.htm 00000024 - Disclosure - Accounting Policies (Intangible Assets and Impairments) (Narrative) (Details) Sheet http://mmrglobal.com/role/AccountingPoliciesIntangibleAssetsAndImpairmentsNarrativeDetails Accounting Policies (Intangible Assets and Impairments) (Narrative) (Details) Details 24 false false R25.htm 00000025 - Disclosure - Accounting Policies (Share-Based Compensation Schedule Of Assumptions Used In Black-Scholes Model) (Details) Sheet http://mmrglobal.com/role/AccountingPoliciesShare-basedCompensationScheduleOfAssumptionsUsedInBlack-scholesModelDetails Accounting Policies (Share-Based Compensation Schedule Of Assumptions Used In Black-Scholes Model) (Details) Details 25 false false R26.htm 00000026 - Disclosure - Related Party Note Payable (Narrative) (Details) Sheet http://mmrglobal.com/role/RelatedPartyNotePayableNarrativeDetails Related Party Note Payable (Narrative) (Details) Details 26 false false R27.htm 00000027 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://mmrglobal.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details 27 false false R28.htm 00000028 - Disclosure - Commitments and Contingencies (Operating Leases) (Details) Sheet http://mmrglobal.com/role/CommitmentsAndContingenciesOperatingLeasesDetails Commitments and Contingencies (Operating Leases) (Details) Details 28 false false R29.htm 00000029 - Disclosure - Commitments and Contingencies (Capital Leases) (Details) Sheet http://mmrglobal.com/role/CommitmentsAndContingenciesCapitalLeasesDetails Commitments and Contingencies (Capital Leases) (Details) Details 29 false false R30.htm 00000030 - Disclosure - Commitments and Contingencies (Leases Narrative) (Details) Sheet http://mmrglobal.com/role/CommitmentsAndContingenciesLeasesNarrativeDetails Commitments and Contingencies (Leases Narrative) (Details) Details 30 false false R31.htm 00000031 - Disclosure - Equity Issuances (Stock Option Activity Summary Of Option Activity) (Details) Sheet http://mmrglobal.com/role/EquityIssuancesStockOptionActivitySummaryOfOptionActivityDetails Equity Issuances (Stock Option Activity Summary Of Option Activity) (Details) Details 31 false false R32.htm 00000032 - Disclosure - Equity Issuances (Stock Option Activity Summary Of Stock Options Outstanding and Exercisable) (Details) Sheet http://mmrglobal.com/role/EquityIssuancesStockOptionActivitySummaryOfStockOptionsOutstandingAndExercisableDetails Equity Issuances (Stock Option Activity Summary Of Stock Options Outstanding and Exercisable) (Details) Details 32 false false R33.htm 00000033 - Disclosure - Equity Issuances (Stock Option and Warrant Expense Narrative) (Details) Sheet http://mmrglobal.com/role/EquityIssuancesStockOptionAndWarrantExpenseNarrativeDetails Equity Issuances (Stock Option and Warrant Expense Narrative) (Details) Details 33 false false R34.htm 00000034 - Disclosure - Equity Issuances (Summary Of Warrant Activity) (Details) Sheet http://mmrglobal.com/role/EquityIssuancesSummaryOfWarrantActivityDetails Equity Issuances (Summary Of Warrant Activity) (Details) Details 34 false false R35.htm 00000036 - Disclosure - Equity Issuances (Inputs Used In Black-Scholesl) (Details) Sheet http://mmrglobal.com/role/EquityIssuancesInputsUsedInBlack-scholeslDetails Equity Issuances (Inputs Used In Black-Scholesl) (Details) Details 35 false false R36.htm 00000037 - Disclosure - Equity Issuances (Shares Issued for Services or Reduction to Liabilities) (Details) Sheet http://mmrglobal.com/role/EquityIssuancesSharesIssuedForServicesOrReductionToLiabilitiesDetails Equity Issuances (Shares Issued for Services or Reduction to Liabilities) (Details) Details 36 false false R37.htm 00000039 - Disclosure - Equity Issuances (Stock Bonus Agreements) (Narrative) (Details) Sheet http://mmrglobal.com/role/EquityIssuancesStockBonusAgreementsNarrativeDetails Equity Issuances (Stock Bonus Agreements) (Narrative) (Details) Details 37 false false R38.htm 00000040 - Disclosure - Notes Payable (Details) Notes http://mmrglobal.com/role/NotesPayableDetails Notes Payable (Details) Details 38 false false R39.htm 00000041 - Disclosure - Convertible Promissory Notes (Narrative) (Details) Notes http://mmrglobal.com/role/ConvertiblePromissoryNotesNarrativeDetails Convertible Promissory Notes (Narrative) (Details) Details 39 false false R40.htm 00000042 - Disclosure - Restructuring Activities (Narrative) (Details) Sheet http://mmrglobal.com/role/RestructuringActivitiesNarrativeDetails Restructuring Activities (Narrative) (Details) Details 40 false false R41.htm 00000043 - Disclosure - Related Party Transactions (Narrative) (Details) Sheet http://mmrglobal.com/role/RelatedPartyTransactionsNarrativeDetails Related Party Transactions (Narrative) (Details) Details 41 false false R42.htm 00000044 - Disclosure - Subsequent Events (Narrative) (Details) Sheet http://mmrglobal.com/role/SubsequentEventsNarrativeDetails Subsequent Events (Narrative) (Details) Details 42 false false All Reports Book All Reports In ''Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Statements of Cash Flows'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. mmrf-20150930.xml mmrf-20150930_cal.xml mmrf-20150930_def.xml mmrf-20150930_lab.xml mmrf-20150930_pre.xml mmrf-20150930.xsd true true ZIP 57 0001136261-15-000329-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001136261-15-000329-xbrl.zip M4$L#!!0````(`,"#<$<5+F,.-+T``%UD!@`1`!P`;6UR9BTR,#$U,#DS,"YX M;6Q55`D``]A*2E;82DI6=7@+``$$)0X```0Y`0``[%UM=]LVLOY^S[G_`=?; M[2;G2+9D)TWLI-VC^"7QK=]J*>UVO^R!2$C"AB)4@)2L_OK[S("DJ#='Z=U: MLJ-\R)%)$!@,GIEY9@");_]^UX_$4%FG3?S]3GVWMB-4')A0Q]WO=SXVJXWF M\?GYCOC[#__]7P+_WOY/M2K.M(K"(W%B@NIYW#%OQ)7LJR/Q7L7*RL38-^)G M&:5TQ?SCW>T%_O3]'XD7NX=M4:VNT-G/*@Z-_7A[7G362Y+!T=[>:#3:CGOUU_Z1VB/\.:OAOOU9_N7O7@>@G,D$#^AN7 MZW7Z[[M6_<71RY='M?U_KCA:(I/4%:/5[FK9/__XV[NVC?01_2^@_M@=W3G] M_4YI@J.#76.[>_NU6GWO'Y<7S:"G^K*J8Y?(.%`[^5.1CC\M>JY^>'BXQW?S MIG,M:?!\C(,]NMV6;M(S"7A/^SE)<#=,B@?*C5_N^9M33?7"IM_YICIO&JJ9 M=DX%NUTSW,,-M*^_J-;JU8-ZWMRJSE*1O]O#W;RA=N;%?OW5??/S+?('4E?M M2CDH'NA(U^;&V0T2YN6T,+AC3:3KQ">[%3S!W;O7+B3W:9QO]]QNC^(`*R]O"MO+(&)$W67"!U^ MO]-PUQU>_OH^B9EH905+IJ9TEF/K^/S'G1]@JO7] MUR]?U>IO]V8?G@RWMW"\;+0!]&W"!5*PZ20_3"90#)'=F>U_JJ?\8J:/SRH) M:WA8G2S,XU-2-H$_1TEGUO1SH-?JB7FT"H-2;$*AZX?)=/*>)O?F'D.0+3U4 MUG-^YS^JYQE*Q^I2]=O*KDW%$T2J;E^5=%/<"B',W2#2@4Z\ MK"+4:.F)?D9KKI$F/6/U[RK\&(?*-A,3?+H> MT/V;2,;NW?CT3ME`.W4#9J%N9=Q5C3OM=GX@HG"TN@[?[BT4MSS5O<5S?9*^ MXO2TC+`G!0U'LN MU3;54%DJV]_(X)/LJBN3*/'UR.#U M4"YI>EMFBY-'C),_=6?JGM!UJYSNQLP.&G%X8QSF;+O*GO8'D1FS3JTE"D`? MOP;<_%&%;$/8?2%L"[-'"K,UA;(M7AX_7M85TOQ!-L=*N)%CV8Z>2%*_%!Q+ M9[P-2O<%I2U0U@:4-865[8IOPHH_X"F\O.#;@K"]!J81JA#Q$]$T@5L)FRI( MK0IO$$RT<\:.24]/`Q&W*J(9WL#ICEM@!DX&1![^188]Q< M#^B[>3KN\H1*@%HVVZWS6GG3XL/%>VO2P>-&R1_V2-/3W\)F5=B\4S:6-FPF M)I+V*\7.`AUL`;0J:=H":/,`M'E\9Z8"M07-1H!F3<6C[>IOVNJOJ^[3U-T8 MZQ%@,%^4_TK1L$0/6Q:R*@O9`FES@;3Q;&0+GHT"SYI8R18%FXJ"=;&3TTNI MHS.K?DM5'(PO+HZ_4D0LT<.6G:S*3K9`VEP@;1X[N< M+X;0G`:V7FA5+[0%SV:!9_,\STQ>M`7,V@&SIEQHN_*;M/(/D/\`6D7`P.6`D:_1%P6,?#$?G*J>R4!'F.EQ9)R.NT\%0/1U@B!)+:9T;%SB#[\I M.\P.,^4-%\Y^2U7O_46'+6#6#9@-^-F89L_8I*5L_\+(N#4R)ZEJF59/6^^; MGP8JEGXS::79;]W(O67\+8`V#4!K^IK;%@F;C(2-"##7L6*]E.G_UX2+Y?/? M!IF5@\P61)L"HDT(-%LT;"`:-B+8Y$'X:T7&\OEO@\T79S1;$*T;1)L0;+9H MV$`T/,1&W<%C?^O&S1K_]88^G^L,>C\DE;E'X5%&X&0$CC;6'X,?FR1QB^DHZZ.Z'[)72 M1VB3=Y;?FAZ">EO2OW]CRM(A,B5PHS\\!N2[63).J(>`ZKQNZ=DK>L$TO?Q] M'JE?H(-9&1?U6AKT1,4`9/RY83^OE]EQ%W6L*(KV5F/Y?6^)+E[D4!'G M<;#[=F]9C_,C'L/Q61F=P]?>_:C&*P]9#B!+>RL/=V("SN5;X\'J$ZO7JC_Y M_LN/+^KVAAWEJ7>C*_=?I@-+>RL/QU&)6IQ%LKOR,!T9.>5'F.J@W/-Q:BU= MUBZ0T:]*VB^=2S5/J>_K;1X`OZ@H^C$VH[@)@)M8A>?.I0CDJPY[9$X4W0MZ49F,QV41IKI>9`A^R3V`SW!M]6#Y2SR"JJVZKJ3_88<^./*8WT;)6\&PB7C"(RX@X>. M1+TV2$0+7-6)*S42MZ8OXXJ_4!%-3+GS1O2E[>JX:G6WAR=JQ85(=>COG6^[ MR1OJNDT?KJY;IZ(NJN*JT?IX>RJNS\3US>EMHW5^?=44C:L3\:[1/&]^^Y?Z MP1OM?@V];'7SGO;&_`G:N?_^_.$+\(&1PWQS*J.`L!#D1C14U9I M])K&D7*.)3$)+HZT4T+'H0Z(DE>$=.);V1^\^*7QS((M&]MNH8 MM*?Y^O=3B&<8-E0=#?>(NY$9/:\(P[#V(DG1UF8`IMB7@4H3J#H"UEF!HD.V M@68FYAY#-40'`[(?%@3-^O2F0AGIWV4AAND(.,FNHOYUOY_&O)1RH($@",<] M)?020^X'K0-Z&93E'KDITCI'O\KHZ":UYEZ4<&.7J/XN5"B(^'K&(RN9T;0"J6! M>)3T@85TDR^J0YR!-4-^T050-$+7%E MXNH'$W8_Z1B21^/^H`?#VA77L?A?&:<(,F+_587F>%CA$7),XP]KTFY/7(XO M%1E&=*N`L=#-00H&PICN%=<$'D8*`!:R:BC%9PB8M.JBU<%P9X$M`Z;B:F"J,!.B+"$>(8*`B@-D' M)2.H)EN=TKKS73@3>DZA![TQD[#*F/W-[J.*;C,;_0U0=#8KHPSBW7B$Q$H M+X434,^--6QB!0P9@NPHD$RF49);I?#OA&]?ADOY;I(]%M$Y+'P,`C,ACR8C*1?B+07D3> M!&%X8LI[S8$*8*,3FPZP(NS/V/"7>)]%!LE"%$;YP*"^)O=FH<379/_U.FNX M0V_3(_,KF65FS1I-T2*6U(#P?:$[2C0#^"!:>?ZETDH&>G4'A3L--SXFI/3E M'3#QNX\70QFEBC1"UC2SD).%HIMP<.3?*DM7S<>I:0=+W<4F,EU>U0(PXV6. M+/=S)-I"7R,:68#0#`W%,E#K3.:>'$(K)D'44^3[80\3QD'M)JI\Z"7^18EG MO*(6ZY!/".1!<:@O40;M+7.>!^1^C`G'S".SM.&E7XXV+%'0U9Z2X6^P[419 MW_[".-&(NRJB:1PW'EH;!:V]@0<+-)LV%O88WLE$.O3,8EVTM=7CI#B3!/H" MDP)?(2+!A6)R([E]E"`8!":E&YA'J5Y"RT"\;2I6%3`DPZ!UY6APGQV+!AP6 M>52;$[6D5.F><$$927Z4%EU%FDM&&#`=@`L%9>VN;<7?2:=923>(+=#D>M<: M9LE.8V#50+*CR):2E4S>KXP$EB:-)?SB/;C@YVU("^']5P8-ZFTPP7M7Q6`L MQ#1QGWZ?/,RI)94%\1=E_]XN&G`;<)=@\99%>-]HW%0XMC$D='^Q*(0(%D#' M_FMB'/WA"NE%K8)J7V*06I<2P\T/#"TP:_M4+B`@ZS6(KT"G]>P(YM#/D,G%" MED>&_TY=XL4EQ(%UTN"Q@C$[XF3/^*IC$*'3F,2.("56A4E@J0-/,$E>23F. M)7`7EH9\HR#*GMQ-2%),0;L/^^HYP2LHBM_-%P^$H@)>3>""X+L")+ MND%`69MW;F2N9Q:$%=9ZX*NER-ADF[[<"M_$`H'Q*D5*+C?*&"*L^9O#W<-7 M`GE1Q.9PEEI:UKZQJB+"U&=4*QH#&S/`D#+'C`S&<'E!Y)MZY7#_H++_^COV MB1T_#!E#)+DRH^-I39_`*E).[KR/1(XWSD+E60%-K!/0FK>YS2P.34IE2SD8 M`&AY603#G$-LL<\Q%Q10G!<<^B=/"1&"YJ'[TW\2D51&K<)TY$\I<:RB^J;%VOCFH'50.#@\JY)G(!7$25&%'(%W/U[/H`[EZI$+L MQ,4'34FXKP'Y]:7:(;4<4^K#N(FI&`_G;V9O8(U@MX2\6$7>8!U0>\YA?^L0NASP:PF0KPSZ7%2 M-E(3^67H04BEM90=N/=S93T\D]X3Y77@C%I.#_Z< M!]K?K7V7#Y2+DT4XXG(^JVD;:\UHBI#-3B3U$C`EQ:**CH('R,QU7'34A<\! M()2G5C/PGU2/RKH+4U^N6`XKC-@O:L=S&&,9IG&6+QUHK2%GV\]=/!OL6#2Z M5OERKV<5]Z!Q_ID)(KEB4:JB3;+%MADJ=B\("):JCRD%8`(G>L+=-&%#])&- M*S>T&Z7C5/G"'->]Z1J%[5WA<]8^TCR5Y:#3"N-)#_S+2`L/ZDD;'Y$JD.=Z MA/PR8Z3Q%D9AIH(4VN"*S,@=P>_N'A[.(9@,,O#D<@SHK-8; M[[]KNZ_W"PO(&Y`1+T:(F?$]?GQ?%)D(,#402Y&IQ3TT!9N*_F`%)%M7VJ+F M-K7$/I:[*2#`JT?Z]YRP3)MC*4-::"0R!VMEL6^I>+++Q280"FON-/(DQ$\6 M!#[CX-7$.0VECDB%2YT#C<';2>`X8-!99L18(,.SNTQQ\HC+NJ!M&:X"3UQU M*=1FOFU9N*W@[H"NB;+3#ENU4T:!%T/"V-'D- MO"_86]K+FAZ;2CZ!U>ULUTLB%$,<.G[!QS9QN8UG*G[.7'&UAC9@LCJ^LD,J MZE>R33BNJV=;%47T57E]G*!-E`+>`HB+(L0FR(9Z>6E]K38QQWY-!8?A!32%U>&J'Y8+(ES@1!SSNSE,57R*S4SLTE`QL]CGT#0A*'$.3 MDK,D8N&1\67D8EEIC?+=<1 M>2R5Q[B_/NDBYU7%XF-R0&\&;+0J<:K%Z_%0E9:'+.PP^:Q_5WOP@9_,/.=G M]'9O^3&QV8-DI1<<-(K"_XVAKPTHUT(8?1?!LV[>X;)]417-CY>7C=M?Z719 M\_S]U?G9^7'CJB4:Q\?7'Z]:YU?O_4F;ZXOSX_/3YMKJ@H7@S^1S<=FX:KP_ MO3R]:OVM*3XV^6C<:;-U?MEHK5'$5B_WBS*GNTNVB[PKG-DRXBV'K'#A2ML' M?@O_$])&T,H^[P\QG2S<;>8??1C*,CPJ[5$FW"\V*$N'-6:KISE3YU)0)ZO7 MWU,97]1]K!(^-,0!A?@YN$Y,I[NR^JJ28#6V.(;JOX1")Z&RU#0_UT6<6$/O MI?DK.K/`\Z9=U4(+Y7,RGMR4\L5<%(MD'[:9<'8J*6GUFZ7$H#@^=M*H6(V4 MR7Q^2J)8Q#`_PT@[\`@UB;QCDBCOLMC6!?MBWAAA$M7(U\MB+HL@2>`RH==^ M9;9C$#7F2/XH2BE7X0R`Z%B5<@0^A$?ZS/9S?'0NX0$1V;=#Q[VBFCE%.&.^ M.926RE998M.1`9I.;=\46F^K2$.)G'XRK:7#US,97Z!MD/:)_HA)I.+^61VY0GL+:=D&?MY^*XT?S`IVGYP^E/'\]_;ES`M:S/D?RB MB@W!N6IUMAPFIK,]I,6LXH^5*I,E/@&",=`JTG@ZK/".FH[&4]5KHH%Y79R= M4)]BG8<@`'I8@U,84Z(EZ,ANGM(/D,_QR4OR&+OB%Y5AA_">;8]QK_CB.`%VR&2Q MM`_#F4C0FPSF#\PRF`MBFN]HHA_CO,>@;LHE>%^EHJGGXEOM/I$-Y?/+1`JG MMQ;\?E1IP:C>.KT[<4]Y;?$F1WDS8_U[-!/K"9Z+UFWCY)3-Y[KUX?36UUU/ MCT]A1.\N'C@8MTV2F/]K[TV;&S>2M='O-^+^!X3?]G%W!"03W&F?F0BV6FUK MCK:1U/;K^^4$2!8E3(,`!XO4G%]_<].IIZ* M*$DWK!M%E#FBL^NB;"J;[D:\@8/L!IIW`:$7!'.`-8D4A?8BK2][\K:EC&P\ MQC0MB:/Z"+_(ILYF3_$7/WA_0Z<5:U"#!K+\%:*W3B2A^6+5V+\@F> MX&70XTR#C-EL$$BW&+K?PX'7I6@^WEIBS M0;O&=%E&E'RI>X.AB\$@+)^LJ)*R3!7:E1=0J<@@S!H'\>JE8BJ]Y`XS>"[ZL&^2):3Z*,A+.7)#+L3"L MZ-.H0K),DTO9!+2K_L^IPJ1*,>D*1_#L!=;%&N7\2-^+^A-P>@K MI4UX>,I[>R;JXH/UN7UQ9X$=^87>II\OKMO79Q?M2\X7N[Y_N/MRM743\[4% MM._/K&:Y=.*4;)S9P]]9GS&;[`^\7[BR@DN6L_<@IK"`]06_B^E;/_/7]#N6 M0!`\?D;T^+-\.5&:FKXOL_>FIR&Z8$6CO8E&%')V!0@C@5K M[1`CH-L)QHRL@'QWI"K3[I,I7+,L-^/+'&R<,:?<4L4%E0+!8LFO\NR;%O]& M;B3&#'0,C$)9^Z"__A0ZRI.)NTYFQ$53Z$6+]_1C:4E0`SI]KI&M2M?@U).4 M,=7&TP=<\>"H8J"@'[D#\1)&7S49/#H18FP%D#`EM7IJ#K:MO%,N1@1[F?:2 M&1C&L`-#U_&=K/)+@YX+[P/87]]C$Q5.1"KS$EXH0LK^E1P%8/5B<()5I_#H M`W"M#?B1*17F[/G']J07BECJ._XBOE\#D(E9`^R!A&6^<>LQ]=CUZ?HQ']RQ MG<]6\>3!QH(%,Y)*4U\M8'`PQ,Y$D9.*"'8PB$ZGS`N&J136@1=,?#(-LL]* M:XL^3Q;Y-)G;!W:B_M+"")8AY1K$4@M&0DB[D&.HM!R.H[$]EDJ_AQ028VV_ MS%H;A7& M6^A7/36^_%:Y^>.OEIP>&'/:J,&$\C_`N&EQHZ0W9UARC<';5[E%DG"H*:R4 M"\P%H^'233:GTV^!TYA+IQZCX=F]ZB]>VK>6U;.O:MW+!C<.M M5WNN'B/\^RM&*!I"AW`NT[WM'L,5-?,QSMTNV6?T<9%;X8?%A2$G[FA"3S5]MT"&PS+:.X M=Z+_P;JXNFU?W*$'`KT3ES?7OYU<7OQQ_HD(:]_?GS\POLS%]4/[^K>+O7/D M_ZEK;TF19&%7F6/$L=9<6GN6_JBR1S.$$X53*25\+&C+@3%XJJ`/%ZPF=+OB M9+'U/DX[_Z*8>XA/>SA^#+<@(3BFE(6B$5^IE4XJI5/CY\RD5?$I]&\!T\QX M,M-">I/\V40]VJ?XJ);.IWX32W>%#%T@`>3- M5A:C_(Y**>N,&%%&EU.I<7A3)L92!S^K%62/)%:7Q+2Y,M"A4U-5`:U4-UI' MJ)3%GL!G.\$0/,E0)<\$JY3)J@G['"7AZ)1`AO9?6[>,3N8S$*93G%%KRP(: M=D?!6"P5V>[!5D6/(N-#(L$J.&VZ+],ZE:MG7$OJ$`02^%,\3KZ.3H(NSN9D MF:!YXT5+WVC&=1LRC,/"ZY.R(58E`C#"5<#P) M9X,D#S%IL@*;9ZIFZTEP-.D*T9F467HM)]-*'38M@]S,3R^JSR(81AX]1%R!+09*B..3-?'ADCV9[#B#)+1Y)`3EP1 M,7B*#"]PB%\GK8PX29T9F0_PY4N9\Y'+K8/"8&)Y5C6@A406@C-+`I7;3,X, M/+*PO,S/%HG$]7PUS#`K6TMC]U'(="*JTS*J91@8";-#9#T7IC?3M85:G3,A M0+_T5#&"Q"')!:XSZTZG(DDOEQM(.3V!>7'S94PM2$F_H/\%ME+*(\Q-N6)= M3##I(&1*CAZIUSL">!?HJKL^?X>X04Y4=AAU8"E@-@LAR"A)F3"B.HQZH6[5W/@R_6W[2DA!79'$4P4! M.Z#SS)E_^O&3_=#WPHG*09EZ+:&#U`2P\8(STA4DC^MS#H'\^.WO=SKC_]2Z M9!*5)VLTE.!L0S!57+T`E"3,-0I(H+"4VZS=E%I/IA1&XD8H"PT"14$:Z MMI.N%K[6IN1Z@L[R$"7%)=8/P$3L-(.F[R:2WP;3\GC--.!B.9X`:JW:(#%H-J M2#FJ,E80I9B.0I:9XVKKE'$:R3HB.8@Z\.2"3P=987"LLP@S;6UN9WX-F23I M\G1#0Y-!D^=/)E&*R[PYJB`QP__+1Y6E?E?'51Y2>CP83Q!55CEVVXS1/['F MGF:U+#3/EJ.?CW,NG3&B0!5D,>7LQ/F47HN$F5`XI`8T$SF?URBU9VY\QFW1 MO^7,A4#F074IG81#79E.UIR@O&A,I;,&:%,-"2@/1:C.?Z5;E7+MB&.M*^)+IG+T>.H2M2,\=>6NI[%RRRAI3UI,&;)ZKPY75!$TN%/T,("HZE MJH-YU9I:)<-V)D#T0%&6``L.B9',;V`9TC<,!Y,)R8K28J9.KDY3)G4J=2]? M*O\4OHALX.PDR9.,=3\IEJ4`-9%"$N'$KA03EF.%`<'!ZW[J]SUUH1D"3Z8H M#7_"P\N_,7(^)GRQ43[^VJ6L(QGIB@16C>_"#?`GYQ5W51ZWNBJH7DCTC-KZ M@P`!/R(MHJ$+:I@Z56E-]!,]`TA1DJ4QHER(@@R^J23KP*0V4/TL[1,7EM!+N=>DLKY<$CN3HT,E:+.%XB2 M(V0=;JDTN+/+=XJE<7]^AJB4_;YE9.]\3.'%"S\9>-?W[8\&JOUU>`H+JAK& MR4,(+U?+J?PRS4S)V61(U!=98N;%.E-HS)NNUD+OP)GN0VN:Z["GE/V3*Y5U MQ#Y)]<`:2[B/"*\$78M37)E4O6[X,DVT#N5A].(IGDB9Y:UJY("9::S7IR3( MW#'S7K(G+R45#C`4,$'`ZM6.W9JV'G3FO>F#AS#UL9`F[HCT0N0W2XY^/ET>`+#!A)) M:_R3H*%`V2"C])-1.UT3H/D1Q33;-3CB6/6F,-#=K%J&PH72_\\Q+,--%%E^ M.AB>Q.D@F\9\I>C$WYRFU.:`44YJXI5,TL[/P%Y(R9KZ1=-\]5%C7>FAKKCD M(M,?.RLD??I@W?_>OCL_^=B^/_]DG=U9&]G:`G0.^%("!--;\RQDEN*3!4W2\$GDTO4H#F.\/1&4;E2.MVO M5FB$43#)&ZX`'%SBY7R2ZE^7!N4FT]]-#,<3E=KKJ/^_TMXCOSNSBG9I5"@Z MS'!UC)NXS M%_3D,^D?DE"^T23$(@9L-+%FF0,ETX\SV%@%/05!"OK"D[EB3"F6,L-0C.'$ M?G7Y*04T99TDRI5Z*BJR[P"]A"`FN/!T-W%Y`^8R?6 ME#MYKX\?$/(HZT,RPU54`\5:,T\Q']B3C\256WV7A-0@PSI7XXV=:.JHL3A1 MVM2F5SVZ#R6^:NY\OTR\*!@B09I6YK/7R&N7)>@/^=^RC.`9\WAZ>+OZ'H<: MWSL?^&F$?]:5."YA8'EK!'($<9["N=)H3`S*07`3^C7:!*0#I(Y48D, M>66EY!-L5):<45/%2?;RH)C!,Q4N5%O"@*22``JGJF"%M`&8#".@(Y]3:-8H M,)!VG*O,'1^)`]4\&DJZM%SXVVQ-D`:,A'03Y?6NO%2==3@I6(+M4@.PM M[^0]*5%V8&5:>GL[Z91+IS7G1V",4RZ?-LH_'M)^.N7*:;7!Q%=/R\YLXK>\ MJW<(2]2/*!]*PK!3;&UKVUHZ+56)+Z>5YD%M:>FT4D/"2Z?5^MYLY_G$VWM[ M.WF-P>4#VL"Y]&YYWSYKNW;;Q^^PSMQ"!VVS!5P[A+)5H=CD*?^02N.L9T+N M148$T3-,QG7R;Q;LFOH+^38P]I!F2-\J#)-2&EQ?_Y[&N-5'.== M@?CE7R=]D>:8>I!P8C7HQW#]KFKY)MTR6=:K3#+-ODIY%GE7H>'6U(\X#.%1 MD,Y(.)F.A,G>3P,Y\%?RR*@DA4YL1`VI%(?"B<.TXWM=5M)C>Y(; M\50+:PK/>00C$SCGVY6?EX]PQ*OA7:'6#(G[55!WF,D>#>0<\WHGP]#+LALI M`,K>=AGBYE:'7O8`5^E.F7,Z!NY4L%=I)J;1=#L#&4U96YQ;1"K%)CU)F%?6Y<0`;.T@ MV\2ALN-C3QXN]27U\?Q'T.5,TJ@]6Z!]\"/2F9M$7B=-%'Z0V;Y!=7:0/NL7 M@(`>R&INU+>D)LJ4*],'LH;]$:8O@6-C4IV@=IZV!G;DZ](!4-&( M^QBX"99IVP&WZ'B6$)O?F%2FB*C(X%[5UW1N`/-1AR_4/AIL MXJD1WI,!O#&E"3MNZTEWX%O^9O0IS?B7(\M<_RN+5C*46[RYH0NV(U7.VX[H MNFFL^S&/>+/R5,HV47AK9]-+);H[V.E_?<"JU/,W=S#3^?G6\?&C"/ MARE;GREDN*P5I9$"=B^!AU@C?0P1@TB>IVF?LKX,*?#POGW_Y0.-?5)JV58N ME>9,IV92+/!,I??:U)M9*'(8:@@&/XAPG&?KMM&(E?0V!,4K&$[4" MH,PV#PO6$74^SOHDRLPQ!/O*OFG\7859:#VJ'DO:N816JHNI8(U`=M-FA@<4 MTL0,M5ZHRQ0'7I)PLIH!-L6_9QM>OC5DJ2?G9R11J**,;(@A8.@@E3$BJ>>( MT\P`A9S:3OBI0*^!%P/O.Q:R$M.=]K4_N;**5MT1X#(RMHLC MAC2/0O9^M0T\QPLYO\0`D-NV-H%SVDX?00C-H]K^>*^/(:P2\S!II4Z-7RL9 M7"=NVA?=+,?3`'APN,[I=6JXC8O9K8CCO MR#<,`'L)52\SAEV^Z05FSL7&:?\I+MB^B./82:@SXM5NJ5[?QK;)S'N=3YG# MRV"QQX.F15_EV&1=2ZGK-M8X**33W%&3=<;RI2M;7[M]/'T*B)-(P/9[P*+Z M*=JC(#,*_5B#;6O'N%T M3ER=**/G"DQ5\U/\^ADZMF;:\<1OD=5ZNJQU4['&3!/MG#!G)_7%3?\>P6`? MX/!]$IUDCQLY5:P3,"@OVP_GGZS;]MW#7_"_?U$#!MNZO+@^)][??+;.[LX_ M73P0MA-]3WYJ9[;F39!KL\L9P:"[43ME75W)PZRK8O%FF-=4^I:LMAA1R*D% M;KYU+RXFQ:G5=_$SM.HT.S;<63I3\=ROPZ24%2A1061QAV$<,LL2)2<7&1SJ MXG@SN@7 M"WU%Y'#5S@[9A&;$N4K`E_8P\GRKW%)7Y`75N`>R38+.',P+!1.8=7//RY1R M)*J41=W3QK$;]:I=KY:U9V2R1R;Z3=^53DNEBO&.#X,Q"3EG_X<;4QT3MG)X M4DV@QQG)R7$*TM=(1*4^FOPP,9VCN5W=MN'YN_9Q8O->KHD9EQ:R%+2'AQ\! MY.M6?G["ZTT'QF--PLQ,ZRP\)D_\7'SGE$IVJ51"`7GGX$_Z7Y7\/9-B$`'_!;[I1.YEFG>1DE\0+U^HJQF%0F=8.< M,19\J6&CN()A*5ZD6G7EFA&^WYW0IG,;H6]9+!^F:@#R]F40^K(7``MD'^3F MM.ED3:VG=<6>U6A]RE0+-5A7)*RYR7IVDEYOL*X=!<6ZJ\^8.3>+M:O.Z@^4 M@*R/H$K=U6X=JF%FSR*_/N=Y%R?3\BCR]JY2M^NP$]S+JVZW:N6QWES6##+D M"RG?.3GGIUG,\\EZBX\EZ,&R7:U4F*Q6TVXU:Q-D44!-5CM+VE3;(0XI+-0Q M@AVMR()&K:%:F]GPV-BW5F5L*/PK#?*6`M\#TZT%6IHN;B%D>=G73EEQV8,6 MD6`"5[6`U[TH]??9DR&A-OGQG`#UKM3_[\KREL(S*QOF4>D@-LW3L&JJ);AL M*2!;B*#_#V]<-QKEB`QUDUK+['>/Z&-`$]/CX4%]7RE]D'42(VG=`<,5SE8P MFE`':F?)(AU%H)SX@O!],\M>_8F:9%JRH)3]'=-TZ[V^AA"_T^-*_X'@NF\J MSI$(^&X>R'OJBW@[#-X#A\QK=!=F;'_L-TXN!RGM4"(?#6!(H MB2"A=1V=!A>4/NA\@$@-ISW*V(DE1P4#R++Y!!_.',OJ(D0O>B3PK00Z&1B8 M!@3T1I#*03_B^P8Q`;H29'.\NM9H\JAJ8&44(NN3;#1MIIP=6@3=!<:WD3YX M-M%E&:GFT!+<@-BO'/#P6UUW)WL[,G8AHH;(X#^#>L@H_[_@?1/WO*ZJL,4W MO&JQI](BE`U'$#D8#:"?3I+PA)Y,]!G&2GO!Q(\@UZ:,S2]:@8)^I+N+-G_F M%EK9]CWDG/Z,[1(HW$'";L`4"<:9X'YB]`8E2H&U,OXP1.+T M&AD^=(YM9:)HG&$"%S$Z,0X1LAUSZ)!]?<^G-9O@(**G,V$B:64&H4Y%4&E] M]!$OT1".R&,5I-/NBTB@<]`>&RH-C,I-0YSBF>W@MLWYJZL[Y.\I'4XDK.MB M\1SFQ,4RX5%$6=,U8;=8)^7G5_*)T(5\1(8'V`;]!\N MB!^8S.4&^3M:UGM$JZ37N_/!)D>)/G3L;T[BV8=/:M__B"@\19B@W_P07E7L M;N',)HRHD1$LXVBLTW1*%"RD0Z(A\QDHNJB!P@/![P3-%MGG&A?+IB]YB1(5 MJO.]KX(RVVAT++26GU=!2PE\CT(5&PF'L!P)_X.,)8VB1"R00=38=!<8&Z`] M2WQ9<,TP)='V%DKJ.1KA.UGG'JSX+>[QNJ>;9_'/L^#'K?TSC7$0MX,>IW2` MML%@Z$'8_S6PI\'ZO[IXH!0YBF.>W5#VW/GUV<4.'P2:3FU)7&+DPT#0V!EI MY_K:RM0N^_$JTG?"WGX%^H[^*7:_"A MP'.552QA:=CI)%.3I,>PR68J#YVEKF09?:J1`5$@`:+P'GG7M,NUDO*K5&?0W4R0&$N^3/L&O-(KZ>63/8S(4!B,#?FE\&(\3 MS)*K0\(J&.M7MGA%/19<6^<<2QX[I3M]&%O805P.!5CR;D.K*3!U MN6Y7J[4C7]<]-3R!RV6G`%\/\%36#U%<=B.!3K-AUVJE(\.*,NS$>IMGIG$4 M@<)74JEN5TH'>2>]E3.3A,-='YBFV>D/(ZQO4@I6?+$N>!E5P=ASWOIEM%66 M[L%UM:?;L-\JLU:OVXTW?Q3V_CVSZWOF$B-?JH)'`L^_<9G8/_5XY&9!;K[G M0_AAK\\>Q].G1[8/41@VX&::*C3ETS)*32],.[Y8J]@<\%UW^,P_6>[*'(>G M/S+ MWLWFORPLRS:+,PI#YJSE8&;EE`TW@4ZVS>W9B\F:C#&E1,DT:);I8I.KF&^5 MRG:M5+7+%>?[J3O8V3KWJN!A"W?Z0:YM[_?0*'$N:IU,J7[0W3_!*E)=+C]R MF=RM[P;Q'ELV#;!LSO_YY>+A+^OB_OY+^_ILQ^4.=.UQ2REN3&FU)<3]V*VX M13@YN`S*I9(C^YMBL2$6UH%E@[L[AEV$'R2"\&]&[WKQ;4@5T+"@?Z0!&D5X M!3ETHX#!HIOMH@$C+YL,J8IFI\D(8(EK\;A'Z&4*Z>5NL:B>E4()!EL9E?JI]7: M^'>G6$>\+80V@%#6$O=:EH'B)(17Q=/():EI)/83`S\1*B\8EB%V?>Y:8U.K M@EF%_X;@>KKD6L'OY/#L]#R\-=@L/#^B'BJS9E5]NJ2S,H7U/\49\]=W5I:# M(FI;<3H88.VQ;@JN^XP0-0O5,WFQPA-#G#'AAR]9>V#5$;@SLE3%==9<.S%: MP.+/5R)ZA('Q^4=4R&+>)`I=60NEL"PE)D3?9QQM`IW`HGY<"$$.$4:FFA`^ MBS^S*!9HH[I_I4ART&KKQ^*NQ@6.F3B-SKZ06]KX[7AERV2^%/V MBSEI<[^8,0NSN`._*!^6+$LY#!%9*-+W7:24;*(*Z1#'7.I,+GT8#V:I=ZH$ M^G"6NHM#R,.1 MZ27'W!%[;[&W^%XQ=T>,>(](3_&'O6+%VSG%?[A^NGMSKS#=-V:F3S*9=;9. MV=AY+G6E8=>JCMTHEX_)XNN>NG3Z9E/PJZ?EUAM=V@X%9@]*2PO3^AL'AM_4 MUA]F[=H;D.E#Y.F;7=B^"\N>*$#E5CJJP(-8V+Y+]2'R],TN;-^%92$5N*&J M[S."(_?W0?\=`0Z^!Z$_1)Z^V87MN[#L@X8<UZAM=VIM2H)M[9?\A8E5DQ4WON'3D&7Y]..)P M'/(XY,$,N0^64V$TOPV;51M[G!XMK4.\.(^6UB$N[4U96AM2N#*8016T1YUZ MU*E'G7K4J7LJ,&N"U_3?"IX2]L)U55&-Y:E,=NL9LRZQVRNAG='BD1*W$SXC M/(?5H:[L"%WBPP63M6S'5NR$R='#3\'5TTU]0FS@+O0A#]CS^GT1"43XZ(CD M!8$>\-="!L41(Z*K<2$4S`V,233@[_Z=$GI*[G,Y[#57`WI$@G"Z@T<&O]D^ M?PV(0;44":(B84,4U`;1LE1W^@W2ST!WQ%,)%2*['B,B3!=O4K4.O3G+M$%V MZG:CUI)MD&N.7:]4[;$^R-L_&-S.F+:(1)QA4T"A8!]DD/\!`7BI@Y$F.3[% M>=`_&/\10HP)^%'B^%<7*F0G$LS>.QLT/WV2(,^GXP::Y3=)`=YCIWS;L#1##<)_8=#]E;6^?Q0&SK M0.S_O7S$3-HM([#S!'?/VB=FO"$&(YJ?=7#(5(?%X^-IWNO3?#QY;Y;'14_> M_ALBA[+1QS&/8Q['/(ZYNS%WI,L+7$MKS6=>\$HLG99JU@F,5&JMDXJ=YX@[ M9;O%#:$/,0E^1[Z:^FF]ON^&YL&4"L"1:ARB[+W-PW4\"7M_$HX7]'3F.26Z MH)W:GA^QQ7A:KMC8=;E:=PY&A^Q>+55.JVM%@/_.U9)SD++W-@_7\23L_4E8 MZ()>#"M@;QBWJ$>9N%8O_[HG%_16P4BQS+)DEP](R>Q>;U5/JVL5D^]=;^U5 M(Y#CZ3L>E<,^*E.O^#D43KGU-]+'_KN8Y_"`A;Z+;3G.#P7NJ?,]2Q3 M]/JF!YQRQZX''\K<2,2BV4O$J"U/]Z<;8:^X>,O3MB78STC!2+F(0^0E].\P MC:P711<2T@\CJS#RD1=;PTC$:,SVK([PPY=?9BUN"NY/:3>X/Z]X@^2(M:FX M!ZOK)T5PYJC+)VDA:\';ZNVRK470!RAHENU1NVM4W"ZWZQE(I-B2@F^W16X``>#O5 MJW:]>L1-WH08EBH'(H>;;I5:@(0BJ,%'"=P&$//!-*K<:BCIO0-ZLD8)G7N` MK_\V!!149/-`9'23K0*W[#2M-6RG6K%+M>.EOPF)KN]IEM`>YX>\C2'W04UM MLDW,MM54S6XX+;M:=8[*:8W*:0&5]'8[F-EL`<,-1,E2S18,I'/,8G]]VGT(![OD:H$E+W0=SQ:/ MXC>O;'[K(S:)%U@C1"=984,69%;9.K%JUE\K3KJ<%*Q2NE6`["WOY#UUF.&^ M1\^A#WK/]Y+1]G;2*9=.:\Z/P!BG7#YME'\\I/UTRI73:H.)KYZ6G=G$;WE7 M[[SXJ]6/!'7@@NLK3JS(3<3VMA6LKRKQY;32/*@M+9U6:C]2>66UOC?;J=5M MSWOV>F"5;5'57H?!*G*S]0V<2^^6]^US&/6%EZ1@/V[Y^!W6F5OHH&WWH>9I M,K*?MIL;1_-RNH=UP7W^\#D#HSS#I0VOF,BZ$[VTJ]\R26A=>FX'+W)/IHCL M@O9/^6:$<]Z41`G:]C:\M50O0S`,;(BWK6T(V0%_1"C00WD#1_UX4)'D76#G(8A5TA>C&. M1,EZ0_@-&$G8T]+M=L,T2&+]J,RZ^D7"C<-@H1?BCMKN+>IF-8_M;M-M=8NZ MZJY;U%VC5%^Q5)_/\)2L^^E6+&VRBKV!=H6DF$;#<`64<[6$1=(/ETAOK.R. M0RNF[FV'0:]FEZ[(_QU*Z!]X7VSY8.Y;^.8XY/J&W*"<%!9N;0&B'31T1VAH ML&D3A`DHF[<9^W:V30&PU M=ZN)Q^%0C\2^,K72M)W6TO7R6SX+%/'=*YV_Y6P*PW>P3US8X;VPY0V0CICE MSLO;S<1X$CFWEO1T2>\6I1F`M69U8=+([2:IZ_LCH@D#.)&'$8!3Z_?P18`> ML3$C(7D2L5#??W*?^?L=(0(K$H]>C*&?GI4&L/7DJ;H7W30BKZ#5[B9H*CJM M2H6&<@?LF'N/G^-]JU1_A4_IGS_8RCTVLEST:&NBK'X4#JS8]07,E7B^97QF M"A4PJ(U>RW_#`KW^B/QH,!A_77TH2GV^S`>I_TC^.OJ;]M#!(*=6V_>M..T^ MY5@(^K6;LHO/36@LX":ELG;],,;_L`)W`Q,S=YVJDKFXB6? MYL2W;EO/^.>)O`U\H'"?S/GK.&/#5/>DIQ?%L4)'O>X$-S; M6)EF$8I8A$+,:Z6/P.\'[@B$UG)?7$I(2H_S36`)%T3UD7*,4.J(H>2\[A') M<<84(J;C8NJ2%%-BN91K#1L+FP\4"] MIL@+-!'H>1\,W6!$ASD,R,RC@QXG\!\Z+R24/`I\8/HF;^M8;U.+Y&_:[V%B M/=U__YS&)X^N._SE#,0#I(;VOAWTS@=#/QP)\5$$HN\EM[X;Q`]@TWST0?+_ M_O_^/V@F_;?Z[F48/#Z(:/!)=!+](;J+X1]WHO^W'U`CHIR?E!SX_Y.0?VZ= M5$H__'W#"^5XP\W#N=6T3BS\X=ZZ;?_5_GAY/N;(W-X&7*-C2?F:Z#CB5=]3 M^!8Z*G;,E]S+$=:2GEC`B[[MM6R9'6:9?0%N+.0>^%[$!5=7=[_Y80>>/FY,V3_TKD1G"KT2P0;YZCZ"(4%4X5#P(.FGOH]/L';Z MF,:)Q%(IM6S./0I"?GGT=)KM3J_!S;H05\!_J=N-9A%TB".3MM\59]^TYG&$ M#60=[('.54XZ]>$)^>Y$UL^YY;R>\Q##XKA2#[U)MV&H2L M-E;U/9)WR+864^M$RKZI]JWHO7+-KE:K^Z>R]VOQ1U5\'&'_5/&S"'IA%'.B M.T4"0)^))/%)!U(6/=#DHKO=Q'F1:>U$E!S1UD/#AYVF)3!DQV$`?P2_@R_[ M/KO=,0`D`O3BH5[]1PI_+S=8JY)R%CP+_LT-4L3!Y3\[SM[;TMO1.>6*[3A% MX%2^[]4?5>YQA$7%8$::55'AO'\*(S!;132P_-`-E)IUN;;H!#T)(]9A]1\/ M67DMYEU<,"&H:I?JRW<_?NOLJ=0*YJH=U=]QA*,8K-O\J-1;*Z%3'_KJ2W:E MNBWTWJ)478HX_L7JIE&$CY8AYC:%P0'NRR:OC?=238[C".L3@Y7?WA+%@U_?.3^E MBNU,2/+"`2;MJ;1E6C.^\9VR\UQA)TIVGQ!C0E3!]IU3QT&6\K' MV5,[Y]`TT\]5@*IUN&>G=B-?G=4;&G:C#DNYR=MWY+Y)9FWS(,S5 MVFOP]>[!(=G`):NDQDCJ:B",:P#;6F17E3RVL'Z^^ MQS^V@]Z9._02U[\4;BSB3UZ,B"TIO/3U]_:O(+]EG5AG-]=_G-\]7'R\/+=N M[VZN+N[O;^[^XCK]5Z1OG$1!'=9Z=6F\HW)D$^;,Q[ M(_P0!-QN-AMVJ=Q`GT_7&)+3DB,Q<+T`$0&R-..Y`_L^4<```K&P^&HE7*.! MBRCZ/=MZ4O!'6$-RQG`@&A#E]]#O8>$)?<5%I)<>+OZK$$/Z>\?UJ=2/`&IP M=.M6WMMJ!*2"V=8F/HXUCHTS=?GK MAZ/YQ:K"1UD6SA%YAA:,YP=V)1Y#+G\4@8A@4]'-Q[BAA*,8>_/@S%-?T2;% M#VXUD#XO^&'RL[Z7_ZRD+@\$K@'L"(+="[K>$*LU!YB8;L'&*Q0I`M)AO@O@ M+O`"G9)$M=S/,!#4DPAQIL@(0X@J(B:AUF#/(DXH&Y[@GQ1F)##%36P&($I$ M8+UW2A_@$Z/X)R0'AGJ)O`3_`',C$(\L96)9H>,U<,'JH\SZ"`U=8?5`B44" M[3[;`KTE@@QDGF3:2T9,`R(EN8&%R!?X:03H\;YQKCWMRJF%7.$CT84/=N`K M:03C1')2D4I=;2J2\@#*K.G:]T;)+=6=!U;:-*Q!/#%]66E@EKA0(3A)Y MG32A&T(?248*ZGKPC;.,$Y\%W3X*V8;/H-E*0G8.S%I"+`B7Y7+5S3OL`MI4 M?13+51O!`@OT47R+%NQ>&XH7KJQG%A8620NRY_)5@_1=50DH2[?%-]%- M4=7$K#?Q:GO'R`3;QDN<_4Y(M%;G%X;"*]U<[\[P MNDDCZ^S)]1!#FEYD9T^>Z%OG^J:^89@;MKKNP@YZ!'\_M2[#*.X^V6A;N'[, M#J(97T7#`)^H=[]?6K]%83JT+;+><+8G;#B/:73/(6$X#,,7_,(S^E9\7SU% MNVRJFTZ4Z4->18HRJ^=%8/!(!&8OT/],GN#SCT_3OFY;'?TPAD^&+T',+1&_ M>0.0//B54S^M_LC>6^";=!`;Z!)R%43CZ50*<<&87TCXU?AV%J,)S*`'@=ZP MMH2J)W\FP4@#0X:1Z(FN0`.7R`C8C7TO^+UN55#*Y'.=#LJ8_[<#K-VVB9MC M`PE,8+HFT:W(UB89GNQR(;M5^BO9Q$Q]9*V=H5ZC\P_=V:+[%&#,,0-@!S:F ML3)^7PA[&^'V0]E+@(A1C73(4Z]0\N0?B03U`3N_C1E1J7Q;I('1(@#L9W3# MPEQ>$K,[!@GM(%8Y_D&[4U!Q/7E#=E1WR4'K(A(ZDC$((R%]-<`JA[LHP+*Q MZ:9$&4E(:6H#/^CZ*3'*]Q0Z>)YJ_%9(7E0\"K"`%!'E^=N(2X^;(#N,$O=( M>/G(9V/@.=?+]X)^Y"JE#L^O=#BD!%KF/5-$@"O*]P[\2@/?&WB3?.J[7?F. ML1%\Q1LRBI4KOA.`KUV*+!:618.;:5_X_@H`-HM1.* M2VFY1*"P3$&A'Q&4R"U(#S:[AO46U\.\<1'R"IV;<=I!%92@0X^F9"&!Q_,( MVPV,N'/%$[T#Z2L(?,_/QCB_T)_B0E2X9O/X*4%>#=R>("8;2_P?+W)! M06&(RWUV/9^U$G,B'H9?T0F(6P"J'/:1/_CR%*+6R%@'1,)G81>9&;0G+!%R MH)!7/^RJ^/;D=;Q$16\^PYFRFB?_0]U1Z',L M8,H#*1N&,'A82?!B)6MV$&'D3\Q`$-)2.16 MMFN@-'M3FS,3):_ZJVTXT=BJ`^?Z*A+E$)'\U8>:CM9'5//PT?LD]%UL6B/- MCQ!DENE"_8QTM9IVS:FRW)+_NU&URXT*;DHZ(/.GT*U_5&MK]-UYH%C0!F)8+WU, M>@+6$0Z5JB=2T!N6B(`\6%+RX["?O&"?#;#7?!B([E?0`'C+8&T;*.4L)U$C`S][-Z2)A$V(XI9JDQ<-+NFV3 M-,N-7B\9/ER"DQMSY=VF+;:TZ%SRSV-A*2MWX[WHAPFUHWE7@L7RL9JVW]TP M-B)G*GPZ:UFS$TAF'7N];L"6YI9-;R*IE.:H'I,[JIT7JZUI[-FH MVK@)#&:@?UQ[_BG7IXQ M2UVP:\'`Z"=HOUZA.8%"@X^H@-^P4[]KCZDOD\M2-\GT'=-R>S%:DFA-[\+(D_Y!>AMAR,`.QSC9^GBU!%@X*V` MX\OW&MN*WX9^Z'$;,=5.1D:)DUA^<..W`I./A@I:*5Y,A[99L@:>[Z-:824G M;U;C5E9/)R(HW]CMD_J3^L4'4K$)R$6"#`7QC9$L[,:2PLUM#9\PI29(44?AU!'NAR^O9BS`]ALAX=L%FL?D^N[J#&\SJA=V4"#'>4?QX0H*&3Z,8?2#R MLZQNXK3OBY/[&-$YII3L):N/3#W*[ZY7O-UN/AP/OND^BEOKCIWZ>=F"RMY/P9;91]#@.6K1/K_LO'^_-_?CF_?K#._X#_ MW5WT#TPFSOQ'US^W&-6\A%_J3J.Z_2T8.62BYU*#^A[Z8CQJMJH:E.Z@[^Q- M-\'PI-6TLY1D,`@%6#P]G=(N??=$#KGNI!V)+[2?8ND$@R4K_QV9Z/14DV\Y M]G6"C,*GVUCMYK,]>J']H#+J(/I]M*P00`0S;%7CVWCH>V`C8S]G%>-)V**D M5]W[V@?#R*4L?FZ?32\/(]1XQK;OO0J'CE&'@_@^IL_+Z7L\,[^2\9'SWI$S M<3RS_^J(^:<5?^P>Q\Q>5]*]8_Q-TB&9$08(J#]]0;QJCBQ0(0<;\^R;S!*6 MY=N:75NIWU-;C"__B+4'"B+U$2;S'@8%JUXM2&^&09P<@9REOB=2Y4F*1-C' M]SW,YDNXL>F1+UXL&?<`5Y2B-M/+=GY<=5'SUK?H[3.SFB"73+T MI^X/RZF>P>G-@HM9["-C!@KA^;?N$X9@Z*"`$"M7)VD'U7,BD6'3@HIB!^&H MS($YSAAB+,:`*/*D?\],Y0`"5@3UE3.8TW(OKN_:LX5%)98J+P\!%EDKU$Y%!BA3V$_^&X,/DO0!%*[X#/ MWOI(D$N\%Y+TRI316Y:BBJ*Z*\"W:6<$62Q"*@,BUN M((^>D-)IJ50I4['6KA2XYD/K=3XT[&:K.IL-KZY_ZO*;,@IH1*$QK`,#8TP& M_PE_5[ZF/6=0Y15!T1RZ!XONZXC<^^%+P+'IO(\??>I]5#*RIL_TU<_DH[*# M]YV7Y?+KO*S;S6K9=DJU[U'8,@9-RP247EK.M!IE+QBD^^,F6X&7D\P5B*#.4Y:P;^<$\POZ!9 MPIU9G-?`:N+T[?W5P^+\G7^8K4SC<\QTRX>Y-L%-]0Q:2%2/_J&#F/CH[=N+ M%6=^OP+.NW%_WYD;/U'99OQT_N_4@R<#?KR=G+E1A.5J?U#VJNGQ:\Z'H#UX__]D/IA[]72JU*JY+15VBRM5&H_)#S M*"SMBKA*`?8YI4JMM2L"JP6XYU1;3LU9E8=MV3SRCMZN>"U++>6(^F*K':! MZ6XY2^"<\P!`=&[08=&.8Y'$*XJ`4R\[S6I&1H&IUD1=$1Y5&\UF;27BUL*D M6J7AL83_MST>+DWC]MA(WAAVQA0@KEZM.ULX ML(I_VR(.2Y\BT4._$QA'Y%7"!\9'-Q:]=E:_%5\JV)45%5^]7*H[YEE9EH"- MKJ2(VCRHE?SO9ZY7'9WY80QW=A&9VM3Z;B,Y$L5<%_6!?(N]7P+/_]L/292* M'ZR?EQQ]Q@Z_-CHGG"Q%>(ZY#;@R',-0'Q]WF7D+O95+Y7*K67S>/#=!E]Q$ M]Y@PU:-/WXJ(L`H+<^&6H0U-HBZN/__P=W1O.[D'6X%9UT?K5,YMD5:>J9TF M3V%$A5F%^#F#OEII[*J?/]?JE$UR;WN477!BUBK\>H4>GF$U6@IS:&VTW!A9 M:AMDCC'-&JA:%YOF4&7HNVTILP)3KHG*5=38:E2N58$Y9:DH2E/)>TU-+$A6 M8:%;`UD>PB]?L$T+`E=`Y8P\`WXUC>)&!`;>:!5^N M5>IUXS6^P)1KIK:0!W!OJ-4O8^S:B&T7+D,WN`G$^&-M5,`VK^7%<.=;\+86 M-76G'E["9195+NV+_$W=JMVOZDR79`RI?M6-O=@VUZ]J]6,RJC473,S=Y"F,LR:]B'TH2<&2ZL=`EG\2"A7; MREA(@@U2DW[J:S,^0]3C&>4F]J2/F)`_L>VB^PUGA_^09M"..-OR81$G/I7? M,^"<2GN2W+?'!XZ\9Y?*&R>V))#%("<(A47E@#IL2N!:<4X>(NQ4B)^#@9\\ M^&)$`-&X"1$]++CX/(#Y@>]I+"&]^JZL^']R<]!8'7A&``.9%*K&M!"B+0RX MH9C&P^IZ43<=H+><<*-='_:!P!V[U*J."]%1?V+9>L_K(RHU81#P?ND%'!\F M._0M'-C`!\CMQ:M%\@;(9%\(4FYWF6[;N>>+S8K'#]8=`KQ\.8?_GMW\=GV! MO1Z.QL024O&GD+U;\4Y.(W6A2?CE6&/U$[PF7QD4UAL,(X\N@KY$R:3+%RLR MHS#PN@8./:'_8:.J`0,L2O@1$_+Q&;%>-7ABS)XMJ<`5?"6.;R#FH+_*Q^E2 MQMREC&F-6<\-"/[4]_)_A+ZI"2GEY4EPG;^L_T2$[F^X&KBM!:(O>G0%V02- MF;J$1"D0"E0B(TM;PH0.)V#-F+$?)`DX+@Q`?;IZO*@709>HON5&9%]%S,AN M2"O2G<,4L(H"3XQTKR9;MC.R MNL`W+[&Z;B2YJP'3M>%+9B.;K:;M(CR2.ZQM)3D]0C1QJW'0&\TRWE8`3Z#K?A14`+E@R2S1YWST`I1&L5V:'Y M:/#-9!CQ1\G)V/S4`$-).XR*B-/,!\1E=0FHUD?@9[)\N14,":LYOK27MZ^$ M)'HH2SQ^5G8;R3-G_NG'3_;AA@HGVW?(-H5#D`TXJW("1)Z5O1TDDK/KT_%6 M'[_]_Z56P)+$NDD+3 MRV1"6M4Q=D_!7@B)7AB#MA)*KC<0?+85-I#^R$^*@UTX1?G)]7(5!:-, MG>E=R&C3;U"@(J/`:'^@X&`4ACY=+7RM37D<@L[RX-.>2ZP?;`+\^?7['C$# M#`QKE$AN(JE^(Q?*@JZ0U>EPD&K7`-$2XDIW._`"A8,OT<+@9UAO2+&H:>@5 M?DX8IYT,ABW##52[10<,,9Y3DC<7111&2>`2890#9CH*&6^;*:W*MQ#Q/:P& M40<>[GUOD`ZL1]A4!%9@*X)(R+2UN9WY-622I.'Q#`U-!DV>/YE$*2[SYLBK M7PVM9&M%!S!%(#FHGL`-`@>$IS?:9.&NJW1-)%()_Z>#EC0)0V...? M!@BGKE"@CZT!VE1#'_F"CI2(H"@(4D.:#5D_F:SA"YD+.6=:^_[,JI=J)^4: MGMFL<[Q\.EG&V\DZL:[DI"?G/H]H)J23(J`1K!THA6F&QR7%(WV*EE5!CE1(W8 MQ6!C\=C@ZD#$\*6`GE59YR[E5U,:6K4>2,ETR@"$5*<,VS@%TIZ274/`L@:# M/!HIBLUF)-FWI>GBZO8C:$D&U"^N1\\Y\H/"NX_P_>4E'"#/"?"0GEMHD:1&N3GG>"V?\*73&?O8\Q>=5X(9A:Q2: M(?!DBM+P)SR\_-M(MVYBHWS\M4N1&/B]Q#>$FW$7;H`_Z98.\=1K=$54[!1@ M$)G+1K8,R0F?"V]@:EHHNT]EJI"VB5HT$K?D#"1-@9S&Y^A%#`\:BNHHQ"EZ M7!MCP5`*8Q2L699)]1!?2.^]<*L04Q"T_P>V-Q:)=/08!*%-BDR@`T\=F-1" MLJY^2B3(3K&-\5$N<31I:@_H]4@G/_8&'G50T0]1U<;IM16H5YQ)*E%"Y.[4 MR*#S)T6II^5(]0"1!G=V^4ZQ-+!_WGWB]OM6.U//'U-X\<)/UOL,3KG]T6A2 MPH*JAG'R$,++U7(JOTPS4W(V&1*E>K3`]CZF'I&CX+#'S"=Z!\YT'UK3 M7(<]I>RQ1R$IZXA]DNJ!1230U=/!IW6$^*T1NA:GN#)18YB^3.D@RWD8J6_E MN"=20DVKH!HP,XWU^I0$F3MFWDOVY*6DHKF&`J:40;W:L5O3UH/.O'?X>N:\ MP\$0=UQ?/4:G%7;;1=CF!^TSI=QUCSSY0-'OVQ7OI76>)PRJG+APGP2_6'B& MBITP)<"3GG-3!W:\$%O[JD`]-JE5=R1Z`;+;Q7Q^PI:=P+#X+"(/[=@G04.! MLD%&Z2>C=KHF0/,CBFFV:W#$,>ZKH)W!^!F*+EK)#(TO_?\I];\UW$21Y:># MX4D,CU4]C?E*T3U^1H[<;]7J#*WK###2[FKP2D1X/85]Z\';NP5TWI>_)6ZO; M^"WD]A5@9$1\7U[I5)N?8@OAI(XA\B5D?5;#4&X68C/+JN=(=F$'+EN2>88KM5KMCE M9IW[4/,TU);2)2>(%^2E!,])FK5@:`>N/Z)P8=_ZK'/U0,9D$WC\S)VT%.$C M-T/IW(_Q50(/PZ,JZ8(,-AOZGPO*'D;BU;<#=LYW2R3]W M;U6UI[4(U`Z`*0UC7]`JV MWL_NOTJVG9'!XA@4Z=OD@,!S?EGUBI0Q3*;F%-8)&.PALSUY6;2'S M?7HN\6AB@1QE(61O3-PNC@22`RCQ5+<@RK@E[U#8H2=2KO$LG2TX]1@[CHC) MH37`;JI&]%A9J,K7I%,H^/T'3\PPC>$F!C&`7R.R8^&>)22;OJ./S7+'*M6V= MD#$9%S+E3&W=O<`&8/K#LCW.*&O]:G&QX!QIG/R.V3RJG>O7I-./W4[X+%U% MW[#'"@J(?+]C,E4G3!,ZB,I?P-E<(%FI;`'%P=HNFQSLW,07.;R`,B^TP3!: MM,1]UQI4>_B$KC&TXB>4?-GV1;[_9[;MYGY4_9!Z__Z"*/2MUH0DZ;"*%D)\ MQJMKLBN%)]X:$A&.Z)\MEFMD7G)^D.^K9P3!-#J/CF&IAS'4W+.\6#3#HF;]3:>JEML&:NGMM[8 MS^@;.31EVQ_0&95&IIR>7<\?2QS/4Z/"%3VP<2+3:036`'[EE$P<=>,2+\C7 MZ_NFJC:N6JG;9EVW&`1+$I\O,]UXVS`4+;,U-=[P2NU.&8HZB4@*5E[M M3#YPP.F96U/O1+**^G"H,]]=`!:F#9.,O]=')I3_HDX!=[M0GLM3D3.Z3K,W\N,`KWR,) MO3U^M0HRD?.F+VLA/FXS+U[:")3B'C4[\T>R1DML/9&3"X9`15/G=A)LTCF) MRWF65`K%A@5+QF+&13RC8.Q%1*HD+F<;NKIVC?7`B[`TWC3.PW(QR4^*G7`S M.9V=A,9C[U^@)@WW]H"2:J5=I3N$>V8+_J]^*#];E]<6?]T;[\0O70 MGR^NV]=G%^U+Z^+Z_N'NR]5.>U=CQ*M9+ITX)2/EC MT@N!SY$L-=;X%->Q=BB'A1KC8I4P4MKHY6V&6Y]J: MX;FD\+CLTY/MB:ZCR>J/,%=A&,8>[DWN*:N[NMFY4F+SA8NO"\SKP*TP]I$? M%7HN^6'URPB=G[K6VW@*QJ8`];(K#9.KQ M_U-HTSH3=W[;A;QHLG>U>,\XE@/6$CW.;LS*F3BY<=I)RIAJX^D#KGAP5&/N M/SX0+V'T59/!HQ,AQE8`"5S,2(4!74P`$STS?7.HHI%(A3E[_K$]Z84P,^L[_B(:J@'(Q*P!]D#"C(0ME41EN7[,F MO`+39&X?V(GZ2PMC3["#1Q:I48:L#_K6EP]76H[$8:!'(^4L4JR!A,18VR^S MUD9O:JL+S]IXZ.*S&=$6Z=]#="+(?R^\_A>OESSA1TL__I!-BO-%^I]H4]*O M>FI\^:UR\\=?+3D],.:T48,)Y7^`<=.L\J0W9UAR\75=7\4+DW"H*:R4"\P% MH^'233:VK>6U;.O:MW+!C<.M5WNN,_KP MNI'R$$93M"M?>O#QP/KW48Y6E*/*OLC1EV!RI[5(Q.G0K)/EJ$<$DB)WFO?= MDQ`-V=>,!`-IN.??@]*+AZ*`Z9]+2L+/[`6>XG4[(-_2]]=<>G&/5"$OT[AK MBC#QJ3^0V33HAOS&[:!W$6#0!906)M!MVU$EDY:\`'4D_-LXK^Q+>OI@W?_> MOCL_^=B^/_]DG=UC[GL&/+95!&D7",\C,%/VT6`!^^ MX!I.\Z1L^M?:+RYBXF1`Y.A8.*?P5.9.HTHI?&Z.]"!6N:2J8^23BD@R(-U< M'ID3R%1T4@R&?C@2PDP)&JL+SRU%NE[,_(=)9:T&S7&$IS=`].3C&1-P0P,% M!ITF8"7@X#+H]TE6KZC4@OQD^KN)43=/T(+Z8?BOM/?(R049@I]TZRDZN%)L MR&@JY.RANRE/GH[Z&HUAP*+A(*;X)J*NAT%S>5>%78]8]!QBY8J?W7G&3#V/ MJH%ZTD_W#TDH%^3(/#'$F]'$FFY#B M.0`O/X5^#_8F,':><2TCHD<6-S=`$6=*O1(5[<7$+T0>^62\`3P8=Q"7'#NQ MIMS)LJ3Q`T*`&/J0S*ATKY5J)S7S%/.!/:'+Q+K5I3"A=0W#6>=JO+$3G40" M9&YAHG2E(+D@T9\NDT1SY_MEHB"2(2%E99B9!6/XB>@DL6O4^"W+")XQCZ<7 M;N1[C)3TWOG`R37X9^W9=BF0SQUEB/42#TM!.'%!5HI.4_8?(^UNQ`Y[&9TW MG+66]+U%6"6(&0TPXOORM(G'!_XISDWMQ:IT#%9Y,XWSI%"8F81@YB?T:[1: M20?):`-I'R\RDGLGV*@*T;*`A,M.*WE03.P?A7:DMH2S*B4!E,&CL%9DX@63 M862,RVI0--(5^&D[2_R>-A+C;/%H*.FR\(J_S<50I`$C(:O<\WI.RJT.OF@. MYL%!C/22:0OWZ`X*=(R#IMH%0$"N:';L?L-J8_-JX)A"D(D??(@OH@R9Z:/O MPE5\WWT**9E$PFS!38XE+D`/9F,G:`7-G-?M^]:G/5L M9J]K]NG)A[993D!2M;#GH$.9WMK!VT%1L9Q3?)D3AGB^9`&?(2(J_%[7;X0I M>Y5_&13W+1SLDJL%ECS5A;2X>!0E]EP9;#XV9O$D4MH*&[(@L\K6B56S_EIQ MTN6D8`6R2P7(WO).4F<]67^?:>GM[:13+IW6G!^!,4ZY?-HH_WA(^^F4*Z?5 M!A-?/2T[LXG?\J[>>?%7>/L0G*,1T]_>MI9.2U7BRVFE>5!;6CJMU)#PTFFU MOC?;>3[Q]M[>3EXC-M8!;>!<>K>\;Y^U7;OMXW=89VZA@S8>$'DS81"%))7/ M_I;(3++P*_'G3.W^P]],H)/F5/#(*8ZT3&Z!'(-Y8+@'OV6':\;VN M"@Z23RZ5GG2C/8HF-)YJ84WA.8]@`!GG?+OR\_(1COF?O"M47Y:X7P65N$X6 MFI%SS.N=#$,O`V>E:BOVMLN8-;=/]+('N$)KS)S3,7"G\@%=*EI,H^EV!C*: MN!0_R1?^E]/[4^LA(N_2R/J$U0Z)Q"7-Y1PJ0*/I+T)U00F"LKW]?RC,B^EE?Y8R*7_55&5XS`!^LZ_,'Z^+Z[.;J_.?+F_M[Z_;\CB/A8YZ>8WE/T0`9 MQ94IEJJ2`:SSI^J&])0R*SC9@^.$A8HSE]"1S:EM8`&E?3UL!Q.$LU+@`+ M*P@I$H>I<+&N+27K3%4?TEHUB;EB=)-:C6_W0K'7#"G2C%Q[?1EH2F3S"_EE MQ/Z@#\LH(O4\D1E8V83RPU1QR67"S[QSU#V@)R1%G,JM$6W4UW2-)/-11Q_5 M/AILXJF]2(*Q(&LPY'&B)]W^"9%+9.3HC'\YLLSUO[)H)4.YQ9L;JBVY(O$7 M2\=>.J+KIK'N'C[BSWUSLZO'ZSVV=G-E^N'B^O? MK-N[FVOX^>Q\T\6IARPQ\X_912`1G%2M98:H9Y1$WAPI:G;*`SU9_`GEM*I7,WM`\D2T!3^,^Z MNXN7R/>[:J5`X_@BPU>FJM4^6S!#H(I`3Q[#L!>;$-=DN"GZL-KMBUH3&S:< MB#+TW2[>B'&28=M,Z[:D+5DOL,A]0LV/J9K+P_:SB-,09W!O$OH:R^>R;QI_ M5XD6M![54$IZNOI>!-2H;E"P1B"[:3/#`TIJPIK$7JC[K`V\)&&T;:-\BW\? MFS5ILD20,S23*%1Y1NR*06S)02JS1*2I1)QF!@P8A]AJ)^PL)'\@`10^F2 M4CA# MID5?9=EFX(MXTJA)B\(.R!TUV2A1^KH%/V[0^W.J@_B*L,OD55V5H@:A1[+>!5Z8\4>I/&$JO5*/*W9--SR=$U>GRNJY M`E/5_!2_?H8.VWA_,V;OKG!G#F_@M_'TF#_%<2]VCEJT[^O8'V'=U(MYJ2?P M1*T>IOVGOKCI9\$-66=!%524BB?S^?_@VSL,VEE4\`&=PUL.7[P*F:>J:8WV M4=/SQG5X7L6MG]42.9-<>OHR,-Q9&WQ,LSZF61_3K(]IUL-K1V>?^<+XKNG` M\JE3AVX8/-9'BHC)V@TQ&A)6[G0Q3LG0S*%B)8\56^\IJN]AD@&C%D9BP)VI MY6Q<<8$(/M^Z&&E%O*)`D.OAPWC#JEG<.20?W1B\X.*>)'0T6.<:99+U![IUQ5\T"O%O3JZRXFW;EDY6#^7_C1VMA M=JY'?/B&?>LG;]^9N^:C>1@2?QQR3X;Q MA1W$Y5"`)>\VM)H"4Y?K=K5:._)UW5,[%;M<=@KP]0!/9?T0Q64W$N@T&W:M M5CHRK"C#3JRW>68:1Q$H?"65ZG:E=)!WTELY,TDXW/6!:2I(WI-NRWRJS5ZW;CS1^%O7_/[/J>N<3(EP+3 MDKCV;UPF]D\]'KE9D)OO^1!^V.NS]T#M(*9'M@]1&#;@9IHJ-.73,DI-+TP[ MOEBKV!SP77?XS#]9[LK<<%JF?\#I3&]CBG4/O%<0QV]DCW:=F[="]MSLE+Q/ MHI/L,M/N.D0`8+`(.'\W2MH^,VF+Y]CX)XEYKI3T> M8DVB4%12;PDT,`ZC$<)G&7:.!+-E"R<:4#93W^LBWC,8/E=7=[_Y80>!>O$K M$3?0%0C\C/A^8(-\=1]5UPD/(QRZSAVF49RZ##N)'YZ0[TYD_9Q;SFLD MW0EL3\ZH1YC%K^J>S]6OQ1%1]'V#]5_"R"7ABIGN&(60OZ3"2)S["_V-I$(O&:W4!<1N%C ML'$YHJV'A@\[34O\&X%VJ?^$CWC7\&7?YVI:;%V]+;T?GE"NVLT+.]_>R^J/*/8ZPJ!C,R,$H*ISW3V&4 M<-](/W0#I69=!-*/>B?H21BQ#JO_>,C*:S'OXF('O%JU2_7EL_/?.GLJ-;M4 M*I([K:78\KWKJ8-/S+1-;PX>W+)J^- M]U)P9^>J?K=\(9'>;`YO46IRN3BVY4_+AM^3_2NPFDUD@NXD]?W(Q%V65^V# M"CJ.L/>^SIEO;]EOC%_?.3^EBNU,2/+"`2;MJ>26!OS&=\K&(_][T#TK>/5* M%;M>W\,HTH%RZ:B"CR-\9RH8V^1R='Z:_IV<8)_V:?OOGEJIH!OQR)ZCHCV. ML&>*-E^SHQKJ2NVZIPZ#+>7C[*D=N6>KGRJOW&\?12#Z7A)?!-UP(.`7MR)P_<03<3OH7KO; MC5+0CF8I?#N^Z1OE[U8:>/R'+_>??K!ZHNL-7#_&4O"_ES)*5YA]?"'G_;[H M)MZST%^^`Q5^%F)'ZM0+'B4"0!C$14OXLS70!&TK3@<#]*=C$YPAEVU(NG2SZ\`+!"<8QY@R M#+(RO4&/Y<&="YN*E8D]JR/\\.74DHNU'K$E-OYZA/4G%G#V%+O%XA1<>](# M%BLH!%DP\N0^"QA'!'"%)U%(A`E_9*'@T(T.7XU$WX?-(D+PJ\`^T.LQ+H3V M2!:\\(3P>?PYQKV)3V<=XPP#8?\P#^2@U=:/Q;%Z%K@2%HN#LE1K[P%';#KP[;J%7\P"\7G9`1/FK10 M:\,]6>R&#\E"@O+X&(E'>`86X-Y1-;T%-;)KB3O_)J*N%W\'NNG2ZQ_0*O=( M*5V`3O>"V.L>E=*R,<@-=6`F+^3AR/3&P`@WPM[;R.ONE\+8$2/>8ZOT^,-> ML>+MG.(_7#_=O;E7F.X;$\DEL7*]OC6>YYID8[,*OL!B*PV[5G7L1KF\=)A_ MOQ>XPXZJI=,WV\.B>EINO=&E[5!@]J`W6V%:?^/`\)O:^L-L_O0&9/H0>?IF M%[;OPK(G"E"YE8XJ\"`6MN]2?8@\?;,+VW=A64@%;JAMXADB_?O^/NB_8X?0 M[T'H#Y&G;W9A^RXL^Z`AQQR)N6Y?G'G]_DO@ICT/WM&+5JM-I6E5E;FYIJ)' M-^/1S;B,V)S6EB]5WN^EO2D%NKE7]A^">FT2[/VWH>C*\I'GQ6&A#R/0?ASR M..1NA]P'R\F@;.Y/FS:K-O8X/5I:AWAQ'BVM0US:F[*T-J1P93"#*FB/.O6H M4X\Z]:A3]U1@3HX`*8'U+WS13][$;NB!IV')+`M/LC#@"4%M MM-/D*8P0%^9+`/>M,84068%9L>0&V[R5&$B5N)TQ1IR%;0@FLDNL72=ZM5RRP`K@G\=#%KI%_ M^\'Y84]Q4-9YJW5#7'#PMQ]:/\RU"[=6IF(9`1^BNZ-%6_H M/EN$0=\/W,UU2EC&![G.7?/N`,$1]XE]QT/VUM9Y/!#;.A#[?R\?X9AVRXBP M;W$`:]/\_'DO5D>%SUY^V^(',I&'\<\CGD< M\SCF[L;GW?#!+V_B0<+^CIS'-*=$$[M3T_8HOQM%RQ M2XYC5^O.P>B0W:NERFEUK>#RW[E:<@Y2]M[FX3J>A+T_"0M=T(O!$.P-XQ;U M*!/7ZN5?]^2"WBK.J6/7*R6[?$!*9O=ZJWI:7:N8?.]Z:Z]ZC!Q/W_&H'/91 MF7K%SZ%PRJV_8A/[[WB>P\,L^BZVY3C/<9[C\5SHGC+7LTS1ZYL><,H=>X2> MVA/8G@VNZ'L`I#IP5KT969M\V!$L-AGD(?1HS/_YUZR>@Z3,2? M;H2M(N.;Z`[Y%>N!WC1"6%OB@8VLL&\E3\)R)2X;_CM,(^M%LH4(Z8<1?2CP M`F$-@)"GV!*P,[UI2*Q>;`UA#_&]V[,ZP@]??IFUN"G08*7=0(.]XC"6(]:F M0J.L;L(H@IL;'7ZSQ-O6(VKX),2Q5#D0.-]VHN0`)13#+CQ*X#1CX@VF3N]5H\WL']&2-YQ"]C:&W`CJ<46'/_%W MM\ZIX>W%@LTJ:GUU=??Y%PZF7,1Q*GJ?PPAH>O:Z`K\$@W\M)QRR7:X=MR*BF%L1=>^*A!N' M0;Q(#'U'[;46?2OM3UJ=;D55W74KJFN4ZBN6ZO,9&1:TD.T%`*4D5+$'R*X0 MT])H&*Z`9JR6L$@.P1(Y"I7=<6C%^/MV&/1JBLB*_-^AA/Z!]\66#^:^^6". M0[XM?Y:V-M$.&KHC-#38M`G`E(W?J`/;<:+H_>V",[9-`;#4`V\3C<*A'8E^96FG:3FOINM@MGX6','']O=+Y6PZ) M&+Z#?>+"#N^%+6^`=,0L=UXV7..V!;?U`7K&#YGV8TAG`V[RU;W;DW[RSG@) M61M=[(]B`"_YCZ/L([?N"'_5?G&CWF?7B^C%W@8J!MS]'4CI"R])(W&''MF" M7G0K#3S^T"U\\P>K)[K>`"[*O_UPJ6NW"AOEW6\@/UBW7)25VUL^?4S3XI&3*:>)/J3A+HPA^S"V^'=_TI\K)E_M/ MYGI+/_R]7*]6C:.UV*1+DGP1/+R$U'AM6:J=9J-6*RU,=C;QDI0O2V^M7F\X MB],[3N69._02U]^H0#B59>MICJB5,^ MJ3C&8M@M,*%X*HU:U6F4UV&3SJ)O)PR8W,WODP'_VTWC)!S\[_\GHO`V](($ M?_CL/8N',/GMQ@64XY]4JI?%",(IB#^"*X%9$7]A:WHF]Q9S]RQ]CL@QDL%C7T6]DC0M3L>Y]S/R;<3OHG7\;>A&-L-=;^RK1 MZ^:248.WEW?O!'V[9,!AW+W[S;(]O'OWDF'[>/<68]0R`:K)"2Z"!*Z-V.N2 M\\-9]H$W?JXV0MRZY>4/$2>BQQ<`N;$?0OR504#[\3$2CR`@>4K6Q:5=T+Y] M)BHDP_:SB-Q'D<-(+H^8M4.! M.UAFK62CS65O:1TA\C?'WN+VW'S9W8R+X#"9NXCM-Y^KK;?$U==MG:FWR^9L MG9FT[90)6S;X5F0"R^XK`/:3\/67X8N(^"=OX"4%?3D;O!Q>S2Q8ST(/@:GK MNA)>%=(WS]+U701O03R_#(?[=>9?O5W7L]!#8.JZSORFY'0IEB[E&7O3[Y8= M.1PVP-ZU".Q:GRT'S]N]?+9LFZN,7741Q$F44L;03?+$/)$$78?!,WGSUI#L MTRB5RLWJ6OP^B]*]/89M*"#O-.K5>G4=H"_CW0O2OCV>R0C\ M!MCF5.NU-45Z%U_%#O3;F+JE0_`)+@B=T;R&^,!:;)LU+NE0V+Q@9*&TC@*` M@V1S7G4OQNM"RF(^WTN5[=]/>\3]_"6P9>YO_Y;;'N?GU,FE\ZM#^,XOIR"2UP*^&;^&2LS0!JEF2FVYS)YM+3'H2I%Q3U M4=._%'$L!!:*>,&CL2?Q6%'.@OXT#5X* M?ZK0"/+EO!KZ\'S$B?-^7V`W6V%EV*G<=+!"8,"1",2+Z%&;6Q]I(M3=L-]' MMP""Z`K+"ZS+,+;:P`4?9S]S?0\^%'BN`@A.1#20T+Y1F#X^6>WT$=:LVALV M3ZV')R&'[W(ED#^"J4&#H@RZ#%T,OQJRY!+6<-,NUTJGAXYELCAL]E*B^$JU MVAU\!;5$$(MKL98SUJPW:]69Y6KY^58F;E%%ZY1;Y49]0>I(72A,MW9GDCDN(=_@:(:KD7_[DAUW(#"/GL":P"^3SBD9T^>Z%OGWV"O2-_? MD`Z/&/S]+H2%)M;OIZ#*H[C[9&-GY9I+(H$AY6<,>14IRJP>W`E=O!]P M&B_0_U1WRY2OVU8'KC&@V8.Y1U;X$L2,*/\-A#`1\"NG?EK]DH@,0HT]A0T7_+F*=6+=2>#\6S=*1OSK6T::M=P.L';;EV&.#20P M`6P(/N/IDL:&#LBT+EBP;C`B:EZ>/-A""1%*YS%.?62M;86LA,,`6(]<243W M*4"P1BM6T*+`QA1(Y$'(..D+W"W+C8F_2(PRZ$ZM=DPM!I2LP1^)!/4!.[^- M&5&P?62WI`'6UX,:0IZ[7=P-V$ZOG M)BYFE2,9@S`2T@X"5CG<6P&6C3T+:`1@&^%XJ35Z0==/B5&^1Z^,\>-!WPKQ M84E'`1:0PJF5WQZX(]H$V:"!N$?"RT<^&P//N5Z^%_0C%Q^M7=2Q5IP.AV&4 M*-XS1=1<4#5=`'ZE@8^1U0D^]=VN1":S+;3FAB@8-A)-)"!O<$BP%@?$.2!9 MZ6]:&>X\+"T>P4MY`+1?@"KK]3SZ*&Z[00)N<>.TY1NG'51!">@MBZ9D(1'1(ZB_%]C>/EQBUA,35P>X*8;"SQ?[S(!04E>K"[SZ[GLU9B3L3#\*N(>0M` ME<,^\@=?GD+4&AGK@$CX+.PB,X/VA"5"#A2B!K<"D;R$T5<20GR[D(!M6_D! MCU!<8/FLM70W$E+%8VRS)5OE/>$:BL]R,ZN=]0Y80:"\X"/#D;XGC8\_1H(_ M#*SK>SZ>.=*\XMN3U_$2?(XAKS[#F;*:)_]CXY_I7]^9@'55R!$ M57R%E5I\H<86*!/1&>%)#R,X/'3E=$:L;$70G7'-[#GNXAO&C#RN:`]6]"8$ M]VU,,<5GLN1[<0,^+#:82^J!QKJ\B8=M?7US:6B*;1:[5XL7")27?=2$8`TP7 M&KY(5ZMIUYPJ&P0!_J)1MQD=%U@RRR&81^@E<6_Y:=CT!UA,8) M.4']$9JC2'4@N)N'NB]C-IKU(G"H3H@KZ(M-&!^_6'7XZ.'JPUU!0K^9FVI/ M_=`'OE^'?*\=I]B?*0[6QKCW'@,/GOIND/P!%WJX)3L#J8O0'28C@G%&AO5, M=.#[6?K&A-43'0^T'&KCH<0M<>'VJ)W$<]I,7C&"XPZ$/`Q$GK(!\J&XT M0J]-E/)3^&IT)7KH2;P3\*3MQ=;M[W$HH^*/4W*42&),Q<2<$-3Z:;&J*@[P-7H#XL`."=@ MO]E=`#,^1NY@@+^P_IVZB&3,C`S]S*$E?:5Q0A]#EPKZ1IC/2(IV530,_2M\'^>JDJPV^C_-F_'I`_Y3<9!55 M<-F5SCU_3]%9\5J?6B)DFLGY)*2_7G#(+I9^6+1BT>T.4QIS6>X`F\>RB^]= MBUVP9%?RSWEK,.=QE!XZ';7`"A3K72FWA29SNV%L-*F%#8Q@)Z:UWZ4ED;_Z M=;.5V:!-UVSUO*X8#'BAP@VY95.P1!K57EV=;,.AO`C-;L,;A M(TH7%(1*CQ8&1E!I?_H87AP)-S)"5V2=GI\@Z9:FW;:`>C9VW&>O9UV"484A M9^(3FG.8]Q!PVLG4[]IC#PO#_N'4#GXYG'$^@LXCP/"93,F0WD]@KT,A[*`; M45(BF5DB&I`UYV8F(=A=>GGL$Y1A=`OL9S!&\=-6$`8G8)R"[17#9XD2XBZ9 M:TPYO/MMZ(=>0G.>#^#GD1#61\I?26+YP6T'._]4"\)H(X8:O9@, M[&;)&GB^CT\`?I#P8 MW`B$=H7OISX(T/`IA/=!0#6(F%%P,D`AT)\TDB$PYR023T"Q8CG2,%WN.)\G M$TX*_,4"`S\XDNS%W:I M8,!,AN`,""1H^#2*,9%)9HP`$1XP!O0&YH><6E02K^4U5G2VU>KHE`Y=CU^Z M[\HU-O%A8//044@9'H:"$QT,+WY?4,(O)4)@A!G&+]N-1@/^7].*.6=(@*V$2P-X;'K_X?>G?/K1 M\10N'&JY;/GHFGA,YMY61`$^IT@5O)/OG4H#XR'X`'S]T904#C90YG*]:M?E M!^3/_+2. M4[R-AZ%,YZ9L[H<(##J74@YDY4F,;S[CU_&?8+N:7UDEJV1^<4S-Q"E8DE95+\5-4*UL)B=2)]HZU+!(S*V:('[#,7L(S._!`K;`^Y(/!B:EZC-1#1 MHXCXWY_=Y\CS?6&4*WA!YMQ%WZH@%ZJ+(DY M/HU^FW>-NMUH5K;MO.2X^C_20&CGC!DXCP1FEW"&*F)O!%UV&/J>VY'%2_FP M>+UACUBRWA'0;S_`3[?FKZY#?[V\X M(#KE(;2(QAT#]Y!GY)*.2#*2=:P/X6>2Y^LPT-*L8B#Q1>`TKQ@(`E%U7-\G MI(/[!*X$F/\F^$?JC\H-*F6:`U@Y7:7/[;W;<.#4:<"0S9*>XU.^HIYLD3/6 MLSS9>:9EU[KB1AWTM%QP<1JF=B/,D'FEA;4.=`D'_V^LX>#$1,N3LRB>1*7< M:)7'&R"^2H\9P;CI7P2)&SQZV",ICD5AY*55K>'Y1*Q.\KH,^$HC]T!?C&QV MU-"NF-;E:O"KC6K5:30J!ESMC&E6H*8PO%*K!#9TM5QQ5J?&Z.FP<089M/_,/Y/[]<_-&^/+]^N*=KO;,#DX63PJE^VNH",PD?0'(3#=N. M`*N98#U"67N504M@%K6;6)AP^P1SP*=\#[[=P^Q4M^?YY$J`:SKQI)5,$V"\ ME9XJ`_3?LF$/5G6K9/7<$?R(`%BN++&F M4>'GCAM\!2FC\#[9^*DBT:;1F#>(QB"^=87`DC&L&DN3)/4R%N(/1(2Y8?@Z48'S4L6NM"HK M5>%M\MWRO>28'J?+/U8**>Y)GU)7P$]`>BL1U"D,6I;+^(D',RK0:W,&LSS M?;P%P*!+?,Z_887T0,!1441>%(:V`44395/9B!!"=2P!)W.1:P5S@WIAVDGZ MJ:\5IVUY^+&1G9''&I;SJN"^(82H'HT(EXL/-B?>*30MZ4;U$7;P%)V-^LRB MGGWRXB2,".:H&_H^>^>8@D@$/?A*,AK2`AF"343LNW(?!>=994:1P0&92"BS M]`2(*KSANBBRG+>(4#I]"RX+TMV@Z9\0@B0F'GM1-QW@H%U]V6!.6R(O%E32 M>'T8TRGO54QW'&R9-QBZ"$9#7L-']$CUTTCFY9F0*;).12Y<.\OZ?.GK88D* MF>QFL!AKB7K_2F,).Q1&R`6LV8%=>8'['1G4MX8NB!@6Q4RC]^5)!`;?+='O M4PT7W<$=`7],X8(F2"/81W7UJB_(.GEV#N(<.[RVOA-U_B:GVYG),65BT[DW MZ^H;OR0O`E0D833:ZRNR]\&ZN/X#WCPW=W_M[$+4K+*H+)&N%OG@<+N4#XQ5 M@[:%L'*/ZB*R^EX4)R0Q1'\&]XL6[!.;$Y9GRTZ@#->:<&[C^*)9Q"$S,=O%F\;'"$:;@ M?PVC\%^L.V/.85;/IA@AHT`'#^BFZ:>$)=<3`TK1CE2^>W8AT6NEY_4)8PH9 MXLHW",,!\X-#7K4TE;$FO@5DRC1=0`H-C6EZ"5._Q[]6<1K2XC$9"8]AV(.] M0)P\F=@\Y-X?^&,DGKV8N!++]U_O.]+RW]U;*--^LW3:A.XC4P=E;](-^=D+ MX`3X8/\LT4AFKM>VX*QK)'8%+/MEB0VZ8.X^N-_V\%;A*HOV_9G5J)9.RHV2 MC9-Y^">+Z;:`<)CE!/Z9P+@,?WXGL$(>-3M*''W<5IX:#>"(;AI2:*3_A,9G M3]QO%H+Q<8&#*B=G3YF,$NO2*E1=V=O%#0*\6?10?*_(X!R M#8Z4PX?1J.^2QE2A_IX7=R.1"-+SP,`T2&.<".O\@S[[]Q&9-^RB%B>05PT? MRL'M[-GQK[3WR-4W';S>LNM(V_OR44.+(->2\6VDSW=?Z"T3\0TA=;G'[%?O"V37T"AW3)9RJ(4A]1F?ENG90S60SG4KF+UZ4*+"EV MZ@&;#F5FP\#[QN5(W@"_@V]O-F>`$9A;@0`048R%1;P0PV[8=CK(K0'*+$_P MQ.G-SB>?8PW]`&)$&1=4!J<,)%SN$"V%$&O&@'U]SZ&0KAB*5,]4YSB MF<`2V^;\U=6=A.,&,43"NBZ(+3[Y)7YSJ'#X9>H+Y'AF8((!?`N,#;A_5Y3]<$#\P&:''?@@CL+G@]!'"!^%O/G=1/H]I"!@B5R'1(.`GT?L\WI$ M@%\A`2+.H4W_LJ*&)"HZ,'17Y>N=)00)Y9J&(J MI&.S')9#;A%F+&D4)6*!!(:.E5>J'^8V@):*?A)=V\=N?R2L_SJHRRNB^+:- MW)W71[QI4_YPDM&6>9Q,-XTG.U^!N?D`U\\GT:'_%LXJX=0>"0H>W_2UI8&9 M)/,I0[ER@G;7BMW-.@ID69Y#9@3L*@Z#&;"ISZYBT/2Y1D=PW9`!"4I5NG[( M.H4+9Z65%Y?,G7]QBBQ/RNCZI/B.H,KHSFT'O=LP3JXHVYGS\JAG6@:^ODY) M+B)I4T2-G)61];-F:"9ZXZU$C*7198N+.^'56=GR)@8TUIN35VME6=W.CG)Y M3TQ[)1,OM[1E#&"7!Y?CT*3J2";-]`F>FS$ZG;`A1[?U-+`13A.38&"S5;LS MS\@5)3@%$72E]R`_0V!A`FEFU7*;")H1_Y8S>AW8WWW<6OW-R]`-'E["3ZEX M"!\P-DPU'VO:9IJ%L5RP6X_:79>CT">,[+`)+7W4S7.V^R80M-UFD<^2&U[$ M\IHO"1+E@V4A=T"EIIQ4T^XH0_@@X7'*/V9BD]^2+0G0*JQ9$\6KB.*N:5^) MA+U3HP=ZKO3%M?FCM6MY.YZ5U<_*QS"*J!_8U&J8R<3U*54&]5*E6IDR>3;T MDK,7ZDM<;U6=T@9G7^Y97Z!0:/T4R]TZ((I7?G3.KY"N5JN;Y/-A4?WZ6*X]0WRHVA&Z M;Q#H!W^#,9#/@K!_]B$'`:?EII#H$H+_4MS:PR(ORUB"E3DVZ"*_YL:RLV*" MB*$JV]]BC_5FPRZ5&[(GDAZ2'21<.$^]X;6#8^[`RBW:EVB&1`KGVE))#N9K M/84OJ-AM$ZE5`5U:OQ.6J_P*`792HL)7(8;T=U5%3\"1^?ZX<@2DG(AX,H<2 M,BL,@VA)J)8JL37Q*UG&,`';SL:YG%GUL@G$QJJ&RC_'E!!:,+6=]8)8.K-5 M@U2.*?H2%%0#U:)(Q[_,(BWU\P;?21(.0?J\X(?)S_K>N'%(U/UJ37/"8,K" M,/*"KC?4G0LLV'@,=F-B#66X,-\%1CJXJP%1+?<3<6!5N@55;6'.A,Z7-)H0 M4P:&!.7MR9HLSEH0@?7>*7V@XJ^?D!P8"M/&\0\P-W:/E;Y6EA4Z7@.7D3FY MR0=Z!SD'AM)&0"$("2=*.1%<9C9B&B:1@V/O&WOZ:%Z'.X&R:[_B#D0%!(?F$\X*@^# M)69'@X\%$2-;>T?4^!0CWNRWQ@^IJK+Q[ZGCQ%E0(=52SU[ISZF_H9-UZ/'+ MQ8.+"U^&DXE[+#AKK/>OU1I-,Z,P/\,2!"R:SNB4JTZY.`5Y'GX)TECTM/EQ M)K->EH`CXAJ@_Z4^\K*-/,%NL*/Z7G3Q$LT#-FP'#AX]H&5]T[^PLLYWCI;0 M\)Q50_#P%JW#D@NAKZBE&%8+WVMYY'"ZG7!J]5W\#"N"S*^!@.*VD;7#5[-) M*>MMD^R9\%'1?D)L,$Y>&0!,UQ`HCJ=F5'612S[;6 MY*QG7!RLT$.FLI<([HQ^L=Y['^0]IM;Y1:MMTXIE],`J?)" MP00JPW9;8JV0NSHFW';B"R=K4\UU9+K'>ETU*I0E<:?5"UQ,XDY/Q; M%XPY!G9*<#\Q`Y1;?(\SDJCHA8*SL3"'+/*HRMOUDVF@[+E=W78RWN^Z\!#! MQJGL84):R#A631#XY%(6'K\Z:(^_>0,P!)0)UU<5Y5D/^%0#TH_)$Z>YZB93 MU'"*6DRI?U5R_ZHB'#O^2Z=!3IE]?$'0 MNN2>$T[I1TNFM%$&;9$L_J06"`.T'ZE=NN^^V*JC>LR*V7H?>P,/TVBE M89D3@`_X+=[Q&8_"]2K:K^ M%C`OG<:\-IV<,COAVQ;+AZD:@!`(7%4,I%YCZC7YSCEM.KH1Q50T?EDU#.]) M>#E(P(+IRD:K2`7VGX-FLV21L$R\T+51TV`.(KIR^`T6_X*JIM525!K@<697 M-A(X3)?4)\G.-QU@30]#-B'(#G><%814X`UT=CA M5_M(]N+QWD3L]CE]D`%6/6 M(UUS>*8SC`PZKL?'"PJ.I8=F!1D$>0,/^`8VXS6,N"_IXF\F27SWV>G'/3R` M[/3BKJ+7W1P%`<,_N4E1K]$J'A%\A9Z4JB?EE@EZ,).B<>+1#$!W&%D!9](R MG1/86I[2>8ZI9BV/8S^-J@D41WE-R>"(L69/Q#M;27T,D;\(E1-^-PP6ZF2! MZ#YK`+B[=3FU:GYAKQ,Y&4*%QP15E&%$#&Q1CM-G`?F/H^PCP"\*U[^X4>^S MZT5_(%11.X[3`9W!^)P*T40/W;E.X4#F;>VOTE7IDQE6W11-NUW]-,_PSE?_ M\?69/H[/A"!GR2A3S_$-&J,/3V[`R+3QYS#J"P\]^/&?`B\P$'?,J7D4OZ%3 M#76>IG8I)_[M#`3.TFFI.<;*G2]P#E1"],F+AV'L^C?]RS!XO$2CM4WH!1?J M`3$.:\!U63L!+I@`OJ&+>Q=8-YJ"]_T/UL75;?OB[NK\^L&Z^6Q=WES_=G)Y M\\0>*0#/B&7FF<`2N[KD_LRJU$@C1J97]K%ZVL7[68JTZ,&AB M8;1<3TL^P:-A-D8!I#A+H<3)\#=/A'`\"NW@6;J!-71?YK;%N#@20%@4`WAK MIY$N5E:H<)T1N>_<2+W7YXRCP@$$@R&5JRIV3@,,V4O'"Z+ZT4N^3RU?5>4U M.7`)DXFINNC319X/B07^WX>][L/]F_@FBMFOK%IT$Z3IS!"Q`I"U!G#S0?#2$1=+Q:W M$=C*=ZAXY&_P?,E+?NQFOU/=7*@#'X.0H%U57O!!^?^)*+P-05OC#Y^!%P]A M[E?7(-'J(7E;_ZM<:;YJ'6Y]R6]L)VX"@3\;&P&_P:W1^U#YRZD=]V%#^_!; M)#"BC?;US`VH_N74RX>Z`05>;W)>HSW`X:B?C2[O@#F\+K5RY.^&U,56&?L1 M`51O^M+Y"%_8IZ<\$8M,&MFGD,(P'O5M&;WP.0J$D# M%RQM>OSIB#6YGQD#8O+=KSP5%.+EE'K$Y97Y_IA[UL7\M2R]Y$M`P]]S8B/( M4GL@,`W,AM<]D?!;NWUKLR=`8B=.)45W4_$";@+'\>O0PHH]8.')/RB[K_N3_4O?*U'^D!W:6FV:.+@()DP>J MC//G,:=QH+N.VSIG0:?V4*A?XR/')K!@EHSP7N*'2NC&`,G&QI@2MM,B`2)])RY=^0\?2_& M9@I4'"*S4<W611%#,Y)](/Q*/K7[D)7-$QMC6B1.9'!(@2\5YA9><"452[=0E7 M/6>I67(!Q!9OI]&JZ>6T>"%YP7/H/[-"?G8C1/DE8GS<`;0GT'=/90J%UR_XRBCP@TV;;+J9 MG[U>BJM4`0Z%8FLST"Q>X)PXJ6L@P(+`FC&A\M9E@[GIEL[Z]AU%_\3UO4+?$=@MS$,MTG/%/UAW')R<,_HV\.`^@X@C MF#Z7HC"77IV>9AX?!SX'EE% MR(H^;@8N4/5(Q[]@'3REN9I=GBQ428,A=Z&4K9ZX/D9UDLH">-EL\CQF8'L. MBT[9GL6'ON=3\BOBUJ=>HMYG]RE!U4?6&9P0':^CYQHEG8,XPWH"S]4[?(;4 M8-LL(N$RC,%D?!3XU,)/="*JIJ;"6MXA6'3"R-2LYA"6.Z\O<#_#%[9)=1'^ MNTHI8RU(M\Y!YSW1`))$154E^DH"825*`G$ZD*)G1H7"UQQC@>/S!U4;`RN* MKU;/'2"N*O'9F/M];O(/G#6,%%,QC`XYXKCP310:ZI+S670BWIB*ZCB)7Y*[ M@"^T^(7[*0"!/V&LVP/%0`GCBC`7`^:J!T`W"N/XQ/PC:$UZTU-W.VV;9_SG M(D*Y"39*$6I6RA"'W8#[@^C,%07:$B70-0GW*XW0P<&4;''XVX>D- MU,.5"9HA"TKJC'7H_<"`>K(L+\;VP!JY9HXRX.%+D]T"Y>]E0241H?5$S>0;R9VJT&D/AP*+.KB, M$#:\C45Y`3\R_XR\A(M#`WSHV7@SZ<*`).*Z`=P$$;&FY]W`3Q3:#GZ^WX[Y M0_0)9]I@F'&:;!.^LV&>*9.H9[?+.)64HH'Z?2IU6B2G4HALE!6:U5D3/0D? M-58`]^V3X$P,A6;/4VA$>G4G8A/Z.3F>I2S(M M5+F>Q;6>"'5"LDI"RMT6^GBQPIMTD.QQ/G+X"NR`\KM:P M^NYS&/$5A%>#\4^VH1`6'[L[CBE(LGGB%!,[/;S53/]/!!85>92(7IG3HM(S MU"6#@^@^*#/8@&Z/L,/M(+9K(&OYD,JIPC>'NL8R#=*7CL0AVSK8"L:3_GM] MBO^98O'2)\]]#,(X\;HQKRXS;^@#F8$SW7OYR8M!/(%S?)+TA2A0N?GZSTH% M9'>GH75(>F>00S5R1#U^\LOI_:DRX*[#4ZMI5TJ.7:W7Z>S<=),0-9#C3.%. M()V[X9!;,4O9IU8_Q#P28"`QQRSXMSEGTZZVFG:S65$-+@RE;;)5I:=AL9NZ M-$)-(%$BB[`K>>59+G,.3F5"B>KS3(:=48DMC"\6Z`XN/UQ/ZRK(T M+GE"Y6V*]>$OLG2SZ^-^G`(/0&_TJ&A)";3<(^W*&Q,VV2#IF30&M75BFYE! M@_J"4N*H8)7N"ZF8E#TWH'>O+&#+5_>"IO1,TG$RK&!#+23AZ'=P]#/S:9I\ M9Z*H+YEYI_]/T;GZ9/T.=Q[P]BR,AJ?:['AY"O'VA\Z1ZLXR1#,&\;!!>@L'CW"#)%&29,7HN=J)2%`:JCQM`_%. MG]0GDIH5=&_^S<+;HG7O/&UW'<;&(D@^M`)<46UE*:H+JRYK36J+M?"RJLM: MA]KBK5A:=8V#$NRGVD(L#Z>QNKWR#[#>PD>8_O+R;`P]0?Z)=HI5X$I6"Y$R MX_2,62TYHA39\2MV2A9UDP=FC"\QQJI5'G>.27-5>MOWNX-4LIR]@G*^8B$RVAI$W'RC@ZAL$08_8I^\TE^NH+UK0/Y[6] M\8EYMJ:I"?G83FA#I=RKT_;4,#?)WX+KFQ!;98T:-!&.(B-"])2FT1%Z_#BM M9>FEC"OUAPE?D?&T1!-6UX$[6H%69+LR*E?G5?>\&"OT9+[%W-TX7B3?_46R M7(S`/"38-U4RC4T]V6/OHXSX6%?4J]O0?F"$/ MT0-'5##5A7U:'T,XR\;PMP_MCS]]R)M:['QDT6N>..5)9CQ(@$W8*L_7N6$VZFI MUUW.4&5H3HQ.2(\>W[&?18\03L^P*LF#DWVOX3/48K\X[YTZURW?3'T7#:O69] M)A_UGQ*W%%29)YN^3C8$IJ/TDWI]8X@A2JE/Z5\E"`#^[V'Z[GG*PW[ M5]CMNG!!1W#2`G4Q-W^U[MPT>;*MV],ST[2X_^OLSGSJ&3@COD"-PQ$#=/E' M'2\ACS8C(*&+CJ(^L#'#E-+CGC5\2ZSV!Q#>TI=:-"4Z:*+;S#\*8+^SHG;89STUK6L;D+06`9 M=[3=\IL`]>*!X1[C5GV&VQ'LVZ3''G2%[\<&?!Z0FK?5X`J=3DQ4HX[2F8:J M**F34V4A($[>,B,-BL%9]$0Y$W4$!6-5N/LJ7"4-/')B(+C.F--_@FRIOXR@ M8MEAF*&YKP=YU9@OB'M8)VQTD+-K<8/^"J.O$@$-+WZ\:CE81A[S+L)VF1+CJS M8</ MIE6I-VH->:?-(6R5!:AF21M:0`E,ON(+4)NE"VLN,0$S_DS0(%?P?!FD`UD) M&7]*Q47P@!BY?V%RX[)MZ,HEN-4,W;C$U#GV$YJN_*!.P;L!1=2_>RBXM M#XR!FMVE9P3:3C+6QTSC$H'/EQB=+8-D5J<$_/&:O/C<`W&5M6IE,N% MEOLZ/6.'K,=%@#=].4"\[LURRKG-FCGC:W2MCYM@7Y?*SFQZ\GPJC'@6SX(\ MDW7.!%\67P2WF"G<*_SL6AFW;0'0MO4MX;579SOY1QJ(2@G=1\54WHSEU6H- MIU6M.K-?F>94ZZ[(_P.4/ETP&@TPQ%\M7M*^`*9CY2]8\!KK[]>WAOPS>5_( M:B`Y%N5,PQRPQ[4AU]2B M)D'HN99D/G"[]&C,=XB66HVFB<168_/%_)*7&3 M]3U9D0WX/#;(F#_)ZB058LXJ)!$FMJGV5N1/I5ZJ5(U8P*SQ5Z&CT,N[WJHZ MI<7IF'$9K'IX*N52U>@Y/G^6U6DJ%E9KE,I+TX0)@9BW=X?0SRD:-=Q28M7S M57,J3MDT?N=/LPZR"KG%2N7Z"F1-FH#2G;L^_5RMUYNM^NS^&//F7#.YA1C: M;#G55F,MY)X/AGXX$BI"L4:>MARG9#S%7IUH+905:GC78(RLGZQ"8SJ M`3,S_+0`GQJU2J-4E:;UK,&7IJ`(/UJM4J-<*4C!%!L"??=&GQ5V$RS+CG*E M5JLURE.-E:D3K8.P0I9"JP*/N-KRA*V/1R?U1K512"MU%EO_$4LAGJUTFB:1L/KA9!32(TRB7U^8?.&UUTO%Y]]0+&UV M=O'A1%Z76,.ZN7M0;%R!7_0R.5>]FVZYI3+([$UPCRVT\-YB:WRN5?N_G]TN M80.=^6$,LQ5(**NVRC65LU!L_O$MOA8)'['+,%Y+1O>)TRI7RDW#_,Y-L?#\ MBZJ/$\O[A50'AB* M7F,U!.P`O)0G;[#\3,O3LZA85.IEL-8W1\^B8E*MULM34HS7R)[%Q*94+56< M1>DAQSM+USIDIEYJU,;=^CSZ@A,O;G(TRLWR6J9>5`[05;JF)2^VX8LL6;UB MUGU3-%KE>M.9\ER:K;$*TK+PK5&NUEL5L]!E?;0L?H/4X`*=EH2]#K8L)"65 MF@.T+$3)G8CA'=M](LWQ+/QP:-2;$38ROM[:7>Z"<1'<(M)T')^%\5JRPB/$"-"AOM7@VBMSKH'$A9\*M0JD:>FI%Y:27].:%]O\9JE1<9Q"4^-%=].7R39KT3"-5LV\@',3+#S[ MPMM=@9=T>5VS+^Q5J)5;S34N?:%=;^9SE.9.?N_Z(I9_NQ9K.>).I=EPS*A_ M?HHE*%@<=*/2*+5JZR1A40%H-.KUZIIYL.#1;]7+#:1VV(`TC'LVUD3& MHB+1J)4V1,D*3ZTU,V0A^5B0#-DL*5[G_5`K5XUGSM@,2Q"PN$70*M4JS762 ML*@PU!KU=;-@02U1;N:")*^08$K);V'8B]>D)1IEIS5=5:E9EJ5D8:%H51LS M+J]525E4.,K-UN:8LIB8-*IF54HA4M(.@[-Z8;!.I>'4RU63E,EIEJ1D<7=( MJV;ZS-='R:)R4@N@\/Y4M@-=6 M/G9BJ+E7YET#F:^*TWZ0^:JL[0>9KTIB@9K!!:DT\CY'_1L.L#5^E M"<]6I^$T#16W$"%K7\5\.9ZQBD8%DPY`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`/1[$JY+9<^]4XRY5B9L8;FLU*MS&;<0<9,X*FLI M)T%\M2(G)YMV7:0N+(:5>KU<7XW6&78U;D2\I:>,4ZZ];N@7)&CSRUM\DTJE MJIEAU!6:=V'_>0%>R&O5Y',G&K#?72>65VWWR`A&-$,4%?D,U@FMY=>1T0K%Y MUT?MHHR=M_.%2+T#>X&_QW$;!&^=#IF\]EKCHA.OE^3%83`JC753C9"-=4J)"U\N2Q'$A4^BUZ, MLVZ82[.F6H6D1;G4;#HFR.\R),DN5;I-P[HOWSE3K4K6HMRJEF=NX&ND35KS M'\/PZ\VSB'J1VU^/R5*K._6Y#[+\E.L@<86[=5'R3&[K'C94N:.:+JW%>=1J M-&8?X,W$>G'/54&1?WM9@HE5*K8E9U+T+`NHE?7(2;3BX!8!7B9SS#/WL!'(2M M.#XJU7PYW6H4;7Y]"V]7K58KFU6]ZUT@ELN(?Z<(2H-.PT]"%\\4W9R__Y>? M_#JTXF3DB[_]T(O2"7ZP2_'_XM1_^ZS'Y]2:P;KI)B,C$3=O"R6SK15@1.>!$SWJ)O"01 M1&*,K\\^D/=?_\>I_!JFB&4\&+K!Z*?8ZH1NU+/"OM6#)R2,%\56$EHN=NZS MDB=AG871,&3&P*?;4>)U?:`5OH`9EOIO^"71[\,(E@LT8'LQ`>M%[/!XZ'N) M;<5I]PE&=!,B0L!CU>H#H=;[V@"/9BV(5WU*U)PC/V`#PH@_UQ$!0KWU!8#H_N(M4IHZCR8Y<;$_CCU$[4@O1D&<7($&WAC^9Y(B00L-A9A MWX818"ZXN6C(4Q3=GXGQCE)`KNB>$'=8NVQG@CX,06`.B%UBUTH_X"SP"SV%"FX`=*3D>EHDP M#FELZ;9Y\)"?WGKQ8,^",$'A9@IQ^U/07#Z1`B8I<*OO(8B1U1E-L`M6[(&- M?-]]$KT4-M:IGL'I[:/NH;^_>,D3KSEC!@KA^;7@#)LN?`I!P18X%O>)8,&IFI=+*0[1X<1(-1GR^N[]JSA<5" M90B_&A"4E$T,&Z1QDAW;X1#N)3BR\L!90[`B(AQ0[J#+;5.)BKWA(\IDP$#X M0(I4V$/X'Q`#T&T>+AH4X;]3-P)A]$=$3R2`W,3JA22]D>C[BF%3K@A+2'1N M9$5'$(YG)NT><[6*2XQ36G?R1#R0_U)3(WFH-7:@N-1][-2-"_D1W]ZH_2U* M9@+RB!*G9(--C__/N/T04#;RNEQK27<3\P=OY``.?,1I#&V-8'!`RO MW"$U=80AWI5.2Z5*V0)K9F<*7/.A]3H?&G:S59W-AE?7/W7Y3107O`O`^LMT M(-Z,L@D]_GTH>\_N.8,JKPB*YM`]6'1?1];EY9D5O@3P%[@)/KE@`%N783]) M8U1%EMM')0-,S.P=L@2GBQ'RD8@X`%Z6RZ_SLFXWJV7;*=6^1V'+&(2Z_.[W M2^NW*$R'-MXKIS;?>8$%ZAS]0%I.>GSIH<5T]N1Z8#($RB1N_FJ=G=\`;3!Z M8OU^"G(6Q6#&"E^K\6$:@0D!>KY:GR+%.1T'K.4KDRAA'D\P%FR6<+^< MDV8W2A'G%VWKUBN.<^*47R_4AENU5:[5F@B]4VPZ(.Z_?_[6B7SO%_Q?^.?_ M#U!+`P04````"`#`@W!'XIN6U2T3```"VP``%0`<`&UM`L``00E#@``!#D!``#M76USX[B1_GY5 M]Q\0IZXRJ3J-+;_,C+T[EY)E><)$%G62/+M[7U(T!RP!C>Y^&MT-H`G^_)>7E8N>L$\=XGT]ZGX\.4+8L\G<\99? MC^ZGG=ZT;QA'B`:6-[=W/B MWT^,+;''(%A?'1\_/S]_],B3]4S\'_2C3>3(34GHVWA+Z^YNG_RO7JASM>CE(S/9Q^)OSP^/3GI'O]Z-YS:CWAE M=1R/`6/CHZ07HU+4KWMY>7G,OTV:YEJ^//AN,L;9<<+.EC)\ZPC:ISBASA7E M[`V);07+!?,8W7,OCT&A,(5]H*>-Q]X@1-L&%S^BG,+$G!RCSY>?#V"SHL. M@__D\NR$C?E'F;[!9@T3A3JKM0L:.=Z7S6O+93J=/F(LP`# M@QEJVR2$*>HMQ\1U;`=3/O1II>KWH-60&!/L`NQSF"C!9FQMK`<7TZ'C@5;[ M/IX[S.FP8>.O.`MG5>*\A69#8AF04JSPS'J)U79>Q7-IAX88ZI/5R@GX]`+Q M^X0C"XE/@NM%%8/2!!KS(<3^\4C<.>1.-QALT@GX.)^J_4A%QX88'/P>LEA( M:2`)DT;]Y=*1U;:HS'K\R#E#AR@/_;)RJ&4^!L^*A_N MLMKXY/HWYI1HX('>P\9X=.$].D-AY]Z3:_6,QZH/CW$'S(X(DYDF@4B?`D[';0@)K\;B:D9JDU)G+<57>HR&6\N;.TGH&$_QB M.GFR7`;6&77AKTFF^75+788ENK8?->*EN+<<8C`-*LGZW@3;%ZAOK9W`L:UMX$VXGY?'UI;;;*W^[&D?$W1/[RXJ>^H&0;\S(2M>;SY MX`7[MD.9QVI>"_L,V[YRO/DOS`YAD?+"PE%MA]\`Z9:$3/0>,_%&\Y:C=AA1 M&K?:?>FW(Z[AK6'\@O1'-N_:EUY+Z+&E/(.?C^Q8S M,G2L!\?E&RY[0OBF0=H1/+&F-[J4*C(M^LAKXH6TM_0QWFLM]`:2+:RO)9D6 M=&E]6[5^CE674KM;K?572[7(M+SY^I:UG@R=EK9CZ[(MVU_$KFVY=NCRM?L0 M_M[I@5\"[,WQ/*'#F'YKD0-\S(C$]2A=U$%)K_1_(6*CB`3:H=$>[\7%##O, MG@*'VT-R^#_,64I<9\Y,!\7]44P@YC/AU"7V#G MDA+2SM*RUL<,^&/L!C3YA)M"YZ0;5Z;\,?[X']'65#_T6>5#,H!K/6"7#_N/ MN%VFV;$ZAHLW#WM!'ZQY`]Z$%S&5"R+9/2M@RG9ZOHV(/\?^UZ/M@8OEVSL6 MDR\3BEL<4Y9R\BH#!RPCZ;\`)R[2=ZQ;LH\H:5R`BR/TC)WE8\"Y5XACO$=( M)]C&P#O;*\-!M1T*>\FA=JH4-1FYM0/+\%C$8#D&%H"SVTH.C#.E8!3)I9WR MQSY>6\X\WDR`&6\&C]B7=-Q2G>6@.E<*50TM:(=@Q&55=-4EZI0YKG>A:E@. MK3$K)'.M*+.$R+AF&9C0!R^V&[*-MV^$S)\= MUQ7%&9G>>L2?TL`CKP#MT$OMIU7&GZ*V>[&>7\^RIR*`E]="T?2ZO(`CUKZ\ MN6K?6Z[4Q'3$_&MJ*S5
J33M#2#89XN,,2`OA$S^L-Z=K$9$#^T(]V'NH1CMX$X.=X"?LA4R&*".0 M"*V5/>6`_*0>2%DE:(=>ZO`N?>98B5U5/SGD/JM'3DX!VN'&-YQJ(5;>0PZK M+^JQJA):.Y32O&;2;]>BU%DX$.BK@*M%1`[+2_58[J$:[>!-5\2:#ZZSC)[D MK7:>%?TDE_\GZE&4TX!VP*6?\XSJ@\K!*FJK]@`F2C4X7Q4'S(6-56\NE2L_ M?\I2)JIV%L4*S8DG@TF^I>IM)&E`RH34#HW>'')OD-MRQY8S-[S83:7X%ZPT M)?JJWCZ21DQ>$=IA.&&%8!Z>#RS?<[PEA95QN`IYHA`_FE^.H4Q?U3M"TAC* M*T([#%-Y!"R)ZT3=ZIZJPYBL;!DTW[JSH_",H8Z8@H9",7\^SDHYA+\/4SI9 M?./23AWEF7P=)?JP0^_/;5:`5MS,M"/"N4B$5T*(+%"*E,)FVMVAM+ MHB*05#M8AH[-BNAHY33)-52>A4N!42*?=CCPS55I9UO<6GE.+86(2%+M8/GF M$TK'/EF(UCL[C51'C@*.!?Y)9]WW"0W,1:5CRC13'2.J]5\H5X'V.XH]4G)_ M1G0]R!#$$CBDHL:JIX)`@@PD1:#I-AVB2ZI=5J4P7SF>0X/HD;VX#%[@GJHZ MJIXR-7"2TX%^DVF*73>Z2>#.\G]@)FPE;J(^JI,O>%F?W[-]#QV/=P.ZT\\@($V2 MB8*99JKC7R'7V6Q<`*QN$9"O'"(^*Y9&22/5D4T*@;Q4VFG>\`+L8QKP2?T0 M5(:NLO:JPY8,'F)9*WS3@3?0Q3?O[VP\7\AO/#-**"*E\A#YGR&-[HX;$<\& ME@Q@D;('*6SXV^$/2[^".2.,:P@F3P[H[WH3776T]6ZO%XN(CI[;&E%I??#: MQ[9CQ;>1]5;$#YQ_[5RL450:+.BD.JJU;1BYVN)*!3;HKDL>;VEIU.#P4=$(EZ)IC@MP^*^2[P=%OP]L^C/)H^4N1YY+HJCKR'GC6 M2BM3/SOHN9PXGO/[[*ZS]R17YEZR_54O*0]L$?74JET&7LRU8/.HI+WJA[,. MC+I8;>T'[E2I7^YBRI+H+>ZB^IFL0X9P&>5I-U'3":*Y8"O(&X?R5&3LXY43 MK@2>N[JKZ@>[#NVT9979_DR>A@\!"2R77='UR!X#3LN1O-1AZ"35>B63NS85 MK1+2_(5E=7+2HM[*%I-[@2&9:I:K23MOE6<^N0=-N%52T4W9.K--5`L4\P[@ MW+TKK0ZBV9[*5I!M@EJLGG>`J\S=!?LX9S$]96O&0[AK&57JMUU0*<_NX[UO ML(DL(65+R0,:0['RWHD5,!N>6JY5-Y;GNBI;=+:,=)&"W@.VF?M.]MD8KEDO MV<**LDUL2Q2D'[9,<+D5-C?I&^`+A==MK^F#K8F]-D[3FHI3[_YD.,_>YET#=SS736-*0U#7J8R MG=&.*ZNG9!$\6[[H"J+R+IJ&N:;0+5&1?JB6Z.'6\2Q(<1J/:=)TU;ZYP<9X M3F_!9B9X'6-J+M*WU@EL7JJWIO&L)NSY-T!(*TZ[3>XT\\D+(TW^I+"YJ+JP M1J:OIN&L.<3%2M,:[_HS>Y_9?/!@UARV[V(&U_?5;_7/[94GMH+H'CY9N\WG M:T)^F$_8G_O60K3`J.ZINA:Q%8AE%:;=Y$U[F^U+Z_E;ST6G1^)>JJL56W?+ M98K2#MVTYQDZ'J;)JX/D?'.FB^HRQ-:=NXRRE1/T,H?@'P&/L.F6@6]C\SY`[8FCEJT/)%K3SUU MM^BT/&5K3SUUO9%.-[*.K"#T3`3)OD3D>3'HSPQQ-46]T@ZY[4V/*/A]/!M/!:,:_ M8AV`.$HKH7$YI\Q(_(VYF#I+SUDX-GMC:E3Z!2"-B>O8`!N7\K18RL]9*:?W M=W>]R6],G*GQ;63<&OW>:(9Z_;YY/YH9HV]H;`Z-OC&8)A*>MBEA^I60\2J3 M#E.OC`1<&1/Q5US2LV))OV0EG0R&O=G@!HU[D]EO\/.WWO5P,/UO-#1&'.7^ M9'!CS#C"(W,V2%HD8I^U*794#3"S7F+TSHMENLS*9(SZYMT`S7J_ON)SWB:C M[.$F)ZIM8&Z(.X@E]K9F=U'(>/BG6:X'_WMO@/4;T^E];]1_5?7G-AE.[QEQ;K\4OMD+`N3*H93X&\X_9_RRF/'SO'F/O@\F,X.Q/9Z8=Z!O$YQL)$\LQV6[ M?I0&?FA#6-R)Z%$`/"F6XB+O,:>SR7T?PB"+`[W^S/ANS%+SDQ$Z3"B8^99' M+9N']DB&XBC>S47Q7:\_F_1&4R8(B^6)%"V'[`>*?P_996+L09R8^^+HW"V( MSM=3F++@)M'@.W>6"=.M1F&Y/"/Y72Q++O[&1-E5/2FRZ)4N2@BB#\G_VKT` MGSUEW7G(/F8]XTE'L5"Y`#S]:V\RZ$!&.&`Q[&X\`//BZ>"'B$RK`@B"L4"( MTYK!^!"29$*:B/M<(,Z%M$,PG`YI(FYS`7@WI!V"U?S$+5Y$CMBF,+N6](:] M.\8M$2@7HPOG+[^+R_+FT:5LA M%_(+]?`Z$HJ&XDI)#::%/DH4RBT)E16SP:R]0F@^4,(+,!4JQ@A@OR/!0Q,TTX@9Q=@ZDRW2. MDEJ7RIE0/E>)J"%.+HKS,<$2*U%X05N(9\1<0`R'Y9/IIQ=3U:]PENBK]-T2 MJ4.42F&*6ZO>9):')_?BB7+AM3L=%#[U6/?M\"6]5>^'[XUD'>5HM9F;V@N3 M\Z.Y55-$`7$2AX^O@JQ\>T+#C^BH4*K<^BE%-TJMTI31ARUM%!'7(TYD)+X- MV4;]G>,YJW"55#W?B)X%E2:@PSLGQ#Q6OVV])AW54:8FN&5W>-?2FG9!2%(, MPYL]D]^PYE.KP=!`3R.ON'5L!C(H;LX,4,=4GTX>RA)S^WJ\MW)+0 M;\H44K14UR`?R!)RVM,JBQ5D@>DR+7$.F-MNKL@!8\I:98`[TM;/_R2[*RUB MD^"P,O>K1T5UYE<+U.R+Y/;0UWN9VI%04LO6L_PQC'AR1[31H9>SF:,9O@%A M\@W8^%AYLSTMW/U8*'S^%(@*,4'-[(4)^H5Z,VW3R;PFPWE)E+N2*I" M24SL>!P4#Z1\5B4F$_,E-8=R1U`%9$[4)(174/C-[PU ML%1PIB8\3SO+G1SEQ8\H%Q^1'>IT+(L].]^CN3O137^"YR&O[9F1U.650@WD M]GP+#(`/AZ+QT(+X*!D1\B.T'1,%!*5&5:.:Q$+E'%YN:S@O?$)0P?ERD7^_ M)EY(>TM8NLL?L9_E5C]E?IU31Z_D%0B=K@<1"76>R_IXS]=SWL.<4)05.4H! MI/JG?GV2C+S'`8%ULQD?#;)\,F!$((ROLCXB'7[`=\GAN#`^BONMR3J]E@0+X_7.M#ZMZ&?]F MD]FYKN]`*+7_THP!#9Q5=%J^`76Z,^O%]'+BE5B-;&?5)S>-8E]/8UKMYI25 MF&*TWP\($P6WLN)U)N6?E*!D5T1)+$Z+$?K*`0/ODW4$L#!!0` M```(`,"#<$>M78'S^Q@```Q8`0`5`!P`;6UR9BTR,#$U,#DS,%]D968N>&UL M550)``/82DI6V$I*5G5X"P`!!"4.```$.0$``.U=7W/BN)9_WZK]#M[6P1(#[L)L$!Z9NX+Y1A!7&VLC&R2<#_]2K(--K9LV4BVW)UY MZ"$@'?W.'^D<24?2+_]X6UO:"T".">TO)\V/9R<:L`VX,.W5EY.'::,S[0X& M)YKCZO9"MZ`-OIS8\.0?__WO_Z;A_W[YCT9#NS6!M?BL]:#1&-A+^'=MJ*_! M9^TKL`'278C^KGW3K0WY!OY^,[G#?WK-?=8N/K8?M4:#@]@W8"\@>I@,=L2> M7/?Y\^GIZ^OK1QN^Z*\0?7<^&I"/W!1ND`%VM.[O)[?_>=X[:^-_6F?XG_.S MYN7'MR6&WM-=7(#\C;]N-LD_GV;-B\^7EY_/SO_)V9JKNQMGU]K9VYG_GU?] M%\NTOW\F_SSJ#M"P0FSG\YMC?CD)\?C:^@C1ZO3\[*QY^OO]W=1X`FN]8=I$ M,08X"6H1*DGUFNUV^Y3^&A2-E7Q[1%;01NLT@+.CC']=N+L*X<*7I]Z/X:)F M"ND0:,?\[%!.[J"AN]0$,Q%IS!+DKT90K$&^:C3/&ZWFQS=G<1+HB0H;00M, MP%(C_\=&M6MUO48K"S[J%K:D]2GY]10K<[,&MMNQ%WW;-=TMT2Q:4[28`TKN M"8'EEQ-<>=D@EG+6;IV1-O_"4]?=/N,^Y9CK9PM+Y+0HS!O=(C*=/@'@.EFX M$@O+`#+6$6;_";BFH5NY4"76%`21]$=`].*,EJ-G,DAA?60*+;V6!&A=W7FZ MM>!K+F2Q2H*`#?$0AD"8U5V-HF88)'-KT>:;H"]`2Q,8$6%CM"]Q1W.U8 MW^J/%G#N3!M+M8O`PB2##FG6_XE":&6QU\RAY' M,BH*`MC_-LR'CO">$J"UQJ)5&#'*;IA(W[.G,@8]809GTVCLY=$],? M([@V'0>B+6V5-M?.-CZ^^L(&)<=%&P./[MC&.X9KOIAN8.?-L^SAAZ>VA/%S MAG3;T0WJB;S6,ET89W5A/NO1`7]N\!C2?R$#B=<*AWM*K5:J0PW^+\:E'E(3 MQ6FX"<09\/9&HE"8,^'RIV M#4&0XN9.PGJB)OP_(I,7W2**&^J(A,\OH`=PU_*FZO[@`V#8<3>F&" M\AGJZL^FJUNBV$DC)Y\9K]F\AE68H!R?3^>7(SJR^,']=A?L1;_FY$\4_?+9 M#?WFC#8NW5XAB#O*/>`+("V) MR4#N/H@CS9N/6CFL"+?:HO3EL#NPGW'[">$/;]Q5E)XD[9&8SR%_@L4M1%.` M7DS\]0A-<,Q'URUF\,[4'TV++K@45.%1C4+#(2Q\@;:&^@M]06"0[*J;M MGN*BIWZ9TT0"\G'O&FLLX%HWP40;5HYCQUZ9MDM'N#O\9P0W>7&`OP")`3@@> MF^.$OR9$_,RUIM;0@EKACSA@USP26H2&-.C)J4P1K.<8X"Y%!G_&'MN!EKD@ MCD/SZVL!@7*`)F'S(ZZ=]U M9OV>-NY,9G_@?__HW-SUI_^EW0V&5,?=2;\WF%']#D>S?E`BX+HED6MVAE:$ MI?8A2X-A=W3?UV:=W_?:N9"(DS]1*XR[>7:(&Z.^'\SN<<_Q^E-W1"VM/PR; MV:74D2XKD2O"0#/6:6:C[O_^.KKK]2?3OVJ]/NXTV'1\X)\D`D]/\HJ`/C\$ MW?^_AP&V_,%T^M`9=O>"OI(Y+K/3OR)@6[&Q%W?!Z6$?O)9JVYQY8!'<%W'3 M'G[K3V8#@GH\&=UC:8_PZ.JQX[/1ECJ`Q;TKRFJ$Q"C:D@#AGY;1%9Q>*)1%EY,&X(#"V,0PN` M:*.E%H*B$2S:P-8\-%,/C4;AE"/*O'ES$:'$(Q2/FD;)>>[=)\BP$9^M@#$+ M&A%N+')"%*+$Q5BZB+K4G4>ZDKIQ&BM=?SXE.RZGP'*=X!NZ!],X:_I'0O_B M?SW?+>B0J?@`?]SQ:.F/P*)MS_W"265/%8!.QUT.V'ZY0\A[,^J@`+R_$LVY MW.\M?W\VL,O&AM>W:&M?3ARP(A\"9$L\]\B4IR\[F,I!6,`8R(D&$9[N?CFA MLP`?"S9&L/AR@F<,"2R7J"56S'^S#?_2>3-3#"\/#:':3=S2R])F5$FP,"=, M+2NCSYZ_9X.CI1N($'S%4YFN_JP;-+O8,9#Y'$X%R-)=-J6: M*923(:8O5,85AAS&!'^9.]HDE937719VIJ=344V](FKJU5A-O2PU78B-1X+4 M[J_DW_UBR4&P<5!*7>&RP+*D>2E%FF-D&F`,$%T$2Q=II&@MY!I'S!+N)['" M[;\]FU[Z#^DD^Z,R#`&SBJLMY%34+$%?B14T\?YDS1;:&&W7TAV';NPQ8B!2 M):6&VN+.`LZ2^'6ESI*PY`1)4]T-0J$9<]Q+)I4N72LYA`WYT+-4TZY4-?YF M2+"7&/+R9*NC.FYNTA:SJYP@;L`,CI:848"<$0JGE65J,KMN??3( MR0M3B]5.\PX$R1A_..3P]XPBU^+R$GF6^#.Y;%YE'0*(G2TQZ*W[L282J6 MSQ:BZ^6[A"EK'W:T-8]XY71KVXI]:%$1JJ@&K>-D)!9EV"_DPBQX\1&U' M[[931\L[X#@`$-SDH`]9`E[Y9W>CX6W:GG0!.]H&VI'DTM8#H[MC5:'GX M4SD3-=E7+D:D%#_IFE]*X0*.%L+AW=BQ1_(^]WN?^RD]]Q.D);)W?Q,[(T1O M,.QLW">(S'^!Q0,>$U"H`X\MG23:^MT%T$2`"7&ZZ:G[4AI3=+XJDV4U(Y@C M6(TSFI6K+J6Q:HXCR#018<:8I2'E#C[4W1J57-GX$2RVU/65?P($QQ!K@GRX M-5_`#$:^&N+0(G7%A9]`187*N$CFJJI31W+,7-R4KTAQ6X3BO/ZF,WK;\!=)\3P4Z8:[T:T90.OS#%,K%TP]C+$"F3"#N>K-54S7/)!& MQ!N4,AJF`:B'698D!Y8I%CW'\_>\M/>\M)\]+XVZD!EN)3VC[*"8VKE@B3S58V4DK*K,K;K\J=EK.#<$_\6? M89-17:G<*4&C`2MY*D,,9:=.D0]3\RV:]$,^\RLVI;I:J5.2-9LEAXISIS*5 MFEE/K=PI\=KD$X#PY"G6V>"B^XG^5'IW:[`SA1WNH0J;M. MIX)@2G(:9;*9G515MN!KDW"E@F!^L&2L3*D,R;.FC@L6TG:(\T)0USXKD83" M25U29)`_FRCWP=&*8/[$AEU46J)3Q$J/#XIG@\EUAK5/$E-'/*)SQZJ*85/3 MQ$H)S>J0/5:%($0GE55I89S#?Y4FR`GQW49S24ITNIA"1ERM*Z]]PI@ZXE$\ MCVQ@/^.X).')[=3GMENQEZ7CN40>Y>07M$MZ//LPCXKFM)(_P>(6HBE`+UA+ MS@A-P&)#W[F:P3M3?S0MD[P%D2J`V,WC"[;8>[:8`"W1]TMVN9IX<"$. M(CUS+*6*VEEDF;RJEE&6"#@KFR>U4C7Y7=F"YU"4XBE;HG6E<@*50'V6FA/E M`VBFYE)$"U64W\33`^+/2C9+3T;R&S[GD>AYM8E%Q41Z7D$6D-]TBT>HK6KS M>XH)M55!3H[?]`6/4/U"\T]U$FH8-$NHG^0(]9)'J'ZA^76=A!H&S5R_DR/4 M3SQ"]0MA+UHGJ490LV=+$1;%!JWJR5NXK"9HI6DL>ZNN$2[4V`L59. M*PJ;*5I)?NN:RVJO=^JOE>N*PF:*5I+WNN:RVNN=^FOEP**PF:*5Y,/:7%8; ME,)!=IU$&X7-7I:0)%HNJPU*S<]KY<:BL)FBE>3&VETNT78#C+5R8U'83-%* MP'&6KFQ*&RF:"6YL>89U[+668"Q5FXL"ILI6DENK-GD\F.[8O-6 MK1S9`6[V:JPLZ7*YLEVQ>:M6ONP`-U.ZDIQ9DVMM-B@U;]7*F45A,T4KR9DU MN59H@U+S5JV<610V4[2RG!G7.FU0:MZJES.+P&:*5I8SXUJM#4K-+^KERB*P MF7L+LCP9UYIM4&I^42\_%H'-%*TL-W;%)=JK`&.]W%@$-E.TLMS8-9=HKP., M]7)C$=A,T^-T5@AX MMQ/Q'3%H\UY.3*EK>_+O!P[>#QS\9`<.>D2Z.%X`-O[@THOY]UW'2?@U_3!" M07)J'U0X2D:JQ5I)S&2DQ:=4J>8`PW$*R5:NVD<;1&I0Y6,-I6BYU`,/]_JV M>8:_3M^H."A5T9&'['X!4R&+'OW8(CV_YA%IN%159Q[RRC2&F3DBR;B?,'[8 M>?^.3S0N]XHS9%^(5F49U#EN!RC&4TG]@H&0+A.,,4CR M&6&I(VX4_C,X+"4P*Z@N^@S@'*L.%<14_?6S!;<`^):2?/'<[C9$>M&',X.N M;H5_[T+''4+W#^!.@`%7-GGZC!V326M280,IAW7FWD=%"UL8)1Y[]&W6(TL7 M9X<+5[2FYE=]7Y!Z7Y#Z&1:D'MW][4E9JTWQLJHO);&X4V^=*(R4Y]T:=HVJ M5HF8LDY32@W>(Q*G&[77?X[47ZEK.WB:L28[\4L_Z"E"?GKI:48149:M$&5T''L]623/F"7#,E>U=\V9)B*:?(HWI@=4K`^O^$8'2(G''RG*HQ9OJI[)_)H M)!T\2^2BT^RF3Q"YY(+5.ZC;LU?8VX`9G#V9:#'6D;M-%3]7W:KN#,VC"GY& M6&IIRU3+R`84T018.%[-JQAV[7FS!@-7+EZ8?D?T2)5H,<7TPZY=V1T$1_<= M%B],_10>UD0]1>(S03CG629)+%_9$?$#4W1<+19&@0)DGF)/_47)I@T=T@ M%)K$QQ66@TA]%)F;*=6V)+ID-`]W*D($M3U% M?P,C.:M6W@7E>'Z*PPW#W2#C>!C[?R0M0@U;4_N/5GX?6_FY]J; MB?0$LO_:L1?X.X!>0/I&369%M7=M./E6+=R=X09&RPCXK'V"E"K5;.+PBA[R MLJ'HEHY(7:F\J2-8GW*V>,2H]%8WR+,LVRX>OC%@YB*.7SZQ>$7;.MG]!_)A M+VGOIHO`PL2%24IMZF)9O&!5N<#<(DZ!S1S+JO4[T?";]&\Z0]I'SCW@&,BD MSV%QQ@P95.:7BJ^5Y69&S8B"P09-Q?-/HH_Q"."]MZ`1HY'G[(!D.9^8BHK;L"O'"LV(E0U<'JVV^F M^]0%R,6<>S;5?P/&ABPQL8[7\!-06T4Y^6"I1_0CUU'C<+?^HF_0Y8?0!@&P M7;SPO>K+H.Z"Z9=';!;`<$!DN1O;_;*SM^=7YV5F;;R`5WJS:IE`* M]RP#^B36@/J.:ZZ]_8$M%I0UT]]&=HQ!AAGP559;F3EX8*FDZ+/BPHY;`X2B M9U.ZNO-$#ZR$\MR, MOIA>25W%<&)GB;XM6/2&0:`$>Z<^));($PLK+FHVYK2='HDA9;J,DPNK+>,4 MS$P9A]9-2MUH#R>OS?#PY^CTW6[.O>A6?"^:DM,H/2U,\'TW^GTW^F?;C4[N M6C?;\"]9&]/\-%3?H\XK#?46E_EA:N MQ5)/'TY^O?N*X.8Y_4A:I%!%6\LIY@[3H):TDWP#D*VCQ=2%EHY2I9E0LJIG MG_EDR@+,7.D6+-K9Y.L@5:+[`E6]2LPGR`.\9BW@&B9 M*LODPI4]G\LGV#30S/XO_.XSHO`GQM@&]N[N_1W'AFE*WNEE$_2J:C989Y@2??T%W-Q!Y?N)OW0 M>JQ<9:]I\DF7@9W1JPV0\V0^C]"];NO>PG@7 M!ZY83%YJ`0Y`\<\IT]>"!"M[$)%[7>(HQM2?WH:F&-[:O#-:AK[+O5Z11$1] M)>=FAMFO552L?^NA`)N`% MV!L)EI&+>FW-HP"7S"ENM9D%![<;D..CF:D#S#KJZS,+.TM+HG.ZDB\'#EM- MD0NMX_45UD@!/EC:$9PPQ8'*"Q"*:\>K7W_MA/E@::?:W"F,$'?S?]$`?;0< MV*YNK\@1\8[C@+3'_-+K*:RY'/B9RX:5:@QC!=CN@CN[^<*1E$KJZRH3/$M1 M15.CQ"AJK-.+]IP9[!A_;DP$IG#IOB;?ZN_785917TD9T)DS_A!;I:;]3#>/ M#EWS<_LOW`_775PG;2K-'P&R3^/N@/P-_\/4$L#!!0````(`,"# M<$>J5I/\\5(``$+-!``5`!P`;6UR9BTR,#$U,#DS,%]L86(N>&UL550)``/8 M2DI6V$I*5G5X"P`!!"4.```$.0$``.U]>W/C.)+G_Q=QWP'7NW?3'6%WV_7H M*O?.W(9LV3W:L2V?K>J>GHF-"5J"+$Y3I!JD[%)_^@/`ATCB24H$TZK9N)NI ML3*3F<`/B40"2/SQ/S\O`_2,2>Q'X9^^.OWVY"N$PVDT\\.G/WWUZ>%X\'`Q M&GV%XL0+9UX0A?A/7X715__Y?__G_T#T__[XOXZ/T96/@]D/:!A-CT?A//H/ M=.LM\0_H1QQBXB41^0_TDQ>LV5^BOY[?7]/_F7[N!_3NV[-'='QL(>PG',XB M\NE^5`A;),GJA^^^>WEY^3:,GKV7B/P:?SN-[,0]1&LRQ86LFYO[J__]9GAR M1O_C[0G]CSF[']Z__^'DS=\LOY9X MR3HNOG;R^23[OY3]CX$?_OH#^X]'+\:(=D@8__`Y]O_T5F;X[>GWWZ.9U_E MC<];D$0!OL=SQ,W\(=FL*%9C?[D*F%+\;PN"YW)E`D*^8_S?A?B)]OB,?>B, M?>CT>_:A?\O^?.T]XN`KQ"@I%I5VG55D94S?N5;V#A,_FEV&[;2N<_>D/AT[ M)-G!@#*_(%K90O/B-1V+G+NQ8]< M[CH^?O*\U7=LUOP.!TF<_^68_>7XY#1SW_^6_?D?X_GFAG;(*+Z;1G066R7'0=KB*?N<1$NC"EEC M10;"?P2/A=RT9>FG%094R`B.>=C2J&/+5MBT9*;=,J#4+`3$X?&GAZ_^[]6: MA'ZR)AC1.)#&.9_9O^,_?K>5VQ]Z[DBTPB39W%&-DT$X*RPZWTSHMP>?_5C1 M`E:<+I'5P)0RSBS8P*#.7M4RZA2D8)"FUZ^.KIQZ"RE8&'J(YLF+1_`HI.NL)_\QP(,X MQG:(,O#V@2\K#%L68>;BS%)6);FEC&;D,18%#<3N\Z MGK=2C@,F!FWEH%00F[RY*,1E@9K#J;*8T!78,%IZ?L@2>K'6YVKHW:+6H'85 MGPIB0$C4:UC'7$K'\Z]`/.6=1Y?EB1X[-1JG*P^9>I4U1ID`#"YD6@GKAI1F M5Q@LEV3.._?D[.T)[UJV;?"/OV$2W45^F+!_7%'_-HDJ?[KU0RSM],;<+N#0 MTB0&E(:LO4.HG;YU]Q.$I3GB]&!@[!W= M;;253`VG)^G4?L)5BW,D8>J&D88<&JHK2Q,?9/ZHC<[`VL_ M8>K@Q2,SPP9=C<9E:"A5KQS450AZ!XE.*R&0FB[P;!U@%,V1*JA"`T)87)3O MK97I[KP-_S/_UE'Z7^GF&TM9LSB+)UXL$#?L:$'8N]\Z:_>D_X-DH4VP<[R'$&K%W,++#61@@, M^.V@N3`#YQPH8T&/8?PIY%#@(9W=1G-Q@\H3)Y7(51#SR*\6&!H_67I8SK[:K MN85G:RNH=SCN0_LZ8DOBTE4!%7B<2D1;D955QEY$"=DI*&+@RJ5<'#B=$&24-]3/^CG#QL(A(,L%D>1UYX7"-)]%D MX9/9G4>2C1H@-ES.D&)O0@$9,PL,[%CK*6X54<9CNE98(L:**"^:1(AS'W/V MCO`TH8YL,5CR"QC4C5(OF+!+)@]XNB9X=D=[S8_CB&P8RM7X:B/%&=[:FUC@ MK[D(&'ALK7<=GUP0RB3Q^3&7A3)A:"N-3XPPE@;W..!7Z]@(FM"9._:F;(:/ MSS?E7S1+AB8"7"XEFAM67F+8<_>.X]8JBP$>)T.<#I5%\#WVZL^=KE>N_/D> M?&X;*>XR+ZU-W.9=&HOH':N[Z2T$EKYKGZN*.6E/_Q@C#M[(YS;'^^_I%$ZY4FXY)J%'9@])%'A$W<-2,F?=K%&RZ&L)#8P.5RM6[_6, M$J6D7:WZ[W\<:5;SI5_=K=(%E;:K[^(G&)TIZ",=N?@1A_$L(G,'`_A'3%7' MVT]J]OT5E.XV^[6J;G?XI60P^E^K6QT+*7$)#AU!X+^\Z:]_>Z&+`?])W?L2 M(F<=KU2PZ'.!`D9WJ]2J]S2C0QEA5RLQ_RGTY_[4"Y-TFT&S$%.1NEN'Z97= M+L/D=#`Z7Z^H,"`9E"R`H MZ&``0:]<'0B7QXP<%?1'B')TA(6A]^S/KJ-YLM:<:Y`0.>M_I8)%SPL4,/I< MI99PVH71H900QK['E3?U`S_97`11[(?RB,!`ZW(W0ZMN>>-"2M@[6&RT$PJ4 M><_$#P(P^V3LJ-8T61.J-RO7DF:N,7G6W78P6@=M'2?1DNJD"?%DA"ZC.K6BY4!. MI.H=*4;5ZE#)ZLGEE!W'9PN/)+[&0]0(W$5E,L6V`5GYU]Z[6*F2$(:E-%T% M8,O'=<"H-Q7'I`G)]`SN@C0;Q;=AFXX:!A9L5!1"NX*G-E.XN$`P>8G:W2%0 M,_9SC&$B"^SN@:$,0$=8>S3PT2-H=*/SC`B*%1@H/@%1A_7U:GW(?T= MI34L.NJZGQ=4OZLHFFG6QB*-LXY4J5?T9YT`1KDF!DB--UU;T>N[^? MG&HZMT;AKFNEJFT[MO(SD&Z5Z20>BPO7'EW5GI[PFRDP\I_\V8;Q/#-@3.[] MIX6NC3^V$:;P!Z#3>6#F--Z?I=;8KG\0[OV^E[]ZWQNY]VU?WOM5W[UN`W?NV M4?<^8-H2LV[[]YVQ?]_UU;_O]/W[#F#_OFO4OSQKV6WWOC=V[_N^NO>]OGO? M`^S>]]KNO<*/).W?_<1T^I[]WMBSW_?5L]_K>_9[@#W[O;9G;ZAF"T1'+)Q0 M_<$+<'R/GW&XQC^RI>&MX1%)'8/3MUJ,BE>>7%%2]PX?:Q6%72C&``-%%ZR_ MPH3P`G_W?OSK^>8.`HU2PHU:=IT:#<#ZE!(T6.OHX7[8!QN/,>YV7.<]^8YS@V>XQRBYSBW\!SG'?>J MYBZN0.*\5U5W;VN_P^I5_5W;M%>[NEV;ZS`T]^JPMUX=&GIU"+%7AQ:].NRJ MO+8?^Z-PJN[3&H&[,MHRQ;:EL\N_PNA-F4KUOLQHNJI^\]?;*S_TPJGO:>ZA M28B<=:I2P:)C!0H8G:M2J][!?[U%!6%W9VK2@Q_:DS55$I?G:V3*E4_9E']W MVKG/F#Q&,;[6'+F1Z.;\X$VUOH:ZD^5T/=4R472WC`C&@-9H9BIATE5\A8,G MK'MQOD;@+K:2*;:-K,J_PNA;F4K"EZ:@O;[S-Z0G;.5#WID#BK#\5RA4] M6OL=1I_*E1)W;8`=KQKBN1_BV3F%VMQ/^$/F0S^>!E&\ILTC^57[:%8,/F@T=@<3UB8.ZC(E5(<.DC[=O>-'4/O:I+N`HGSWE4EW6N_P^I=?=*]VKM=)=\S73Z: MQ^['WL9N7;EZ[WZ$.'8_ZL=N5IG(R=#]:!ZZ'WL;NG7EA,Z%.'0_ZH=NI7,[ M'KEGYI%[UMO(K2M7[]PSB"/WS#3K;O*#?ET/W#/SP#WK;>#6E1/Z%N+`/3/- MN=N^[7K<:K:[!1+G?:O:[J[]#JMO]=O=Y;[M:M,[UT2SZ2V0..];U:9W[7=8 M?:O?]"[W;5=;W_FES1-CWVY)G%^"/='W;?X[J+ZM*27-7[BX+W%Z:@ZE2C3. M^[:NGM"YIQ"CJ;I68GG/$*/3-T[BJ=-3*P1 MN'L%5*;8]@'0\J\PT"%327CV,Z7I>(8Q%SLX[:W:05TY87J!6._@5%_PH#RY M=+UDUVU="B3..]=0[`#6UJ5<*6WG=KQF/S77.3CMK=!!73FA]5>>H*R=T+<3Z'*?Z`AUIU[X] M<=&W'\Q]^Z&WOOU@Z-L/$/OV@R&2V*`W9VF4V'4&\:.Y;S_VUK_SD,\W#Y-9;XIK5:C(7 MD#(IR1"DHND=,`;%A&Q_"HDM+6+$_<'B@A=-"49TB?GY+WBC-$Z@!CMR/L2(Z$K.J/[O"@DRI'`+EWT#TO$0AY63! M:/KLY3M,_(C.=;.AE^BZNT;GNM^E:M8!4"$"A0299DI(I,0TA)@A1MX'.GCF MD2ES%7A/$KMJO[M"@U2M'`65'T'TODPC\?'`C`8QHC[Z^F)-"-/1CZ=>\`OV MB-H9J$E=(<"D;`X&%1T(7!B4$V[\I^0HI4>,H5?GD`8K/^,@^$L8O80/V(NC M$,]&<;P64A86]&[#28/:U;!200P"1#8:UI$TBO.%J8<8Y_&OC!7EO"AE_L_^ M0/53%*S#Q".;*S_`I%Y/0$/G%D0*-:O@J1$!`HU<,QU8"@[$67I$2.8,[_$J M(HD?/CTD7K)6`T5%[G@-JU6ZMI25T@)"CU9!)8C^$*."`Z4L*)/4(YHXFB_H M//H4$74&I$;E%CM2%:N0J9``0HI,+T7F@Y.BG+9']Q(MEU'XD$337Q\6'FV2 M\3J)$R^<4=BJ1X26R;&KL3"@YG`T'(#`9*&F*JO&.1%G/4(I,RIQ]YE^26/Z M=,5_1?\FF\DTM*[3,$IUZZD8@1`$DDS:*5,RV=(KR\QPEOY1PQ:"=I@I4?:# M&$%5.5X*,H!HJ>MFP@I?IN\=*3L\PL..#S(%Q_.BT.M=%/N:_>=FK$X?YFE@ M3.6)'@N^WK'70EGAV9Z??N<3:?L`YB&.YSG M!QBPN?#BQ2")!<>(1L:Y/_D!>OZED9#7J[Q%%/-'@-\BY-LZ*@&H9;% MJ5>S4+[BW#3T8,!FH:0P,68LB!0\1RC`<8R\((A>:%B%^6OF_W[ZX>W1^[-3 MY(?L#.E[CLM]'";=#Q9'X3.UD5T\PBKL54E<8DVF7!E;Y=_!8$FBE)#ZSDE@ M8.".X)7GSRX_KW`88^IT>17FRKROL-6*TR5B&IA2!I(%&QA\V>M:AUW&B7#* MFE;F&F&9^<"@L(&R8D26 MLV:>#A`04V.TGKR/F4\]Y4&<&XH88*UR%Y/1J7]P]_0,/+J]'%:`(.JW99>1U#3WBTR,^KJ2%BKEFF/M@R[IRN5UQOOO9# M/)Y?$#SSDWL1"53MEA7#`H=@],7Y(R*5YZ)4U+W#BQK%>OHNB^CB?[G MAJ7+@01>S&>#5AIDB=^3B?.;=T8O%U[>8Z?T]S-[-J3FNV$ M@<'UKA8(Q[OP,R9L\[&([(#,WOE^Z5TZ!NG*B/Z%K!LXW$82^M@2;V":;(?< M@AT,;)OKK-P_SYPRSP-[J9!BAPH&=/,Q>D_'5KAFQJ9AM2G\-++UX7=-1LC< MJXH'#!PM%96\0\S9Z&J'\\&`VT444A^>L&0T*]^:CS$]V$Q,3D^H61E0.9JF MY0`#,RLUQ0BT8$(AXX(5AO+3`_8X4Y.[1)A)Z3*V5+1@4&504"@`7<;04;%! MSR_0[K>67'M0E:VIY0D"+X[]N4\C7BW.&DEP";T6II71V(`=#$";ZVS`+,#D MXH6W\ME&(J;KKO%CX#_QE9@APC,QN3T6;F-`]3RXC@,,^JS4%$^`**0%=#`X90J MJ(Q?-1QN5PA&U:O+`R4Y'#=EU%&2FLXYTLLJ91[T]0/&_/D.=/8-#+PU/HL" MY?1)L_,FK^"$2>,S)66&/Z`9GOM3/P%R/>^.9%D8KJ3N,IZ4TO'M`I6JM=L$ M=3(PT%'K)KDMD&7'8D:*CM&_GWQ[S(W2"?%8T+GVD*-H65?D6!NY*56.T-T`%,M<3I4S)^NQ8I@&#-85B MLGDP"E.4'14@\PJ0G1Z]>7^B`]K9R9NC]R?OCMZ\/>58^_#AW=&[TP]'']Z> MY>1R)"*/7]%[H)W`GX!`;T^.MI?TAGB:_?64__4=6[C&*SQ-_&<<`%FW#F8S M7K?!"^X\?S8*LX5/J>E5.S@6C$XWT:P-J>R=&;G`C`9K586=LH(1L>M;QWZ( MIBDO#`C>X\3S0SR[]$A(!U4\F$[7RS7/\`S32$/1(C:,+B%H;T@9@F8N,!"T M5E6R69L3YM$C#.R)D;!UR-SW&L1N[0$K=:+43YXZB67+#AC`,1W2-^>.%&R0 MKE48LG-2'EB`L]16#K]2QHX'=(#A.,AK1EQ%9!BM'Y/Y.A"+4AC.1S63X32X M:V->)7 MU#$9I,[SJ#C!H+&1NH9LT-%V@0X1EFDEWT&1([!J$9&I/QBJ#%##K\X!%'8* M-8UP$](^<&''G\IH`KFV@CNSMI>FI#)'.[12]7LKHA7Z4!`QB%8F*QE)0, M!BP>UH_QE/@K=@(ETTRU.2RC=+K'KE:ULLDNDH&!B%HWX4AO2OF("1"<>`&. M,Y59L*8QC]SY5'T"H5++$A4*R.A]#,L MYR`J5H<"IT`K3@($!CC$Q`M8L;+9T@]]M@IG=WFRIW14EIJXG,+%SH0*A/0L M8-R+G9X"RE*NM'IMQ8'!N"[VR`$^7BZ"*,@>MJ@V58B#.R/ M5Y@Y_/`IW6&YIE&':L$KHW2:-E"K6LD:B&2P@C^U@G7@?,U^^R;+'"#6&BA* MF:,0B._DN8W4$%VB)*=PGF:JJB9DE]*?G>+C&9/'*,9:A`BJP4\IC<($T^9( MN-M\3/31F8K8\:-N&H5KS[A)*-V`YBP%38B?>.%^[8:Z1DO)BVV>7SZ<(C3QC2$VZW.#'.3C4:IS4M9>I5JE:6"6#-13+5A/*3.$%?!Z69"`8J M\FOX^?G<('UX#4^3+8VZZ50*&W!4I?"QH5J.-4?`:>I70PH/8S]I\65)L! M>POE"=^N61FG\5PX_&GPJ,W%N`1C6R/+Z&PJ`PQ<6RI>QV\N!GFI'#3-SOT* M!WZ!.%%;N_G`W+'M,AD0,5TQKPV@N8!7A^:RUE)7#!JDV51B>RFBL10`0#69 M:`%5E0CH8#7H+3R]`RE>*`[EC^?L[;6K('HQK;;T+&XKBYF5K]884].#`9F% MDF*-X_QF131'C`EQ+G#W+.A*C6EW1Z)G?X9GYYM/,=N$*7+J`U9?-*UXI8=@ M&T&.LTHM#:VEGAI*`0/BUJH+N?*<`WD%BS8@A9,K?`.I-R1ZR?(H+(T"PU<, M9O]S!9=8]?H`KEDRB_7B3;C[EMH)P=XU5K3F\_^^`&24=&B?6-2X^ MA9((D?QC;-N&CT'V5_;O*9O,OU[3SR`__(8=*>1?1H^;?#/9WC.Z?#5T14WR M^58W.]2V9$\._<[_IZ+MM1QNWPHUJEY])E1)#@;79AW%QT&W'.GQPA+/KA!; M+LF<`^?D[.T)A\W-S?U5_5G=GXF?X&@^K]FD)W4!%!ME&4)T=%!VGRUT-+Y= M_,+HCRD##-=#?35A#Y\-#.4H'JM5._7R+!!_PK[\KKW^1(TML^NZQ?8&U0L6FSG!3(^-U!5V43Q" M/.8.LU=6YA%!,2;//IBBQ7*K5+DG!;'3I)Y6X4HZ3TH)!EA:]:3/E!T_,FJV M$U>0=Q1ME>H"I26GKB+RD.%6%B3HZ9W%739J%\&7CKAWD-AJJ*O.!-?IE-<8 MXSD[TJGRQF<_I'&AK1F7Z,S'UCKVFF@IK@!(?VW$((B]$ MLXP5"`"W"99;VL]>O!@E>+E[7L><.MKSYWK*(G;2:(I,XEZ_!>N$;L=62@HC M<970,0JC\)@G#[VM"C"&IKCH*PS,WH4S%_.S%M#OFMUDF'[QKN(&,W\T5KF. MU\OY'$_YIO5T0?_.JIF&0%+8HFWBZS76S2)C[1>9:F/TF!3YX.>4E#HK7#5= M!#2Q]8LRN1%ZH%5YX&--JJ_DW0U&5%1N*%TB607Q->E@(*ZW,1&&*^*>'7@EJHO5LI.GZ1>4:I-#FW(,&;#[<$+O$8AJ\#7 M.U1E9AC!669Z%7"4*"S9B"@VJ7+\085??EY`7Q;3@@_&$1!-^4PC$WSXR176 M'`'A9!WMD^8957:>G:>HRNE8'C+34.3:5\2@[40XVTUM:5RQP=J0OX_%U$25 MH=_!`%W6G1W9Y9*0'Y9/Z')A//(LO&>4^#+CBSZRY91MN*$E@]NI+60%:8*+6C(S?9?J?>E/C?9\!`%YXQ`43H*$VJ'S_*`/*ZR M;1R1KU=LJLS0PK+.!!Z1"H7K8+RB,3%UD0R*]!-@#JMLS'E>\`NX>EF!:00"&@86A%M#7 M2(&^!#.K+@87&0?`)1A[@`#/XBO:]?=XE,Y6U8F M&XO&43'VA4B](2H\RKE`HE&KJG@FK(S#K.IGZ4+97.(S88!3W#(\CZ)?QW0< MS8@W5Z8#S&S][N[*C=!O[E9YP(#24E&ACB*9\8EA# MWQ>NI&JK@%4AAHPLF:)*E_5USO<-O\1/67FRG//"PQDK3S`(9]G%TFL65HX? M`_])F_5N(J`O)-H9IH*FGALR5JTTU_G%:^X M=6,I\55LW32S1;EU4SY!!S=[PQJ`#_MXP?)3SU[`QO,=)GXTJ^<-%,W83(1+ M^+\/QX2CR3-.U.ENG#L@K(=H4?\Y(=A?J:'?_

_!M#SUX&6K# MK&:*R_L/LROB-CWGL)3E>K4*^#LG7I`_C3(*YQ%9IK6M#<_6V'([+7;9S*1* M]4L[5C"9M6;ZBI=LMMR\UESV-FBZ$*#1SYR*HU-%(0_(_G[^5O.=YZO>^:R2 M]/&*=EDYV=O9['\8#N9?L8`!1"LVMO$^\Q2@!I,U*@<[TW* M5*QM199)`(%#II<)'_S1X(0QP6E6P)9=BY6$2O56-ME?X\F"1.NG17&B:F[`\5[%.P-X!XU2('^/LF$,B?T; M)#A\X1`>P;/U-"^SO:\B/XH1PL?V),JF*"\H'A5511O67,[P;&]"`5,S"PST M6>LI9%6YFZ5.MF!%6UX@X:Z7T+AF/#?OA$D(G0:P2D4KD:I`U3N$C*H)J!E, M/MU?HO$5&M]=W@\FH_'M`QK<#M'YX&'TP/Y^=W_Y<'D[X3^A8\1@ADYAX.G! M?PK]N3_UPB3SU30DOHL"?TKCX0G^G)P'XC3>E-EIEK"1094DH14G&'PV4E>8 M/C_=W`SN?V'@?!C]>#NZ&ET,;B=H<'$Q_G0[&=W^B.[&UZ.+T>5#CM# M^\DO]#]_&9Q?7SXO1+?>M%_>7P]&$^]7;\>0RI\CA^18&/(NI45Z:V)30@X&CA9)"%9K;B_'-)9H,_KIU?^]@X(LMC/STA1*V:\0U%>+T5$@K`RL[T8TD@,%I*[6%#-+XYF8TN:&Q9AJ!7HSY9'YY M6Y[)W\.`\C5^\H(;+TDP$2PV(=B2UR5P&YE3QJL5(QB8-M&VCD[.BS)FGH2O ML`/#)\\^+:)@1I5-;XR];`-^I[%G4[,J0:@M,QB\-M586"A-QA=_^?/X M>GAY__`'-+RD"R4:A69(_1X&4LOEI5DML^4JB#88G^,0S_WDCMIC=*C-1#@. M"!H;5PL'K/G!H+:%TL)[8?_OTX@NI$8/#Y\&MQ?;V?\##,Q>1^&3[>)=0>MT M=M>I6YG-981@<*733DAKTE7V0WV9_1$&>B3W84I1LM';V;.[Q%A3H\JPL^4% M@\2&"HL+G=N?+N\G(P;-N_OQ#75SX_M?4(K9#*MG,+!ZC^.$K*?)FJ3G6K(- MT.W]%?N0LITHMY?UVAM;O;;77`X8;.^@O)@5?9C.+QK?A&V&X@P2VD&YM61;(U.R``-]59G\V?W`]N'QAX MVPLJ=C`(-->5W'' M\_R!KHDN;R?H\B>>(,V!"&1G\X(.L"CP9WS1Q_=Q-^95NX[%[2K=K'QU5:ZF M!P,V"R7%@A%^./5707K9IB(`!LK.O=B/BW-Y^8F!C1W>;)E=(J^9064,VG&" M06,C=85R<8R90?*.JL5.R<-!Y+7_V]J?^C!(,U" MR3J^?HS838H+UF`DY%L[-U[H/?&3DW^($HXJ:#B4_J>2L$#`R&*Z@QV`9D=+X`R&Q8AF@TC&/0U MT59ZQ9%O1[-_E-AA`/(>3S'5B%UGL$.ACL%MYL2D>#51HJ(&`S*CBG5D38@W M2Q]1'R<+3%!)``QLL0N7(95MN0!0D[L]IZA7NGI&44X+[VU?K9ZRA_(X.0P8 M77D^X852QO/BZLPH9%GPY=8-*RRWY'4)L$;FE-%FQ0C&G3715G@FA/(BSLQ" MN.U]J1(_#&B.EBNJ*K^-2.AZ9A7%7C">LXWP:_\9S]*'UD;A-%C/V%WSV@ML M3;(CG7S)J5_MKJDJ+GG_GP$SI+JS39@!BB^Q`AH&14^A;Y_HMN!S&]A:FE&-;PU,8$!LJZFPZ9?RH1(C#-CQR^+G7HQGY8-U MXU5VO(Z.1SJ,Z.#A!^NTP4HK24[W`-N;6MD3;"X&#'S;ZRXM,C`[YK)061@, M6%]ZA!6-9)5#N:9VOM3(Y1*NEB:4H6E@`0-#.SUEA5W3*VO?74=QC"@WXNPP M(#?$\93X?"B-Y[?XI;0;1:*0_G.:%DNXC9)?<#*81:L$J^JVM93E]DCF#N96 MSV>V$`0&RKMH+P8)S/VBK0A4E0$#Y\6M4=N\F(J\E_N[5GDQ.2T8S!D4%!-B MO##A9!^%"15%?[@;?JS'%1.>S=65_;'CD?&Z;>H=-44VFX=_PH M1'MH`BAC7RZOD,>Y6;FMP8M'9OS"6QKLQBP_E]XABN/U,OT;MZ5)N8Q]?*2O MXAK[:R!5*8[=O]#[L.G4+&&,91]A2:M"""I)8>6WACC!9,D>64H6&%53S5P+ ME*G16;U.Y5U\L[MOP.RP.F=#@TI%.2TY>X=Q*W7%$IP%/QH(%]1AS@-7:U:H M[,8/_>5Z><]+X.9//UU%)"M?%CZE=ZP:NO^=9/?C]??0'')GOX/@W@='%];H M7'LJ'67B42H?%2^2L7J=Q2>RHS?I`V7I]V`,L>WQ1UZ1M(@'L^LQ%U&F3#AM-XG<0)G6C8?).*0GQ1`V2J,38!+W<]6">+B/B_X]FG<(9)J5WX7M;Y M)G_<_8[X4WQ/FV+WP;2'#X,:;'MKR$:#<>>OOI[!NB]3-8.YD@.H#&T62F:B MX3P!7FHR:36JGSU"//;.+[GWGQ:-+AXWE=?34&QGMF*$-1,&<>"TLL!R--?C^G'(GYE.0V,F!-]+G*SRVA&3?:V MHKO<7HM'_$&/JX@\8/),IP8V'/*'/2;1M>\]^@&OH:)=*NQ#H-L-N5T-K^[4 MM976N[/'7D< M\840^8796Q8]LL.Q0YQX?J#U2[O+=.:]]F5^X>-V%=@[7O=I11W0Y;-]F=ST M:O5`QP2NS6'9FBT$PQUB.QDC<9CAN6"[#PI]W\!%W MZ82N&FB;8MCW%WH?`YV:9>/SE4>/BT,UXWGEE"33@,X4*$W@94H@K@6L24%^ M'GO`DM1I(:CSC7!2@F9W8L#M``%;9QQ681MB!TS?)3 M%%`Q@9]L[KTD/V6HZQ='"O1_%;O+AC7?X.[BZ[`&N$N3A4T&?BYAQ8XTH.>" MCX[WE.O+&>^I?^NQFW(%#FV\5QO6]7A/O_Y%C?>*R=;C_6#G]WL__O6*8#P* M$TR[,W$\NVL__VK'ND6C=C;2-=\^S'%N-EBH6$`YCN>4A4;P*0\BE(E-Z\LO M:9B[F]2UGS^L8>YH0M=\^PL:YMK)7#W,#W8VSV.>H?_LSW!87%1R&6^)WWZU M`]S4G)V'Z_4/'^;0-EBKS,+-,GJW]6%:YA>O(C+'/KM$RSR7\I1D5Y_KN1K- M7AO-4,1F+]_J?:0Y,E`H`UT0\9("'M!AZ"H%"$%%3R4U%73((61 M(DZKA4N'S:YZ]/1\4_YE\-F7=H<]-[R[1BUT%ZLZI@4*."7Z.Z,%,NS9,>SM MHP3L_H='H3"DVJH.$&@Y7#\(;U"]_@:\@AR,:S#K*%3%H+^Q.XYA!"6\J-KP M*5S38.H\(B1Z\<.G"V_E3=G3>=N2J59-82.F/^S9&ZD&I%D&4)1:*RX^=L<3 M1RA@[^!']I_"K0`YB;.T ME$*Y(I54^[WWKM8H5>_;G`H]I63\,G3,KT=WV].\U$O^&H)&_QJ=ZSZ7JEGO M^`H1J-Z7:::`0'9R986S_N^H^R\_KWSBY1YG/,\!*#-"3>L,!B9U"RBH"&'` MP:"=9):*)G:@)X_+(4CV7J>5P M^S264?7JZUA*E4%UEK?\8PJ>HY#//?Y@^W96X0X]`(61_)WA-.AD`TGA9?> M2:++&7(/II=GT!W$]0[T_=E0'P-EB2CQ/J/'3"8,^%_.YYB]KX`+$]FV8_H& MUMH/G[(G>Z)0=72NB0"GSTPW-JSRXK0U-QCH-E99X:T91O>QK=S\H;W:"U06 M4<`.PB`\Q&=GL,W#?'I)O6-T+^HW>[AO^]98*A-6U%$SN/(R6WZY9;C&AH?% M&DMQZ8!;FECVP@U%]`[SW?2NX_L7[!&$TR<>AGB*EX^8H+>G0/9<+&W4)RJ; M"@&(7TT"LYF$UX9>?6*3H09]?8^7GL_//D;S;UX5;D?AY"5B(U`5][:0`Q"] MHIDM`+P5\MHP+&@N@?'WKPVW]*MX/\@M28*)7<'4=N@MQ+Q"_-9UER#XPRM# M\!5MRKT`N"0()'X%0UO!MY#R^M!;5UT"WH_\;:ID@0E&WCS!Y%6!>;<&`@G; M';#J%*`)VUK7G1IIIK1\YSXK\X@")H)MX7,N]ZFS["WU?23.]*(@I,ULC+5) MFNGD].Y+]Z!\LX19)A!DNJQB;,MD64,9+CUO*_/*_K>1@-ZAO8O6-DDR,#DR M*P/U&;)F(L"!5I,=:\(/[B\7H-%00*GT(I)P7KSBZ3`2JH4E0_&\VL,V,>VI:=L[Z%EON7]9Y>LS>R-77 MY&RJ#&`@:*.E>(XY+`Z\=W7!^;>UGVSR8D8QO_`QYF`>L#-8]+>']7+ID.["&N%"-Q>/"ODH?:PB%85R62C[!GM> MKOX3J*1/ZPK"J57Q>)W$B<=3`[=KEA=0N)@.OO,JZEF;FFDOM:M5'W$Z(.D< MXD>SA\0CB6[YU)610BBTI4->4C[;=83H6'AW&,./EZ2)1^$=;_R.FKS^D=+V@AR6\BXK:'50L=-I;C!]EF*[1`_L7N2VJFDK05BD9[L=R!`WG'H M;HO'LPW-;06BKN<)B^^^IJG#NAGW.9L8/PIN$#HR6-AG9ZNO(-"/6<#HZFE% MX#9WGZX)+L-.$:0VTK`F>*!=G"T*3OBBX#WZ^E/HK6<^Q3R0C<)=&^S$&EH<'W,I^S\?"O.7ZQ*(O3, MZK5\(3X@"V]9X:-.![OD.Z]I5"N;:9_#5_C(XCXN.Q/]:A_B` M!V')7_V,_:<%\VG/F'A/.%]]\@K#W<=(^J^_I@';L$D["JQUGS[P!+R%Z4*) M[(SE..-!.1/B7/$1.I#$?=PHO]J%2]BG!J#;F_L% M6'L-NS98;EZO'J"A$J_*";1JX+WZ@48:'(XK:&-VV_*RO2=E\MB M/OLP)DC%+D`IA]C##+FK4J]IBMQ/!SC8";/4Z&`FR;TT0W._H]E7.PR/TZ]K M.4@?TJ.S@.@57._&=;D09_([N@;&S7LTM\!CZP,$M89)ZP6P)\FCD%\%6GO! M!)/E(#G'3W[(?AG/I2=1$A"[%8$4".UZ]VM@FZ0C1P8Z-[3_ M]E='OD`\62L%#\"3[=`Q#CQ9"^T.W9.U;Y)]>;+7D6W:H>7A.*N#]TI`W,^7 M[&?Z=RA[3%O!2%>78KT1M=L/8W_ZDQ_P M,W!*Q[LP4E5F+#T[@S@#J`+T.S2&V!37T0LFZ;_\I:\J[MWM)_L/!/?;>'L: MGL;OP7+\W1HI%#;GPS*:UXZZ':'LE8\#'*J?5BO70U7XY*L=JHK&ZVRHUKYW MF$-5;J3]4/4^FX8JX)1`3Z4!WP*'TCYL$Q],X0SE'-\12GD8KE+T`O+X.ZR! MFA]'>M/1:JR5)J]I_;Y#4^]S8=]"#5@NH!?;K5R$9MNYMM7\^N<@J->%#W*^ MLK*X'41KZ8<[.L5QK5XI0GLJUPC,179BFPI?)8[7%26U7(64[,V:H)/(J0?M M^H^F>NL2UBYH8./Q%[!I6E@`'9H<3N(MHG$.GE',W_ETR.L ML-(SWNGA3*,P`"]E6AIL\32F05+O(V(OZC=\_#*$OA%:7PVM-CP_L!4#X$QG.N(X5^ MAGQ6M.X!DV=6'6-,+@+/7ZK>:&\HPR7<6IE71F$C`6#`V49KX49*Y@'!O(V= M*=3-X]@FX0#F_)8-TN9Y;+WDWF'>B3GF&&'[%'8^-@[L+>RL24/:+FOVQWB< M+#"9++PP6P_<1N$S/^W;S?L[S;_?_VF+#IMU+TO@IA\_J"M<+8U73(4QBEY/ M19U.FJO;9[H;?_XP1G^'3WLW_/;K.-3KZYP]C4,L; MU-O5XOX++BARJKD"Y"7N6]NT))7XK2Z8969SE/RV5+[*: M!GH8N4H[)95`PENV@ZS<83_T:H<9^`IM2*>C*\\GG13QV*MJAQ']-.\,QY.3 M4:\O-,=IVR[*VG1>=NX'Y^=^5NDUM<>\D#EZ]`(6>1VZ/](^$PO`*376[S`\ M4\MNZ2/5"LM'=7(4L:,6:>R=GK[$-"X\G]18O\/P22V[I8],\;]\4ML6:>R3 M\O\]0[,U88%3&B4>NH\J/80+ST$U4^XPO%.;#G&:Y+;2[`OP2RV:H[%3VKX2 M;>V47B7H#R"!\64FWNW;I?F$G*;I]Y2_L$_,-WB2M9V(/A/WMO?\VO#W[O-W M4-HFT7^$7C)!2([9GMPR'[(3VI*J05-GLV]= MOEB/T'V9SD/(WC6O1:>Z,0Q,Q\/(Y>W0/6[R&RT4['V5![E5;`X>EJJVY,M( M4A06"OPY]5YY8:%7%]`TK.WH9G*Q5NH`@IL6Q35A:-2[6P'5#"W]B'TZ"J3W M4-;==!J$EC]_`!Y!6\S4];-2>8@) MI/]&7.1Q+M.F9AS$/'1QV&I`[5RF/N#>CW^](I@]2HMI!R7W7H*S;=*]II@; M?AO>Z1/GE@M[6)3G>$Z9:"B6I8K+FDA`YP[92P0*?`@4,C*G4 M$JK,<#H4\^K>/J?LJ*\+B(WG=%9@07*&?)GZ&F)G?6]4N,"`DA(&%DSJ"1-L MX0RB.5IE'$A M).T-##5EE6C(Z&#"H:JS2!A#R-YXN_%BEO<*!H>U$<:1X&6"\V#3 M8B#L9\;9SV'VB\"+X^(!ES&Y9_M"Z6&7\?P!3]>$9UHN/'9M_7R3[R9EA*KC MYSM+=7E@?$]-4,Z_[RBR]P&T7SOJ8VC[(/1+OCD)JH24U.K*7FOQ8V'J:9,6 M-,OJ'?^VYAI1;Q($&^N6VJMJX.?%#U84[CS\`0SPB9\$N!C5PE@NG7ANTH!- MI/8.^N9-8(2_O4C8`Z&Q'4+@Q`0PGU\<2"GQ='E:3=R[VCY+?AZ%ZWCP1##? M&M;D[=H)9+K=A.81V:YVUTQ>]I8QEX@* MD5TG%N4&\GGICMK(?F[0,#6^OH$J-<.$RPH3:!C*-+5'W5$:1>POB%!!3!PG M\N>NC=3NX&14>0LB)2D0Z)CTDS]Y7?-"L-Z^OERN@FB#<38.Y&>SBN)C_!A6 MS!,LY=\OHCBYC9)?<'*/I]%3Z/\N',1P\#V7L6GGS5:.6CO[6._#RI6%]8'Y M*20%"%A%)V.V3(7Y,KOT0CQ*L*28A)W9;U4&G`".J*D7,E@P>9`3=-)B9 M4!^Q)Q#N/\.T&EJ#RYSZ=P=>$X.H&9@MV>+<8VB@OGH3C M?'3V(,F&+ARM^W2G$],TBJ)ZL@OS)1-N6X"RGHCK:H'\<1V:`TO"ED[>LX_WYF)S9=;F]EEBS@,R@[,<#^ M$M.X_@I[K&Z\8BRWD.-R9FMM9MG9-A;2.[AWU;R.<"8'^86@(^IEXRGQ^3TR MX'C.]_.%B\A-FTPC"`2BC89:05HI!3ZF3:I+03TJ@;HDZPAMCW'DU[FV`F%` M?C#[YSI.N$*3:#";^6PTLD-A_FP47G@KGR=Y"I.8N3_[R<+6L^]/O,OAL>]& MJ92FWY-L,$-ISP8)<1'!7GY9):3!$)KY\13.X<"J(_D4>DNZB&!IS6&FII4# MDO+U-R%HS%#[?PD3&(S::BI++@(#W"!5W4LO?%WYH1=.><6D.(D'86&0*C*Q M9W?J!RFQ,]\81%X(#*ILU&W=?#8'L+HF^4!,CY&K MSH7:L[OVE$V,JCM,&UY0?K.!PKJ<1L@3&=-A?%?EJX,_"7=.63*,\KMA4&`-^6!EL@W2`).N;M MU%=?@<39Z<08L8;U'(\0B*YE4%.1B$#^`$G28#3,@%B@\B:K:D$YT]$-S-- M>"':CAT&A%OIK"R2G5V_\6(4%W+2>B<"I#M"Y_9X##\=PW>3Z#+=\\-T0%Y^ MQM,U.RTCO:C8A-L9*IN;5"#2GA4&&AOK6T=BZ714FE1\H2+0-)61>TY<2'$3 M*22;O&Q*-BO<1F&A0S$SC,+3CS=1F"P"?K3`"P*^;_J0L).+X=,X_*]UL'GS M@;;BF<5&LWHNDLRI]BC((TZ1F%[&?5 MV<+6TEQNUNQHW(E$F$U6$PA@/ MI8NDFPF-`&.//Y203O'Q>%[ZFW(+K($$MYN4C4VK[DQ:LX/!=W.=51>$N0A4 MHC]"F12&]]+?0<,X.\047U%@E/[,4[!EEF;-:2\5`-R;-H'%$+`5"7U8-+2C MP5#))2/61>6?LM1]A17T".+OSM[C9QRN]SV,&HH&,)9:-8;%@&HD%_JH:F-, M@Z&52W8RM)K5W2P;UKALK(RY[PJ<:H-,93A%SMYAVTK=)@4Y2;FV2C^57\MV MJ-\P:<`,"8&*=TFL.5\-`K5OC31`(*0G1:IW_T9A0FUBMZ0&<8PMKVZ*3/U= MV%09H+ZF6>?H'8V-U#3>Q:0`I`$O1G/W`6BCK.F*3AH> M55P$#->0/_2(1C5+J--20S @T%.:A[&_Z,G6A-%C[)R\;203*+2(P>-[S@N.I-RSYZ\$=6.PN3R<(+_X9) M=!?Y83(.\16=+VXPNUTG=*.1`U9?VJI;[]`_^T^+=#%0?H0.\:.#_"X+'X,1 M]WG:*;6KGKOV0[8QST^1J=9N6D)8_630LMX]C)R/'\Z`'O-JW&BVY@?**\NV M;_OHGTJ":CHE:U9:)%UA"EVDH8752V9%]06TO90'^1E3'QW#$X*/]:=+2J>" MSS=;DFR5Q]\S$0I^\IT;YEG&J1O('JSTBB*A\MRKFV_#`HY[PX43W'3F#8L+ MXWF9GI#ZBI>%/UUL7]'%6X'L"F/V2LBC%_`Y.UY@G/"+M6CJA>B1_E=Z=#S8 M;$M7L0LKC&FZIM/$DC]A4TPF-GS%[U!+/!NRD_!.N/`+;S\#0 M:?0%#A>+YI`-HI>,[=A+^;+(2#M4O"0;9>D3U:S,&QT\7IHXXTS9@"1IH9YT MHV8;*(?;X;D=;N6!^J\!)_3G?7Y9A9^FI"O$M1>P>NP@QIY*N7\-0T/+Z$8D MRD?D]IY2X,]Q/B[+XZ483MIARP:A%P1?_.A*?>(]$W<=O6"2_LM?^HK=]7YT M^<+&CK$A9$-E'D01#P`]&S3S`;!:DU7$SB;2WUGUW""*^0W`=,):10G5T:>C M9)/.5VQTI3>\HNW3W%FZ8#OJ^/N(*&*6T='*IT$6-;)[T.D>\2HM5I`5>\GH M%>/PX`?=I]4*S*"KZ?+E#CIY0\@&W13[`;^B_Z]AU]^PN_)\\I,7K-DYE?4R M[=2KB,RQSR[EW$NKB-;\.-6?T_%^$+Y4*28A_CBU^./JH M9EEE/)[X3)=!VP55LJ"++#]&ZSC-/SQ3M=*BD%F6F@GRV764ES`;1?T!6#S/ M-R;W>+;F!Y,G47XMW\?QA-8&566X`VVBO:$LNR= MSNO("R MNT@_"&?Y8+@CT;,_P[/)@D3KI\4H2Q#E%U3YEJWBX/W^/P$+")W9)R^%4O(2 M@A]@=8@+U['*ODKIRB.F/Y(+R' MXA6>^G-_FD?;:)95DB[]@HD?I8^E^\M^8M[0.Z>-X?>.V\-O?,6>6?HG7>0>^?=H?>.H7,@ M]\V!=XUASH$\Y1SZC&.8<"#/-X<^W1AF&\B3S:'/->_U7?,><->\/_"N^5[? M-=\#[IKO#[QK/AB2-Q\@YVX^''KJYH,A<_,!.ACY\PP=LX@CYVS0Q\[9X:Q3>N3CT MWAD:>F<(N7>&A]H[GQXF/P;1HQJ?VN^/B616MR_VB4JO>,S6Z/EKXU@^3 MQ8"B;(9GZ>/N";MC_("G:X)GU<<7%)W07`24?MI!?V-1/96J2TOK:=ZN MJA``Z"F]7D)Q0$YUA#*Z7AM9W;K@FM70GCTU8^F(K@:P(A6@YM4H)];A*$C[ MQB\_N;B(@ADF<7J=1=;P(A6@AMC_U1 M@@8[?FK5.R8>0'UEK:IFR/"3LBEY7X/&"U@M95XB_A9+756-!%`7J#03:]!P MDB-$B7IJYQ])%+.CUW-?VL:EGP&UKTRK>MMR&I02]=2V8[KH\]@;P*-P&BWQ M-55(UL82,D!MK=.NWN8%+4J)T=>,_)N^FI_=IDP5D3;[]F=(S2W12FAF?DTT M)>JY1C>=88;X,2]G+6MF.26@%CJ.T1M_;6)@2[,5XB-/_'H7%,\\+CSQAJ=,W,@'HF^:ZBH,E MY4!?Y[S?L`N:.3O*^/M*+,S^N8X37E7@EE)[\6*4X&4\B>XQX_8#%KQMI[U) MQ)[JSJ^IG6\^Q:S(8#'G#::)_\RC9VFJHJ-O`8))YR8*;F#[01I"IY]$_)M' M;)%9?):%U]6(A/W,OH[RS[,2N%]_2F^H?X.V<;3$_+_BJQ@NFG.X)9X6QM M?*OG`=U;"E4M.RSC[BD`-KN.[1WSK"1P*,WYP71=:*Y]V5S;AA]`=^ZDMN2=HB9R>AJ:3#N[!3HK".R'K*A;]F,42AWN;A(! MH&#/A@C'GG#2-"MQA+9?0-M/]`09X>G!&V^Z\$-,-A30;#N9/RXH@X8=)R`( M-%2XWM4Y.TM$90)0(:'8?>6ZN&Z7.> M=H^9UHA!=I-*1UWW9#PH9X(UE[*,5[S7N=12(J#^W9,A#>?20CS8N?0>9Y4, MX_&5!,&:.*_\T`NG^YPX+24"`L&>#&DX<1;BP4Z<3'D^(.(%6T,] M>P%#^1V_?U?/QLD`TH0?$!Q:J2V\X\PZ/O4#]!\E.44L?I=O'F M+@K\Z49:BM]$"ZC_C"J*^>&,@?8-9T%_S_Z;\2+._-^]7;$H11/:VT8B':`^ MT:JG>ODWI>[[TI%VVT]W8=&"#U`/-5)7=8Q4N9O9=R<6&5\>CL57_%V6&S_T ME^MEGN48RO?(+%D!=653C=67#U(!1R@5@3(9J,@+#9WOFFTGZ6V4KK10,SJ; M\`/JVE9JB[%):6FB[UUVH8I.@9,7'#Q3"AJ<+OJ+1BU,;]W5KZV/]]&Y?=[B M31]!&O+J'FE`G+Y(PG^L/4@WD_5J*E*?6&$:7MN?J[MO/Y>5G M2^E1F-HEA537'X6$0&>V=@G8DA;I5N]6CUM'J/@^X@J\-H0:GY*]C?BN()[=KNNUF9Q__!`0W-KF M#A"=%2(I*8/2:]0)56>+]T(C^L]UCX6ENFOS'_F+PYT$%`V_?0AQ15N3^T-X MJM#KC3.,+?X3'[_]`+SZ[2\"X`J3^P-XJM`!`SQ;/O2%<>'S7P3,U5;WA_1" MIP,&>Q&0_8S]IP7][\$S)MX3YM/8T$MP\=)]3^&Z4:\O*Y*W;PX007ZN+LKT M3<,CQ#1&3.5>5KK9^^G4S$=S7STV[JL\7WI'_"F^9^*NHQ=,TG_YR^IYQKYU M`3!ZP#2!=,3TH].ACXA/JQ68$5'3Y4L<$:HFZ'-$U'3JZYS/,B*)_SNW1#&_13KTX_2,B_2LCR4OH`"_LE&UL550)``/82DI6V$I*5G5X"P`!!"4.```$ M.0$``.U]6W/C.)+N^XDX_X&G-DZ2:Z>WI<. M6H)D;E&D&Z1\Z5^_`$A*E$B""9(@DB[W0W65#20S\\O$)9%(_/7?GU>N]4AH MX/C>W]X=_OSAG46\F3]WO.7?WMU.#GJ3_G#XS@I"VYO;KN^1O[WS_'?__O__ M]_^RV']__3\'!]:%0]SY+]:Y/SL8>@O_WZQK>T5^L;X2CU`[].F_6=]L=\U_ MXO_S;'S)_AE][A?KY.?3.^O@`$#L&_'F/KT=#S?$[L/PX9?W[Y^>GG[V_$?[ MR:??@Y]G/HS/\3_1=W_ZCK>]U_X'W=V M0"P&B!?\\APX?WN7DO'I^&>?+M\???AP^/Z?5Y>3V3U9V0>.QX&9D7=)+TXE MK]_AZ>GI>_';I&FFY?,==9-O'+]/V-E09K]U).U3G`3.+X%@[]*?V:&PJ]+/ M6(4M^+\.DF8'_$<'AT<'QX<_/P?S=XGRA0:I[Y(Q65C\_\Q2-E]=K>C2]>]L MEYG'ZCW_[7N&T'I%O+#GS0=>Z(0O'"ZZ$MPR"02Y>TH6?WO'.B\../P?3H\_ M\&_^"Z1O^/+`'"5P5@\NT\C[JFR>V2[7Z>2>D#`HXRNWL0Y&;FS*Q+\GH3.S M726N1@>I4J3]]+`6M\.[B]<_TF)LTRGAAB[9N,2 M)6G)F5&?V8'#OGE#2<"^+GY\<.V'Y+",XVK4FM+Q>K6RZ6-[SHSAP3BTT>EJJ]`JR$QQL1EL,^9HX0O-_:+?>>2X-+QF%;[ ME,P=/NCPS\:_$BP2/-1M#!H]\((F^`IB>I-U:G5"3_SY3:TJ4>[;N M/.#[!S90KQX(@Y6C.A4S82GGD,[Z9R48LV`">@9]&)/23AH&?1A7Q3T:8BEK M[GQ9SV%B_^,Z>;1=#MRU3?GR^9&])9^D>D%`A$4. M5P^V0U?-B%F-OC9Q"P8*'JF9KUVVVF9;SYX)G3F!'S$:EX+53ZK7SG>_%=NAVR3\LRG(^4!OP'2FH1, M]!XS4=.\8=3:$:5QJZU*7X^X0^^!?3]G^0-==U6EIPD]ON8+^#_)_,*G$T(? M'?;C$1VS-9^(6TS]2\>^DA)2 M:2]4@Z2&_360:4D7[6%5]366*B6]H5;UW9(2&%85;:A_67L M/J3.22_9#W:ZD.>0>',R3PAQKNMF.;`?%-5 M9:PVOT20M'89"ZU#T&>"4-L=,I=Y_@=YD6&0:0H$X1`?"@52FX`AD6/*R.9K M?[<%4.E'F)2>)Z-)7=\0ZOA,@CE/7)0K?:\I4/O'&+6?*[4)&'J,FSGGZ,*U ME_GJWVL"5/L))K7G2FE"W?TUY2)>.,',=G\C-I4:?G%K(`@?,8%0)KNYB?=7 MXKK_\/PG;T+LP/?(7(0/J&P"+NP"1.83)F1`6C`'SS??73,-TI<+QR4TD,&2 M:0J$XS,^.`JD-K@\C?QW3!Y\RH]PHEL"TE5J00\@*%_P@2+7@3ELA(WTV6"Z M]*ETX[#7$(C$*3XDT M#(G6X1?L9P4#F:0Y%!Q4>^Y2\&8$12C:%XH-R.%XB>@\9?W^<&7O5% M9?/O:>V$88^L`VMS_X?]O>][@>\Z4/-C./$X_9`X^"N\)W9&M&!!0 M9V-ASPHX*6@#!WQ`H*I!TGSHL\H@5J)\QON"L%_.+R.I"SD4[(4^SY'G+0U[ MG?]`^!UVUX[VA6Q&?>"+*>GX)^]E+&!7?T$(40<.?]N_J,48'#S/W#6/77WU M_?F3X[JR"0S2VUQHKSZ2*OK!@6C$9]G0:3*FU]2&Z[4,GJD<;396I(M"1,G$ MY5MJ.`4HZMJV:#505]43#G],<0T.D!49K!O76V:P>!LW#8K%X&FQ(1 M*)+:3E:5D:R@(QS@IDL%C>Y<9QF5."X?-DOZ02'4%FI1'S9!FL"!FLIBL\Z: M$D$H1B+%ZPAA2PI?R58MDDY0=#$>_P&T@<,%JYPU-'"Z<(SQ3*DKYPDWR?@@ M&"[)V\MM#$5)8ZIEJ:HS:2Q%,N,`)74%I"R3,M,2"H?&(SE%.(JDQ8%%;SX7 M_LX\WW;F0R]>$Z68E@2U`'VA>&E;V"OC!=<(#@3'O"B/1^8#FWILY@QZL]EZ MM18;DOB9A&($(7VA"&H\0E5$$*X1'`AF!5194,`1TK:V5T:H6.*NK^W+TBZJ MIZ7`<=9V4JN,,U0;C:)N]B)<_M-@.[?BCN&WXJR?=NC]Y>V6W*NXEX5P1]>! M:UD]U_6?N'-<^/3<7]^%B[6;O>52?A:K1L98!340,'X=T3"!:RBZHG'?\8,% M5]A$-:)"ZKG8Y]X0*@H\0.,MQ?U-W_6J&8$I4PQ&,*/2'+UU>.]3Y\_M4J@, MQ&P_TQ?`:H)7I`B\H$4ESM4`2_J8OAK6"%B["L`+E+P2D$3`*J6`M&6!-@*9 MYAI`C82JU>JQ[.[,;-E*DY!IC5I)P1W]*J#AGM&RS!:-IT5=D!P M9:\N2!AG,L6"=D6B52IGA^>,M6(5N]9#DYM=:)!^SCX_+'DB"TMN"5G^PDJ1 M,GD;FS],N&&L/%Q0V,'HZ9U(M0:4Y\JV-%T$J@2`S*E4>%A.V2(.:,%PT(I%4Q\EN;#OY!L9"(B@.,2V?& M:^$$I2Z1:6@Z:`>$H$!`'-H7MP721B)UA?S6IN-O0!QDHN(``XQ#50BT1=4J MC$;YVN]D1D;?#\+1HG0`VVMF.JRFMK;*E1&'VWRE?A#<4'\ART/;:60Z(J:F M^ASYNNXQ7XG'MG>`N-/_\7%\:3P%C6T7C@3!%;F")P.-J$N&[T M'/&53;\3?HNB%#!9'^/Q,S6LRL7'`=.8:9'QP*OIGK/QVO5%J;N8U4VUM-[L MC[5#^7O,;&B9D2#@([PL-E"#J/'HFVHD2SN\QH; MKT^FAIQ$X*Y/F6+[$HE5LD%+&D&QTQ:C4,0N*V!ES!X)O?,#8AZUH1<2IO90 M#"5W8>ET6=3>>)4Y-2SE8JO#>AK!ZI&E*.MD'%:V>84,J7O-C!>K4P,Q5\BN M#Z/)C9TDD>#,#IP9-U/'73/3$H/0N1/,7#]84\BA266"QJNKJ5E#3<7A6!"5 M"%$9903%T^KBHX0V+E1_)<[RGG'58].^O237Z]4=H:-%YMB\W)G5*1DOP:7F MQ555U2V@A;761SDF8[Q:5V70JF&_HSW4P,>CD4*6D#(AXP7`]()?ID%L&4:\ MNN>%ZS\5)!A]A"<8<4I61`K%C<>-9$HW'7-ZF=T6<89NJ/_H,(#/7FX#'A_; M1&5ZL]!YC.[JE@I9A9;IBW00.+.;K(HJPS$R:]T):YM1:VA=;8]LM.[*?Z^# MJ.H5KV4^\[V9(UYHVS(\]1MS5SU?,YWQUIB=Z`0#A[F=$P;.S(F@\>:]%7^F M_D_QSV*KD78RG6*G%;/]LLBERM/T$L=>7>U?J1,2?['(@8PW+VQM.A>O#:RD M"G@MD6VF+\JKE9Z3Z/]#;U-DG^T1EK+ZD8"NIE,%6W1IL"*[;S.\)L3,3K:1 MXO&%](L,I8=>T/ZFLQQ;M!XUE>)8`>2S*MG&%K0WG1C9(LQRE6F:\E,WRZ+K M?Q<^G1#ZZ,QR1W?>1][%=#IE6Y,_1'$X7#&]@!PM^!$\/_KA*Y<;2E;.>B49 MC,N[&L^Q;',@AFH2"?!;S5PSK3`5#$.RJJ\ET,:_X2\:3P]MT\PTX];UM(WL M:GHC;%P]%W0Y%TS#>,:JT9U*F6YQC'59OK.%Z%2L(:\WAOQ757#*T"W64O>W MHEEIA]XCT[)/I9-823<,F;1-6T&.7EXC_&R5]F`[ MHQU`WH^L,EG(Z6'(^-4U?4`T^1H2^$ODWWV9K88)[1."VHZV<*=^V\G7W2LU M&NXB$]NU55?EZC*>P]@5OE/$VUAH"^K',-IE"@'Y.F4!!( MGZSO1'B$9XG<\[?&T[MO45.=38Z7CF1YPP97-=.01^L+&3EZ(5-0V*,89VA^*K;8060V@_$H2OY98 M24;>(8/-6SI\;R\F607CR':%VH6VJ)D^NRC2TVLRB;C^R<1?A$_REU:*NT!- M0%L03(,)%.BE^]##==7(JA-,%VI$VJ)AC1E1,QI^I6O1^"&K1M:B4EI0>VKC M/?N::U&`SI"L17F=+#(/+I@NQN0A'DQ'BVL_)$E(6#+#@'J#;PRU/$Y`0-I_ MQ0:N+7SX\@1)_DS@2)3<'2W*WJ:%](5BJRWRH`5;N:9P()N-TI[Y_O?1(Z%S M:B]D6X3RGE!4V[X,JHXJ5$LX,$W;X*\VI38O<4CHS`EDYU/R7E`LV[ZP6<]# MB[2##T?UF;3:[-EV%*<>?GAG3/554/V53]N1%G7L%%8['=UEIR6\=#S"*YLP M(60%S"5=H,BW'6"IAWRN7EX7]/PZ2<^;QR?EEWS-,+ISG659,$6%!M0XV@Z< MU#,.F.:Z;RUPY342C@/3A5J5MARDQJRJ&0UW/1S'52#\*;CG^\]'MA/E:7J$ M.OY\?UM3;%5J5*`VA"D$5T5/K],V>LQM*'UAWB`>YE4UBDQW<+47]-90H)G* M9O`@K(NQ1\,?PQA^/X*;`Z8L([!PC1C$P$.P/IFL'QY"(222U^V]L1U(0>[<5%!QM<2-53><_5Y`6&0L8/*-V M:C_S((@$?T]Y`G;*6CBLSY_51EEQS(HMHOZH2@P.G;)"NCX->3 M6"N6!^,%C>I#QUP,S_<<+Y39/R3=6!M7])@_[CN36_'`VMT M88UN!N/>=#BZGEB]ZW/KK#<93OC/;\:#R>!Z*G[%.S#BUF&ENN,%OB&\LW!FMA?&@P0;6&Y\UYDY)!`.=)3O0)_W'6AR>W75&__&/64R_'H]O!CV M>]=3J]?OCVZOI\/KK];-Z'+8'PXFB?,F>7@\F_6I?#:S&O]<>#\^%4S&G7H^D@:9%XX_&;-P*\<79/YFN>X3>Y]VDX M)73%3S$A?EC:LYL>"%0(!M]+A2.$8YWD.];IOF,-K_NCJX$U[?US.W>=O'F+ M0N!KJTZ`I\A[==)+((K`X"%\P^=$10'X&8@X*U\2;[,6_)CK,80"^P.[&'M>JA:N2;C",HR)D=N^[3)G!.6$;%"<4X^>G_/'S,+.7GH[Z M__C[Z/)\,)[\/^M\P/;2;.4>CYN?WL9-R*-\6P2BRSB<8:4A4X%$)T=+915A M\*R(T21$':U*/N=[U=&^5PW^\W;(=L;#R>2V=]W?+D0^OSD4:"&R>=N"U]!8 M/;C^"R%GQ&/C6WCCVAYDFE*CTDFWJJ(H#)Z5/A,4;O4EWZV.,R22^1BH[!'5*GY3=,9"<(?"HFR&C..9HR?#K\-IZDX$R/TYE^` M*VUI*#8)(EM0E/9.U:AUTN_J*`Z'#VY/)*>4K4Z9J#Q=(7+"_/29PTSZS.[A MXW3:T1OPAUMB M'\O/L#G,R;`YFPS^\W9P/;4&W\392N):;YDT:F?W>S"H'=\7=^ZD*RFH!8<+ M03+7DO_G>U8F=28F:OD+*T76VM*U$H+63\G?_O+F3[V`P8/V[^91I)IV<"!ZZ?RQ=N9.^**TB)3W`K]? M@0H]B"9P8'8;\"J"0>BLF&B2?/G]=N#2F:APR9<6!Q(%U2+`.(4O/XI[`)%JOL!:S=11N0:Z M_[K:A>U0455CM-BH9^CQH.IJ.YH4`P[L#D2_^?O7M=!7T@T2EUT],*;%O5/* MEED/?F"[HP4_[[UT'LD\>F9CZ,W<]9S?8=U[?T-QLZ'E8T!3:?[&=[V!0I_> M<1A6_)8@?ZMNZ3E*`05`5R#HS5_TKCF/`W6"`\+)/5,%VT*3>3I+:O00YTHQ MZV0R,VL565)E`W\E8N"H`RZ<:R@.!_(#FWILV.%5]H0L8-4J%OZCOL;_.(IF9-GXC86_N/X3;B'Y>)DXE]R8!?V[NZ&5Q/HHHG/T5D&CWV$@P7\%MR\`7KBN.X>3-YQP5Y>D\VG8OK M%]$,'O`M7N0`0;!>13\3HBA>+&_B.R:/UU3L07(1O3EU8_!JR:U&B6'>I9R7^+A"?Q2.?K'F-7^N',]9K5=C;@!N\MKDA4\W#U5'N;GJ_EV+O$FW M5K:#0M]N0,,87'KO%IO,C3-W0S.WV&IY;D/[@PV#HFC<9N2.T_3Z?A`&V[$] M0:R\P&9=NBA&A?R]>WH^BG.%7^I,^:JT38T'#2$+7@-4TSF.;5>I//RG06\= MWOO4^9/,;]D81%-"BFC0V4ORYMD-=69D;+.AMPD;:^#;QE*`C!IA8Z"A,]+< M"^7QPWO!B(Z=Y;UJLJTJ26-Y22V95#45H[.4U[@CUO9H06O#5*/[Y=:S$60Q MIH"OM.?>>XXK96J9%MXA35:1I+]M)B4`TH M!,_.+%T%0;8MRQ07V:V"H".:DF4-@H`.*:4!<_E<>U/-Z&;\3(,6E<.@M M5@`&7\A>J\G/][SFRP]^^GQ.0MMQ"SPF4S4$<(T( M]2RA.%$3HD2<8T-!JL%V:9/:*D:/\9ZY]NS[03"[9P2#*W].7.G`D2GSDCMP M1&R(S:N5YL-*&+%&"RO%BL5YL8:>%7$SB;BQ!#N:QA6QD5965(Z>RA(BFO^. MZ4S1C#0]'N=:BGR=LY?,#E7$+389\REY!\\/9,8VMKS@V*%DBZ'QFT:S*G19 M8%Z2JE;,D,0Q<^/Z63DS,369G-]\EY%QG?!E;(?)";=J\K,>'HS>U&[5>%L% M]<%FY_7)9R8/2F?R<-&0#H MCV+&K8[(4@Z,%CYX/6;\ZD?C9!8Z=QZ=.?$VIY(MKRJRGS=:`**3!EP&I::G MIQO=GE[X=$$KM3]CY2K80;T3- M$N2B\J`Q0?U'*$!)2@*9RE2,/C,47Q\4I_B2N6BO79GS9JRS>1>N"%;F$:%= MP=+WYS'@PKR3#-E?9>N$G+:&\2E0KAR!%/N;((99%(JJ-)^]I'_3>W8DZ*C0 MZ!!J*F*EXJM(P#SW5[;CP4!+VN(`1]TD)<`EHFT/;YI]E5A+B'<% M`FY8\PF9L9E^OOLHS159W1%:,*%6(63Z:D:QM:57B-55A&.'S//_MN6\DON` MYTP&R3&EM)-IW(HGWISG:DI$QXC1K;=FFXTSGU+_R?&6??O!GO%ZLML:'U#@ M()1,WV:IB"9<23@@+I@4"G;V\IE$:7.N['VHE'C!8)K@7:+6YNK$2LDH;+Q-6D93[#\S"L[S$&^ZX=!.*5 ME((5#^\B[6&LQJJ2K@%"XY@=N13!:-%GNQXG[*\IUT#QM)C?VF@%5(BF]]]R M*!:Y^T6QXVSGY%Y9:@G`+ZB4`0SK;;86JCKB*CKIO@6%SQ`S@N#'3PURQ4J5U"D!J#"?=FQJJ!'A[,/,$9D3!$B3TGV=+^"TY MPP;U-/F\E$>CDO%_DCGC\HQX9.&(YP'B(K?$LUT^K8KBXI$EQ895/'C5(FKR M@HP"SOL/5]77(X[9:K!8$%X1C6Q8YR'`J%3CVO&6<6E%WY, MZFK",.Y*ZF_NE M:SN%4I,$2[:$+J^YJ4P(:659&/9[_EU1BSC&<"#SI;M'53JFSYRK@E8)>I1[ M32#O0V_ZY/]&;"J9Q"N0,GU*W2K^61UVS0385TEC1I`B9OK,NVTSR.BQ8X9P MX:]I4W:0HF7Z6+UE,\AHL5-64!MZ\^?2K>)=^W@A]$/;W3MP M?#>8>3FH9#<84S:V%\R3K/I.4$[-:,&^%&/5=X&*9)#N`2&89^KV5=`?CC$? MQ'KI[D^-BNF]7S6X*D#^ZLZ705+7-!/S>\/6[./5KPPB\4'G=L?9M\?D:X.( MMJ7[/`\F'0&?\M6@A^%N9/?NK-8&\.WV*K)[D%INKQ:X_^X>K^#:*6^9U[`+ M.BWBO>X%4I`^"^^$9KE"]+$@2$<%Z9>*EJ)/LGCI+TS&KD3.^U%&X#UE`7#L3W MF.-/C<;)C-<$?G2ZW\WT;@B,($A\#*DM>R^IIEZM2AYXG*Q7*YN^C!:[/Y;N M7[*/KHK/6)OO6#^)+UD132LA:L4?XU7']WZE:4M35_Z2'4YSY+M8ARY^_FRT M#H.0[5J9.URO"Z;BQ,&:_Y3)T&K3UM545;DR8"H'8=BPY_AS-DS2T'R$KJYZ MQ,768.C="*'T&>W^=XPN/)&;;#XF.-8\0E?1&W[G:\H?^XB\0;SMEWX/,GF; M5F93%6@9+$ZW,C-.%=AC:PT!]XK,-UO)`A%_;7-FST^_U&+%@WG MP&BU;N1FKHHCDE5K3:GC!9>H?:O93',^9;2*-W)[+$3F;=#=F9-^)<[RGGON M(Z'VDB0["%&#J955A)P!8V65.F#BBBC^('&M0"F(HLG\FV3"6+4K#"[0/)H= M67B4"9[(9MJ2%?DP6B<,NS%7PK0C]EPWV&-FG5*3+;-%TDR;>QN0OP[K[\IZ M7"'6IZGT&W*;5M#CVVZT)'24VL&;<8JZ?)DKN=/PWHT7A27VM MEQY;81GJ,=TZ&\6O=W3S`P9-21Z&PL0CU&>Z>]"*1-$_@),43\IXG*02CU`G MZ>[I+Q)%OR8G0>4-6LV^NR?"9N!%9-_-Q-^&3$['"YR9>,R]E=#I_B>AMOHZ MCV[K0O6#Y"MTR*)5PO^O\P2WCN8P1'UPV'3YZJRW7%*1G-^6S==@"7SSZ$?T MB-I0(UJ7-+,PVQ6SG>5UYIM0F^WN(:Y6L#I6O"!]13`U10FOW(@JK6EPU$!- M@W2#P$KQ(8JZI3@Q7^U`16'-%4&H]E4,I<:Z5PRN)6-X*QF'I;R9A/W:)>-T MKJJC2]Z]=7CO4_Y0V"V;(VC*)&]CK&"%A?GJZ['X8TCL2)\_-F>,Q4K44V#POPCU;WS'"_E?+IQ',O5W M?G3-AE5IR4$5`L9KUNGSI'0BA;I.-;U_N_GJR"/\[RD^V$\X9S!H2[N;?NVG M;6"!^M0$ZU=*V(Q(I_>VIX0GH)^Q&_'M`@G6(*)H55-:N?2?"(W^YJP<2?E* MO5\U/A=`JU^VH?Q7:&:W#P\&S"SSUH95+/U-$U; M48U#`?7\RJ,2.VN;&=-O*ZI9HAFH$-GJ#W"=%,'^P<#H^$/>:\-;':OY1-&V M;0M2ZLJT%66&\XHKU92LL?2Z9F,##!JK]-/,#&T,4D1V_G8+6&<1'X,C:\59 M&U-:D#?_E;]PMWV-!?0Z!/]V MJ(U9E:5RY+?'^6@($,F\TOF%.L$Q<232QJE&6S_E)9(FA#ZR(288T;YK.[+, M'$4R2!_:J`9S)15B'*Z3I+.8?="#4R>`$7J;AIF,S7C>ELJ7M;F\RC+Z75PS MQN)[3(:U*"TX"N^C`\IXZ7+M>X\B]U[;SEN=!9P32T5[;&JI617)'_QZ7*G: MM#]@I]ST)77N9"9?CZ0/_![ M1Z4:BXO*FK7^'":Z\M`7,@%_K#UR_($U/B[8RY?VZLK#6VJV`Q(=4Z"R!2O?.V81:_]S-F!?V`[550*B M4>ZZ\B87UF$.;`!O\0^5;3-*OU)FL2NO@2%SKHJF\-HGG=W=-4H/46:Q*X^% M(?.0BJ;PVCTD]40/2O=0XZ\K;X\A\XTJ1O#:'>.U[%=4*CH:KU^'S"_4M-RM MH(UB`FI!)*.9MV0Z=AY:21>=24BJ6#_N8Y44)0Q%XE3%5\Q:JDX>0[FP[I=] MJPOO6WTW;'6]\-9W$ZN**?N*O#+;7K,.Z7Z/<\S5T""/,F_%\>8\=_S:7E4L MAU;W:SAL(-=^&WL"6R9_"Z7,ID_IZDSL7_!J5Z7=C9>NT>@"A77,``K57<6, M_V7B/.]6W>)_A^,J[6Z\M(<)7`$*;;>,62F@@'[&RQ"TA"18A9H@K%S9HS08 M4Z5N6:U'+)O@R/C$4'J/UKB*:H;-&DCV1F#*Y;71VL:I@W73C*O(O"EWYE0% M3>(J@D6>]EH'ABZ@=?LEJU*EJ13TSOGOJ(J M;PZ>S56;#9&?P559Q# MHBBTB41#[X&M0FX#GF5]YMJS[P?![)ZU"UQIXM"G\L2AB++%25M#SXJ(3V+B M[:0)983;DTTM*PA.S?3.N8JM;[(B>TS>56+>\>/`;)#5\2(NX)N(:A.I6E-3 MY=/!R'0\NULFYS??9618C?A7;!6P6N/V.LXCU3Z/J>P/)C,M`PQ; M?#)/ANVM8NYD34<>(5_$5*FGJG5I5Q+:>*(0*>#_)/.=&N]C,E_/^!>G_J5C MW_'5M4,":9#Q,^!VHOB<%7W/6OC42K[([,3:?-,*?2OUU98N*592A>)-Q9K? M:'(<8F:^\CUQ8S=BJ$"$G':(HGS-H)8>"`KUHFD^V#`Z6K!AA9]-Q$(5X"%I M;S2V5:PW'\1\VTKNK?RU5^2WDO9&HS%5E;PKK*Z53>Q\-]3G*ZJYU(R+&AN- M'H#4*Q>S)=UR0)U"\RUL;73+6DF[>X)J4N_4#VTW7M6-%KW9C+M+$'M/SYOO M;]],"!@O561`59(0_$153Z MKAT$FWH];+/,D^'D!54D73J$B40*'(561*7;5E"=(IN8]L74K-0SD%+/5)6*;'+:%U.O4K^`+/6+LJ4BFZ#V MQ=2L5)"E?E&V5&23U+Z8>I5Z"K+44U5+/4(V3^V+J5FI($L]5;74(V03U;Z8 MFI7:!RFUKZI49!/5OIB:E7H.4NJYJE*1353[8NI5ZN$'4#SJ@ZI2D4U4^V)J M5NHA:*9*-8.&I9!-51E!=>L5-%FEFD'UBFRVR@BJ6:^@&.JAJ@=1C9-/5OIB:E0J*I1ZJ!E./L4U7K893#T'QU$/5@.H)MLFJU9#J M(2BF>J@:5#W!-E.U&E4]_`Q2ZF=5I6*;J#ZWJM0O(*5^454JMHGJ2ZM*/04I M]515J=@FJM-FE:HQRR6J;SA:3,AL3<5MG;[MNF1^]I*DP,4-5;.45`B;SN<` M%^5M2(6([6&G)EOJ<;E8`DF%JXKD\%??KRL2G/(5Z8[T9FTT5X%7$7H6P MZ02D>E:@KD*$J?;B0L"9[ZV#WI*2Z.D>6-K]*>`.,B=N">K6EGS[2?@0(15O M%RM1Q)`$WOGD_"H@OB7J(TL*1YRH?TX6C*?Y&?'87T+^-%FP'=Z"G-_*D_@K MDNL0EA4EQ)'\G\=\2>J_I`L.U&I9,`!AN*].+*\H%#_D@ZFARN@UDM% MQA$K&JP>7/^%D-@L\HL`;I[7$T79`E&'(/W[OA^$UW[X&PG'9.8O/>?/W(I7 M\3.L-"I0 MC93IS6F9K:57Y'64I:UR9N`LO4A;WOR&+>>N"%T2&JT.A;'Q(\:H1G(YAM7) MF5XWJ^!85VF:L/S&EL8^#=(K&BE8DO:FBR"HH%$JMK;@CD]#_N37I6][TR?_ M?$VF_O3>H?,;FX8O4M4#^X('-PPX*.FC#4Q&'A$\C(G+EC.JJ,AZ0W%!,5HI MZJ1-;ZF&C*RW\=OQM3U&'S)-O:H2,\TEA>PU"]J;7KB!`V5R@1&"PO\/!21N M:_P<0:YC"2`[PB(#X\RGU']RO"4$C71CXP<,E>#(BHL#C_3*,#6Z\O1IGF/I M+!PR[Z\IUTLQ3DI$3&]FE/"KH)X4KDT\9-?ZL4"?'VLP$9G$-TQW3A#X]$7H M`92'>G*X?UJ0(FAM*<:'"-I33U-?3X.IF&ZJ3`5-A"_%N9@.>.5Q_I.`VB'[R0V9.(]WTP0!Z%@;.KWYG.'ZYZ_3>#,AU[??G#$2?5&*B[NKTYXKS`P-/<% M8ZOKYLRE:77C,*)=)[CU[!5;-_$L_N5V-K>)UC1(2!>'`LQ>Q M9T>O8UTXGNW-V'Z$9ZD$/6_#M&0V@%,PML9OT*D5U=7PLM^0PV_'I%B+_#W1 MS=&J>*=&YFW5]%73A&@5*NT_FH=:#>HP,$7-?S3:T`GJLZ'+`G M[Y$7Y_7&+3,-C9UV-@=<@?`8DOU1)9DB#C5<\?$^)J9+9G9SPA])/*\ MS]*.'<*G5!8<&:%3]H'18H?9LI1021<<^`#M;P\PB5@U,T2;0>K"GO''W%_Z M;,9GO!5FA<3M"YJ;3BXHM;<]5*12:\K(Z;/=N\,:\^NNTN2;O(:F3ZC!"BX2 M`-/.97>QPKU8G,)NERWG))A1YX$K%SBME%(Q[2'@])LJRD$-J[@S%Q^RW#!W MYXP'`]=9.1[_M3+`I?2,)_?4A!JH,%V)BTEN_J5CWXE!6K#%.)SZ44+_A?U( M'=Y;P` M254BQG.#0,!54XTFG/9R=,3!(J%L`^]%-C1X)K,UW]47%;Y0(6`L;*^$C[I* MVAD>PY?^Q=E^. M/C/EG<+&3PV?-1;-KS/`:E._)NL9!*&SBC(.7YAJW*G]//(R,A78`+2SZ'P+OE(2P@WM11R)U!R[8S!2E>;8U2`)Q_F)\G5M;;28/X@L\ M.3H)CI8)2RBR?*U>!Z.U)&=F2)^D@YW\;.7M*_*3M=AM/H M$&HJ8N$XQ4 MG,D53=.*]XQ0SZ;S2>B[-I4J,[>EZ0`J3*,2(36I=3K^.I1J,]W`],X7IL2L M2)IT]Y4P,R^8ON#"TK^6!-O]G)YV9?JN+`U]#C?\)15(JTF'9_; MC\[\TE^$:WFANIQV4+T:GK@*)<1Q)'`MKGGR&^2KE>^-GCQ"@WOG842O;,^. MPMI]WPN95J),`+:49+^6[&N^83 MZ5!:D[)J4&,:WS$*+IA&TEM"GH20[J*,,YPP_NRGIB3M@#V,PGM"Q^21>&L- M1J%('7]Z5:/B8C*/_?*%O()4Z7&_I(_I0`+\/+]4<&U%-7,?UDF;2)4'H?+Z M=R0=2E4AYH")IO_JP"3]NY'=I*P0'$/:;H6,(5.KM^0WM7M!0.!E1++].I.J M!%,`#K#V[L##5AW23J:CL&"8`*)WOWC+C?V2%*":_;%V*)GXB_`I_PF]N(^D M2P=RGLJ%*'2_UA-S)NN[0,3ZPL$C@3[H?G*RGY"S)6-%=/3GX91Q7I)_`^]N M,KUCETG0?4)9'Y,5,%7QVD__*%6%DCO%O^%_W-D!83_Y'U!+`P04````"`#` M@W!'8^YCVY\3``!GT@``$0`<`&UM'-D550)``/82DI6 MV$I*5G5X"P`!!"4.```$.0$``.T]VW+;.I+/.U7[#QA7;4VF=A5;OL7V)#,E M2W*.SDBB1J23<_(R19.0A`HO.B!I6W^_#9"4>`$A4K9#9J0\.!30W>@+T$`W M0>#C/YYM"SUBZA'7^734?G]RA+!CN"9QYI^.[M561^T.!D?H'W__[S\A^/?Q MSZT6NB/8,F]0SS5:`V?F_@V-=1O?H,_8P53W7?HW]$6W`E;B_G8['<+/D/X- M.G]__8!:K1+$OF#'=.G]=+`FMO#]YV^XYT=W(-?\Y.X,_I2?OB_?,,6._I/@"PWU#<;K,_EUK[_.;BXN;D M]%O)UGS=#[QU:R?/)]&_YXEP%=]]^>1XI^F7? M?E#,IXOEZO*;=>M__7;Z/&/ZSYZSCA"Z?SMZ[='Y\>G+2/OYM-%0YW%$(>/-L$>>["+Q]?7U]S&MCT!SD M\P.U8M)GQZSZ0??PFC+4$@D\<3Q?=XP4O.FO$9+`%\=A90J4"$$O0U`2@YHX M`^=AX_W>*VYKB_7*#/=>^"DHPJ&&#%8NYXC8`[-GC6"+9- MYY;[H%LP%&T.?')]QIR(A6WL^'MD-TZH&O"/V`!ZD@#BK/8:A M%S`^.X[9=WSBK]@XI#9OX@@1\].1%((U"BSP9DT\(P[AO$6CO8U:*$9//NJ. MB4):*$'LXW&63()XX&%3T"&(PVA($*,0`J0#-TR`JL:SH85(4I4 M$*M[-P/ M1*<@V`+[!-@5*#M=+]?\67G-HW4I,V7)5DK07-3E"^KD%CB7 M66!#$;DSM*%YT'U7]Q9WEOLD4/VF2J[YB_*:9R01I[F?FA_#2ICB9*^&B?16 M]PBH>Y(0M#5V?=P.35(11VZK2S;SPH+:U^VD?*'5(F_6E'&RAC M%77&/73;40*NZYM$Y_/W=#/859G+@L[:X=U$:I\.YC4!.V3K`G``*.!-H(Y)YR)N@KW M9OUQTI5=[*=-5-\UOB]GA>P:"[LW!]"O8NKY#H_S>J\_Z_[`SI?+%7V66_/"-*IFY]&K_=0R^.M'3'T" MRIQ0UR:>Y](55S'7[77LX[=`R2UPGG?QXR_]J39@^I],E1'T>056LJ%A(H-< M[Z=!IMCS:6!`S`?3:,?PR2,T&.FY?1(O2Z4P@JC:][T(_6#<)SU.;!P)'F!B":,V=A>69RS8+KN1 M:V)K2Z]XS2;D72:7D1!VF9"?6\8/2C*$8HZ0,D,)GA!C"@T<%+*EAFPASM?> M]ZADVB+Q!E/L,7#V!>^Z!1;1P8@MT@N_Q&20IS6 MP0:E0KAH5XXS'V+P3%[*,M71Y/;*)4,2#82KIV03Z-VZ$12V3)("'$@R%G\=L M6#ITH&(;.^97YF`=O__,HL.":.8E!.0=(9?KVM(1F&FC!E'4XF&**#1T/'(C MC96:$+;@R,V9RV0)S+D9P;$A#YZ^G/UV=.F5J#=2-X'G=./)=E&C^T!'2 MUHM=8*FU52&PW)BY/%?>F#'EPVNB+4OC6]<)O,Z<8BQY);@+HMR$N317T5*8 M-X,V[1P,6K!O(F4P4874(.>YC!4GL7GALM^*+M[?7I1/+`TO-TLNQ92@C#:D M(VL=AL:V;?)%+S#+`[&-MD+);9/+JFSHH9#@?[I)V!^VK6:*9X@?&G;#SI;Z=.01>VFQ([YX MV8+BV:7X-42V](>J(@,*MMY0UB&C_ZI"0N^K*F2F MP[Z1J-U-*Z\J,`R=J@*G1]L;R=M;-Y(4-SI:[7ASMEKT.WO^VD<0W*4^BQ6UVJ>ML_;[9\_<<%J%B8T:JC$1X^W`A/BL MPI+-QPBLW8M*+18=95C0L!"'/;0VR&7;EYZ+*&M?B'B,+=^+2UH;4KMPDS_3 M<'=V.*T=^"EQG&.9SI'$'(>(K)-]'7)SHDZX7$"&6Q8H^'4%HP]PC.YGT!MPF<4V->WK#XC,;$9]HFUZ$6UE;D.(;RPQ[T^VQW;#8CC%_&]J:[`>%CW$)[( M"!7X@?AI<6S7@9"#KEY!H#A+_9G]90>]AH+DB^O6?,31!/P5GF#*>T2&VVS= MKEVGQ@;%1!V'RT&/_3LS8:+BA\Q92V% M\]/ZR#7-90%V9OB]M7(=?R%M1JPI;%E\?<(*O#$ M=F`JSJ^!M3K]P&;AC2-Y\W:VZCAQ/*=4^+4J%D$J0GRY>3:>Y`B6(\918?5YKN%C*` MNJTKX"UM-QE`4RTBF$(Z_J^!@\].3D_:9Y*9)@-6=69YBQ7I+O%RM*?]"SAB MF#79%LTE-N!1?BJ))LZBL-=&1YW/8D=&LEM.+#: M<`7ZV0FSL1':,''V==*\L;22^J8NP?J`9H>,KJAK69K^K#BY"#$6L#1T4\5- M=+1[@CCUAS4T5C<#@C;#]@&@M?"6/7EQVF MRR;^UY1/<3![3C`+)8S]`NFVP]*P5-2#;J@7*@R@+5+D^I$VE-2\_!+ M8JGM\,V2327/Z5[%GB6RR>%KEZV@<^6%*@-8NS1ASE69S6`NIIXR@\+/?!?? M>@TRT8WO$)KP!69:P!UQ:Y=YBCTR=\)8SC$GKN>/,)UC&J;F>1"W"?$$N[O0"F(JU!:%A2)`6HQ1D[?)H\&O1 M@3*3IPG8_F\6"ZC8"&`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`RZML*X&?2!DY\XNOTWY!?]I&L/'* MJGHM]39=[4ZO<:K:^53&2"<.NV2/+T`4?Q&>SQ)YGM3ARU-&;N@^81H^$9ML MR3S^*!8:<5+^#Y+^?KFLVP!Y%OYS#5!\-*GP//,F,%+W">EOW1-YEBI(?TKW M(YO\6<\)KB)LR6-X?Z@!RO.T:W8/&\36K9_41C_8'_TT-S9D%GX#9PF>-)_L M+WJ#L#-ZXY:)V15PM6O,2BZK7TBT<4K+G=2;3-ME*^IF-F.,.+2I&&-O1VN< ME42!VO2BNC-4[PS-G]X&3Y MS@,@'M\&=Z<_4N!R\3O3%9)IZ84`\WX;.J..IV/=#&&66ESJS MV;0\UL[BO_&=`OQ^H9![DT\QR;/#H/4$JXY*IXS?/)@,B_Y_?[CV46Q^7A:Q3UXW%X>S@\ M_C]02P$"'@,4````"`#`@W!'%2YC#C2]``!=9`8`$0`8```````!````I($` M````;6UR9BTR,#$U,#DS,"YX;6Q55`4``]A*2E9U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#`@W!'XIN6U2T3```"VP``%0`8```````!````I(%_O0`` M;6UR9BTR,#$U,#DS,%]C86PN>&UL550%``/82DI6=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`P(-P1ZU=@?/[&```#%@!`!4`&````````0```*2!^]`` M`&UM`Q0````(`,"#<$>J5I/\\5(``$+-!``5`!@```````$```"D@47J M``!M;7)F+3(P,34P.3,P7VQA8BYX;6Q55`4``]A*2E9U>`L``00E#@``!#D! M``!02P$"'@,4````"`#`@W!'64T?X60R```"30,`%0`8```````!````I(&% M/0$`;6UR9BTR,#$U,#DS,%]P&UL550%``/82DI6=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`P(-P1V/N8]N?$P``9](``!$`&````````0```*2! M.'`!`&UM'-D550%``/82DI6=7@+``$$)0X```0Y`0`` 64$L%!@`````&``8`&@(``"*$`0`````` ` end XML 58 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814
Notes Payable (Details) - USD ($)
9 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Notes payable consisted of the following:    
Short-term debt $ 369,410 $ 360,343
Related party short-term debt $ 253,664 253,664
Severance Package Notes    
Notes payable consisted of the following:    
Short-term Debt, Terms

Promissory notes payable due to the former officers of MMRGlobal as part of severance packages, due in full on August 31, 2009 with no stated interest

 

 

 

 
Short-term debt $ 76,783 76,783
Resignation and Post-Merger Employment Arrangement Notes    
Notes payable consisted of the following:    
Short-term Debt, Terms

Promissory notes payable due to the former officers of
MMRGlobal pursuant to the Resignation and Post-Merger Employment
Arrangement, due in full on August 31, 2009 with no stated interest

 
Short-term debt $ 25,444 25,444
Notes Payable - Vendors    
Notes payable consisted of the following:    
Short-term Debt, Terms

Promissory notes payable due to vendors relating to settlement of certain
outstanding accounts payable, payable in 18 equal monthly installments commencing
on July 27, 2009 and ending on January 27, 2011, with no stated interest

 
Short-term debt $ 223,116 223,116
Short Term Loan Two    
Notes payable consisted of the following:    
Short-term Debt, Terms

Short term loan due to a third-party with no stated interest

 

 

 
Short-term debt $ 44,067 35,000
Related Party One    
Notes payable consisted of the following:    
Short-term Debt, Terms

Short term loan due to a related-party, payable in full on
May 31, 2014 with 12% interest 

 

 

 

 
Related party short-term debt $ 50,000 50,000
Related Party Two    
Notes payable consisted of the following:    
Short-term Debt, Terms

Short term loan due to a related-party, payable in full on
January 2, 2014 with 12% interest 

 

 

 

 
Related party short-term debt $ 203,664 $ 203,664

XML 59 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814
COMMITMENTS AND CONTINGENCIES (Tables)
9 Months Ended
Sep. 30, 2015
Commitments And Contingencies Tables  
Schedule of Future Minimum Rental Payments for Operating and Capital Leases

Future minimum lease payments as of September 30, 2015, under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:

Year Ending     Operating     Capital
December 31,     Leases     Leases
             
     2015 (Remainder of)    $ 26,445    $ 13,221 
     2016      187,550      -  
     2017      206,305      -  
     2018 and there after     146,410      -  
      566,710      13,221 
     Less current portion      -       (13,221)
Total minimum lease payments    $ 566,710    $